FHIR IG analytics| Package | hl7.fhir.vn.core |
| Resource Type | CodeSystem |
| Id | CodeSystem-snomedct.json |
| FHIR Version | R4 |
| Source | https://build.fhir.org/ig/hl7vn/vn-core-ig/CodeSystem-snomedct.html |
| URL | http://snomed.info/sct |
| Version | 1.0.0 |
| Status | active |
| Date | 2026-05-21T02:34:35+00:00 |
| Name | SNOMED_CT |
| Title | SNOMED CT (all versions) |
| Realm | vn |
| Authority | hl7 |
| Description | SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO). |
| Copyright | © 2002-2016 International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO http://www.ihtsdo.org/snomed-ct/get-snomed-ct |
| Content | not-present |
| CodeSystem | ||
| csiro.fhir.au.smartforms#current | CVDRiskSCTSupplement | CVD Risk Smoking Status SNOMED CT Supplement for Aboriginal and Torres Strait Islander Health Check |
| csiro.fhir.au.smartforms#current | HealthChecksSCTSupplement | SNOMED CT Supplement for Aboriginal and Torres Strait Islander Health Check |
| ch.fhir.ig.ch-ekm#current | ch-ekm-snomed-language-supplement | CH EKM SNOMED CT Language Supplement (de/fr/it) |
| uz.dhp.integrations#current | screening-body-site-cs | Observed Body Site |
| dk.ehealth.sundhed.fhir.ig.core#current | supplement | SNOMED CT Code System Supplement |
| uz.dhp.core#current | action-participant-role-cs | Action Participant Role CS |
| uz.dhp.core#current | adverse-event-outcome-cs | AdverseEvent outcome translations |
| uz.dhp.core#current | body-site-cs | Body Site CS |
| uz.dhp.core#current | goal-outcome-cs | Goal Outcome translations |
| uz.dhp.core#current | recommendation-reason-cs | Immunization reason translations |
| uz.dhp.core#current | route-code-cs | Route of Administration translations |
| uz.dhp.core#current | target-disease-cs | Target Disease translations |
| de.medizininformatikinitiative.kerndatensatz.diagnose#2025.0.1 | mii-cs-diagnose-lebensphase-supplement-snomed | MII_CS_Diagnose_Lebensphase_Supplement_SNOMED |
| rki.demis.disease#2.2.3 | translationEvidence | Übersetzung Symptom und Manifestation |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-cs-kardio-supplement-snomedct | MII CS Kardio Supplement [SNOMED CT] |
| ConceptMap | ||
| hl7.fhir.us.davinci-hrex#current | CareTeamMember-NUCCFunction | SNOMED Care Team Member Function to NUCC Map |
| hl7.fhir.us.davinci-hrex#current | NUCC-CareTeamMemberFunction | NUCC to SNOMED Care Team Member Function Map |
| hl7.fhir.uv.omop#current | AllergySubstanceType | AllergyIntolerance substance codes to OMOP |
| hl7.fhir.uv.omop#current | ConditionConcepts | Clinical Findings codes to OMOP |
| us.co.bha-ig#current | BHAServiceIdentifierSnomedCTCM | BHA Service Identifier to US Core Condition Code ConceptMap |
| us.co.bha-ig#current | BHASexualOrientationCM | BHA Sexual Orientation ConceptMap |
| hl7.fhir.be.mycarenet#current | BeCMISOToothSnomedCT | BeCMISOToothSnomedCT |
| hl7.fhir.us.vrdr#current | CertifierTypesCM | CertifierTypes Concept Map |
| hl7.fhir.us.vrdr#current | ContributoryTobaccoUseCM | ContributoryTobaccoUse Concept Map |
| hl7.fhir.us.vrdr#current | MannerOfDeathCM | MannerOfDeath Concept Map |
| hl7.fhir.us.vrdr#current | MethodOfDispositionCM | MethodOfDisposition Concept Map |
| hl7.fhir.us.vrdr#current | PlaceOfDeathCM | PlaceOfDeath Concept Map |
| hl7.fhir.us.vrdr#current | TransportationIncidentRoleCM | TransportationIncidentRole Concept Map |
| ch.fhir.ig.ch-term#current | DocumentEntryClassCodeToDocumentEntryTypeCode | DocumentEntryClassCodeToDocumentEntryTypeCode |
| ch.fhir.ig.ch-term#current | HCProfessionalHCProfessionSpecialisationMap | HCProfessionalHCProfessionSpecialisationMap |
| ch.fhir.ig.ch-term#current | ch-vacd-immunoglobulin-targetdiseases-cm | ImmunGlobuline To TargetDisease Mapping |
| ch.fhir.ig.ch-term#current | ch-vacd-nuva-to-snomedct-cm | ConceptMap for mapping Nuva vaccine codes to SNOMED-CT vaccine codes |
| ch.fhir.ig.ch-term#current | ch-vacd-snomedct-to-nuva-cm | ConceptMap for mapping SNOMED-CT vaccine codes to Nuva vaccine codes |
| ch.fhir.ig.ch-term#current | ch-vacd-targetdiseases-vaccines-cm | TargetDisease To VaccineCode Mapping |
| ch.fhir.ig.ch-term#current | ch-vacd-vaccines-sct-sm-cm | Snomed CT VaccineCode To SwissMedic VaccineCode |
| ch.fhir.ig.ch-term#current | ch-vacd-vaccines-sct-targetdiseases-cm | Snomed CT VaccineCode To TargetDisease Mapping |
| ch.fhir.ig.ch-term#current | ch-vacd-vaccines-sl-targetdiseases-cm | Old Swiss vaccine codes To TargetDisease Mapping |
| ch.fhir.ig.ch-term#current | ch-vacd-vaccines-sm-sct-cm | Swissmedic VaccineCode To Snomed CT VaccineCode |
| ch.fhir.ig.ch-term#current | ch-vacd-vaccines-sm-targetdiseases-cm | Swissmedic vaccine codes To TargetDisease Mapping |
| ch.fhir.ig.ch-term#current | ch-vacd-vaccines-targetdiseases-cm | VaccineCode To TargetDisease Mapping |
| ch.fhir.ig.ch-term#current | documententry-confidentialitycode-to-fhir | DocumentEntry.confidentialityCode to FHIR mapping |
| hl7.fhir.us.vr-common-library#current | ConceptMapBirthAttendantTitlesVitalRecords | BirthAttendantTitles Concept Map |
| hl7.fhir.us.mcode#current | TG263CM | TG263 Concept Map |
| hl7.fhir.uv.ihe-sdc-ecc#current | conceptMapCAPex | Example CAP Concept Map of SNOMED to CAP eCP content identifiers |
| fhir.nwgenomics.nhs.uk#current | SampleBodySiteSCTtoISUBTYPE | Sample Body Site (SNOMED) to iGene Specimen Sub Type |
| fhir.nwgenomics.nhs.uk#current | SampleTypeSCTtoIGENE | Sample Type (SNOMED) to iGene Specimen Type |
| ch.fhir.ig.ch-elm#current | ch-elm-results-geno-to-component-code | CH ELM Results Genotype To Component Code |
| ch.fhir.ig.ch-elm#current | ch-elm-results-geno-to-component-interpretation-code | CH ELM Results Genotyping To Component Interpretation Code |
| ch.fhir.ig.ch-elm#current | ch-elm-results-geno-to-component-observation-profile | CH ELM Results Genotyping To Component Obersvation Profile |
| ch.fhir.ig.ch-elm#current | ch-elm-results-to-foph-patient-name-representation | CH ELM Results To FOPH Patient Name Representation |
| ch.fhir.ig.ch-elm#current | ch-elm-results-to-interpretation-code | CH ELM Results To Interpretation Code |
| hl7.fhir.uv.phr#current | symptom-pghd-to-snomedct | |
| hl7.fhir.uv.phr#current | symptom-snomedct-to-pghd | |
| tw.gov.mohw.nhi.pas#current | nhi-sct-body-site | 臺灣健保署身體部位代碼對應SNOMED CT |
| uz.dhp.integrations#current | dhis-observation-result-to-snomed | Tuberculosis Test Results to SNOMED CT |
| uz.dhp.integrations#current | dhis-tuberculosis-to-snomed | Tuberculosis Diagnoses to SNOMED CT |
| uz.dhp.integrations#current | screening-breast-finding-to-snomed | Breast Findings to SNOMED CT |
| uz.dhp.integrations#current | screening-cervical-cytology-to-snomed | Cervical Cytology Results to SNOMED CT |
| uz.dhp.integrations#current | screening-colposcopy-to-snomed | Colposcopy Results to SNOMED CT |
| uz.dhp.integrations#current | screening-hpv-to-snomed | HPV Results to SNOMED CT |
| uz.dhp.integrations#current | specimen-feature-type-to-snomed | Tuberculosis Specimen Feature Types to SNOMED CT |
| uz.dhp.integrations#current | specimen-type-conceptmap | Tuberculosis Specimen Types to SNOMED CT |
| dk.ehealth.sundhed.fhir.ig.core#current | activitydefinition-code-to-do-missing-measurement | Activitydefinition-code to do missing measurement |
| dk.ehealth.sundhed.fhir.ig.core#current | activitydefinition-code-to-do-reminder | Activitydefinition-code to do reminder |
| dk.ehealth.sundhed.fhir.ig.core#current | activitydefinition-code-to-measurement-resource-type | Activitydefinition-code to measurement resource type |
| dk.ehealth.sundhed.fhir.ig.core#current | activitydefinition-code-to-perform-sharing | Activitydefinition-code-to-perform-sharing |
| hl7.fhir.us.ccda#current | CF-AllergyIntoleranceCategory | CCDA to FHIR Allergy Intolerance Category |
| hl7.fhir.us.ccda#current | CF-AllergyIntoleranceType | CCDA to FHIR Allergy Intolerance Type |
| hl7.fhir.us.ccda#current | CF-AllergyStatus | C-CDA to FHIR Allergy Status |
| hl7.fhir.us.ccda#current | CF-NoKnownAllergies | C-CDA to FHIR No Known Allergies |
| hl7.fhir.us.ccda#current | CF-ProblemStatus | C-CDA Problem Status value to FHIR Condition clinicalStatus |
| hl7.fhir.us.ccda#current | CF-Severity | C-CDA Severity to FHIR Severity |
| hl7.fhir.us.ccda#current | FC-AllergyIntoleranceCategory | FHIR to CCDA Allergy Intolerance Category |
| hl7.fhir.us.ccda#current | FC-AllergyIntoleranceType | FHIR Allergy Intolerance Type to CCDA value |
| hl7.fhir.us.ccda#current | FC-AllergyStatus | FHIR to C-CDA Allergy Status |
| hl7.fhir.us.ccda#current | FC-ImmunizationRefusal | FHIR Immunization Status Reason to C-CDA Immunization Refusal |
| hl7.fhir.us.ccda#current | FC-ImmunizationSite | FHIR Immunization Site to C-CDA Immunization approachSiteCode |
| hl7.fhir.us.ccda#current | FC-NoKnownAllergies | FHIR to C-CDA No Known Allergies |
| hl7.fhir.us.ccda#current | FC-ProblemStatus | FHIR Condition clinicalStatus to C-CDA Problem Status value |
| hl7.fhir.us.ccda#current | FC-Severity | FHIR Severity to C-CDA Severity |
| uz.dhp.core#current | allergen-code-to-snomed | Allergen codes to SNOMED CT |
| uz.dhp.core#current | dmed-administration-route-to-dhp-sct-cm | DMED administration route codes To DHP/SNOMED administration route codes |
| uz.dhp.core#current | dmed-position-to-snomed-cm | DMED Position To SNOMED CT |
| uz.dhp.core#current | lab-methods-to-loinc | Laboratory methods codes to LOINC |
| uz.dhp.core#current | manifestations-to-snomed | Allergy manifestations to SNOMED CT |
| uz.dhp.core#current | reaction-type-conceptmap | Reaction Type codes to SNOMED CT |
| uz.dhp.core#current | snomed-to-ichi-procedures | SNOMED CT to ICHI Procedures example |
| uz.dhp.core#current | substance-to-snomed | Allergy substance to SNOMED CT |
| hl7.fhir.uv.v2mappings#current | table-hl70165-to-sct | Table HL70165 to Sct Map |
| hl7.fhir.uv.v2mappings#current | table-hl70276-to-sct | Table HL70276 to Sct Map |
| hl7.fhir.uv.v2mappings#current | table-hl70443-to-v3-participationtype | Table HL70443 to V3 ParticipationType Map |
| hl7.fhir.uv.v2mappings#current | table-hl70488-to-v2-0488 | Table HL70488 to V2 0488 Map |
| ng.gov.nphcda.immunization#current | NGVaccineLocal-to-SNOMED | Local Vaccine Codes → SNOMED CT |
| hl7.fhir.us.davinci-alerts#current | direct-alerts | Direct ADT to Da Vinci Alerts ConceptMap |
| tw.gov.mohw.twcore#current | health-professional-tw | 臺灣醫事司醫事人員類別代碼對應SNOMED CT及臺灣醫事司醫事人員類別 |
| tw.gov.mohw.twcore#current | medical-consultation-department-nhi-tw | 臺灣健保署就醫科別代碼對應SNOMED CT |
| tw.gov.mohw.twcore#current | medical-treatment-department-nhi-tw | 臺灣健保署診療科別代碼對應SNOMED CT |
| tw.gov.mohw.twcore#current | medication-path-tw | 臺灣健保署給藥途徑代碼對應SNOMED CT |
| kdlgoessct#current | KDL2snomed | KDL 2025 -> snomed |
| hl7.fhir.us.bfdr#current | BirthAttendantTitlesCM | BirthAttendantTitles Concept Map |
| hl7.fhir.us.bfdr#current | BirthDeliveryOccurredCM | BirthDeliveryOccurred Concept Map |
| hl7.fhir.us.bfdr#current | DeliveryRoutesCM | DeliveryRoutes Concept Map |
| hl7.fhir.us.bfdr#current | FetalDeathCauseOrConditionCM | FetalDeathCauseOrCondition Concept Map |
| hl7.fhir.us.bfdr#current | FetalDeathTimePointsCM | FetalDeathTimePoints Concept Map |
| hl7.fhir.us.bfdr#current | FetalPresentationCM | FetalPresentation Concept Map |
| hl7.fhir.us.bfdr#current | InfectionsDuringPregnancyLiveBirthCM | InfectionsDuringPregnancyLiveBirth Concept Map |
| hl7.fhir.us.bfdr#current | NewbornCongenitalAnomaliesCM | NewbornCongenitalAnomalies Concept Map |
| hl7.fhir.us.bfdr#current | PerformedNotPerformedPlannedCM | PerformedNotPerformedPlanned Concept Map |
| smart.who.int.immunizations#current | IMMZ.C.ConceptMap | ConceptMap to and from IMMZ.C DataElements |
| smart.who.int.immunizations#current | IMMZ.D.ConceptMap | ConceptMap to and from IMMZ.D DataElements |
| smart.who.int.immunizations#current | IMMZ.Z.ConceptMap | ConceptMap to and from IMMZ.Z DataElements |
| kbv.basis.terminology#1.9.0 | KBV_CM_Base_Terminology_Complete_German | KBV_CM_Base_Terminology_Complete_German |
| kbv.mio.laborbefund#1.0.0-update | KBV_CM_MIO_LAB_Overview | KBV_CM_MIO_LAB_Overview |
| ch.fhir.ig.ch-emed-epr.r4#3.0.0 | CHEMEDEPRAmountQuantityUnitCodeToCdTyp9 | CHEMEDEPRAmountQuantityUnitCode -> CdTyp9 |
| ch.fhir.ig.ch-emed-epr.r4#3.0.0 | CdTyp9ToCHEMEDEPRAmountQuantityUnitCode | CdTyp9 -> CHEMEDEPRAmountQuantityUnitCode |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | Alcoholgebruik-to-AlcoholGebruikStatusCodelijst | Alcoholgebruik-to-AlcoholGebruikStatusCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | Rookgedrag-to-TabakGebruikStatusCodelijst | Rookgedrag-to-TabakGebruikStatusCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | WerkelijkePlaatsBaring-to-ActEncounterCode | WerkelijkePlaatsBaring-to-ActEncounterCode |
| rki.demis.r4.core#1.23.2 | LOINCMaterialToSNOMEDMaterial | LOINCMaterialToSNOMEDMaterial |
| rki.demis.r4.core#1.23.2 | LOINCMethodToSNOMEDMethod | LOINCMethodToSNOMEDMethod |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-AllergySeverity-1 | Concept Map - Allergy Severity |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-AllergyVerificationStatus-1 | Concept Map - Allergy Verification Status |
| kbv.mio.emp#1.0.0-kommentierung.1 | KBV_CM_MIO_EMP_Overview | KBV_CM_MIO_EMP_Overview |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | DagdeelCodelijst-to-EventTiming | DagdeelCodelijst to EventTiming |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | WeekdagCodelijst-to-DaysOfWeek | WeekdagCodelijst to DaysOfWeek |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-cm-onko-krk-stoma-obds-sct | Mapping oBDS Stoma-Anzeichnung zu SNOMED CT |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | AllergieCategorieCodelijst-to-allergy-intolerance-category | HCIM AllergieCategorieCodelijst to allergy intolerance category |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | Condition-Clinical-Status-Codes-to-ProbleemStatusCodelijst | HCIM ProbleemStatusCodelijst to Condition Clinical Status Codes |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | ErnstCodelijst-to-AllergyIntoleranceSeverity | HCIM ErnstCodelijst to AllergyIntoleranceSeverity |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | InterpretatieVlaggenCodelijst-to-observation-interpretation | HCIM InterpretatieVlaggenCodelijst to Observation Interpretation Codes |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | MateVanKritiekZijnCodelijst-to-allergy-intolerance-criticality | HCIM MateVanKritiekZijnCodelijst to allergy-intolerance-criticality |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | OrderStatusCodelijst-to-RequestStatus | HCIM OrderStatusCodelijst to RequestStatus |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | PositieCodelijst-to-LOINC | HCIM PositieCodelijst to LOINC |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | ProbleemStatusCodelijst-to-Condition-Clinical-Status-Codes | HCIM ProbleemStatusCodelijst to Condition Clinical Status Codes |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | VerificatieStatusCodelijst-to-ConditionVerificationStatus | HCIM VerificatieStatusCodelijst-to-ConditionVerificationStatus |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | WeekdagCodelijst-to-days-of-week | HCIM WeekdagCodelijst-to-days-of-week |
| swiss.mednet.fhir#0.20.0 | mni-obs-bloodGroup-toSnomed | MedNet Interface (MNI) - Blood Group Observation SNOMED Mapping |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | CategorieCodelijst-to-AllergyIntoleranceCategory | CategorieCodelijst to AllergyIntoleranceCategory |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | VerwachtRisicoBijBlootstelling-to-AllergyIntoleranceCriticality | VerwachtRisicoBijBlootstelling to AllergyIntoleranceCriticality |
| kbv.mio.kh-entlassbrief#1.0.0-update | KBV_CM_MIO_KHE_Overview | KBV_CM_MIO_KHE_Overview |
| tw.cohesion.fhir.clinemr#1.0.0 | treatment-region-tw | 臺灣診療部位代碼對應SNOMED CT |
| who.ddcc#1.0.1 | lab-test-pathogen-snomed-to-icd11 | Lab Test - Result - Pathogen - Mapping SNOMED CT to ICD-11 |
| who.ddcc#1.0.1 | lab-test-qual-result-snomed-to-icd11 | Lab Test - Result - Mapping SNOMED CT to ICD-11 |
| who.ddcc#1.0.1 | vaccine-covid19-snomed-to-icd11 | Vaccine - COVID-19 - Mapping SNOMED to ICD-11 |
| who.ddcc#1.0.1 | who-ddcc-map-icd11-sct-agent-targeted | ConceptMap from ICD-11 to SNOMED CT for Agent Targeted |
| who.ddcc#1.0.1 | who-ddcc-map-icd11-sct-disease-targeted | ConceptMap from ICD-11 to SNOMED CT for Disease or Agent Targeted |
| who.ddcc#1.0.1 | who-ddcc-map-icd11-sct-test-result | ConceptMap from ICD-11 to SNOMED CT for Test Result |
| who.ddcc#1.0.1 | who-ddcc-map-icd11-sct-vaccines | ConceptMap from ICD-11 to SNOMED CT for Vaccines |
| who.ddcc#1.0.1 | who-ddcc-map-ichi-sct-specimen-origin | ConceptMap from ICHI to SNOMED CT for Specimen Origin |
| who.ddcc#1.0.1 | who-ddcc-map-ichi-sct-type-of-test | ConceptMap from ICHI to SNOMED CT for Type of Test |
| who.ddcc#1.0.1 | who-ddcc-map-loinc-sct-type-of-test | ConceptMap from LOINC to SNOMED CT for Type of Test |
| who.ddcc#1.0.1 | who-ddcc-map-sct-ichi-specimen-origin | ConceptMap from SNOMED CT to ICHI for Specimen Origin |
| il.core.fhir.r4#0.21.0 | il-core-diagnosis-role-to-snomed | IL Core Diagnosis Role to SNOMED CT |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-edqm-method-to-snomed | EDQM Administreringsmetod till Administreringsmetod |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-edqm-route-to-snomed | EDQM Administreringsväg till Administreringsväg |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-route-to-site | Administreringsväg till Administreringsställe |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-site-to-qualifier | Administreringsställe till Precisering av administreringsställe |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-rate-unit-to-ucum | Snomed CT Doseringshastighetsenhet till Doseringshastighetsenhet |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-unit-to-ucum | Snomed CT Dosenhet till Dosenhet |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-ucum-rate-unit-to-snomed | Doseringshastighetsenhet till Snomed CT Doseringshastighetsenhet |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-ucum-unit-to-snomed | Dosenhet till Snomed CT Dosenhet |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | AllergieCategorieCodelijst-to-AllergyIntoleranceCategory | AllergieCategorieCodelijst to AllergyIntoleranceCategory |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | InterpretatieVlaggenCodelijst-to-ObservationInterpretationCodes | InterpretatieVlaggenCodelijst to ObservationInterpretationCodes |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | MateVanKritiekZijnCodelijst-to-AllergyIntoleranceCriticality | MateVanKritiekZijnCodelijst to AllergyIntoleranceCriticality |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | ProbleemStatusCodelijst-to-ConditionClinicalStatusCodes | ProbleemStatusCodelijst to ConditionClinicalStatusCodes |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-cm-biobank-fixation-type-sprec-sct | MII CM Biobank Fixation Type SPREC 4.0 SCT |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-cm-biobank-long-term-storage-sprec-sct | SPREC 4.0 Long-Term Storage Mapping |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-cm-biobank-primary-container-sprec-sct | SPREC 4.0 Primary Container Mapping |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-cm-biobank-sample-type-sprec-sct | SPREC 4.0 Sample Type Mapping |
| de.medizininformatikinitiative.kerndatensatz.mtb#2026.0.1 | mii-cm-mtb-therapiestatusgrund-sct | MII CM MTB Therapiestatusgrund SNOMED CT Mapping |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_CM_MIO_ULB_Overview | KBV_CM_MIO_ULB_Overview |
| ehealth4u.package#1.0.0 | cyehr-cm-allergyreactionseverity-snomed2hl7fhir | Cyprus EHR Concept Map: Allergy Reaction Severity - Snomed to HL7 FHIR |
| ehealth4u.package#1.0.0 | cyehr-cm-allergytype-snomed2hl7fhir | Cyprus EHR Concept Map: Allergy Type - Snomed to HL7 FHIR |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-chromosomal-sex | Genomics Chromosomal Sex |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-laterality-of-hearingloss | Genomics Laterality of Hearing Loss |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-condition-liquidtumourtype | Genomics Condition Liquid Tumour Type |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-condition-pancreatictumourtype | Genomics Condition Pancreatic Tumour Type |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-condition-pituitarytumourtype | Genomics Condition Pituitary Tumour Type |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-condition-solidtumourtype | Genomics Condition Solid Tumour Type |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-fetal-maternal-screening-genotype | Genomics Fetal Maternal Screening Genotype |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-patientpregnancytype | Genomics Patient Pregnancy Type |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-procedure-transfusiontype | Genomics Procedure Transfusion Type |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-risk-reason-for-specimen-specialhandling | Genomics Risk Reason for Specimen Special Handling |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-finalsample | Genomics Final Sample |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-primarysample | Genomics Primary Sample |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-samplepreparation | Genomics Sample Preparation |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-specimen-tumourcellularity | Genomics Specimen Tumour Cellularity |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-typeof-transplantprocedure | Genomics Type of Transplant Procedure |
| ch.fhir.ig.ch-epr-term#2.0.10 | DocumentEntryClassCodeToDocumentEntryTypeCode | DocumentEntryClassCodeToDocumentEntryTypeCode |
| ch.fhir.ig.ch-epr-term#2.0.10 | HCProfessionalHCProfessionSpecialisationMap | HCProfessionalHCProfessionSpecialisationMap |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-AllergySeverity-1 | Concept Map - Allergy Severity |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-AllergyVerificationStatus-1 | Concept Map - Allergy Verification Status |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ConditionEpisodicity-1 | Concept Map - Condition Episodicity |
| nictiz.fhir.nl.r4.labexchange#4.0.0-beta.2 | AanvraagStatusCodelijst-to-RequestStatus | AanvraagStatusCodelijst to RequestStatus |
| kbv.mio.diga#1.1.0 | KBV_CM_MIO_DIGA_Overview | KBV_CM_MIO_DIGA_Overview |
| StructureDefinition | ||
| ee.fhir.vris#current | ee-vris-observation-attempting-to-concieve | Observation: EE VRIS Attempting to Concieve |
| ee.fhir.vris#current | ee-vris-observation-blood-group | Observation: EE VRIS Blood Group |
| hl7.fhir.in#1.0.0 | MedicationRequest | MedicationRequest |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ITK-DM-ApplianceUseReview-Composition-1 | CareConnect-ITK-DM-ApplianceUseReview-Composition-1 |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ITK-DM-EmergencySupply-Composition-1 | CareConnect-ITK-DM-EmergencySupply-Composition-1 |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ITK-DM-Immunization-Composition-1 | CareConnect-ITK-DM-Immunization-Composition-1 |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ITK-DM-MedicationReview-Composition-1 | CareConnect-ITK-DM-MedicationReview-Composition-1 |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ITK-DM-NewMedicineService-Composition-1 | CareConnect-ITK-DM-NewMedicineService-Composition-1 |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ITK-ECD-Composition-1 | Electronic Discharge Composition |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ITK-EDIS-Composition-1 | Electronic Discharge Composition |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ITK-MH-Composition-1 | Mental Health Electronic Discharge Composition |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ITK-OPL-Composition-1 | Outpatient Letter Composition |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-NEWS2-Observation-1 | CareConnect-NEWS2-Observation-1 |
| nhsdigital.fhir.stu3#1.3.0 | NDOP-Consent-1 | NDOP-Consent-1.xml |
| nhsdigital.fhir.stu3#1.3.0 | eRS-ServiceSearchCriteria-Parameters-1 | eRS-ServiceSearchCriteria-Parameters-1 |
| rki.emiga.case#0.3.0-alpha.6 | CaseComposition | Fall |
| telus.dw.emr.extract#1.0.0 | DwProcedure | DwProcedure |
| rki.emiga.outbreak#0.1.4 | OutbreakComposition | OutbreakComposition |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ACVPU-Observation-1 | CareConnect-ACVPU-Observation-1 |
| ValueSet | ||
| fhir.rehabig#current | VSBodyStructure | 身體部位與結構對應之Snomed CT 代碼 |
| fhir.rehabig#current | assessment-side-valueset | 評估側別選項 |
| hl7.fhir.us.cardio.ig#current | AnginaObservationVS | Nivel de angina presentado por el paciente |
| hl7.fhir.us.cardio.ig#current | BallonCounterpulsationVS | Observación de balón en perfusón |
| hl7.fhir.us.cardio.ig#current | CardioplegiaInfusionModeVS | Observación del modo de infución de cardioplegía en perfusión |
| hl7.fhir.us.cardio.ig#current | CardioplegiaRhytmVS | Observación del ritmo de cardioplegía en perfusión |
| hl7.fhir.us.cardio.ig#current | CirculatoryObservationVS | Códigos para la perfusión |
| hl7.fhir.us.cardio.ig#current | DiagnosticsResultVS | Observación de diagnósticos |
| hl7.fhir.us.cardio.ig#current | EjectionFractionVS | Fracción de eyección |
| hl7.fhir.us.cardio.ig#current | EndocarditisInfecciosaVS | Valores aceptados para endocarditis infecciosa. |
| hl7.fhir.us.cardio.ig#current | ImplantTypeVS | Tipos de implantes. |
| hl7.fhir.us.cardio.ig#current | MyocardialProtectionVS | Protección miocardial. |
| hl7.fhir.us.cardio.ig#current | PerfusionTemperatureVS | Valor de la temperatura de perfusión. |
| hl7.fhir.us.cardio.ig#current | ReasonForBallonUsageVS | Razón de uso balón |
| hl7.fhir.us.cardio.ig#current | RightCavitiesVS | Cavidad derecha |
| hl7.fhir.us.cardio.ig#current | SmokingConditionVS | Historial fumador |
| hl7.fhir.us.cardio.ig#current | ValveInsuficiencyVS | Códigos para indicar si existe insuficiencia de válvula. |
| hl7.fhir.us.cardio.ig#current | ValvesVS | Códigos para las intervenciones previas. |
| hl7.fhir.us.cardio.ig#current | VenousCannulationsVS | Códigos para la canulación venosa |
| de.fhir.sterbefall-krebsregistermeldung#current | StfObservationCodes | STF Observation Codes |
| hl7.fhir.us.pco#current | goal-barrier-codes | Goal Barrier Assessment Codes |
| hl7.fhir.us.pco#current | pco-goal-barrier-types-example-vs | Goal Barrier Types Example |
| hl7.fhir.us.pco#current | what-matters-codes-example | What Matters Codes Example |
| hl7.fhir.uv.lab-report#current | laterality-uv-lab | Body Structure Laterality |
| hl7.fhir.uv.lab-report#current | siteQualifier-uv-lab | Body Structure Qualifier |
| hl7.fhir.uv.lab-report#current | specialty-uv-lab | Laboratory Specialty |
| hl7.fhir.uv.lab-report#current | speciesType-uv-lab | Types of species |
| hl7.fhir.uv.lab-report#current | specimenAdditive-uv-lab | Specimen Additive |
| hl7.fhir.uv.lab-report#current | specimenContainer-uv-lab | Specimen Container |
| hl7.fhir.uv.lab-report#current | specimenType-uv-lab | Specimen Types |
| hl7.fhir.uv.lab-report#current | technique-uv-lab | Laboratory Techniques |
| hl7.fhir.uv.immunization-incubator#current | immunization-recommendation-reason | Immunization Recommendation Reason Codes |
| hl7.cda.us.eyecare#current | AidToVisionCodes | Aid to Vision Codes |
| hl7.cda.us.eyecare#current | DiagnosticAssessmentEyeTestCodes | Diagnostic Assessment Eye Test Value Set |
| hl7.cda.us.eyecare#current | EyecareTargetSiteCodes | Eyecare Target Site Codes |
| hl7.cda.us.eyecare#current | PosteriorSegmentObservationCodes | Posterior Segment Observation Codes |
| hl7.cda.us.eyecare#current | PosteriorSegmentOrganizerCodes | Posterior Segment Organizer Codes |
| hl7.cda.us.eyecare#current | RefractionMethodCodes | Refraction Method Codes |
| hl7.cda.us.eyecare#current | RefractionObservationCodes | Refraction Observation Codes |
| hl7.cda.us.eyecare#current | VisualAcuityMethodCodes | Visual Acuity Method Codes |
| hl7.cda.us.eyecare#current | VisualAcuityObservationCodes | Visual Acuity Observation Codes |
| hl7.cda.us.eyecare#current | VisualAcuityOrganizerCodes | Visual Acuity Organizer Codes |
| hl7.fhir.be.core-clinical#current | be-vs-device-type | Device Type Value Set |
| hl7.fhir.be.core-clinical#current | ProblemDiseaseCourseVS | Condition Disease Course Value Set |
| hl7.fhir.be.core-clinical#current | be-vs-body-topography | BeVSBodyTopography |
| hl7.fhir.be.core-clinical#current | be-vs-bodysite | Body Site |
| hl7.fhir.be.core-clinical#current | be-vs-laterality | Laterality |
| hl7.fhir.be.core-clinical#current | be-vs-reaction-manifestation-code | Reaction Manifestation Code |
| hl7.fhir.be.core-clinical#current | be-vs-score | Score Value Set |
| hl7.fhir.be.core-clinical#current | be-vs-severity | Severity |
| tw.iii.ltc#current | ConditionSeverityVS-TWLTC | 疾病嚴重度擴展值集 |
| tw.iii.ltc#current | ExerciseHistoryVS-Sport | 身體活動量測-最近(目前)運動史值集 |
| tw.iii.ltc#current | GaitTypeVS-Sport | 身體活動量測-步態分析值集 |
| tw.iii.ltc#current | GoalDescriptionVS-TWLTC | 照顧目標描述值集 |
| tw.iii.ltc#current | ServiceRequestPAVS-Sport | 身體活動量測-適用運動處方之服務請求代碼值集 |
| tw.iii.ltc#current | TreadmillTypeVS-Sport | 身體活動量測-跑步機類型值集 |
| hl7.fhir.ca.baseline#current | encountertype | Encounter Type |
| hl7.fhir.ca.baseline#current | ethnicitycode | EthnicityCode |
| ans.fhir.fr.eprescription#current | fr-treatment-intent | French overall intention of the treatment |
| fhir.kisumuhie#current | KCHIPDiagnosisVS | KCHIP Pregnancy Diagnoses |
| fhir.kisumuhie#current | MNCHConditionCodeVS | MNCH Condition Codes |
| fhir.kisumuhie#current | MNCHConditionSeverityVS | MNCH Condition Severity |
| hl7.fhir.uv.ae-research-backport-ig#current | adverse-event-contributing-factor-vs | AdverseEvent Contributing Factor |
| hl7.fhir.uv.ae-research-backport-ig#current | adverse-event-mitigating-action-vs | AdverseEvent Mitigating Action |
| hl7.fhir.uv.ae-research-backport-ig#current | adverse-event-supporting-info | AdverseEvent Supporting Information |
| hl7.fhir.uv.ae-research-backport-ig#current | adverse-event-type-vs | AdverseEvent Type |
| hl7.fhir.be.medication#current | BeMedicationExposureIntentVS | Medication exposure intent |
| hl7.fhir.be.medication#current | BeRouteOfAdministrationVS | Route of Administration ValueSet |
| hl7.fhir.uv.shc-vaccination#current | SnomedVaccineCodes | SNOMED CT vaccine codes |
| hl7.fhir.uv.shc-vaccination#current | lab-qualitative-result | Qualitative infectious disease-related lab test result codes |
| hl7.fhir.uv.shc-vaccination#current | lab-result-findings | Lab result findings (SNOMED CT) |
| hl7.fhir.uv.shc-vaccination#current | specimen-collection-supervision-status | Specimen Collection Supervision Status |
| hl7.fhir.be.mycarenet#current | be-vs-basic-laterality | Basic Laterality |
| hl7.fhir.be.mycarenet#current | be-vs-toothnumber-bodysite | Tooth Number Body Site |
| ihe.iti.scheduling#current | sct-services | IHE ITI Scheduling Snomed CT Services |
| ihe.iti.scheduling#current | specialty | IHE ITI Scheduling Specialties |
| hl7.fhir.us.vrdr#current | vrdr-certifier-types-vs | Certifier Types Value Set |
| hl7.fhir.us.vrdr#current | vrdr-contributory-tobacco-use-vs | Contributory Tobacco Use ValueSet |
| hl7.fhir.us.vrdr#current | vrdr-death-certification-event-max-vs | Event Code for Death Certificate Composition - Max |
| hl7.fhir.us.vrdr#current | vrdr-death-certification-event-vs | Event Code for Death Certificate Composition |
| hl7.fhir.us.vrdr#current | vrdr-manner-of-death-vs | Manner of Death ValueSet |
| hl7.fhir.us.vrdr#current | vrdr-method-of-disposition-vs | Method of Disposition ValueSet |
| hl7.fhir.us.vrdr#current | vrdr-place-of-death-vs | Place of Death ValueSet |
| hl7.fhir.us.vrdr#current | vrdr-transportation-incident-role-vs | Transportation Incident Role ValueSet |
| ihe.pcc.pscc#current | HealthStatus.Value.VS | Health Status Value |
| ihe.pcc.pscc#current | Payer.Role.Codes.VS | Payer Role Codes |
| ihe.pcc.pscc#current | ProblemStatusObservation.Value.VS | Problem Status Observation Value |
| hl7.fhir.cl.clcore#current | cl-core-tipo-especimen-vs | Set de Valores de los Tipos de Especimen |
| hl7.fhir.cz.lab#current | cz-lab-clinically-relevant-time-VS | ValueSet - Clinically Relevant Time |
| hl7.fhir.cz.lab#current | cz-lab-container-types-VS | Laboratory Container Types (CZ) |
| hl7.fhir.cz.lab#current | cz-lab-speciality-types-VS | Laboratory Speciality Types (CZ) |
| hl7.fhir.cz.lab#current | cz-lab-technique-vs | Laboratory Techniques |
| tewhatuora.fhir.nzps#current | vaping-status | Vaping Status |
| lt.hl7.fhir.cervical#current | cervical-biopsy-quadrant | Cervical Biopsy Quadrant |
| lt.hl7.fhir.cervical#current | cervical-biopsy-site | Cervical Biopsy Site (LT Cervical) |
| lt.hl7.fhir.cervical#current | cervical-cytology-test-type | Cervical Cytology Test Types |
| lt.hl7.fhir.cervical#current | cervical-histological-grade | Cervical Histological Grade |
| lt.hl7.fhir.cervical#current | cervical-histopathology-diagnosis | Cervical Histopathology Diagnosis |
| lt.hl7.fhir.cervical#current | cervical-microflora | Cervical Microflora |
| lt.hl7.fhir.cervical#current | cervical-pathogen | Cervical Pathogen |
| lt.hl7.fhir.cervical#current | cervical-sample-collection-site | Cervical Sample Collection Site (LT Cervical) |
| lt.hl7.fhir.cervical#current | cervical-surgical-margins | Cervical Surgical Margins |
| lt.hl7.fhir.cervical#current | cervical-tnm-pr | Cervical TNM pR Stage |
| lt.hl7.fhir.cervical#current | cervical-tnm-pt | Cervical TNM pT Stage [RETIRED] |
| lt.hl7.fhir.cervical#current | colposcopy-adequacy | Colposcopy Adequacy (LT Cervical) |
| lt.hl7.fhir.cervical#current | colposcopy-procedure-type | Colposcopy-related Procedures (LT Cervical) |
| lt.hl7.fhir.cervical#current | colposcopy-swede-risk | Colposcopy Swede Score Risk Category (LT Cervical) |
| lt.hl7.fhir.cervical#current | cytology-conclusion | Cervix - Cytology Conclusion (LT Cervical) |
| lt.hl7.fhir.cervical#current | cytology-preparation-method | Cervix - Cytology Preparation Method (LT Cervical) |
| lt.hl7.fhir.cervical#current | hpv-genotype | Cervix - HPV Genotypes (LT Cervical) |
| lt.hl7.fhir.cervical#current | hpv-test-result | Cervix - HPV Test Result (LT Cervical) |
| lt.hl7.fhir.cervical#current | hpv-vaccination-status | HPV Vaccination Status (LT Cervical) |
| lt.hl7.fhir.cervical#current | yes-no-unknown | Yes / No / Unknown (SNOMED CT) (LT Cervical) |
| lt.hl7.fhir.base#current | finding-evolution | Finding Evolution |
| ch.fhir.ig.ch-term#current | ActivePharmaceuticalIngredient | ActivePharmaceuticalIngredient |
| ch.fhir.ig.ch-term#current | CHAllergyIntoleranceConditionValueSet | CH AllergyIntolerance Condition |
| ch.fhir.ig.ch-term#current | CHAllergyIntoleranceReactionManifestationValueSet | CH AllergyIntolerance Reaction Manifestation |
| ch.fhir.ig.ch-term#current | CHAllergyIntoleranceReactionSubstanceValueSet | CH AllergyIntolerance Reaction Substance |
| ch.fhir.ig.ch-term#current | CHAllergyIntoleranceValueSet | CH AllergyIntolerance |
| ch.fhir.ig.ch-term#current | DocumentEntry.classCode | DocumentEntry.classCode |
| ch.fhir.ig.ch-term#current | DocumentEntry.confidentialityCode | DocumentEntry.confidentialityCode |
| ch.fhir.ig.ch-term#current | DocumentEntry.healthcareFacilityTypeCode | DocumentEntry.healthcareFacilityTypeCode |
| ch.fhir.ig.ch-term#current | DocumentEntry.practiceSettingCode | DocumentEntry.practiceSettingCode |
| ch.fhir.ig.ch-term#current | DocumentEntry.typeCode | DocumentEntry.typeCode |
| ch.fhir.ig.ch-term#current | HCProfessional.hcProfession | HCProfessional.hcProfession |
| ch.fhir.ig.ch-term#current | SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode |
| ch.fhir.ig.ch-term#current | UnitCode | UnitCode |
| ch.fhir.ig.ch-term#current | ch-vacd-ch-vaccination-plan-immunizations-vs | CH VACD Swiss Vaccination Plan Immunizations |
| ch.fhir.ig.ch-term#current | ch-vacd-recommendation-categories-vs | CH VACD Recommendation Categories for Immunizations |
| ch.fhir.ig.ch-term#current | ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs | CH VACD Target disease and illnesses undergone for immunization |
| ch.fhir.ig.ch-term#current | ch-vacd-vaccines-snomedct-vs | CH VACD Snomed CT for VaccineCode |
| ch.fhir.ig.ch-term#current | ch-vacd-vaccines-vs | CH VACD All Swiss Vaccine Codes |
| ch.fhir.ig.ch-term#current | snomedct-concept-viraldiseases-vs | Snomed CT Concept Viral Diseases |
| ch.fhir.ig.ch-term#current | treatmentreason | Treatment Reason |
| hl7.fhir.uv.cqm#current | chronic-liver-disease-legacy-example | Chronic Liver Disease Legacy Example |
| hl7.fhir.eu.base-r5#current | medicalTestResult-eu | Medical Test Result Code |
| hl7.fhir.eu.base-r5#current | medicationIntendedUse-eu | Medication Intended Use |
| hl7.fhir.eu.base-r5#current | periodsOfLife-eu | Periods of Life |
| hl7.fhir.eu.base-r5#current | siteLaterality-eu | Body Structure Laterality |
| hl7.fhir.eu.base-r5#current | siteQualifier-eu | Body Structure Qualifier |
| hl7.fhir.eu.base-r5#current | speciesType-eu | Types of species |
| hl7.fhir.dk.hackathons#current | ActivityCodes | ObservationCodes |
| hl7.fhir.dk.hackathons#current | ObservationCodesSCT | ObservationCodesSCT |
| medcom.fhir.dk.document#current | MedCom-ihe-core-HealthcareFacilityTypeCode-VS-TEMP | IHE HealthcareFacilityTypeCode_TEMP |
| medcom.fhir.dk.document#current | MedCom-ihe-core-PracticeSettingCode-VS-TEMP | IHE PracticeSettingCode_TEMP |
| medcom.fhir.dk.document#current | MedCom-ihe-core-typecode-VS-TEMP | IHE TypeCode_TEMP |
| ch.fhir.ig.ch-vacd#current | ch-vacd-immunization-allergyintolerances-vs | Allergies and Intolerance values for Immunization |
| ch.fhir.ig.ch-vacd#current | ch-vacd-risks-medical-vs | Swiss Medical Risks For Immunizations |
| ch.fhir.ig.ch-vacd#current | ch-vacd-risks-occupation-vs | Swiss Occupation Risks For Immunizations |
| ch.fhir.ig.ch-vacd#current | ch-vacd-risks-preillness-vs | Swiss Preillness Risks For Immunizations |
| ch.fhir.ig.ch-vacd#current | ch-vacd-risks-social-vs | Swiss Social Risks For Immunizations |
| ch.fhir.ig.ch-vacd#current | ch-vacd-travel-code-vs | CH VACD Travel Information Code |
| ch.fhir.ig.ch-vacd#current | ch-vacd-verification-status-vs | Verification Status Codes |
| hl7.fhir.cz.terminology#current | condition-cz | Condition Value Set |
| hl7.fhir.cz.terminology#current | cz-sitequalifier | Body Structure Qualifier |
| hl7.fhir.cz.terminology#current | cz-specimen-laterality | Body Structure Laterality for specimen. |
| hl7.fhir.cz.terminology#current | cz-specimenAdditive | Specimen Additive |
| hl7.fhir.cz.terminology#current | cz-specimencontainer | Specimen Container |
| hl7.fhir.cz.terminology#current | eHDSIAllergenNoDrug | eHDSI Allergen No Drug |
| hl7.fhir.cz.terminology#current | eHDSIReactionAllergy | eHDSI Reaction Allergy |
| hl7.fhir.cz.terminology#current | lab-specimenType | Materiál vzorků |
| hl7.fhir.cz.terminology#current | medical-device | Medical Device |
| hl7.fhir.cz.terminology#current | medical-test-code | Medical Test Result Code |
| hl7.fhir.cz.terminology#current | referralorder-types | Typy žádanek |
| hl7.fhir.cz.terminology#current | registering-provider-service-type-cz | Registering Provider Service Type (CZ) |
| hl7.fhir.us.vr-common-library#current | ValueSet-birth-attendant-titles-vr | Value Set - Birth Attendants Titles Vital Records |
| hl7.at.fhir.elga.ediag.r4#current | at-ediag-allergyintolerance-codes | AT e-Diagnose AllergyIntolerance Value Set |
| hl7.at.fhir.elga.ediag.r4#current | at-ediag-diagnosen-codes | AT e-Diagnose Diagnosen Value Set |
| hl7.at.fhir.elga.ediag.r4#current | at-ediag-prozeduren-codes | AT e-Diagnose Procedures Value Set |
| hl7.fhir.be.vaccination#current | be-vs-vaccination-bodysite | BeVSVaccinationBodySite |
| hl7.fhir.be.vaccination#current | be-vs-vaccination-reason-code | BeVSVaccinationReasonCode |
| hl7.fhir.be.vaccination#current | be-vs-vaccine-code | BeVSVaccineCode |
| bloodpressure#current | BodyPosition | Body Position |
| bloodpressure#current | MeasurementSetting | Measurement Setting value set |
| hl7.fhir.cr.terminology#current | cr-relationships-set | Códigos de Relación de Costa Rica |
| hl7.fhir.cr.terminology#current | cr-religions-set | Religiones de Costa Rica |
| be.fhir.pregnancy-status#current | be-pregnancy-status-vs | Pregnancy status value set (BE) |
| hl7.fhir.us.mcode#current | mcode-benign-uncertain-neoplasm-brain-cns-disorder-vs | Benign Neoplasm of Brain and CNS Disorder Value Set |
| hl7.fhir.us.mcode#current | mcode-body-location-and-laterality-qualifier-vs | Body Location and Laterality Qualifier Value Set |
| hl7.fhir.us.mcode#current | mcode-brachytherapy-high-dose-rate-electronic-technique-vs | Brachytherapy High Dose Rate Electronic Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-brachytherapy-high-dose-rate-technique-vs | Brachytherapy High Dose Rate Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-brachytherapy-low-dose-rate-temporary-technique-vs | Brachytherapy Low Dose Rate Temporary Radiation Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-brachytherapy-modality-vs | Brachytherapy Modality Value Set |
| hl7.fhir.us.mcode#current | mcode-brachytherapy-permanent-seeds-technique-vs | Brachytherapy Permanent Seeds Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-brachytherapy-pulsed-dose-rate-technique-vs | Brachytherapy Pulsed Dose Rate Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-brachytherapy-radiopharmaceutical-technique-vs | Brachytherapy Radiopharmaceutical Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-breslow-depth-stage-value-vs | Breslow Depth Stage Value Set |
| hl7.fhir.us.mcode#current | mcode-cancer-body-location-vs | Cancer Body Location Value Set |
| hl7.fhir.us.mcode#current | mcode-cancer-disease-status-evidence-type-vs | Cancer Disease Status Evidence Type Value Set |
| hl7.fhir.us.mcode#current | mcode-cancer-related-surgical-procedure-vs | Cancer-Related Surgical Procedure Value Set |
| hl7.fhir.us.mcode#current | mcode-cancer-stage-type-vs | Cancer Stage Type Value Set |
| hl7.fhir.us.mcode#current | mcode-cancer-stage-value-vs | Cancer Stage Value Set |
| hl7.fhir.us.mcode#current | mcode-cancer-staging-method-vs | Cancer Staging Method Value Set |
| hl7.fhir.us.mcode#current | mcode-cancer-staging-prognostic-factor-type-vs | Cancer Staging Prognostic Factors Types |
| hl7.fhir.us.mcode#current | mcode-cancer-staging-prognostic-factor-value-vs | Cancer Staging Prognostic Factors Value |
| hl7.fhir.us.mcode#current | mcode-carcinoma-in-situ-disorder-vs | Carcinoma In-Situ Disorder Value Set |
| hl7.fhir.us.mcode#current | mcode-clark-level-value-vs | Clark Level Value Set |
| hl7.fhir.us.mcode#current | mcode-clin-or-path-modifier-vs | Clinical or Pathologic Modifier |
| hl7.fhir.us.mcode#current | mcode-condition-status-trend-max-vs | Condition Status Trend Maximum Value Set |
| hl7.fhir.us.mcode#current | mcode-condition-status-trend-vs | Condition Status Trend Value Set |
| hl7.fhir.us.mcode#current | mcode-cytologic-evidence-malignancy-vs | Cytologic Evidence of Malignancy Value Set |
| hl7.fhir.us.mcode#current | mcode-fab-classification-value-vs | FAB Classification Value |
| hl7.fhir.us.mcode#current | mcode-figo-staging-method-vs | FIGO Staging Method Value Set |
| hl7.fhir.us.mcode#current | mcode-gleason-grade-group-value-vs | Gleason Grade Value Set |
| hl7.fhir.us.mcode#current | mcode-histologic-grade-vs | Histologic Grade Value Set |
| hl7.fhir.us.mcode#current | mcode-histologic-grading-system-vs | Histologic Grading System Value Set |
| hl7.fhir.us.mcode#current | mcode-histology-morphology-behavior-vs | Histology Morphology Behavior Value Set |
| hl7.fhir.us.mcode#current | mcode-history-of-metastatic-malignant-neoplasm-vs | History of Metastatic Malignant Neoplasm Value Set |
| hl7.fhir.us.mcode#current | mcode-hypereosinophilic-syndrome-disorder-vs | Specific Diagnosis of Cancer Value Set |
| hl7.fhir.us.mcode#current | mcode-laterality-qualifier-vs | Laterality Qualifier Value Set |
| hl7.fhir.us.mcode#current | mcode-lymphoma-stage-bulky-modifier-vs | Lymphoma Stage Bulky Modifier Value Set |
| hl7.fhir.us.mcode#current | mcode-lymphoma-stage-value-modifier-vs | Lymphoma Stage Value Modifier Value Set |
| hl7.fhir.us.mcode#current | mcode-lymphoma-stage-value-vs | Lymphoma Stage Value Set |
| hl7.fhir.us.mcode#current | mcode-lymphoma-staging-method-vs | Lymphoma Staging System Value Set |
| hl7.fhir.us.mcode#current | mcode-melanoma-in-situ-disorder-vs | Melanoma In-Situ Disorder Value Set |
| hl7.fhir.us.mcode#current | mcode-neuroblastoma-inss-value-vs | International Neuroblastoma Staging System (INSS) for Neuroblastoma Stage Value Set |
| hl7.fhir.us.mcode#current | mcode-normalization-basis-vs | Normalization Basis Value Set |
| hl7.fhir.us.mcode#current | mcode-primary-malignant-neoplasm-disorder-vs | Primary Malignant Neoplasm Disorder Value Set |
| hl7.fhir.us.mcode#current | mcode-procedure-intent-vs | Procedure Intent Value Set |
| hl7.fhir.us.mcode#current | mcode-radiotherapy-treatment-location-qualifier-vs | Radiotherapy Treatment Location Qualifier Value Set |
| hl7.fhir.us.mcode#current | mcode-radiotherapy-treatment-location-vs | Radiotherapy Treatment Location Value Set |
| hl7.fhir.us.mcode#current | mcode-radiotherapy-volume-type-vs | Radiotherapy Volume Type Value Set |
| hl7.fhir.us.mcode#current | mcode-rai-staging-method-vs | Rai Staging System Value Set |
| hl7.fhir.us.mcode#current | mcode-rhabdomyosarcoma-assessment-value-vs | Rhabdomyosarcoma Assessment Value Set |
| hl7.fhir.us.mcode#current | mcode-rhabdomyosarcoma-clinical-group-value-vs | Rhabdomyosarcoma Clinical Group Value |
| hl7.fhir.us.mcode#current | mcode-risk-assessment-vs | Risk Assessment Value Set |
| hl7.fhir.us.mcode#current | mcode-secondary-cancer-disorder-vs | Secondary Cancer Disorder Value Set |
| hl7.fhir.us.mcode#current | mcode-teleradiotherapy-carbon-ion-beam-technique-vs | Carbon Ion Beam Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-teleradiotherapy-electron-beam-technique-vs | Electron Beam Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-teleradiotherapy-modality-vs | Teleradiotherapy Modality Value Set |
| hl7.fhir.us.mcode#current | mcode-teleradiotherapy-neutron-beam-technique-vs | Neutron Beam Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-teleradiotherapy-photon-beam-technique-vs | Photon Beam Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-teleradiotherapy-proton-beam-technique-vs | Proton Beam Technique Value Set |
| hl7.fhir.us.mcode#current | mcode-tnm-distant-metastases-category-vs | TNM Distant Metastases Category Value Set |
| hl7.fhir.us.mcode#current | mcode-tnm-distant-metastases-staging-type-vs | TNM Distant Metastases Staging Type Value Set |
| hl7.fhir.us.mcode#current | mcode-tnm-primary-tumor-category-vs | TNM Primary Tumor Category Value Set |
| hl7.fhir.us.mcode#current | mcode-tnm-primary-tumor-staging-type-vs | TNM Primary Tumor Staging Type Value Set |
| hl7.fhir.us.mcode#current | mcode-tnm-regional-nodes-category-vs | TNM Regional Nodes Category Value Set |
| hl7.fhir.us.mcode#current | mcode-tnm-regional-nodes-staging-type-vs | TNM Regional Nodes Staging Type Value Set |
| hl7.fhir.us.mcode#current | mcode-tnm-stage-group-staging-type-vs | TNM Stage Group Staging Type Value Set |
| hl7.fhir.us.mcode#current | mcode-tnm-stage-group-vs | TNM Stage Group Value Set |
| hl7.fhir.us.mcode#current | mcode-tnm-staging-method-vs | TNM Staging Method Value Set |
| hl7.fhir.us.mcode#current | mcode-treatment-termination-reason-vs | Treatment Termination Reason Value Set |
| hl7.fhir.us.mcode#current | mcode-tumor-morphology-code-max-vs | Tumor Morphology Code Max Value Set |
| hl7.fhir.us.mcode#current | mcode-tumor-morphology-code-vs | Tumor Morphology Code Value Set |
| hl7.fhir.us.mcode#current | mcode-tumor-size-method-vs | Tumor Size Method Value Set |
| hl7.fhir.us.mcode#current | mcode-wilms-tumor-body-site-vsCOG | Wilms Tumor Body Site Value Set |
| hl7.fhir.us.mcode#current | mcode-wilms-tumor-stage-value-vs | Wilms Tumor Stage Value Set |
| hl7.fhir.be.patient-monitoring#current | YesNoVS | Yes / No Value Set |
| hl7.fhir.be.patient-monitoring#current | catheter-patency | Catheter Patency Scale |
| hl7.fhir.be.patient-monitoring#current | catheter-type | Catheter Type |
| hl7.fhir.be.patient-monitoring#current | heart-failure-symptoms | Heart Failure Symptom Codes |
| hl7.fhir.be.patient-monitoring#current | holter-event-codes | Holter Event Codes |
| hl7.fhir.be.patient-monitoring#current | homehosp-side-effect-severity | Home Hospitalization Side Effect Severity Scale |
| hl7.fhir.be.patient-monitoring#current | lumen-color | Catheter Lumen Color |
| hl7.fhir.be.patient-monitoring#current | medication-storage | Medication Storage Status |
| hl7.fhir.be.patient-monitoring#current | normal-abnormal | Normal / Abnormal Finding |
| hl7.fhir.be.patient-monitoring#current | onco-symptom-grade | ONCO Symptom Grade Scale (CTCAE 0–3) |
| hl7.fhir.be.patient-monitoring#current | symptom-severity | Symptom Severity Scale |
| hl7.fhir.be.patient-monitoring#current | true-false | True / False Value Set |
| hl7.fhir.be.terminology#current | BacterialCodes | Bacterial Codes |
| hl7.fhir.be.terminology#current | BeMedicationExposureIntentVS | Medication exposure intent |
| hl7.fhir.be.terminology#current | BeRouteOfAdministrationVS | Route of Administration ValueSet |
| hl7.fhir.be.terminology#current | BeVSPopulationScreeningFollowUpAdvice | Population Screening Follow-up Advice Value Set |
| hl7.fhir.be.terminology#current | CandidaCodes | Candida Codes |
| hl7.fhir.be.terminology#current | ChlamydiaCodes | Chlamydia Codes |
| hl7.fhir.be.terminology#current | CompromisedImmuneSystemCodes | CompromisedImmuneSystem Codes |
| hl7.fhir.be.terminology#current | GonokokCodes | Gonokok Codes |
| hl7.fhir.be.terminology#current | MycoplasmaCodes | Mycoplasma Codes |
| hl7.fhir.be.terminology#current | OncologyPatientCodes | OncologyPatient Codes |
| hl7.fhir.be.terminology#current | OtherCodes | Other Codes |
| hl7.fhir.be.terminology#current | PregnancyCodes | Pregnancy Codes |
| hl7.fhir.be.terminology#current | TrichomonasCodes | Trichomonas Codes |
| hl7.fhir.be.terminology#current | be-causativeagent | BeCausativeAgent |
| hl7.fhir.be.terminology#current | be-exposureroute | BeExposureRoute |
| hl7.fhir.be.terminology#current | be-noallergy | BeNoAllergy |
| hl7.fhir.be.terminology#current | be-populationscreening-result-vs | PopulationScreening Result Value Set |
| hl7.fhir.be.terminology#current | be-riskmanifestation | BeRiskManifestation |
| hl7.fhir.be.terminology#current | be-vs-allergyintolerance-type | BeVSAllergyIntoleranceType |
| hl7.fhir.be.terminology#current | be-vs-annex-81-reason-code | BeVSAnnex81ReasonCode |
| hl7.fhir.be.terminology#current | be-vs-bodysite-nursing | Body Site |
| hl7.fhir.be.terminology#current | be-vs-laterality | Laterality |
| hl7.fhir.be.terminology#current | be-vs-patient-relationship-type | BeVSPatientRelationshipType |
| hl7.fhir.be.terminology#current | be-vs-patientwill-scope | BeVSPatientWillScope |
| hl7.fhir.be.terminology#current | be-vs-populationscreening-type | Population Screening Type Value Set |
| hl7.fhir.be.terminology#current | be-vs-reaction-manifestation-code | Reaction Manifestation Code |
| hl7.fhir.be.terminology#current | be-vs-referral-category | BeReferralCategory |
| hl7.fhir.be.terminology#current | be-vs-request-note-type | BeVSRequestNoteType |
| hl7.fhir.be.terminology#current | be-vs-requested-services-nurse-detail | BeVSRequestedServicesNurseDetail |
| hl7.fhir.be.terminology#current | be-vs-requested-services-nurse | BeVSRequestedServicesNurse |
| hl7.fhir.be.terminology#current | be-vs-score | Score Value Set |
| hl7.fhir.be.terminology#current | be-vspopulationscreening-body-site-location | PopulationScreening Body Site Value Set |
| hl7.fhir.uv.eyecare#current | body-site-eye | Ophthalmic anatomical location |
| hl7.fhir.uv.eyecare#current | conditions | Ophthalmology Condition ICD10 and SNOMED codes ValueSet |
| hl7.fhir.uv.eyecare#current | iop-methods | Intraocular pressure (IOP) method valueset |
| hl7.fhir.uv.eyecare#current | observable-entities | Ophthalmology observations (SNOMED) |
| hl7.fhir.uv.eyecare#current | observation-visual-acuity-methods | Visual acuity chart valueset (SNOMED) |
| hl7.fhir.uv.eyecare#current | observation-visual-acuity | Visual acuity method valueset (SNOMED) |
| hl7.fhir.uv.eyecare#current | observation-visual-field | Visual Field Observable Entities ValueSet |
| hl7.fhir.uv.eyecare#current | procedures | Ophthalmology Procedures Valueset |
| hl7.fhir.uv.eyecare#current | qualifiers | Ophthalmic anatomical location qualifiers |
| lt.hl7.fhir.lab#current | cervical-tumor-stage-n | Cervical Tumor Stage pN |
| lt.hl7.fhir.lab#current | cervical-tumor-stage-t | Cervical Tumor Stage pT |
| lt.hl7.fhir.lab#current | histological-grading | Histological Grading |
| lt.hl7.fhir.lab#current | pathology-procedure | Pathology Procedure |
| lt.hl7.fhir.lab#current | pathology-service | Pathology Service Code |
| lt.hl7.fhir.lab#current | perineural-invasion | Perineural Invasion |
| lt.hl7.fhir.lab#current | periprostatic-fat-invasion | Periprostatic Fat Invasion |
| lt.hl7.fhir.lab#current | prostate-tumor-stage-m | Prostate Tumor Stage M |
| lt.hl7.fhir.lab#current | prostate-tumor-stage-n | Prostate Tumor Stage N |
| lt.hl7.fhir.lab#current | prostate-tumor-stage-t | Prostate Tumor Stage T |
| lt.hl7.fhir.lab#current | sample-examination | Sample Examination Methods |
| lt.hl7.fhir.lab#current | seminal-vesicle-invasion | Seminal Vesicle Invasion |
| lt.hl7.fhir.lab#current | specimen-additive | Specimen Additive |
| lt.hl7.fhir.lab#current | specimen-adequacy | Specimen Adequacy Code |
| lt.hl7.fhir.lab#current | tumor-focality | Tumor Focality |
| lt.hl7.fhir.lab#current | tumor-type | Tumor Type |
| iknl.fhir.r4.pzp#current | ACP-ContactPersonRoleVS | ACP ContactPerson Role zib2024 backport |
| iknl.fhir.r4.pzp#current | ACP-MedicalDeviceProductType-ICDVS | ACP MedicalDevice ProductType ICD |
| iknl.fhir.r4.pzp#current | ACP-MedicalPolicyGoalVS | ACP Primary Agreed-upon Goal of Medical Policy Codes |
| iknl.fhir.r4.pzp#current | ACP-PositionRegardingEuthanasiaVS | ACP Position Regarding Euthanasia Codes |
| iknl.fhir.r4.pzp#current | ACP-PreferredPlaceOfDeathVS | ACP Preferred Place of Death Codes |
| iknl.fhir.r4.pzp#current | ACP-ProcedureTypeVS | ACP ProcedureType |
| iknl.fhir.r4.pzp#current | ACP-YesNoUnknownVS | ACP Yes, No, Unknown Codes |
| hl7.fhir.uv.order-catalog#current | example-clinical-focus | All possible clinical contexts for any lab test |
| hl7.fhir.uv.order-catalog#current | example-normal-contexts-vitamin-d | Reimbursement contexts for Vitamin D testing |
| hl7.fhir.uv.order-catalog#current | example-reasons-for-order | All Valid Reasons for Ordering a Lab Service |
| hl7.fhir.uv.vulcan-rwd#current | ExampleDialysisProcedureCodes | Diabetes Example Dialysis Test Codes |
| hl7.fhir.uv.vulcan-rwd#current | ExampleRespiratoryConditionCodes | Covid-19 Example Condition Codes |
| ch.fhir.ig.ch-umzh-connect#current | ch-umzh-connect-servicerequest-category | CH UMZH Connect ServiceRequest Category |
| hl7.fhir.cr.meddyg.laboratory-results#current | lab-test-method-codes | Códigos de Métodos de Pruebas de Laboratorio |
| hl7.fhir.cz.core#current | medicalTestResult-cz | Medical Test Result Code |
| fhir.nwgenomics.nhs.uk#current | GenomicDisorderCarrier | Genomic Disorder Carrier |
| fhir.nwgenomics.nhs.uk#current | GenomicFinding | Genomic Finding |
| fhir.nwgenomics.nhs.uk#current | GenomicFindingDetected | Genomic Finding Detected |
| fhir.nwgenomics.nhs.uk#current | Pregnancy | Pregnancy |
| fhir.nwgenomics.nhs.uk#current | ReportType | ReportType |
| fhir.nwgenomics.nhs.uk#current | document-entry-class | DocumentEntry Class |
| fhir.nwgenomics.nhs.uk#current | document-entry-type | DocumentEntry Type |
| fhir.nwgenomics.nhs.uk#current | order-category | Order Category |
| fhir.nwgenomics.nhs.uk#current | specimen-type | Specimen Type |
| hl7.fhir.us.vitals#current | BodyTempAssociatedSituationVS | Body Temperature Associated Situation value set |
| hl7.fhir.us.vitals#current | BodyWeightAssociatedSituationVS | Associated Situation value set |
| hl7.fhir.us.vitals#current | MeasSettingVS | Measurement Setting value set |
| hl7.fhir.us.vitals#current | bodyPositionVS | Body Position value set |
| hl7.fhir.us.vitals#current | bodyTempMeasBodyLocationPrecoordVS | Body Temperature Measurement Body Location value set |
| hl7.fhir.us.vitals#current | bodyTempMeasurementDeviceVS | Body Temperature Measurement Device value set |
| hl7.fhir.us.vitals#current | bpCuffSizeVS | Blood Pressure Cuff Size value set |
| hl7.fhir.us.vitals#current | bpMeasDeviceVS | Blood Pressure Measurement Device value set |
| hl7.fhir.us.vitals#current | bpMeasMethodVS | Blood Pressure Measurement Method value set |
| hl7.fhir.us.vitals#current | bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoordinated value set |
| hl7.fhir.us.vitals#current | definedLimitsVS | Defined Limits value set |
| hl7.fhir.us.vitals#current | exertionPhaseVS | Exertion Phase value set |
| hl7.fhir.us.vitals#current | heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set |
| hl7.fhir.us.vitals#current | heartRateMeasDeviceVS | Heart Rate Measurement Device value set |
| hl7.fhir.us.vitals#current | heartRateMeasMethodVS | Heart Rate Measurement Method value set |
| hl7.fhir.us.vitals#current | heightBodyPositionVS | Height Body Position value set |
| hl7.fhir.us.vitals#current | heightLengthMeasDeviceVS | Height Length Measurement Device value set |
| hl7.fhir.us.vitals#current | heightLengthMeasMethodVS | Height Length Measurement Method value set |
| hl7.fhir.us.vitals#current | respiratoryRateMeasDeviceVS | Respiratory Rate Measurement Device value set |
| hl7.fhir.us.vitals#current | respiratoryRateMeasMethodVS | Respiratory Rate Measurement Method value set |
| hl7.fhir.us.vitals#current | sPO2BodyLocationVS | Oxygen Saturation Body Location value set |
| hl7.fhir.us.vitals#current | sensorDescriptionVS | Sensor Description value set |
| hl7.fhir.us.vitals#current | sleepStatusVS | Sleep Status value set |
| hl7.fhir.us.vitals#current | weightMeasurementDeviceVS | Weight Measurement Device value set |
| ch.fhir.ig.ch-elm#current | ch-elm-interpretation-codes-avidity | CH ELM Interpretation Codes AVIDITY |
| ch.fhir.ig.ch-elm#current | ch-elm-interpretation-codes-sero | CH ELM Interpretation Codes SERO |
| ch.fhir.ig.ch-elm#current | ch-elm-lab-study-types | CH ELM Lab Study Types |
| ch.fhir.ig.ch-elm#current | ch-elm-results-bru-org | CH ELM Results Bru Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-camp-org | CH ELM Results Camp Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-chol-org | CH ELM Results Chol Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-cjd-org | CH ELM Results Cjd Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-coded-values-laboratory | CH ELM Results Coded Values Laboratory |
| ch.fhir.ig.ch-elm#current | ch-elm-results-complete-spec | CH ELM Results Complete Spec |
| ch.fhir.ig.ch-elm#current | ch-elm-results-component-hiv-recency | CH ELM Results HIV Recency |
| ch.fhir.ig.ch-elm#current | ch-elm-results-diph-org | CH ELM Results Diph Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-geni-spec | CH ELM Results Geni Spec |
| ch.fhir.ig.ch-elm#current | ch-elm-results-haem-org | CH ELM Results Haem Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-hanta-org | CH ELM Results Hanta Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-influenza-hxny-org | CH ELM Results Influenza Hxny Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-laboratory-observation-complete | CH ELM Results Laboratory Observation Complete |
| ch.fhir.ig.ch-elm#current | ch-elm-results-laboratory-observation-geno | CH ELM Results Laboratory Observation Genotyping |
| ch.fhir.ig.ch-elm#current | ch-elm-results-laboratory-observation | CH ELM Results Laboratory Observation |
| ch.fhir.ig.ch-elm#current | ch-elm-results-leg-org | CH ELM Results Leg Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-lis-org | CH ELM Results Lis Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-lis-spec | CH ELM Results Lis Spec |
| ch.fhir.ig.ch-elm#current | ch-elm-results-mal-org | CH ELM Results Mal Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-maldi-tof-org | CH ELM Results Maldi-tof Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-mea-org | CH ELM Results Mea Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-men-org | CH ELM Results Men Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-mpox-org | CH ELM Results Mpox Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-pneu-org | CH ELM Results Pneu Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-sal-org-complete | CH ELM Results Sal Org Complete |
| ch.fhir.ig.ch-elm#current | ch-elm-results-sal-org | CH ELM Results Sal Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-shi-nent-org | CH ELM Results Shi Nent Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-shi-org | CH ELM Results Shi Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-sterile-spec | CH ELM Results Sterile Spec |
| ch.fhir.ig.ch-elm#current | ch-elm-results-tub-org | CH ELM Results Tub Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-tul-org | CH ELM Results Tul Org |
| ch.fhir.ig.ch-elm#current | ch-elm-results-virus-cult-org | CH ELM Results Virus Cult Org |
| csiro.fhir.au.smartforms#current | CVDRiskCategory-1 | CVD Risk Category |
| csiro.fhir.au.smartforms#current | CVDRiskSmokingStatus-1 | CVD Risk Smoking Status |
| csiro.fhir.au.smartforms#current | CervicalScreeningStatus-1 | Cervical Screening Status |
| csiro.fhir.au.smartforms#current | SmokingQuitStatus-1 | Smoking Quit Status |
| csiro.fhir.au.smartforms#current | TobaccoUseStatus-1 | Tobacco Use Status |
| csiro.fhir.au.smartforms#current | amt-vaccine-1 | Australian Medicines Terminology Vaccine |
| csiro.fhir.au.smartforms#current | biological-sex-1 | Biological Sex |
| csiro.fhir.au.smartforms#current | clinical-condition-1 | Clinical Condition |
| csiro.fhir.au.smartforms#current | gender-identity-response-1 | Gender Identity Response |
| csiro.fhir.au.smartforms#current | heart-rhythm-1 | Heart Rhythm |
| csiro.fhir.au.smartforms#current | medication-reason-taken-1 | Medication Reason Taken |
| csiro.fhir.au.smartforms#current | smart-health-checks-medicine-products | Smart Health Checks Medicine Products |
| lt.hl7.fhir.colorectal#current | bbps-colon-segments | BBPS Colon Segments |
| lt.hl7.fhir.colorectal#current | bleeding-control-method | Bleeding Control Method |
| lt.hl7.fhir.colorectal#current | bowel-prep-score-values | Bowel Preparation Score Values (Boston Scale) |
| lt.hl7.fhir.colorectal#current | bowel-preparation-quality | Bowel Preparation Quality |
| lt.hl7.fhir.colorectal#current | bowel-preparation-substance | Bowel Preparation Substances |
| lt.hl7.fhir.colorectal#current | colonoscope-reach | Colonoscope Reach |
| lt.hl7.fhir.colorectal#current | colonoscopy-complication-presence | Colonoscopy Complication Presence |
| lt.hl7.fhir.colorectal#current | colonoscopy-complication-type | Colonoscopy Complication Type |
| lt.hl7.fhir.colorectal#current | colonoscopy-wall-injury-action | Colonoscopy Wall Injury Action |
| lt.hl7.fhir.colorectal#current | colorectal-anatomy | Colorectal Anatomy |
| lt.hl7.fhir.colorectal#current | colorectal-conclusion | Colorectal Conclusion |
| lt.hl7.fhir.colorectal#current | colorectal-histological-diagnosis | Colorectal Histological Diagnosis |
| lt.hl7.fhir.colorectal#current | degree-of-differentiation | Degree of Differentiation |
| lt.hl7.fhir.colorectal#current | dysplasia-grade | Dysplasia Grade |
| lt.hl7.fhir.colorectal#current | fecal-occult-blood-qualitative-result | FOBT Qualitative Result |
| lt.hl7.fhir.colorectal#current | intravascular-invasion | Intravascular Invasion |
| lt.hl7.fhir.colorectal#current | mmrp-expression | MMRP Expression Status |
| lt.hl7.fhir.colorectal#current | polyp-predicted-histology | Polyp Predicted Histology |
| lt.hl7.fhir.colorectal#current | polypectomy-method | Polypectomy Method |
| lt.hl7.fhir.colorectal#current | radicalism-of-removal | Radicalism of Removal |
| lt.hl7.fhir.colorectal#current | scc-grading | Squamous Cell Carcinoma Grading |
| lt.hl7.fhir.colorectal#current | yes-no | Colorectal - Yes/No VS |
| hl7.fhir.cz.order#current | ft-category-vs | FT Category ValueSet (CZ) |
| hl7.fhir.uv.pddi#current | valueset-Hx-UGIB-snomed | Upper gastrointestinal bleed Value Set |
| ihe.pcc.aps#current | Advance.Directives.VS | Advance Directives |
| ihe.pcc.aps#current | Antepartum.Education.VS | Antepartum Education |
| ihe.pcc.aps#current | Antepartum.Family.History.and.Genetic.Screening.VS | Antepartum Family History and Genetic Screening |
| ihe.pcc.aps#current | Antepartum.History.of.Infection.VS | Antepartum History of Infection |
| ihe.pcc.aps#current | Antepartum.History.of.Past.Illness.VS | Antepartum History of Past Illness |
| ihe.pcc.aps#current | Antepartum.Review.of.Systems.Menstrual.History.VS | Antepartum Review of Systems Menstrual History |
| ihe.pcc.aps#current | Smoking.Status.VS | Smoking Status |
| hl7.fhir.us.physical-activity#current | pa-diagnosticreport-category | PA ServiceRequest Category - USCore |
| hl7.fhir.us.physical-activity#current | pa-servicerequest-code | PA ServiceRequest Intervention Codes |
| hl7.fhir.uv.phr#current | observation-symptom-snomedct-codes | Observation Symptom SNOMED CT Codes |
| hl7.fhir.uv.phr#current | pcd-sleep-observation-code | Patient contributed data: sleep observation code |
| hl7.fhir.uv.phr#current | pcd-sleep-observation-value | Patient contributed data: sleep stage value |
| hl7.fhir.uv.oo-incubator#current | supply-item | SNOMED CT Supply Item Values |
| hl7.fhir.uv.oo-incubator#current | supplyrequest-when | Supply Request When Values |
| ch.fhir.ig.ch-ekm#current | ChEkmExposureTransmissionRoute | CH EKM Exposure Transmission Route |
| ch.fhir.ig.ch-ekm#current | ChEkmGenderIdentity | CH EKM Gender Identity |
| ch.fhir.ig.ch-ekm#current | ChEkmGonorrhoeaManifestation | CH EKM Gonorrhoea Manifestation |
| ch.fhir.ig.ch-ekm#current | ChEkmGonorrhoeaManifestationFormChoice | CH EKM Gonorrhoea Manifestation (Form) |
| ch.fhir.ig.ch-ekm#current | ChEkmHIVManifestation | CH EKM HIV Manifestation |
| ch.fhir.ig.ch-ekm#current | ChEkmHepatitisCCourseOfDisease | CH EKM HepatitisC CourseOfDisease |
| ch.fhir.ig.ch-ekm#current | ChEkmHepatitisCManifestation | CH EKM Hepatitis C Manifestation |
| ch.fhir.ig.ch-ekm#current | ChEkmInvasivePneumococcalDiseaseManifestation | CH EKM InvasivePneumococcalDisease Manifestation |
| ch.fhir.ig.ch-ekm#current | ChEkmMpoxManifestation | CH EKM Mpox Manifestation |
| ch.fhir.ig.ch-ekm#current | ChEkmOtherNoneUnknown | CH EKM OtherNoneUnknown |
| ch.fhir.ig.ch-ekm#current | ChEkmPneumococcalDiseaseManifestation | CH EKM Pneumococcal Disease Manifestation |
| ch.fhir.ig.ch-ekm#current | ChEkmServiceRequestReason | CH EKM ServiceRequest Reason |
| hl7.fhir.au.base#current | amt-mp-codes | AMT Medicinal Product and Substances |
| hl7.fhir.au.base#current | rsg-type | AU Recorded Sex or Gender Type |
| hl7.fhir.be.childreport#current | vs-eye-movement-and-position | Eye Movement and Position ValueSet |
| hl7.fhir.be.childreport#current | vs-eye-screening-results | Eye Screening Results |
| hl7.fhir.be.childreport#current | vs-neonatal-hearing-screening-results | Neonatal Hearing Screening Results |
| hl7.fhir.be.childreport#current | vs-ophthalmologist-treatments | Ophthalmologist Treatments |
| tw.gov.mohw.nhi.pas#current | apply-quantity-unit | NHI-健保事前審查-事前審查申請數量單位及包裝類型值集 |
| tw.gov.mohw.nhi.pas#current | cancer-stage | SCT + NCI-健保事前審查-癌症分期量表項目值集 |
| tw.gov.mohw.nhi.pas#current | medication-path-sct-tw | SNOMED CT + 臺灣健保署-健保事前審查-給藥途徑值集 |
| tw.gov.mohw.nhi.pas#current | pat-ast | LOINC + SCT + NHI-健保事前審查-病人狀態評估項目值集 |
| tw.gov.mohw.nhi.pas#current | sct-body-site | SNOMEDCT-健保事前審查-身體部位值集 |
| fhir.paciosampledata#current | MAPProblemPriorityVS | Medical Action Plan Problem Priority |
| hl7.eu.fhir.idea4rc#current | alcoholUsageStatus-snomed-eu-i4rc | Alcohol Usage Status: SNOMED CT |
| hl7.eu.fhir.idea4rc#current | comorbidities-sct-eu-i4rc | Comorbidities: SNOMED |
| hl7.eu.fhir.idea4rc#current | hypopharynx-subsite-sct-i4rc | Hypopharynx subsite: Snomed CT |
| hl7.eu.fhir.idea4rc#current | larynx-subsite-sct-i4rc | Larynx subsite: Snomed CT |
| hl7.eu.fhir.idea4rc#current | lip-subsite-sct-i4rc | Lip subsite: Snomed CT |
| hl7.eu.fhir.idea4rc#current | nasal-paranasal-subsite-sct-i4rc | Nasal cavity and paranasal sinuses subsite: Snomed CT |
| hl7.eu.fhir.idea4rc#current | nasopharynx-subsite-sct-i4rc | Nasopharynx subsite: Snomed CT |
| hl7.eu.fhir.idea4rc#current | oralCavity-subsite-sct-i4rc | Oral cavity subsite: Snomed CT |
| hl7.eu.fhir.idea4rc#current | oropharynx-subsite-sct-i4rc | Oropharynx subsite: Snomed CT |
| hl7.eu.fhir.idea4rc#current | siteRare-i4rc | Site rare (IDEA4RC) |
| hl7.eu.fhir.idea4rc#current | vs-calcest-eu-i4rc | Calculated|Estimated |
| uz.dhp.integrations#current | dhis-body-site-vs | DHIS Body Site ValueSet |
| uz.dhp.integrations#current | dhis-condition-code-vs | DHIS Condition Code ValueSet |
| uz.dhp.integrations#current | dhis-observation-codeable-concept-vs | DHIS Observation Result ValueSet |
| uz.dhp.integrations#current | screening-body-site-vs | Observed Body Site VS |
| uz.dhp.integrations#current | screening-breast-finding-vs | Breast Mammography Findings ValueSet |
| uz.dhp.integrations#current | screening-diagnostic-procedure-vs | Diagnostic Procedures ValueSet |
| uz.dhp.integrations#current | screening-observation-codes-vs | Screening Observation Codes Composite ValueSet |
| uz.dhp.integrations#current | screening-observation-type-vs | Observation Types ValueSet |
| uz.dhp.integrations#current | specimen-feature-type-vs | DHIS Specimen Feature Type ValueSet |
| uz.dhp.integrations#current | specimen-type-vs | DHIS Specimen Type ValueSet |
| vcds-ig.euvabeco.net#current | HealthProfession | Health professions |
| hl7.fhir.us.medmorph#current | valueset-cancer-trigger-codes-example | SNOMED Cancer Codes Example |
| hl7.fhir.us.vdor#current | nvdrs-firearm-caliber-vs | VDOR - NVDRS Firearm Caliber Codes |
| hl7.fhir.us.vdor#current | nvdrs-firearm-gauge-vs | VDOR - NVDRS Firearm Gauge Codes |
| hl7.fhir.us.vdor#current | nvdrs-firearm-type-vs | VDOR - NVDRS Firearm Type Valueset |
| hl7.fhir.us.vdor#current | nvdrs-weapon-type-vs | NVDRS Weapon Type Valueset |
| hl7.fhir.us.vdor#current | nvdrs-wound-location-values-vs | VDOR - NVDRS Wound Location Response Options Observation Codes |
| hl7.fhir.us.vdor#current | vdor-gun-owner-codes-vs | VDOR - NVDRS Coding Manual Gun Owner Codes Value Set |
| hl7.fhir.us.vdor#current | vdor-tox-findings-substance-results-vs | VDOR Tox Findings Substance Results |
| hl7.fhir.us.vdor#current | vdor-tox-substance-tested-vs | VDOR Toxicology Substance Tested |
| dk.ehealth.sundhed.fhir.ig.core#current | dk-ihe-healthcarefacilitytypecode-vs | DK_IHE_HealthcareFacilityTypeCode_VS |
| dk.ehealth.sundhed.fhir.ig.core#current | dk-ihe-practicesettingcode-vs | DK_IHE_practiceSettingCode_VS |
| dk.ehealth.sundhed.fhir.ig.core#current | activitydefinition-code | Activity Definition Code |
| dk.ehealth.sundhed.fhir.ig.core#current | clinicalimpression-finding-codes | ClinicalImpression Finding Codes |
| dk.ehealth.sundhed.fhir.ig.core#current | clinicalimpression-investigation-item-codes | ClinicalImpression Investigation Item Codes |
| dk.ehealth.sundhed.fhir.ig.core#current | device-types | Device Types |
| dk.ehealth.sundhed.fhir.ig.core#current | document-class | Document Class |
| dk.ehealth.sundhed.fhir.ig.core#current | facility-type-codes | Facility Type Codes |
| dk.ehealth.sundhed.fhir.ig.core#current | media-codes | Media Codes |
| dk.ehealth.sundhed.fhir.ig.core#current | questionnaire-types | Questionnaire Types |
| dk.ehealth.sundhed.fhir.ig.core#current | sor-organization-type | SorOrganizationType |
| dk.ehealth.sundhed.fhir.ig.core#current | sor-organization-specialty | SorOrganizationSpecialty |
| dk.ehealth.sundhed.fhir.ig.core#current | usage-context-workflow-tele-wound | Usage Context for Tele Wound Workflow |
| ihe.rad.mado#current | ProcedureEuImagingType | ValueSet: Imaging Procedure Type |
| ihe.rad.mado#current | ValueSetAnatomicalRegion | ValueSet: Anatomical Region |
| lt.hl7.fhir.cvd#current | cvd-risk-degree | Cardiovascular Disease Risk Degree (SCORE2) |
| lt.hl7.fhir.cvd#current | ekg-result-interpretation | EKG Result Interpretation |
| lt.hl7.fhir.cvd#current | risk-factor-type | Risk Factor Type |
| hl7.fhir.eu.base#current | medicalTestResult-eu | Medical Test Result Code |
| hl7.fhir.eu.base#current | medicationIntendedUse-eu | Medication Intended Use |
| hl7.fhir.eu.base#current | periodsOfLife-eu | Periods of Life |
| hl7.fhir.eu.base#current | siteLaterality-eu | Body Structure Laterality |
| hl7.fhir.eu.base#current | siteQualifier-eu | Body Structure Qualifier |
| hl7.fhir.eu.base#current | speciesType-eu | Types of species |
| hl7.fhir.cz.ems#current | condition-cz-ems | Condition Value Set |
| hl7.fhir.cz.ems#current | cz-call-classification-vs | Call classification Code Value Set |
| hl7.fhir.cz.ems#current | cz-observation-comaScore-component-type-ems-vs | Observation Coma Score Component Type (CZ EMS) |
| hl7.fhir.cz.ems#current | cz-observation-comaScore-type-ems-vs | Observation Coma Score Type (CZ EMS) |
| hl7.fhir.cz.ems#current | cz-observationOFType-ems-vs | ObservationsEmsOFType |
| hl7.fhir.cz.ems#current | cz-observationVSType-ems-vs | ObservationsEmsVSType |
| hl7.terminology#current | detectedissue-expected-onset-type | Detected Issue Expected Onset Type |
| hl7.terminology#current | device-kind | FHIR Device Types |
| hl7.terminology#current | edible-substance-type | Types of Edible Substances |
| hl7.terminology#current | gender-identity | Gender Identity |
| hl7.terminology#current | snomed-intl-gps | SNOMED International Global Patient Set (GPS) |
| hl7.terminology#current | v3-AllergyStatus | Allergy Status |
| hl7.terminology#current | v3-KnowledgeSubjectObservationValue | KnowledgeSubjectObservationValue |
| hl7.terminology#current | v3-KnowledgeSubtopicObservationValue | KnowledgeSubtopicObservationValue |
| hl7.terminology#current | v3-ObservationMeasureCountableItems | ObservationMeasureCountableItems |
| hl7.terminology#current | v3-immunizationForecastStatusObservationValue | immunizationForecastStatusObservationValue |
| hl7.fhir.us.davinci-ra#current | confidence-scale | RA Confidence Scale |
| tewhatuora.fhir.nz-shared-digital-health-record#current | sdhr-allergyintolerance-manifestation-valueset | ValueSet for AllergyIntolerance Manifestation |
| tewhatuora.fhir.nz-shared-digital-health-record#current | sdhr-allergyintolerance-severity-valueset | ValueSet for AllergyIntolerance Severity |
| hl7.fhir.uv.ichom-breast-cancer#current | AxillaSurgeryVS | Axilla surgery ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | ComplicationImpactVS | Impact of complication ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | ComplicationTypeVS | Type of complication ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | EducationLevelVS | Education level of patient ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | EstrogenStatusVS | Estrogen receptor status ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | GermlineMutationVS | Germline Mutation ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | GradingVS | Grading of tumor ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | HER2ReceptorStatusVS | HER2 receptor status ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | HistologicalTypeVS | Histological type of the tumor ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | LateralityNewCancerVS | Laterality of new cancer ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | LateralityVS | Laterality of breast cancer ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | LocationRadiotherapyVS | The location of radiotherapy ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | MenopausalStatusVS | Menopausal status of patient ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | PatientTreatPrefVS | Patient treatment preference ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | ProgesteroneStatusVS | Progesterone receptor status ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | RecommendedTreatmentTypeVS | Recommended treatment types ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | RecurrenceMethodVS | Recurrence method ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | ReoperationReasonVS | Reasoncode of the re-operation |
| hl7.fhir.uv.ichom-breast-cancer#current | ReoperationTypeVS | Type of re-operation |
| hl7.fhir.uv.ichom-breast-cancer#current | SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | TargetedTherapyVS | Type of targeted therapy ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | TherapyIntentVS | Intent of therapy ValueSet |
| hl7.fhir.uv.ichom-breast-cancer#current | TreatmentTypeVS | Type of treatments ValueSet |
| hl7.fhir.us.dental-data-exchange#current | dental-observation-codes | Dental Observation Codes |
| hl7.fhir.us.dental-data-exchange#current | dental-reason-for-referral | DentalReasonForReferral |
| hl7.fhir.us.dental-data-exchange#current | oral-cavity-area | Oral Cavity Area |
| hl7.fhir.us.dental-data-exchange#current | tooth-identification-valueset | Tooth Identification ValueSet |
| iknl.fhir.stu3.pzp#current | ACP-ContactPersonRoleVS | ACPContactPersonRoleVS |
| iknl.fhir.stu3.pzp#current | ACP-MedicalDeviceProductType-ICDVS | ACP MedicalDevice ProductType ICD |
| iknl.fhir.stu3.pzp#current | ACP-MedicalPolicyGoalVS | ACP Primary Agreed-upon Goal of Medical Policy Codes |
| iknl.fhir.stu3.pzp#current | ACP-PositionRegardingEuthanasiaVS | ACP Position Regarding Euthanasia Codes |
| iknl.fhir.stu3.pzp#current | ACP-PreferredPlaceOfDeathVS | ACP Preferred Place Of Death Codes |
| iknl.fhir.stu3.pzp#current | ACP-YesNoUnknownVS | ACP Yes, No, Unknown Codes |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1034-example | Negative or Undetected Lab Result Value |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1035-example | Indeterminate or Equivocal Lab Result Value |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1435-example | Diphtheria [Suspected] (Disorders) (SNOMED) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1436-example | Measles [Suspected] (Disorders) (SNOMED) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1438-example | Poliomyelitis [Suspected] (Disorders) (SNOMED) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1439-example | Rabies [Suspected] (Disorders) (SNOMED) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1446-example | Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1468-example | Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1469-example | Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1505-example | Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.1507-example | Arsenic Exposure and Toxicity (Disorders) (SNOMED) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.408-example | Hepatitis B Virus Infection (Organism or Substance in Lab Results) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.409-example | Hepatitis C Virus Infection (Organism or Substance in Lab Results) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.528-example | Dengue Virus Infection (Organism or Substance in Lab Results) |
| hl7.fhir.us.ecr#current | 2.16.840.1.113762.1.4.1146.6-example | Diphtheria (Disorders) (SNOMED) |
| hl7.fhir.us.ecr#current | valueset-diagnosis-problem-triggers-example | Example Diagnosis Problem Triggers for Public Health Reporting |
| hl7.fhir.us.ecr#current | valueset-dxtc-example | Example DXTC for Public Health Reporting |
| hl7.fhir.us.ecr#current | valueset-organism-substance-triggers-example | Example Organism Substance Triggers for Public Health Reporting |
| hl7.fhir.us.ecr#current | valueset-suspected-disorder-triggers-example | Example Suspected Disorder Triggers for Public Health Reporting |
| hl7.fhir.cz.hdr#current | cz-induction-of-labor | CZ Induction of Labor |
| hl7.fhir.cz.hdr#current | cz-method-of-delivery | CZ Method of Delivery |
| hl7.fhir.cz.hdr#current | cz-provision-code | CZ Provision Code |
| hl7.fhir.cz.hdr#current | eHDSIConditionPOA | eHDSI Condition Present On Admission |
| hl7.fhir.cz.hdr#current | eHDSITreatmentClass | eHDSI Treatment Class |
| hl7.fhir.cz.hdr#current | exposureAgent-eu-hdr | Exposure of transmissible agents |
| hl7.fhir.uv.emedicinal-product-info#current | group-hepatic-function-value | Group Hepatic Function Value (ePI) |
| hl7.fhir.uv.emedicinal-product-info#current | group-immune-status-value | Group Immune Status Value (ePI) |
| hl7.fhir.uv.emedicinal-product-info#current | group-lifestyle-value | Group Lifestyle Value (ePI) |
| hl7.fhir.uv.emedicinal-product-info#current | group-race-value | Group Race Value (ePI) |
| hl7.fhir.uv.emedicinal-product-info#current | routeOfAdministration | Route Of Administration |
| hl7.fhir.us.healthedata1-sandbox#current | us-core-specimen-collection-method | US Core Specimen Collection Method |
| hl7.fhir.us.sdoh-clinicalcare#current | SDOHCC-ValueSetLOINCSNOMEDCT | SDOHCC ValueSet LOINC SNOMEDCT |
| hl7.fhir.uv.sdc#current | species | Questionnaire Context Species |
| hl7.fhir.uv.ips#current | allergies-intolerances-uv-ips | Allergies & Intolerances - IPS |
| hl7.fhir.uv.ips#current | allergy-reaction-uv-ips | Allergy Reaction - IPS |
| hl7.fhir.uv.ips#current | body-site-uv-ips | Body Site - IPS |
| hl7.fhir.uv.ips#current | current-smoking-status-uv-ips | Current Smoking Status - IPS |
| hl7.fhir.uv.ips#current | medical-devices-uv-ips | Medical Devices - IPS |
| hl7.fhir.uv.ips#current | medication-example-uv-ips | Medications - example (IPS) |
| hl7.fhir.uv.ips#current | medication-uv-ips | Medications - IPS |
| hl7.fhir.uv.ips#current | medicine-active-substances-uv-ips | Medicine Active Substances - IPS |
| hl7.fhir.uv.ips#current | pregnancy-status-uv-ips | Pregnancy Status - IPS |
| hl7.fhir.uv.ips#current | problems-uv-ips | Problems - IPS |
| hl7.fhir.uv.ips#current | procedures-uv-ips | Procedures - IPS |
| hl7.fhir.uv.ips#current | results-blood-group-uv-ips | Results Blood Group - IPS |
| hl7.fhir.uv.ips#current | results-microorganism-uv-ips | Results Microorganism - IPS |
| hl7.fhir.uv.ips#current | results-pathology-uv-ips | Results Pathology - IPS |
| hl7.fhir.uv.ips#current | results-presence-absence-uv-ips | Results Presence/Absence - IPS |
| hl7.fhir.uv.ips#current | results-radiology-component-uv-ips | Results Radiology Component - IPS |
| hl7.fhir.uv.ips#current | results-specimen-collection-method-uv-ips | Results Specimen Collection Method - IPS |
| hl7.fhir.uv.ips#current | results-specimen-type-uv-ips | Results Specimen Type - IPS |
| hl7.fhir.uv.ips#current | target-diseases-uv-ips | Vaccine Target Diseases - IPS |
| hl7.fhir.uv.ips#current | vaccines-uv-ips | Vaccines - IPS |
| hl7.fhir.us.pacio-adi#current | ADIDocumentationTypeVS | Documentation Types |
| hl7.fhir.us.resp-net#current | resp-net-negative-result-codes | resp-net-negative-result-codes |
| hl7.fhir.us.resp-net#current | resp-net-positive-result-codes | resp-net-positive-result-codes |
| uz.dhp.core#current | action-participant-role-vs | Action Participant Role VS |
| uz.dhp.core#current | adverse-event-outcome-vs | Types of AdverseEvent outcome |
| uz.dhp.core#current | body-site-vs | Body Site VS |
| uz.dhp.core#current | condition-code-vs | Condition Codes |
| uz.dhp.core#current | condition-severity-vs | Types of Condition severities |
| uz.dhp.core#current | goal-description-vs | Goal Description VS |
| uz.dhp.core#current | goal-outcome-vs | Goal outcome value set |
| uz.dhp.core#current | goal-start-event-vs | Goal Start Event VS |
| uz.dhp.core#current | observation-codes-vs | Observation codes |
| uz.dhp.core#current | procedure-code-vs | Procedure Code Codes |
| uz.dhp.core#current | procedure-outcome-vs | Procedure Outcome translations |
| uz.dhp.core#current | reaction-type-vs | Reaction Type ValueSet |
| uz.dhp.core#current | recommendation-reason-vs | Immunization recommendation reason value set |
| uz.dhp.core#current | route-code-vs | Route of administration value set |
| uz.dhp.core#current | service-request-labresearch-code-vs | ServiceRequest laboratory tests and panels |
| uz.dhp.core#current | socioeconomic-observation-codes-vs | Socioeconomic Observation Codes |
| uz.dhp.core#current | target-disease-vs | Target disease value set |
| hl7.eu.fhir.oah#current | specimen-type-oah-vs | OAH Specimen Type |
| hl7.fhir.uv.pc-incubator#current | clinicalassessment-change-pattern | ClinicalAssessment Change Pattern |
| hl7.fhir.uv.pc-incubator#current | clinicalassessment-prognosis | Clinical assessment Prognosis |
| hl7.fhir.uv.pc-incubator#current | clinicalassessment-status-reason | ClinicalAssessment Status Reason |
| hl7.fhir.uv.pc-incubator#current | investigation-sets | Investigation Type |
| ans.fhir.fr.document-core#current | fr-vs-allergy-intolerance-type-document | ValueSet - FR ValueSet Allergy Intolerance Type Document |
| hl7.fhir.us.ecmo.ig#current | AccessRoadVS | AccessRoad |
| hl7.fhir.us.ecmo.ig#current | AngioplastyVS | Angioplasty |
| hl7.fhir.us.ecmo.ig#current | CarotidBruitsVS | Carotid Bruits |
| hl7.fhir.us.ecmo.ig#current | DominanceObservationVS | Dominance |
| hl7.fhir.us.ecmo.ig#current | FamilyHistoryHeartAttackVS | Family History Heart Attack |
| hl7.fhir.us.ecmo.ig#current | HemoConclusionVS | HemoConclusion |
| hl7.fhir.us.ecmo.ig#current | HypercholesterolemiaVS | hypercholesterolemia |
| hl7.fhir.us.ecmo.ig#current | MyocardialInfarctionVS | Myocardial Infarction |
| hl7.fhir.us.ecmo.ig#current | NeurologicalDisfunctionVS | Neurological Disfunction |
| hl7.fhir.us.ecmo.ig#current | ObesityVS | Obesity |
| hl7.fhir.us.ecmo.ig#current | PreviousCrmVS | Previous Crm |
| hl7.fhir.us.ecmo.ig#current | RenalInsuficiencyVS | Renal Insuficiency |
| hl7.fhir.us.ecmo.ig#current | SmokingConditionVS | Historial fumador |
| hl7.fhir.eu.laboratory#current | lab-medicalDevice-eu-lab | Medical Device |
| hl7.fhir.eu.laboratory#current | lab-presenceAbsence-eu-lab | Laboratory Presence and Absence Findings |
| hl7.fhir.eu.laboratory#current | lab-specialty-eu-lab | Laboratory Specialty |
| hl7.fhir.eu.laboratory#current | lab-speciesType-eu-vs | Types of species |
| hl7.fhir.eu.laboratory#current | lab-specimenAdditive-eu-lab | Specimen Additive |
| hl7.fhir.eu.laboratory#current | lab-specimenContainer-eu-lab | Specimen Container |
| hl7.fhir.eu.laboratory#current | lab-specimenType-eu-lab | Specimen Types |
| hl7.fhir.eu.laboratory#current | lab-technique-eu-lab | Laboratory Techniques |
| hl7.fhir.us.central-cancer-registry-reporting#current | cancer-core-reportability-codes | Cancer Core Reportability Codes |
| hl7.fhir.fr.medication#current | fr-treatment-intent | French overall intention of the treatment |
| hl7.fhir.uv.crmi#current | example-diabetes-grouper | Example Diabetes Condition Grouper |
| SHIFT-Task-Force.SLS-ValueSets#current | AB352ContraceptionTopicsAi | Contraception-Related Health Topics |
| SHIFT-Task-Force.SLS-ValueSets#current | LeapSlsBehavioralHealthCodes | ValueSet - Leap SLS Behavioral Health Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | LeapSlsHallucinogenCodes | ValueSet - Leap SLS Hallucinogen Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | LeapSlsOpioidCodes | ValueSet - Leap SLS Opioid Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | LeapSlsPsychiatricNotesCodes | ValueSet - Leap SLS Psychiatric Notes Use Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | LeapSlsSexualityAndReproductiveHealthCodes | ValueSet - Leap SLS Sexuality and Reproductive Health Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | ShiftSlsAbortionCodes | ValueSet - SHIFT SLS Abortion Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | ShiftSlsBHCodes | ValueSet - SHIFT SLS Behavioral Health Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | ShiftSlsHallucinogenCodes | ValueSet - SHIFT SLS Hallucinogen Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | ShiftSlsOpioidCodes | ValueSet - SHIFT SLS Opioid Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | ShiftSlsPSYTHPNCodes | ValueSet - SHIFT SLS Psychiatric Notes Use Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | ShiftSlsSDVCodes | ValueSet - SHIFT SLS Sexual Assault / Domestic Violence Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | ShiftSlsSEXCodes | ValueSet - SHIFT SLS Sexuality and Reproductive Health Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | ShiftSlsSTDCodes | ValueSet - SHIFT SLS Sexually Transmitted Disease Codes |
| SHIFT-Task-Force.SLS-ValueSets#current | SyntheaAttentionDeficitDisorderVS | Synthea Codes for attention_deficit_disorder |
| SHIFT-Task-Force.SLS-ValueSets#current | SyntheaCerebralPalsyVS | Synthea Codes for cerebral_palsy |
| SHIFT-Task-Force.SLS-ValueSets#current | SyntheaCysticFibrosisVS | Synthea Codes for cystic_fibrosis |
| SHIFT-Task-Force.SLS-ValueSets#current | SyntheaDementiaVS | Synthea Codes for dementia |
| SHIFT-Task-Force.SLS-ValueSets#current | SyntheaOpioidAddictionVS | Synthea Codes for opioid_addiction |
| SHIFT-Task-Force.SLS-ValueSets#current | SyntheaPregnancyVS | Synthea Codes for pregnancy |
| SHIFT-Task-Force.SLS-ValueSets#current | SyntheaSelfHarmVS | Synthea Codes for self_harm |
| SHIFT-Task-Force.SLS-ValueSets#current | SyntheaSpinaBifidaVS | Synthea Codes for spina_bifida |
| hl7.fhir.us.davinci-crd#current | diet-type | Diet Codes |
| hl7.fhir.us.davinci-crd#current | edible-substance-type | Types of Edible Substances |
| hl7.fhir.us.davinci-crd#current | nutrient-code | Nutrient Codes |
| hl7.fhir.us.davinci-crd#current | serviceRequestCodes | CRD Service Request Codes Value Set |
| lt.hl7.fhir.eu#current | report-code | Report Code |
| fhir.cdc.opioid-cds-r4#current | conditions-documenting-sleep-disordered-breathing | Sleep disordered breathing |
| fhir.cdc.opioid-cds-r4#current | conditions-documenting-substance-misuse | Conditions documenting substance misuse |
| fhir.cdc.opioid-cds-r4#current | conditions-likely-terminal-for-opioid-prescribing | Conditions likely terminal for opioid prescribing |
| fhir.cdc.opioid-cds-r4#current | hospice-disposition | Hospice Disposition |
| fhir.cdc.opioid-cds-r4#current | hospice-finding | Hospice Finding |
| fhir.cdc.opioid-cds-r4#current | hospice-procedure | Hospice Procedure |
| fhir.cdc.opioid-cds-r4#current | limited-life-expectancy-conditions | Limited life expectancy conditions |
| fhir.cdc.opioid-cds-r4#current | office-visit | Office Visit |
| fhir.cdc.opioid-cds-r4#current | opioid-counseling-procedure | Opioid counseling procedure |
| fhir.cdc.opioid-cds-r4#current | opioid-misuse-assessment-procedure | Opioid misuse assessment procedure |
| fhir.cdc.opioid-cds-r4#current | opioid-misuse-disorders | Opioid misuse disorders |
| fhir.cdc.opioid-cds-r4#current | opioid-treatment-assessment-procedure | Opioid treatment assessment procedure |
| fhir.cdc.opioid-cds-r4#current | pain-management-procedure | Pain management procedure |
| fhir.cdc.opioid-cds-r4#current | pdmp-data-reviewed-finding | PDMP data reviewed finding |
| fhir.cdc.opioid-cds-r4#current | pdmp-review-procedure | PDMP review procedure |
| fhir.cdc.opioid-cds-r4#current | sickle-cell-diseases | Sickle-cell diseases |
| fhir.cdc.opioid-cds-r4#current | substance-misuse-behavioral-counseling | Substance misuse behavioral counseling |
| fhir.cdc.opioid-cds-r4#current | therapies-indicating-end-of-life-care | Therapies indicating end of life care |
| hl7.fhir.cl.minsal.tei#current | TipoDeObservacion | Tipo de Observación |
| hl7.fhir.cl.minsal.tei#current | VSServicioRequerido | Servicio Requerido |
| hl7.fhir.cl.minsal.tei#current | VSTerminologiasDiag | TerminologiasDiag |
| hl7.fhir.cl.minsal.tei#current | vs-problema-ges-tei | Value Set de los Problemas de Salud GES |
| lt.hl7.fhir.lung#current | adrenal-laterality | Adrenal Laterality |
| lt.hl7.fhir.lung#current | consolidation-interpretation | Consolidation Interpretation |
| lt.hl7.fhir.lung#current | finding-density | Finding Density |
| lt.hl7.fhir.lung#current | finding-multiplicity | Finding Multiplicity |
| lt.hl7.fhir.lung#current | finding-quantity | Finding Quantity |
| lt.hl7.fhir.lung#current | incidental-finding | Incidental Finding |
| lt.hl7.fhir.lung#current | kidney-laterality | Kidney Laterality |
| lt.hl7.fhir.lung#current | kidney-lesion-density | Kidney Lesion Density |
| lt.hl7.fhir.lung#current | lung-lobe | Lung Lobe |
| lt.hl7.fhir.lung#current | lymph-node-location | Lymph Node Location |
| lt.hl7.fhir.lung#current | pulmonary-nodule-morphology | Pulmonary Nodule Morphology Features |
| lt.hl7.fhir.lung#current | pulmonary-nodule-type | Pulmonary Nodule Type |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-brachytherapy-applicator-type-vs | Brachytherapy Applicator Type Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-brachytherapy-device-type-vs | Brachytherapy Device Type Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-disease-progression-qualifier-vs | Disease Progression Qualifier Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-image-guided-radiotherapy-modality-vs | Image Guided Radiotherapy Modality Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-intrafraction-verification-procedure-vs | Intrafraction Verification Procedure Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-intrafraction-verification-qualifier-vs | Intrafraction Verification Procedure Qualifier Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-radiotherapy-category-vs | Radiotherapy Category Code Max Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-radiotherapy-free-breathing-motion-mgmt-technique-vs | Radiotherapy Free-Breathing Motion Management Technique Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-radiotherapy-isotope-vs | Radiotherapy Isotope Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-radiotherapy-reason-for-revision-or-adaptation-vs | Radiotherapy Reason for Revision or Adaptation Value Set |
| hl7.fhir.us.codex-radiation-therapy#current | codexrt-radiotherapy-respiratory-motion-management-vs | Radiotherapy Respiratory Motion Management Value Set |
| hl7.fhir.cz.hie#current | cz-documentEntry-confidentialityCode-vs | CZ DocumentEntry Confidentiality ValueSet |
| stjohn.ambulance-care-summary#current | acs-advice-to-patient-vs | ACS Advice to Patient Value Set |
| stjohn.ambulance-care-summary#current | acs-encounter-diagnosis-vs | ACS Encounter Diagnosis Value Set |
| stjohn.ambulance-care-summary#current | acs-procedure-type-vs | ACS Procedure Type Value Set |
| stjohn.ambulance-care-summary#current | acs-referral-pathway-vs | ACS Referral Pathway Value Set |
| stjohn.ambulance-care-summary#current | acs-smoking-status-vs | ACS Smoking Status Value Set |
| stjohn.ambulance-care-summary#current | acs-vaping-status-vs | ACS Vaping Status Value Set |
| elga.moped#current | LKFDiagnoseTypVS | LKF Diagnosetyp ValueSet |
| elga.moped#current | LKFSeitenlokalisationVS | LKF Seitenlokalisation ValueSet |
| elga.moped#current | MopedEntbindungsartVS | Moped ValueSet für die Art der Entbindung |
| hl7.fhir.vn.core#current | snomedCT-additional-dosage-instruction | ValueSet dành cho Các chỉ dẫn dùng thuốc (bổ sung) (SNOMED CT) |
| hl7.fhir.vn.core#current | snomedCT-anatomical-body-structure | ValueSet dành cho Vị trí cơ thể theo giải phẫu học (SNOMED CT) |
| hl7.fhir.vn.core#current | snomedCT-clinical-finding | ValueSet dành cho Các thông tin thăm, khám lâm sàng (SNOMED CT) |
| hl7.fhir.vn.core#current | snomedCT-dosage-administration-route | ValueSet dành cho Đường dùng thuốc (SNOMED CT) |
| hl7.fhir.vn.core#current | vaccine-code | ValueSet dành cho Vaccine Code |
| hl7.fhir.vn.core#current | vn-core-condition-code | ValueSet dành cho Mã bệnh tật |
| hl7.fhir.vn.core#current | vn-core-observation-smokingstatus | ValueSet dành cho Tình trạng hút thuốc lá (SNOMED CT) |
| hl7.fhir.vn.core#current | vn-core-occupation | ValueSet dành cho Thông tin nghề nghiệp |
| hl7.fhir.vn.core#current | vn-medication-code | ValueSet dành cho Mã dược phẩm |
| hl7.fhir.vn.core#current | vn-procedure-code | ValueSet dành cho Mã dịch vụ kỹ thuật |
| hl7.fhir.us.breast-radiology#current | BreastAssessmentCategoryVS | Breast Assessment Category ValueSet |
| hl7.fhir.us.breast-radiology#current | CalcificationDistributionVS | CalcificationDistribution ValueSet |
| hl7.fhir.us.breast-radiology#current | ConsistentWithVS | ConsistentWith ValueSet |
| hl7.fhir.us.breast-radiology#current | NotPreviouslySeenVS | NotPreviouslySeen ValueSet |
| hl7.fhir.us.breast-radiology#current | PreviouslyDemonstratedByVS | PreviouslyDemonstratedBy ValueSet |
| ch.fhir.ig.ch-emr#current | ch-emr-clinical-document-types-vs | Clinical Document Types |
| ch.fhir.ig.ch-emr#current | ch-emr-cognitive-disability-types-vs | Cognitive disability types |
| ch.fhir.ig.ch-emr#current | ch-emr-implant-type-vs | Implant Type |
| ch.fhir.ig.ch-emr#current | ch-emr-physical-disability-types-vs | Physical disability types |
| ch.fhir.ig.ch-emr#current | ch-emr-resuscitation-status-vs | Resuscitation status |
| ch.fhir.ig.ch-emr#current | ch-emr-risk-to-healthcare-personnel-vs | Risk to Healthcare Personnel |
| ch.fhir.ig.ch-ems#current | IVR-VS-InfectPersPrecaution | IVR Infection Transport Precaution Personnel |
| ch.fhir.ig.ch-ems#current | IVR-VS-actRecovAid | IVR Recovery Aid |
| ch.fhir.ig.ch-ems#current | IVR-VS-actRespiOwner | IVR Owner |
| ch.fhir.ig.ch-ems#current | IVR-VS-ambulanceType | IVR Ambulance Type |
| ch.fhir.ig.ch-ems#current | IVR-VS-bedding | IVR Transport Bedding |
| ch.fhir.ig.ch-ems#current | IVR-VS-deathManner | IVR Death Manner |
| ch.fhir.ig.ch-ems#current | IVR-VS-diagType | IVR Diagnosis Type |
| ch.fhir.ig.ch-ems#current | IVR-VS-event | IVR Event |
| ch.fhir.ig.ch-ems#current | IVR-VS-eyeForm | IVR Eye Form |
| ch.fhir.ig.ch-ems#current | IVR-VS-findingsAirway | IVR Findings Airway |
| ch.fhir.ig.ch-ems#current | IVR-VS-formation | IVR Formation |
| ch.fhir.ig.ch-ems#current | IVR-VS-gcs-augenoeffnung | IVR GCS Eye Opening |
| ch.fhir.ig.ch-ems#current | IVR-VS-gcsMotoric | IVR GCS Motoric Response |
| ch.fhir.ig.ch-ems#current | IVR-VS-gcsVerbal | IVR GCS Verbal Response |
| ch.fhir.ig.ch-ems#current | IVR-VS-hospitalPriority | IVR Hospital Priority |
| ch.fhir.ig.ch-ems#current | IVR-VS-idSource | IVR Identification Source |
| ch.fhir.ig.ch-ems#current | IVR-VS-intensity | IVR Intensity |
| ch.fhir.ig.ch-ems#current | IVR-VS-laterality | IVR Laterality |
| ch.fhir.ig.ch-ems#current | IVR-VS-locationType | IVR Location Type |
| ch.fhir.ig.ch-ems#current | IVR-VS-offender | IVR Offender |
| ch.fhir.ig.ch-ems#current | IVR-VS-personRole | IVR Person Role |
| ch.fhir.ig.ch-ems#current | IVR-VS-preTreatType | IVR Pretreatment Type |
| ch.fhir.ig.ch-ems#current | IVR-VS-preTreatment | IVR Pretreatment |
| ch.fhir.ig.ch-ems#current | IVR-VS-pressureMethod | IVR Blood Pressure Method |
| ch.fhir.ig.ch-ems#current | IVR-VS-procAirType | IVR Procedure Airway Type |
| ch.fhir.ig.ch-ems#current | IVR-VS-pulesResult | IVR Pulse Result |
| ch.fhir.ig.ch-ems#current | IVR-VS-pulseMethod | IVR Pulse Method |
| ch.fhir.ig.ch-ems#current | IVR-VS-respirationObservation | IVR Respiration Observation |
| ch.fhir.ig.ch-ems#current | IVR-VS-result | IVR Result |
| ch.fhir.ig.ch-ems#current | IVR-VS-size | IVR Size |
| ch.fhir.ig.ch-ems#current | IVR-VS-symptom | IVR Symptom |
| ch.fhir.ig.ch-ems#current | IVR-VS-teamRole | IVR Team Role |
| ch.fhir.ig.ch-ems#current | IVR-VS-transDisinfection | IVR Transport Unit Disinfection |
| ch.fhir.ig.ch-ems#current | IVR-VS-urgency-adequate | IVR Urgency Adequate |
| ch.fhir.ig.ch-ems#current | IVR-VS-valType | IVR Valuables Type |
| ch.fhir.ig.ch-ems#current | IVR-VS-ventilation | IVR Ventilation |
| ch.fhir.ig.ch-ems#current | IVR-VS-violenceForm | IVR Violence Form |
| ch.fhir.ig.ch-ems#current | IVR-VS-violenceResult | IVR Violence Result |
| ch.fhir.ig.ch-ems#current | IVR-VS-woundTreat | IVR Wound Treatment |
| ch.fhir.ig.ch-ems#current | IVR-VS-yesNoUnknown | IVR Yes/No/Unknown |
| hl7.fhir.us.pacio-pfe#current | pfe-device-parameter-code-vs | Personal Functioning and Engagement Device Parameter Code Value Set |
| hl7.fhir.eu.hdr#current | condition-eu-hdr | Condition Value Set |
| hl7.fhir.eu.hdr#current | encounter-type-eu-hdr | Encounter Type Value Set |
| hl7.fhir.us.birthdefectreporting#current | bdr-procedurelist | Newborn Procedure List |
| hl7.cda.uv.ips#current | 2.16.840.1.113883.11.22.10--20240802091633 | IPS Allergy or Intolerance Conditions |
| hl7.cda.uv.ips#current | allergy-reaction-uv-ips | IPS Allergy Reaction |
| hl7.cda.uv.ips#current | target-site-uv-ips | IPS Body Site |
| hl7.cda.uv.ips#current | specimen-type | IPS Specimen Type |
| hl7.cda.uv.ips#current | 2.16.840.1.113883.11.22.57--20171212192725 | Laterality (qualifier) |
| hl7.cda.uv.ips#current | 2.16.840.1.113883.11.22.58--20171212193352 | Topographical modifier (qualifier) |
| hl7.cda.uv.ips#current | allergy-intolerance-substance-condition-uv-ips | IPS Allergy or Intolerance Substances |
| hl7.cda.uv.ips#current | 2.16.840.1.113883.11.22.66--20240802105026 | IPS Results Radiology Textual Observations |
| hl7.cda.uv.ips#current | 2.16.840.1.113883.11.22.71--20240802094107 | IPS Medications Products |
| hl7.cda.uv.ips#current | 2.16.840.1.113883.11.22.73--20240802094107 | IPS Problems |
| hl7.cda.uv.ips#current | 2.16.840.1.113883.11.22.76--20240802105320 | IPS Results Specimen Collection Method |
| hl7.org.nz.fhir.ig.cca#current | cancer-type-code | Cancer type |
| hl7.org.nz.fhir.ig.cca#current | sact-administration-site-code | Administration location |
| hl7.org.nz.fhir.ig.cca#current | sact-dose-administration-frequency | Medication dose administration frequency |
| hl7.org.nz.fhir.ig.cca#current | sact-dose-unit | Medication dose unit |
| hl7.org.nz.fhir.ig.cca#current | sact-location-medication-collection-code | Medication collection location |
| hl7.org.nz.fhir.ig.cca#current | sact-route | Route |
| hl7.org.nz.fhir.ig.cca#current | sact-support-factor-code | Support Factors |
| hl7.org.nz.fhir.ig.cca#current | sact-support-factor-value-code | Possible values for Support Factors |
| hl7.org.nz.fhir.ig.cca#current | sact-treatment-setting-code | Treatment setting |
| hl7.fhir.cz.img#current | cz-anatomical-region-valueset | ValueSet: Anatomical Region |
| hl7.fhir.cz.img#current | imaging-observationCode-cz | Czech Imaging Observation code |
| hl7.fhir.cz.img#current | imaging-observationValue-cz | Czech Imaging Observation value codeable concept |
| hl7.fhir.cz.img#current | imaging-procedure-cz | CZ Imaging Procedure |
| hl7.fhir.cz.img#current | media-view | Media View types - placeholder for cross-version extension |
| intraproc.anesthesia#current | asagrade-vs | ASA Grade |
| hl7.fhir.us.registry-protocols#current | AbnormalElectrocardiacAssessment | Abnormal Electrocardiac Assessment |
| hl7.fhir.us.registry-protocols#current | ArterialAccessSite | Arterial Access Site |
| hl7.fhir.us.registry-protocols#current | CABG | Coronary artery bypass grafting |
| hl7.fhir.us.registry-protocols#current | CABGType | Coronary Artery Bypass Graft Type |
| hl7.fhir.us.registry-protocols#current | CardiacArrest | Cardiac Arrest |
| hl7.fhir.us.registry-protocols#current | CardiacCTAResults | Cardiac CTA Results |
| hl7.fhir.us.registry-protocols#current | CardiacCatheter | SNOMED Cardiac Catheters |
| hl7.fhir.us.registry-protocols#current | CardiacInstabilityType | Cardiac Instability Type |
| hl7.fhir.us.registry-protocols#current | CardiacValves | Cardiac Valves |
| hl7.fhir.us.registry-protocols#current | CerebrovascularDisease | Cerebrovascular Disease |
| hl7.fhir.us.registry-protocols#current | ChestPainSymptomAssessment | Chest Pain Symptom Assessment |
| hl7.fhir.us.registry-protocols#current | ChronicLungDisease | Chronic Lung Disease |
| hl7.fhir.us.registry-protocols#current | ConcomitantProceduresPerformedType | Concomitant Procedures Performed Type |
| hl7.fhir.us.registry-protocols#current | DiabetesMellitus | Diabetes Mellitus |
| hl7.fhir.us.registry-protocols#current | Dyslipidemia | Dyslipidemia |
| hl7.fhir.us.registry-protocols#current | ElectrocardiacAbnormalityType | Electrocardiac Abnormality Type |
| hl7.fhir.us.registry-protocols#current | ElectrocardiacAssessmentMethod | Electrocardiac Assessment Method |
| hl7.fhir.us.registry-protocols#current | ElectrocardiacAssessmentResults | Electrocardiac Assessment Results |
| hl7.fhir.us.registry-protocols#current | FamilyPrematureCAD | Family History of Premature CAD |
| hl7.fhir.us.registry-protocols#current | GraftVesselCABGVessel | Graft Vessel CABG Vessel |
| hl7.fhir.us.registry-protocols#current | HeartFailure | Heart Failure codes from SNOMED |
| hl7.fhir.us.registry-protocols#current | HemodialysisOrPeritonealDialysis | hemodialysis or peritoneal dialysis |
| hl7.fhir.us.registry-protocols#current | Hypertension | Hypertension |
| hl7.fhir.us.registry-protocols#current | HypothermiaInduced | Induced Hypothermia Codes |
| hl7.fhir.us.registry-protocols#current | InterventionTypes | Intervention Types |
| hl7.fhir.us.registry-protocols#current | IntraAndPostEvents | Cath PCI qualified list of Events |
| hl7.fhir.us.registry-protocols#current | LesionSegmentNumber | Lesion Segment Number |
| hl7.fhir.us.registry-protocols#current | MyocardialInfarction | Myocardial Infarction |
| hl7.fhir.us.registry-protocols#current | NewYorkHeartAssociation | New York Heart Association Assessment Scale |
| hl7.fhir.us.registry-protocols#current | OrganDonor | SNOMED Valueset of Organ Donor codes |
| hl7.fhir.us.registry-protocols#current | PCIIndications | Percutaneous Coronary Intervention Indication |
| hl7.fhir.us.registry-protocols#current | PCIOperator | PCI Operator SNOMED codes |
| hl7.fhir.us.registry-protocols#current | PackedRedBloodCells | Packed Red Blood Ceels |
| hl7.fhir.us.registry-protocols#current | PercutaneousCoronaryIntervention | PCI |
| hl7.fhir.us.registry-protocols#current | PeripheralArterialOcclusiveDisease | Peripheral Arterial Occlusive Disease |
| hl7.fhir.us.registry-protocols#current | PriorCABG | Prior History of Coronary Artery Bypass Graft |
| hl7.fhir.us.registry-protocols#current | PriorDiagnosticCoronaryAngiographyProcedureResults | Prior Diagnostic Coronary Angiography Procedure Results |
| hl7.fhir.us.registry-protocols#current | PriorMyocardialInfarction | Prior Myocardial Infarction |
| hl7.fhir.us.registry-protocols#current | SmokingStatus | Smoking Status |
| hl7.fhir.us.registry-protocols#current | StentType | CathPCI List of Stent Types |
| hl7.fhir.us.registry-protocols#current | TIMIFlow | TIMI Flow |
| hl7.fhir.us.registry-protocols#current | ValvularRegurgitation | Valvular Regurgitation |
| hl7.fhir.us.registry-protocols#current | VentricularSupport | VentricularSupport |
| hl7.fhir.us.registry-protocols#current | VentricularSupportDeviceType | Ventricular Support Device Type |
| hl7.fhir.us.registry-protocols#current | YesNo | Yes or No |
| johnmoehrke.testvital.example#current | ExampleBehavioralHealthMedicationCodes | ValueSet - Example Behavioral Health Medication Codes |
| hl7.fhir.us.hai#current | nhsn-pathogen-ranking | NHSNPathogenRanking |
| hl7.fhir.us.cardx-htn#current | MeasSettingVS | Measurement Setting value set |
| hl7.fhir.us.cardx-htn#current | bodyPositionVS | Body Position value set |
| hl7.fhir.us.cardx-htn#current | bpMeasMethodVS | Blood Pressure Measurement Method value set |
| hl7.fhir.us.cardx-htn#current | bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoordinated value set |
| hl7.fhir.us.cardx-htn#current | exertionPhaseVS | Exertion Phase value set |
| hl7.fhir.us.cardx-htn#current | heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set |
| hl7.fhir.us.cardx-htn#current | heartRateMeasDeviceVS | Heart Rate Measurement Device value set |
| hl7.fhir.us.cardx-htn#current | heartRateMeasMethodVS | Heart Rate Measurement Method value set |
| hl7.fhir.us.cardx-htn#current | sleepStatusVS | Sleep Status value set |
| tw.gov.mohw.twcore#current | condition-code-sct-tw | SNOMED CT診斷代碼值集 |
| tw.gov.mohw.twcore#current | health-professional-sct-tw | SNOMED CT + 臺灣醫事司醫事人員類別值集 |
| tw.gov.mohw.twcore#current | medical-department-sct-tw | 對應至 SNOMED CT之就醫科別 + 診療科別值集 |
| tw.gov.mohw.twcore#current | medication-path-sct-tw | SNOMED CT + 臺灣健保署給藥途徑值集 |
| tw.gov.mohw.twcore#current | serviceRequest-category | 臺灣衛福部資訊處ServiceRequest類型值集 |
| tw.gov.mohw.twcore#current | smoking-status-comprehensive-code | SNOMED CT 吸菸狀態綜合評估值集 |
| tw.gov.mohw.twcore#current | smoking-status-type-code | SNOMED CT + LOINC 吸菸狀態種類向值集 |
| tw.gov.mohw.twcore#current | snomed-pregnancy-status-code | SNOMED CT + HL7 NullFlavor妊娠狀態值集 |
| tw.gov.mohw.twcore#current | snomed-sexual-orientation-code | SNOMED CT + HL7 NullFlavor 性傾向值集 |
| hl7.fhir.at.elga-labor#current | at-lab-practitioner-specialty-vs | AT ELGA Laboratory Practitioner Specialty Value Set |
| hl7.fhir.at.elga-labor#current | at-lab-specimen-type-vs | AT ELGA Laboratory Specimen Type Value Set |
| hl7.fhir.uv.radiation-dose-summary#current | component-radiation-dose-summary-vs | Radiation Dose Summary component type |
| hl7.fhir.uv.radiation-dose-summary#current | procedure-reported-type-rds-vs | Procedure Reported Type Value Set |
| hl7.fhir.us.bfdr#current | ValueSet-apgar-timing | APGAR Score Timing |
| hl7.fhir.us.bfdr#current | ValueSet-birth-attendant-titles | Birth Attendants Titles |
| hl7.fhir.us.bfdr#current | ValueSet-birth-delivery-occurred | Birth Delivery Occurred |
| hl7.fhir.us.bfdr#current | ValueSet-delivery-routes | Delivery Routes |
| hl7.fhir.us.bfdr#current | ValueSet-fertility-enhancing-drug-therapy-artificial-insem | Fertility Enhancing Drug Therapy and Artificial Insemination Value Set |
| hl7.fhir.us.bfdr#current | ValueSet-fetal-death-cause-or-condition | Fetal Death Cause or Condition |
| hl7.fhir.us.bfdr#current | ValueSet-fetal-death-time-points | Fetal Death Time Points |
| hl7.fhir.us.bfdr#current | ValueSet-fetal-presentations-max | Fetal Presentations - Max |
| hl7.fhir.us.bfdr#current | ValueSet-fetal-presentations | Fetal Presentations |
| hl7.fhir.us.bfdr#current | ValueSet-fetal-remains-disposition-method | Fetal Remains Disposition Method |
| hl7.fhir.us.bfdr#current | ValueSet-infections-during-pregnancy-live-birth | Infections During Pregnancy Live Birth |
| hl7.fhir.us.bfdr#current | ValueSet-newborn-congenital-anomalies | Newborn Congenital Anomalies |
| hl7.fhir.us.bfdr#current | ValueSet-obstetric-procedure-outcome | Obstetric Procedure Outcome |
| hl7.fhir.us.bfdr#current | ValueSet-performed-not-performed-planned | Performed NotPerformed Planned |
| hl7.fhir.us.qicore#current | qicore-medication-dose-type | QICore SNOMED CT Dosage Codes |
| hl7.fhir.us.qicore#current | qicore-negation-reason | QICore Negation Reason Codes |
| hl7.fhir.us.qicore#current | qicore-observation-body-position | QICore Observation Body Position |
| lt.hl7.fhir.prostate#current | body-structure-prostate | Prostate - Body Structure |
| lt.hl7.fhir.prostate#current | digital-rectal-examination | Digital Rectal Examination Findings |
| lt.hl7.fhir.prostate#current | prostate-damage-and-change-status | ValueSet: Prostate - Damage and Change Status |
| lt.hl7.fhir.prostate#current | prostate-damage-status | Prostate - Damage Status |
| lt.hl7.fhir.prostate#current | prostate-isup-grade-group | Prostate - ISUP Grade Group |
| lt.hl7.fhir.prostate#current | prostate-mri-type | Prostate - MRI Examination Type |
| lt.hl7.fhir.prostate#current | prostate-other-conditions | Prostate - Other (Incidental) Conditions |
| lt.hl7.fhir.prostate#current | prostate-pirads-sector | Prostate - PI-RADS Sector (39-Sector Map) |
| hl7.fhir.pt.obs-neonat#current | document-type-vs | Tipo de documento ValueSet |
| hl7.fhir.pt.obs-neonat#current | newborn-congenital-anomalies-vs | Tipos de doença congénita ValueSet |
| hl7.fhir.pt.obs-neonat#current | newbornriskassessment-vs | Tipos de risco para avaliação de recém-nascidos ValueSet |
| hl7.fhir.pt.obs-neonat#current | puerperium-vs | Tipos de outcome de puerpério ValueSet |
| hl7.fhir.pt.obs-neonat#current | risco-gravidez-vs | Risco de gravidez ValueSet |
| hl7.fhir.pt.obs-neonat#current | tipo-gravidez-vs | Tipo de gravidez ValueSet |
| hl7.fhir.pt.obs-neonat#current | tipo-parto-vs | Tipos de parto ValueSet |
| hl7.fhir.pt.obs-neonat#current | transport-type-vs | Tipos de transporte de recém-nascido ValueSet |
| hl7.fhir.pt.obs-neonat#current | vacinas-infancia-vs | Vacinas ValueSet |
| lt.hl7.fhir.vitalsigns#current | bmi-observation-snomed | Body Mass Index observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | body-height-observation-snomed | Body Height observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | body-position | Body Position used in Vital Signs Measurements |
| lt.hl7.fhir.vitalsigns#current | body-weight-associated-situation | Body Weight Associated Situation |
| lt.hl7.fhir.vitalsigns#current | body-weight-observation-snomed | Body Weight observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | bp-cuff-size | Blood Pressure Cuff Size |
| lt.hl7.fhir.vitalsigns#current | bp-diastolic-observation-snomed | BP Diastolic observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | bp-mean-observation-snomed | BP Mean observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | bp-measurement-body-location | Blood Pressure Measurement Body Location |
| lt.hl7.fhir.vitalsigns#current | bp-measurement-method | Blood Pressure Measurement Method |
| lt.hl7.fhir.vitalsigns#current | bp-panel-observation-snomed | Blood Pressure Panel observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | bp-systolic-observation-snomed | BP Systolic observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | device-type-blood-pressure | Device Types for Blood Pressure Measurement |
| lt.hl7.fhir.vitalsigns#current | heart-rate-measurement-device | Device Types for Heart Rate Measurement |
| lt.hl7.fhir.vitalsigns#current | device-type-height-length | Device Types for Height Length Measurement |
| lt.hl7.fhir.vitalsigns#current | device-type-weight | Device Types for Weight Measurement |
| lt.hl7.fhir.vitalsigns#current | exertion-phase | Exertion Phase |
| lt.hl7.fhir.vitalsigns#current | head-circumference-observation-snomed | Head Circumference observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | heart-rate-measurement-body-location | Heart Rate Measurement Body Location |
| lt.hl7.fhir.vitalsigns#current | heart-rate-measurement-method | Heart Rate Measurement Method |
| lt.hl7.fhir.vitalsigns#current | heart-rate-observation-snomed | Heart Rate observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | height-length-measurement-method | Height Length Measurement Method |
| lt.hl7.fhir.vitalsigns#current | measurement-environment | Measurement Environment |
| lt.hl7.fhir.vitalsigns#current | sleep-status | Sleep Status in Vital Signs Measurements |
| lt.hl7.fhir.vitalsigns#current | waist-circumference-observation-snomed | Waist Circumference observation codes (SNOMED CT) |
| lt.hl7.fhir.vitalsigns#current | waist-circumference-result-interpretation | WaistCircumference Result Interpretation value set |
| hl7.fhir.us.core#current | us-core-condition-code | US Core Condition Codes |
| hl7.fhir.us.core#current | us-core-goal-description | US Core Goal Codes |
| hl7.fhir.us.core#current | us-core-procedure-code | US Core Procedure Codes |
| hl7.fhir.us.core#current | us-core-servicerequest-category | US Core ServiceRequest Category Codes |
| hl7.fhir.us.mihr#current | hypertensive-disorders-pregnancy-SNOMED | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT |
| hl7.fhir.cz.img-order#current | cz-mobility-type | CZ Mobility Type |
| hl7.fhir.cz.img-order#current | cz-mobility-value | CZ Mobility Value |
| fhir.onc.us-quality-core#current | us-quality-core-medication-dose-type | USQualityCore SNOMED CT Dosage Codes |
| fhir.onc.us-quality-core#current | us-quality-core-observation-body-position | US Quality Core Observation Body Position |
| SHIFT-Task-Force.sls-ri#current | behavioral-health-multi-topic | Behavioral Health - Multiple Topics |
| SHIFT-Task-Force.sls-ri#current | mental-health-conditions | Mental Health Conditions |
| SHIFT-Task-Force.sls-ri#current | substance-abuse | Substance Abuse Conditions |
| hl7.fhir.us.covid19library#current | close-contact-setting-vs | Close Contact Setting Value Set |
| hl7.fhir.us.covid19library#current | covid-19-disease-severity-value-set | COVID-19 Disease Severity Value Set |
| hl7.fhir.us.covid19library#current | covid-19-severity-value-set | COVID-19 Signs and Symptoms Severity Value Set |
| hl7.fhir.us.covid19library#current | covid-19-snomed-diagnosis-vs | COVID-19 SNOMED CT Diagnosis Value Set |
| hl7.fhir.us.covid19library#current | covid19-det-notdet-eq-inc-vs | Detected, Not Detected, Inconclusive Value Set |
| hl7.fhir.us.covid19library#current | covid19-det-notdet-vs | Detected, Not-detected value set |
| hl7.fhir.us.covid19library#current | covid19-pos-neg-eqvs | Positive/Negative Value Set |
| hl7.fhir.us.covid19library#current | covid19-pos-neg-ind-vs | COVID19 Positive, Negative, Indeterminate value set |
| hl7.fhir.us.covid19library#current | covid19-pos-neg-inv-incl-vs | COVID19 Positive, Negative, Invalid, Inconclusive value set |
| hl7.fhir.us.covid19library#current | covid19-pos-neg-inv-vs | COVID19 Positive Negative Invalid value set |
| hl7.fhir.us.covid19library#current | covid19-pos-neg-susp-inv-vs | COVID19 Positive Negative Suspected Invalid value set |
| hl7.fhir.us.covid19library#current | covid19-pos-neg-vs | Positive, Negative value set |
| hl7.fhir.us.covid19library#current | covid19-react-nonreact-borderline-inv-value-set | Reactive, Non-reactive, Borderline, Invalid value set |
| hl7.fhir.us.covid19library#current | covid19-react-nonreact-inv-vs | COVID19 Reactive, Non-reactive, Invalid value set |
| hl7.fhir.us.covid19library#current | covid19-react-nonreact-vs | COVID19 Reactive Non-reactive value set |
| hl7.fhir.us.covid19library#current | covid19-reporting-priority-vs | Reporting Priorities Value Set |
| hl7.fhir.us.covid19library#current | covid19-signs-1nd-symptoms-value-set | COVID-19 Signs and Symptoms Value Set |
| hl7.fhir.us.covid19library#current | covid19-underlying-cardiovascular-condition-value-set | COVID-19 cardiovascular underlying condition reference set |
| hl7.fhir.us.covid19library#current | covid19-underlying-gastrointestinal-hepatic-condition-value-set | COVID-19 gastrointestinal or hepatic underlying condition reference set |
| hl7.fhir.us.covid19library#current | covid19-underlying-immune-condition-value-set | COVID-19 immune underlying condition reference set |
| hl7.fhir.us.covid19library#current | covid19-underlying-immunocompromised-condition-value-set | COVID-19 immunocompromised underlying condition reference set |
| hl7.fhir.us.covid19library#current | covid19-underlying-medical-condition-vs | COVID-19 Underlying Medical Condition Value Set |
| hl7.fhir.us.covid19library#current | covid19-underlying-metabolic-condition-value-set | COVID-19 metabolic underlying condition reference set |
| hl7.fhir.us.covid19library#current | covid19-underlying-neurolgic-condition-value-set | COVID-19 neurologic underlying condition reference set |
| hl7.fhir.us.covid19library#current | covid19-underlying-renal-condition-value-set | COVID-19 renal underlying condition reference set |
| hl7.fhir.us.covid19library#current | covid19-underlying-respiratory-condition-value-set | COVID-19 respiratory underlying condition reference set |
| hl7.fhir.us.covid19library#current | covid19-underlying-uncategorized-condition-value-set | COVID-19 uncategorized underlying condition reference set |
| hl7.fhir.us.covid19library#current | covid91-underlying-hemoglobinopathy-condition-value-set | COVID-19 hemoglobinopathy underlying condition reference set |
| hl7.fhir.us.covid19library#current | det-notdet-equivocal-invalid-vs | Detected, Not-detected, Equivocal, Invalid value set |
| hl7.fhir.us.covid19library#current | det-notdet-inconclusive-invalid-vs | Detected, Not-detected, Inconclusive, Invalid value set |
| hl7.fhir.us.covid19library#current | detected-not-detected-value-set | Detected, Not-detected Value Set |
| hl7.fhir.us.covid19library#current | fluAB-SARSCoV2-SARSCoV-value-set | Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set |
| hl7.fhir.us.covid19library#current | fluAB-SARSCoV2-value-set | Influenza A, Influenza B, and SARS CoV2 value set |
| hl7.fhir.us.covid19library#current | pregnancy-status-value-set | Pregnancy Status Value Set |
| hl7.fhir.us.covid19library#current | present-absent-unknown-vs | Present, Absent, Unknown Value Set |
| hl7.fhir.us.covid19library#current | reactive-non-reactive-value-set | Reactive - Non-reactive value set |
| hl7.fhir.us.covid19library#current | smoking-status-value-set | Smoking Status Value Set |
| hl7.fhir.us.covid19library#current | state-codes-vs | State Codes Value Set |
| hl7.fhir.us.covid19library#current | yes-no-vs | Yes/No Value Set |
| hl7.fhir.us.immds#current | targetDisease | Vaccine Target Disease Value Set |
| hl7.fhir.us.cimilabs#current | abnml-int-numeric-nom-value-set | Abnormal Interpretation Numeric Nominal value set |
| hl7.fhir.us.cimilabs#current | abnormal-interpretation-value-set | Abnmormal Interpretation value set |
| hl7.fhir.us.cimilabs#current | lab-result-code-value-set | Lab Result Code value set |
| hl7.fhir.us.cimilabs#current | null-flavor-value-set | Null Flavor value set |
| hl7.fhir.us.cimilabs#current | ordinal-value-code-value-set | Ordinal Value Code value set |
| hl7.fhir.dk.core#current | dk-core-SCTBasicObservation | DK Core SNOMED CT Basic Observation |
| hl7.fhir.dk.core#current | dk-core-SCTLaboratorySpecialities | SNOMED CT Laboratory Specialities |
| hl7.fhir.dk.core#current | dk-core-TechniquesSCTCodes | DK TechniquesSCTCodes |
| hl7.fhir.dk.core#current | dk-core-practice-setting-code | DK SOR Practice Setting Code |
| hl7.fhir.dk.core#current | dk-core-servicerequest-codes | DK codes for ServiceRequest |
| hl7.fhir.dk.core#current | sor-organization-type | DK SOR Organization Type |
| csiro.fhir.au.gpccmp#current | pulse-rhythm-1 | Pulse Rhythm |
| hl7.fhir.uv.termchangeset#current | case-significance-vs | Case Significance Value Set |
| hl7.fhir.uv.termchangeset#current | defining-relationship-type-vs | Defining Relationship Type Value Set |
| hl7.fhir.uv.termchangeset#current | designation-acceptability-vs | Designation Acceptability Value Set |
| hl7.fhir.uv.termchangeset#current | dialect-vs | Dialect Value Set |
| hl7.fhir.uv.termchangeset#current | el-profile-set-operator-vs | EL Profile Set Operator Value Set |
| hl7.fhir.uv.termchangeset#current | snomed-property-vs | SNOMED CT Property ValueSet |
| hl7.fhir.uv.extensions#current | animal-breeds | animal breeds |
| hl7.fhir.uv.extensions#current | animal-species | animal species |
| hl7.fhir.uv.extensions#current | barrier | Barrier |
| hl7.fhir.uv.extensions#current | condition-cause | Condition Cause Codes |
| hl7.fhir.uv.extensions#current | condition-course | Condition Course Codes |
| hl7.fhir.uv.extensions#current | condition-predecessor | Condition Predecessor Codes |
| hl7.fhir.uv.extensions#current | dataelement-sdcobjectclass | DataElement SDC Object Class |
| hl7.fhir.uv.extensions#current | dataelement-sdcobjectclassproperty | DataElement SDC Object Class Property |
| hl7.fhir.uv.extensions#current | feeding-device | Feeding Device Codes Value Set |
| hl7.fhir.uv.extensions#current | focal-subject | Focal Subject Codes |
| hl7.fhir.uv.extensions#current | medication-type | Medication Type VS |
| hl7.fhir.uv.extensions#current | protective-factor | Protective Factor |
| hl7.fhir.uv.extensions#current | specimen-additive-substance | Specimen Additive Substance Codes |
| hl7.fhir.uv.extensions#current | structure-laterality-vs | Structure Laterality Value Set |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113762.1.4.1032.10 | Non essential Hypertension SNOMEDCT |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113762.1.4.1032.124 | Alcohol Brief Intervention and Counseling |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113762.1.4.1047.511 | Ambulatory Blood Pressure Monitoring (ABPM) |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113762.1.4.1104.2 | Systolic blood pressure |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113762.1.4.1108.15 | Hospice care ambulatory |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113762.1.4.1116.418 | Physical Activity Recommendations |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113762.1.4.1116.420 | Weight Reduction Recommendations |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113762.1.4.1195.111 | BMI Follow Up Plan SNOMEDCT |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113762.1.4.1222.24 | Alcohol Abuse Disorder |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113883.3.3157.4012 | Hypertension |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113883.3.464.1003.104.12.1016 | Hypertension |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113883.3.464.1003.195.12.1003 | Counseling for Nutrition |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113883.3.526.2.422 | Tobacco User |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113883.3.526.2.590 | End Stage Renal Disease |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113883.3.526.3.378 | Pregnancy |
| hl7.fhir.us.ohsuhypertensionig#current | 2.16.840.1.113883.3.526.3.509 | Tobacco Use Cessation Counseling |
| hl7.fhir.us.ohsuhypertensionig#current | conditions-related-to-antihypertensives | Conditions Adversely Related to Antihypertensives |
| hl7.fhir.us.cqfmeasures#current | chronic-liver-disease-legacy-example | Chronic Liver Disease Legacy Example |
| lt.hl7.fhir.lifestyle#current | alcohol-consumption-status | Alcohol Consumption Status |
| lt.hl7.fhir.lifestyle#current | alcohol-use-frequency | Alcohol Use Frequency |
| lt.hl7.fhir.lifestyle#current | family-history-cvd-status | Status of the Family History of Cardiovascular Disease |
| lt.hl7.fhir.lifestyle#current | family-history-diabetes-status | Status of the Family History of Diabetes |
| lt.hl7.fhir.lifestyle#current | medication-taken | Medication taken by patient during treatment |
| lt.hl7.fhir.lifestyle#current | metabolic-syndrome-assessment | Metabolic Syndrome Assessment (NCEP ATP III) |
| lt.hl7.fhir.lifestyle#current | nutrition-status | Nutrition Status |
| lt.hl7.fhir.lifestyle#current | physical-activity-level | Physical Activity Level |
| lt.hl7.fhir.lifestyle#current | screened-condition | Family Member History Screening Program Diseases |
| lt.hl7.fhir.lifestyle#current | screening-programme | Screening Programme |
| lt.hl7.fhir.lifestyle#current | smoking-status | Tobacco. Current Smoking Status |
| lt.hl7.fhir.lifestyle#current | tobacco-smoking-consumption | Tobacco Smoking Consumption - Cigarettes per day |
| lt.hl7.fhir.lifestyle#current | tobacco-type-user | Tobacco Type User |
| lt.hl7.fhir.lifestyle#current | treatment-status | Treatment Status |
| lt.hl7.fhir.lifestyle#current | yes-no | Yes-No options |
| smart.who.int.immunizations#current | IMMZ.Z.DE1 | IMMZ.Z.DE1 ValueSet for BCG vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE10 | IMMZ.Z.DE10 ValueSet for Meningococcal vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE11 | IMMZ.Z.DE11 ValueSet for Mumps-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE12 | IMMZ.Z.DE12 ValueSet for Pertussis-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE13 | IMMZ.Z.DE13 ValueSet for Pneumococcal vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE14 | IMMZ.Z.DE14 ValueSet for Poliovirus-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE15 | IMMZ.Z.DE15 ValueSet for Rabies vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE16 | IMMZ.Z.DE16 ValueSet for Rotavirus vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE17 | IMMZ.Z.DE17 ValueSet for Rubella-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE18 | IMMZ.Z.DE18 ValueSet for Seasonal influenza vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE2 | IMMZ.Z.DE2 ValueSet for Cholera vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE20 | IMMZ.Z.DE20 ValueSet for TBE vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE22 | IMMZ.Z.DE22 ValueSet for Varicella-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE23 | IMMZ.Z.DE23 ValueSet for Yellow fever vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE24 | IMMZ.Z.DE24 ValueSet for DTP-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE26 | IMMZ.Z.DE26 ValueSet for COVID-19 vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE3 | IMMZ.Z.DE3 ValueSet for Diphtheria-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE4 | IMMZ.Z.DE4 ValueSet for Hib-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE5 | IMMZ.Z.DE5 ValueSet for Hepatitis A-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE6 | IMMZ.Z.DE6 ValueSet for Hepatitis B-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE7 | IMMZ.Z.DE7 ValueSet for HPV vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE8 | IMMZ.Z.DE8 ValueSet for JE vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.DE9 | IMMZ.Z.DE9 ValueSet for Measles-containing vaccines |
| smart.who.int.immunizations#current | IMMZ.Z.LiveAttenuated | IMMZ.Z.LiveAttenuated ValueSet for live attenuated vaccines |
| hl7.fhir.uv.genomics-reporting#current | genetic-therapeutic-implications-vs | Genetic Therapeutic Implications |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | bodyLandmarkDescriptionVS | BodyLandmarkDescriptionvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | bodyLocationOrientationVS | BodyLocationOrientationvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | bodyLocationQualifierVS | BodyLocationQualifiervalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | bodySideVS | BodySidevalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | clockFacePositionVS | ClockFacePositionValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | courseVS | Coursevalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | episodeVS | Episodevalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | periwoundConditionVS | ReriwoundConditionvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | presentAbsentVS | PresentAbsentValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | pressureUlcerAssociationVS | PressureUlcerAssociationvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | qualitativeWoundDepthVS | QualitativeWoundDepthvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | recurrenceVS | Recurrencevalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | surfaceOrientationVS | SurfaceOrientationvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | trendVS | Trendvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | underlyingAnatomicalStructureVS | UnderlyingAnatomicalStructurevalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundAnatomicLocationVS | WoundAnatomicLocationvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundAssessmentInterpretationVS | WoundAssessmentInterpretationvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundBedAppearanceVS | WoundBedAppearanceValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundBedColorVS | Wound Bed Color value set |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundEdgeColorVS | WoundEdgeColorValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundEdgeDescriptionVS | WoundEdgeDescriptionValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundExudateAmountDescriptionVS | WoundExudateAmountDescriptionValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundExudateAppearanceVS | WoundExudateAppearanceValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundExudateColorVS | WoundExudateColorValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundExudateOdorVS | WoundExudateOdorValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundGradationVS | WoundGradationValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundInternalItemOrBodyStructureVisibleVS | WoundInternalItemOrBodyStructureVisiblevalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundMeasurementDeviceVS | WoundMeasurementDeviceValueSet |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundShapeVS | Wound Shape value set |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundTypeEtiologyVS | WoundTypeEtiologyvalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | woundTypeVS | CIMIWoundTypevalueset |
| hl7.fhir.us.lower-extremity-skin-wound-assessment#current | yesNoVS | YesNoValueSet |
| hl7.fhir.nl.zorgviewer#current | ACPTreatmentCodelist | ACP behandelingen waardelijst |
| hl7.fhir.nl.zorgviewer#current | ProbleemNaamCodelist | Zorgviewer probleem naam waardelijst |
| hl7.fhir.nl.zorgviewer#current | RoleCodelist | Rol (beroepen) waardelijst |
| hl7.fhir.nl.zorgviewer#current | SubstanceUseTypeCodelist | Middelengebruik type waardelijst |
| hl7.fhir.nl.zorgviewer#current | VerrichtingTypeCodelist | Zorgviewer verrichting type waardelijst |
| hl7.fhir.us.illTraveler#current | InfectiousDiseaseVS | Infectious Disease VS |
| fhir.ph.ereferral#current | ereferral-reason | eReferral Reason |
| fhir.ph.ereferral#current | ereferral-service-category | eReferral Service Category |
| lt.hl7.fhir.breast#current | birads-category | BI-RADS Category |
| lt.hl7.fhir.breast#current | breast-assessment | Breast Assessment Services and Procedures |
| lt.hl7.fhir.breast#current | breast-biopsy-procedure-type | Breast Biopsy Procedure Type |
| lt.hl7.fhir.breast#current | breast-body-site | Breast Body Site |
| lt.hl7.fhir.breast#current | breast-clock-position | Breast Clock Position |
| lt.hl7.fhir.breast#current | breast-finding | Breast Finding |
| lt.hl7.fhir.breast#current | breast-gland-density-acr | Breast Gland Density ACR |
| lt.hl7.fhir.breast#current | breast-history-situation | Breast History Situations |
| lt.hl7.fhir.breast#current | breast-nipple-appearance-finding | Breast Nipple Appearance Finding |
| lt.hl7.fhir.breast#current | breast-quadrant | Breast Quadrants |
| lt.hl7.fhir.breast#current | breast-tumor-who-classification | WHO Breast Tumor Classification |
| lt.hl7.fhir.breast#current | lymph-node-level | Lymph Node Level |
| lt.hl7.fhir.breast#current | mammographic-finding | Mammographic Finding |
| lt.hl7.fhir.breast#current | ultrasound-lesion-finding | Ultrasound Lesion Finding |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-categorias-pTNM-VS | Set de Valores para Categorias pTNM |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-estructuras-anatomicas-VS | Set de Valores Para los Sitios del Cuerpo |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-morfologico-VS | Set de Valores Morfología |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-observaciones-biopsia-VS | Set de Valores para Observaciones Biopsia |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-procedimientos-biopsias-VS | Set de Valores Para Procedimientos |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-reporte-biopsia-vs | Set de Valores de los Reportes de Biopsia |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-snomed-hallazgos-clinicos-VS | ValueSet Para Hallazgos Clínicos en Snomed CT |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-tipo-especimen-vs | Set de Valores de los Tipos de Especimen |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-tipo-procedimientos-biopsias-VS | Set de Valores Para Tipo de Procedimientos |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-tnm-categoria-metastasis-distante-patologico-vs | Set de Valores Categoría TNM Patológico Metastásico Distante |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-tnm-categoria-nodo-regional-patologico-vs | Set de Valores Categoría TNM Patológico Nodos Regional |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-tnm-categoria-tumor-primario-patologico-vs | Set de Valores Categoría TNM Patológico Tumor Primario |
| hl7.fhir.cl.minsal.r2bo#current | r2bo-topografica-VS | Set de Valores para Topografía en Snomed CT |
| StandardPatientHealthRecordIG#current | pcd-sleep-observation-code | Patient contributed data: sleep observation code |
| StandardPatientHealthRecordIG#current | pcd-sleep-observation-value | Patient contributed data: sleep stage value |
| ihe.pcc.ript#current | RIPT.Medical.Necessity.VS | Medical_Necessity_VS |
| ihe.pcc.ript#current | RIPT.Reason.for.Interfacility.Transport.VS | Reason_for_Interfacility_Transport_VS |
| hl7.fhir.fr.core#current | fr-core-vs-body-position | Body Position value set |
| hl7.fhir.fr.core#current | fr-core-vs-bp-meas-body-location | Blood Pressure Measurement Body Location Precoordinated value set |
| hl7.fhir.fr.core#current | fr-core-vs-bp-meas-method | Blood Pressure Measurement Method value set |
| hl7.fhir.fr.core#current | fr-core-vs-bp-method | FR Core ValueSet BP measurement method |
| hl7.fhir.fr.core#current | fr-core-vs-heartrate-body-location | Heart Rate Measurement Body Location Precoordinated value set |
| hl7.fhir.fr.core#current | fr-core-vs-heartrate-measurement-method | Heart Rate Measurement Method value set |
| hl7.fhir.fr.core#current | fr-core-vs-height-body-position | FR Core ValueSet BodyPosition |
| hl7.fhir.fr.core#current | fr-core-vs-height-meas-method | Height Length Measurement Method value set |
| hl7.fhir.fr.core#current | fr-core-vs-respiratory-rate-meas-method | Respiratory Rate Measurement Method value set |
| hl7.fhir.fr.core#current | fr-core-vs-spo2-body-location | Oxygen Saturation Body Location value set |
| hl7.fhir.fr.core#current | fr-core-vsbody-temp-meas-body-location | Body Temperature Measurement Body Location value set |
| hl7.fhir.uv.saner#current | AllCOVID19RiskFactors | All COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | COPDCOVID19RiskFactors | COPD COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | COVID19Antibody | COVID-19 Antibody |
| hl7.fhir.uv.saner#current | COVID19Complications | COVID-19 Complications |
| hl7.fhir.uv.saner#current | COVID19DXSNOMED | COVID-19 SNOMED |
| hl7.fhir.uv.saner#current | COVID19Exposures | COVID-19 Exposures |
| hl7.fhir.uv.saner#current | COVID19Organism | COVID-19 Organism |
| hl7.fhir.uv.saner#current | CardiovascularCOVID19RiskFactors | Cardiovascular COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | ConfirmedCOVID19Diagnoses | Confirmed COVID-19 Diagnosis Values |
| hl7.fhir.uv.saner#current | DiabetesCOVID19RiskFactors | Diabetes COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | EventContext | Event Context |
| hl7.fhir.uv.saner#current | HypertensionCOVID19RiskFactors | Hypertension COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | IsolationPrecautions | COVID-19 Isolation Precautions |
| hl7.fhir.uv.saner#current | KidneyDiseaseCOVID19RiskFactors | Kidney Disease COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | NegativeResults | COVID-19 Not Detected |
| hl7.fhir.uv.saner#current | NeoplasticCOVID19RiskFactors | Neoplastic COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | ObesityCOVID19RiskFactors | Obesity COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | PositiveResults | COVID-19 Detected |
| hl7.fhir.uv.saner#current | PregnancyCOVID19RiskFactors | Pregnancy COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | Remdesivir | Remdesivir |
| hl7.fhir.uv.saner#current | SickleCellCOVID19RiskFactors | Sickle Cell COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | SuspectedCOVID19Diagnoses | Suspected COVID19 Diagnoses |
| hl7.fhir.uv.saner#current | SuspectedOrConfirmedCOVID19Diagnoses | Suspected Or Diagnosed COVID-19 |
| hl7.fhir.uv.saner#current | TobaccoCOVID19RiskFactors | Tobacco COVID-19 Risk Factors |
| hl7.fhir.uv.saner#current | VentilatorDevices | Ventilator Devices |
| hl7.fhir.uv.saner#current | VentilatorProcedures | Ventilator Procedures |
| hl7.fhir.uv.symptoms#current | AlleviatingFactorCodes | Alleviating Factor Codes |
| hl7.fhir.uv.symptoms#current | ClinicalCourseCodes | Clinical Course Codes |
| hl7.fhir.uv.symptoms#current | CommonSymptomCodes | Common Set of Symptom Codes |
| hl7.fhir.uv.symptoms#current | FrequencyCodes | Frequency Codes |
| hl7.fhir.uv.symptoms#current | OtherEventCodes | Other Event Codes |
| hl7.fhir.uv.symptoms#current | QualityCodes | Quality Codes |
| hl7.fhir.uv.symptoms#current | SeverityCodes | Severity Codes |
| hl7.fhir.uv.symptoms#current | SpeedOfOnset | Speed of Onset |
| hl7.fhir.uv.symptoms#current | TrendCodes | Trend Codes |
| hl7.fhir.uv.symptoms#current | TriggersOrExacerbatingFactorCodes | Triggers or Exacerbating Factor Codes |
| tw.gov.mohw.nhi.ci#current | body-site | SNOMEDCT-健保重大傷病-身體部位值集 |
| ihe.pcc.maps#current | Advance.Directives.VS | Advance Directives |
| ihe.pcc.maps#current | Antepartum.Education.VS | Antepartum Education |
| ihe.pcc.maps#current | Antepartum.Family.History.and.Genetic.Screening.VS | Antepartum Family History and Genetic Screening |
| ihe.pcc.maps#current | Antepartum.History.of.Infection.VS | Antepartum History of Infection |
| ihe.pcc.maps#current | Antepartum.History.of.Past.Illness.VS | Antepartum History of Past Illness |
| ihe.pcc.maps#current | Antepartum.Review.of.Systems.Menstrual.History.VS | Antepartum Review of Systems Menstrual History |
| ihe.pcc.maps#current | Edema.VS | Edema observation |
| ihe.pcc.maps#current | Fetal.Movement.VS | Fetal Movement |
| ihe.pcc.maps#current | Fetal.Presentation.VS | Fetal Presentation |
| ihe.pcc.maps#current | Presence.In.Urine.VS | Presence In Urine |
| ihe.pcc.maps#current | Smoking.Status.VS | Smoking Status |
| fmcna.caredata.fhir.ig.r4#1.1.9 | fmc-allergy-code-vs | Fresenius Allergy Code Value Set |
| fmcna.caredata.fhir.ig.r4#1.1.9 | fmc-sexual-orientation-vs | Fresenius Sexual Orientation Value Set |
| firely.r4.sample.ig#0.2.0-draft | AllergicDispositionFinding | Allergic Disposition (Finding) |
| kvdigital.terminsynchronisation-tvs#1.7.1-Expansions | KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Urgency | KBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Urgency |
| ca.on.oh.erec#0.12.0-projectathon1.0.2 | delivery-method | DeliveryMethod |
| ca.on.oh.erec#0.12.0-projectathon1.0.2 | facet | Facet |
| ca.on.oh.erec#0.12.0-projectathon1.0.2 | healthcareservice-categories | HealthcareServiceCategories |
| ca.on.oh.erec#0.12.0-projectathon1.0.2 | qualified-expertise-role-type | QualifiedExpertiseRoleType |
| hl7.fhir.uv.xver-r4.r4b#0.1.0 | R4-questionnaire-category-for-R4B | Cross-version ValueSet R4.QuestionnaireCategoryCodes for use in FHIR R4B |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Allergy_Substance_SNOMED_CT | Allergie Substanz SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Apgar_Score_Identifier_SNOMED_CT | Apgar Score SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Apgar_Score_Value | Apgar Score Wert |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Body_Weight_Method_SNOMED_CT | Körpergewicht Methode Datenerhebung SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Device_SNOMED_CT | Gerät SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Diagnosis_SNOMED_CT | Diagnose SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Document_Type_KBV | Dokumententyp KBV |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Dose_Form_SNOMED_CT | Darreichungsform SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Drug_Therapy_Status_Codes_SNOMED_CT | Medikation Therapie Statuscodes SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Glucose_Concentration_Interpretation | Glukosespiegel Interpretation |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Glucose_Concentration_Method_SNOMED_CT | Glukosespiegel Methode SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Glucose_Concentration_SNOMED_CT | Glukosespiegel SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Head_Circumference_BodySite_SNOMED_CT | Head Circumference BodySite SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Localisation_Body_Structure_SNOMED_CT | Lokalisation innerhalb Körperstelle SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Medication_Type | Arzneimittel/Rezeptur |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Nursing_Professions | Pflegefachberufe SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_PRN_Medication_Reason_SNOMED_CT | Bedarfsmedikation Bedingung SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Pain_Scale_SNOMED_CT | Schmerzskala SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Practitioner_Speciality_SNOMED_CT | Behandelnder SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Pregnancy_Status_Method_SNOMED_CT | Schwangerschaftsstatus Methode SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Procedure_Categories_SNOMED_CT | Prozeduren Kategorie SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Procedure_SNOMED_CT | Prozedur SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Reaction_Allergy | Manifestation SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Route_of_Administration_SNOMED_CT | Verabreichungsweg SNOMED CT® |
| kbv.basis.terminology#1.9.0 | KBV_VS_Base_Stage_Life | Stage Life SNOMED CT® |
| ca.on.ppr.r4#1.2.0 | ppr-qualified-expertise-role-type | QualifiedExpertiseRoleType |
| ca.on.ppr.r4#1.2.0 | service-category-eServices | Service Category-eServices |
| laniado.test.fhir.r4#0.1.92 | demog-alert-code | Demog Alert Code |
| laniado.test.fhir.r4#0.1.92 | encounter-department-type | Encounter Department Type |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | ColoscopieAnterieureEndo | ColoscopieAnterieureEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | ColoscopieTypeEndo | ColoscopieTypeEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | ComplicationEndo | ComplicationEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | EchelleBostonEndo | EchelleBostonEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | PractitionerRole | EndoPractitionerRole |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | IndicationColoscopieEndo | IndicationColoscopieEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | InstrumentColoscopieEndo | InstrumentColoscopieEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | IntervenantProcedureEndo | IntervenantProcedureEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | InterventionNonPlanifieeEndo | InterventionNonPlanifieeEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | LienUsagerEndo | LienUsagerEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | MedicamentEndo | MedicamentEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | MedicationUniteMesureEndo | MedicationUniteMesureEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | ModalitePriseMedicationEndo | ModalitePriseMedicationEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | MorphologiePolypeEndo | MorphologiePolypeEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | ObservationStructureEndo | ObservationStructureEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | OrigineDemandeEndo | OrigineDemandeEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | PreparationColiqueEndo | PreparationColiqueEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | ProcedureTypeEndo | ProcedureTypeEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | RecommandationEndo | RecommandationEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | ReferentEndo | ReferentEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | RetroflexionEndo | RetroflexionEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | SpecimenStatutEndo | SpecimenStatutEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | StatutObservationEndo | StatutObservationEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | StructureCorporelleEndo | StructureCorporelleEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | SuiviPriseChargeEndo | SuiviPriseChargeEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | TaillePolypeEndo | TaillePolypeEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | TypeObservationEndo | TypeObservationEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | VoieAdministrationEndo | VoieAdministrationEndo |
| rapport.endoscopie.quebec-bc-0-9-1#0.9.17 | ClasseAsaMaitre | ClasseAsaMaitre |
| de.medizininformatikinitiative.kerndatensatz.bildgebung#2026.0.0 | mii-vs-bildgebung-diagnostic-report-code-sct | MII VS Bildgebung DiagnosticReport Code SCT |
| de.medizininformatikinitiative.kerndatensatz.bildgebung#2026.0.0 | mii-vs-bildgebung-findings-sct | MII VS Bildgebung Findings SCT |
| de.medizininformatikinitiative.kerndatensatz.bildgebung#2026.0.0 | mii-vs-bildgebung-imaging-procedure-code-sct | MII VS Bildgebung ImagingProcedure Code SCT |
| de.medizininformatikinitiative.kerndatensatz.bildgebung#2026.0.0 | mii-vs-bildgebung-observation-body-site-sct | MII VS Bildgebung Observation Body Site SCT |
| de.medizininformatikinitiative.kerndatensatz.bildgebung#2026.0.0 | mii-vs-bildgebung-service-request-code-sct | MII VS Bildgebung ServiceRequest Code SCT |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-cd-common-chronic-disease-name-sct-local | NFDI4Health CD Common Chronic Disease Name [SNOMED CT, Local] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-ne-device-nci-snomedct-local | NFDI4Health NE Device [NCI, SNOMED CT, Local] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-ne-portion-size-snomedct-local | NFDI4Health NE Portion Size [SNOMED CT, Local] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-ne-reference-period-unit-sct | NFDI4Health NE Portion Size [SNOMED CT] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-role-name-type-snomed | NFDI4Health VS MDS Role Name Type [SNOMED] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-study-assessments-sct-nci | NFDI4Health VS MDS Study Assessments [SCT, NCI] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-study-centers-snomedct-local | NFDI4Health VS MDS Study Centers [SNOMED CT, local] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-study-data-sharing-plan-ds-sct-nci | NFDI4Health VS MDS Study Data Sharing Plan Datashield [SCT, NCI] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-study-diseases-generally-icd-sct | NFDI4Health VS MDS Study Groups Of Diseases Generally [ICD 10, SCT] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-study-ds-biosamples-sct-nci | NFDI4Health VS MDS Study Data Sources Biosamples [SCT, NCI] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-study-eligibility-gender-snomedct-local | NFDI4Health VS MDS Study Eligibility Criteria Genders [local, SNOMED CT] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-study-recruitment-register-nci-sct-local | NFDI4Health VS MDS Study Recruitment Register [NCI, SCT, Local] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-study-subject-snomedct | NFDI4Health VS MDS Study Subject [SNOMED CT] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-use-rights-label-spdx-smomed-local | NFDI4Health VS MDS Use Rights Label [SPDX, SNOMED, Local] |
| de.nfdi4health.mds#2.1.0 | nfdi4health-vs-mds-yes-no-not-applicable-snomedct | NFDI4Health VS MDS Yes, No, Not Applicable [SNOMED CT] |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Body_Structures_SNOMED_CT | Körperstelle SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Bodystructure_Body_Landmark_Clock_Face_Position | Bodystructure Clock Face Position SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Extracorporal_Device_SNOMED_CT | Außerkörperliche Quellen SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Laboratory_Analyzer_SNOMED_CT | Laboranalysegerät SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Laterality_Body_Structure_SNOMED_CT | Lateralität Körperstelle SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Localisation_Body_Structure_SNOMED_CT | Lokalisation innerhalb Körperstelle SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Observation_Laboratory_Study_Value_SNOMED_CT | Messergebnis Qualitativ SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Observation_Methods | Untersuchungsmethode SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Specimen_Collection_Method_SNOMED_CT | Probenentnahme-Methode SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Specimen_Condition | Zustand Probe |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Specimen_Type_SNOMED_CT | Probenart SNOMED CT® |
| kbv.mio.laborbefund#1.0.0-update | KBV_VS_MIO_LAB_Type_Diagram | Typisierung Messdiagramm |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIAdverseEventType | eHDSI Adverse Event Type |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIAllergenNoDrug | eHDSI Allergen No Drug |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIAnatomicalRegion | eHDSI Anatomical Region |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIAnimalSpecies | eHDSI Animal Species |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIAnthropometricCode | eHDSI Anthropometric Code |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIBloodGroup | eHDSI Blood Group |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIBloodGroupLab | eHDSI Blood Group Laboratory |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIBodySite | eHDSI Body Site |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIBodySiteLaterality | eHDSI Body Site Laterality |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIBodyStructureLocQual | eHDSI Body Structure Location Qualifier |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIClinicalSpecialty | eHDSI Clinical Specialty |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSICodeProb | eHDSI Code Problem |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIConditionPOA | eHDSI Condition Present on Admission |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIConditionStage | eHDSI Condition Stage |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIConditionStageType | eHDSI Condition Stage Type |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSICurrentPregnancyStatus | eHDSI Current Pregnancy Status |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIImagingFinding | eHDSI Imaging Finding |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIImagingObservationMethod | eHDSI Imaging Observation Method |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIImagingProcedure | eHDSI Imaging Procedure |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSILabSpecimenType | eHDSI Laboratory Specimen Type |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSILabTechnique | eHDSI Laboratory Technique |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIMedicalDevice | eHDSI Medical Device |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIMedicationStatusReason | eHDSI Medication Status Reason |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIMicroorganism | eHDSI Microorganism |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIMorphologicAbnormality | eHDSI Morphologic Abnormality |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIOutcomeOfPregnancy | eHDSI Outcome of Pregnancy |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIPresenceAbsence | eHDSI Presence Absence |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIProcedure | eHDSI Procedure |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIReactionAllergy | eHDSI Reaction Allergy |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIResolutionOutcome | eHDSI Resolution Outcome |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSISeverity | eHDSI Severity |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSISocialHistory | eHDSI Social History |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSISpecimenCollectionMethod | eHDSI Specimen Collection Method |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIStatusCode | eHDSI Status Code |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSITreatmentClass | eHDSI Treatment Class |
| myhealth.eu.fhir.mvc-package#9.1.0 | eHDSIVaccine | eHDSI Vaccine |
| ca.on.oh.mha-pds#0.9.0-alpha-1.9.7.38 | language-use | Language Use |
| ca.on.oh.mha-pds#0.9.0-alpha-1.9.7.38 | personal-income-source | Personal Income Source |
| ca.on.oh.mha-pds#0.9.0-alpha-1.9.7.38 | pre-existing-conditions | Pre-existing Conditions |
| ca.on.oh.mha-pds#0.9.0-alpha-1.9.7.38 | service-termination-reason | Service Termination Reason |
| ca.on.oh.mha-pds#0.9.0-alpha-1.9.7.38 | citizenshipStatus | Citizenship Status |
| ca.on.oh.mha-pds#0.9.0-alpha-1.9.7.38 | sdohObservationCode | SDOH Observation Code |
| ca.on.oh.mha-pds#0.9.0-alpha-1.9.7.38 | employment-status | Employment Status |
| ca.on.oh.mha-pds#0.9.0-alpha-1.9.7.38 | highest-level-of-education-attained | Highest Level of Education Attained |
| ca.on.oh.mha-pds#0.9.0-alpha-1.9.7.38 | sexual-orientation | Sexual Orientation |
| hl7.fhir.eu.extensions#1.3.0 | example-legal-status-vs | Example of Legal Status at admission Value Set |
| hl7.fhir.eu.extensions#1.3.0 | periods-of-life-vs | Periods of Life Value Set |
| se.electronichealth.fhir.merier.r5#0.1.2-beta | er-organization-type | Typ av organisation |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-BMI | Data Standards Wales ValueSet BMI |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-BloodPressure-AverageSystolic | Data Standards Wales ValueSet Blood Pressure Average Systolic |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-BloodPressure-Diastolic | Data Standards Wales ValueSet Blood Pressure Diastolic |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-BloodPressure-Systolic | Data Standards Wales Blood ValueSet Pressure Systolic |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-BodyHeightMeasurements | Data Standards Wales ValueSet Body Height Measurements |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-BodyPosition | Data Standards Wales ValueSet Body Position |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-BodyTemperature | Data Standards Wales ValueSet Body Temperature |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-BodyWeightMeasurements | Data Standards Wales ValueSet Body Weight Measurements |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-DocumentType | Data Standards Wales Document Type |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-EncounterType | Data Standards Wales Encounter Type |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-HeadCircumferenceMeasurements | Data Standards Wales ValueSet Head Circumference Measurements |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-HeartRate | Data Standards Wales ValueSet Heart Rate |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-ObservationVitalSignsType | Data Standards Wales ValueSet Observation Vital Signs Type |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-Occupation | Data Standards Wales Occupation |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-OxygenSaturation | Data Standards Wales ValueSet Oxygen Saturation |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-QuestionnaireQuestionCodes | Data Standards Wales Questionnaire Question Codes |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-Religion | Data Standards Wales Religion |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-RespirationRate | Data Standards Wales ValueSet Respiration Rate |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-UEC-Acuity | Data Standards Wales ValueSet UEC Acuity |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-UEC-ArrivalMode | Data Standards Wales ValueSet UEC Arrival Mode |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-UEC-AttendanceSource | Data Standards Wales ValueSet UEC Attendance Source |
| fhir.r4.wales.test#2.3.0 | DataStandardsWales-UEC-DischargeDestination | Data Standards Wales ValueSet UEC Discharge Destination |
| hl7.fhir.us.breastcancer#0.2.0 | cimi-context-DeltaFlagVS | BC DeltaFlagVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | cimi-context-PresenceContextVS | BC PresenceContextVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | cimi-element-AnatomicalLocationVS | BC AnatomicalLocationVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-BreastCancerDetectionVS | BC BreastCancerDetectionVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-BreastCarcinomaHistologicTypeVS | BC BreastCarcinomaHistologicTypeVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-BreastLymphNodeGroupVS | BC BreastLymphNodeGroupVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-BreastSiteVS | BC BreastSiteVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-BreastSpecimenCollectionMethodVS | BC BreastSpecimenCollectionMethodVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-BreastSpecimenTypeVS | BC BreastSpecimenTypeVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-DCISNuclearGradeVS | BC DCISNuclearGradeVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-HER2FISHMethodVS | BC HER2FISHMethodVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-Ki-67NuclearAntigenVS | BC Ki-67NuclearAntigenVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-LymphNodeClinicalMethodVS | BC LymphNodeClinicalMethodVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-LymphNodeInvolvementVS | BC LymphNodeInvolvementVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-LymphNodeMobilityVS | BC LymphNodeMobilityVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-LymphNodeSamplingMethodVS | BC LymphNodeSamplingMethodVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-MorphologyBehaviorVS | BC MorphologyBehaviorVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-StainingIntensityVS | BC StainingIntensityVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | oncology-TumorMarginDescriptionVS | BC TumorMarginDescriptionVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | shr-core-ClockDirectionVS | BC ClockDirectionVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | shr-core-PositiveNegativeEquivocalIndeterminateVS | BC PositiveNegativeEquivocalIndeterminateVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | shr-core-PositiveNegativeIndeterminateVS | BC PositiveNegativeIndeterminateVS ValueSet |
| hl7.fhir.us.breastcancer#0.2.0 | shr-core-PositiveNegativeVS | BC PositiveNegativeVS ValueSet |
| nr.gp.leumit#0.1.1 | all-snomed-codes | All Snomed Codes |
| nr.gp.leumit#0.1.1 | body-site-laterlity | Body Site Laterality |
| ch.fhir.ig.ch-emed-epr.r4#3.0.0 | ch-emed-epr-amount-quantity-unit-code | Amount Quantity Unit Codes |
| nictiz.fhir.nl.stu3.zib2020-preadopt#0.1.3 | HCIMLegalSituationCategory | HCIM LegalSituation Category |
| nictiz.fhir.nl.stu3.zib2020-preadopt#0.1.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.6.4--20200901000000 | RedenVanToepassenCodelijst |
| nictiz.fhir.nl.stu3.zib2020-preadopt#0.1.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.6.1--20200901000000 | SoortInterventieCodelijst |
| nictiz.fhir.nl.stu3.zib2020-preadopt#0.1.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.6.2--20200901000000 | SoortInterventieWvggzCodelijst |
| nictiz.fhir.nl.stu3.zib2020-preadopt#0.1.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.6.3--20200901000000 | SoortInterventieWzdCodelijst |
| hl7.fhir.uv.xver-r2.r4b#0.1.0 | R2-bodysite-relative-location-for-R4B | Cross-version ValueSet DSTU2.Bodysite Location Modifier for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b#0.1.0 | R2-daf-observation-ccdasmokingstatus-for-R4B | Cross-version ValueSet DSTU2.Smoking Status for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b#0.1.0 | R2-diagnostic-order-event-for-R4B | Cross-version ValueSet DSTU2.Diagnostic Order Event Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b#0.1.0 | R2-questionnaire-category-for-R4B | Cross-version ValueSet DSTU2.Questionnaire Category Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b#0.1.0 | R2-vaccination-protocol-dose-target-for-R4B | Cross-version ValueSet DSTU2.Vaccination Protocol Dose Target Codes for use in FHIR R4B |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.254--20200406100640 | a terme datum obv (23) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.355--20220117102535 | AanUitKleden_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.265--20210525145536 | Aanvang Probleem |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.285--20200616133418 | Ademhaling |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.214--20160125115042 | Specificatie van de afwijking van placenta en/of vliezen en/of navelstreng (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.19--20141222113040 | AmniotomieMoment |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.31--20140922095444 | Anemie (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.28--20140919141340 | Auto-immuun aandoening (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.2.2.1--20200901000000 | BehandelingCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.317--20210322154057 | BeleidProfessioneelOnderzoek 3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.14.1--20200901000000 | BepalingsMethodeCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.341--20210225105013 | BetrokkenheidKinderarts |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.260--20200407134908 | Bevinding_Hart |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.323--20201124142938 | Bevindingen borsten 3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.264--20200409090337 | Beweging |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.309--20210128112703 | Blood Group Antibodies 3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.11--20140814133240 | Cardiovasculaire aandoeningen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.175--20130422173433 | Cervical dilatation |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.175--20201210140135 | Cervical dilatation |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.158--20120317000000 | Cervix Effacement |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.158--20201210134951 | Cervix Effacement |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.198--20161026164418 | ChromosomaleAfwijkingen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.230--20170201162016 | Compleetheid vliezen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.160--20120317000000 | Completeness placenta |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.310--20210201115558 | ConclusieProfessioneelOnderzoek 3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.294--20200129150958 | ConclusieUterusContracties |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.315--20210222102852 | Conditie Sfincter (3.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.368--20220210155748 | Conditie Perineum Observatie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.354--20220110114406 | Conditie VrouwelijkeGeslachtsorganen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.192--20140122110447 | Conditie perineum (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.301--20200901151615 | Conditie perineum (3.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.196--20191010091229 | Congenitale afwijking |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.284--20200610131200 | ContactSoort |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.324--20201124152403 | Controle benen 3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.322--20201124115905 | Controle borsten 3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.279--20191118174055 | ControleNavelstomp |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.290--20200622000000 | Controle perineum |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.295--20200129154254 | DeceleratiesCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.357--20220117103812 | Douchen_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.321--20210412154013 | Echelon_3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.251--20181119182547 | Ernst van de aandoening |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.351--20211214145747 | Eten_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.297--20200129155847 | FIGO_ScoreCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.10--20201117115600 | Fase Perinatale Sterfte (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.15.1--20171231000000 | FecesContinentieCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.207--20201112144120 | Leven voelen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.296--20200129155035 | FoetaleHartslagVariabiliteit |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.298--20200129160647 | FoetaleMonitoringMethode |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.299--20200129162827 | FoetaleMonitoringMoment |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.227--20170201134622 | Foliumzuur gebruik |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.235--20170203161446 | Frequentie hartslag |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.226--20161216162923 | Fundusstand (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.246--20191028105919 | Fundusstand Kraamzorg |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.313--20210210164932 | Geboorte Placenta 3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.37--20141020151252 | Groei afwijkend |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.16--20140814134544 | Gynaecologische aandoeningen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.236--20170203161659 | Hartactie op basis van |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.159--20120317000000 | Hodge Planes |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.159--20210621112616 | Hodge Planes |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.274--20200512160326 | Huilgedrag baby |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.36--20141020145518 | Hypertensieve aandoening |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.223--20161202162349 | IUVD methode |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.320--20201112155937 | Indaling (3.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.204--20141021114554 | Infectie (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.15--20140814134341 | Infectieziekten |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.291--20200129144103 | IntensiteitUterusContracties |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.15.2.1--20200901000000 | IntentieBehandelingCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.189--20140120142052 | Interventie begin baring (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.26--20140919115814 | Intra-uteriene behandeling (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.266--20200414155952 | KeuzeTest |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.20--20210222094051 | KleurVruchtwater |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.7.2--20200901000000 | LateraliteitCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.188--20140102000000 | Ligging |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.177--20131224000000 | LiggingBijGeboorte22 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.287--20200619144804 | Lochia |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.205--20141027141746 | Longaandoening |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.29--20140919144015 | Maag Darm Lever aandoening (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.282--20200526172902 | MeetMethode_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.258--20200406134703 | Methode_1e_trimester_SEO |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.226--20180816141641 | MicroorganismeCongInfectCodelijst_LNR |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.249--20191205111425 | MicroorganismeSepsisMeningCodelijst_LNR |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.353--20211214152957 | Mobiliteit_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.231--20170201164126 | Navelstreng vaten |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.14--20140814134140 | Neurologische aandoeningen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.337--20201207162228 | ObservatieKind_Abdomen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.339--20201208105521 | ObservatieKind_Extremiteiten |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.335--20201203120002 | ObservatieKind_Genitalia |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.326--20201201113630 | ObservatieKind_Hoofd-Hals |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.305--20200921120509 | ObservatieKind_Huid |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.340--20201208121209 | ObservatieKind_Neurologie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.338--20201208102213 | ObservatieKind_Rug |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.328--20201201152903 | ObservatieKind_Thorax |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.27--20140919131821 | Oncologische aandoening (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.229--20181012134434 | Ondersteuning_Ontslag_Huis |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.255--20200406115120 | Onderzoektype |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.283--20200101130352 | OnsetCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.265--20200409144953 | Ontlasting zuigeling |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.369--20220214141440 | Opname Indicatie Kind (3.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.322--20210506140617 | OrgaansysteemFoetus |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.17--20140814134642 | Orthopedische afwijkingen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.272--20190925122834 | Ostium |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.20--20161123204523 | Overige interventies |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.195--20140102000000 | Partus stadium |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.202--20161123213413 | Pediatrische verwijsindicatie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.342--20210225121553 | PlacentaCompleet (3.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.209--20141128125356 | Placentalokalisatie (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.213--20160425122048 | Positie portio (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.34--20191218092252 | Postpartum complicatie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.34--20210413094135 | Postpartum complicatie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.172--20130320000000 | Presentation of fetus |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.172--20201210141721 | Presentation of fetus |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.3--20171231000000 | ProbleemNaamCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.337--20210628164200 | ProbleemNaam_AcuteOverdracht |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.328--20210520161536 | ProbleemNaam_Congenitale Afwijking Obstetrie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.298--20200824133956 | ProbleemNaam CongenitaleAfwijking Pediatrie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.299--20200824154514 | ProbleemNaam CongenitaleAfwijking Kraam |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.327--20210518144535 | ProbleemNaam_Geboortetrauma (Kraam) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.326--20210518125239 | ProbleemNaam_Geboortetrauma (Obstetrie) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.296--20200811105755 | ProbleemNaam_Geboortetrauma (Pediatrie) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.313--20201027113825 | ProbleemNaam_Hb-pathie (3.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.319--20210323153828 | ProbleemNaam_HuidBaby |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.358--20220117155944 | ProbleemNaam_InfectiesGezin |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.304--20200213111855 | ProbleemNaam_KindspecifiekMaternaal |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.289--20200127101358 | ProbleemNaam_Maternaal |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.325--20210518104806 | ProbleemNaam_Probleem Kind (Kraam) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.324--20210518101158 | ProbleemNaam_Probleem Kind (Obstetrie) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.295--20200810122858 | ProbleemNaam_Problematiek Kind (Pediatrie) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.231--20220120134819 | ProbleemNaam_Zintuigen (Neonatologie) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.302--20200211092928 | ProbleemNaam_Zwangerschap |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20210329100741 | ProbleemTypeCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.12--20191009125104 | Problematiek kind |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.153--20120829000000 | Categorie Reden overdracht |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.234--20170203161304 | Regelmaat hartslag |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.292--20200129145703 | RegelmatigheidUterusActiviteit |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.219--20161124113309 | Indicatie secundaire sectio |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.220--20180228115805 | SC Indicatie - primaire sectio |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.370--20220221143159 | SchedelCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.13--20140814134002 | Schildklieraandoeningen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.323--20210506154515 | Sonomarkers 3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.284--20200103125137 | SpugenCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.174--20151019205620 | Stand |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20171231000000 | TabakGebruikStatusCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.350--20211214144904 | ToiletGebruik_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.352--20211214151241 | Transfer_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.356--20220117103400 | TrappenLopen_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.310--20201006145809 | TweelingzwangerschapType |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.18--20140814143051 | Type operatie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.182--20161122140045 | TypePartus |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.182--20200811153819 | TypePartus |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.19--20140814144207 | Type stollingsprobleem |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.221--20161201112008 | Type verwijzing |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.348--20211101122336 | TypeVerwijzing_3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.21--20160108110123 | Type vrouwelijke genitale verminking |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.275--20200513143542 | Type Biologische Relatie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.250--20181119171538 | Type anticonceptie |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.349--20211214143820 | UiterlijkeVerzorging_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.14.1--20171231000000 | UrineContinentieCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.291--20200623135655 | Urine baby |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.30--20200114155725 | Urogenitale aandoening (2.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.293--20200129150222 | UterusActiviteitMethode |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.181--20140102000000 | VaginaleKunstverlossing22 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.253--20200401105232 | Verdenking Afwijking Hersenen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.283--20200527093520 | Verdenking Afwijking Wervelkolom Ruggemerg |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.359--20220131105223 | Verdenking Afwijking Aangezicht |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.363--20220131112406 | Verdenking Afwijking Buikwand |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.362--20220131111328 | Verdenking Afwijking Diafragma |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.367--20220131120004 | Verdenking Afwijking Extremiteiten |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.364--20220131113252 | Verdenking Afwijking MaagDarm |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.360--20220131110025 | Verdenking Afwijking Nek/Huid |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.365--20220131114808 | Verdenking Afwijking NierenBlaasUrogenitalis |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.366--20220131115327 | Verdenking_Afwijking_SkeletSpierstelsel |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.361--20220131110815 | Verdenking Afwijking ThoraxLuchtwegen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.1--20171231000000 | VerrichtingAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.3--20171231000000 | VerrichtingLateraliteitCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.4--20171231000000 | VerrichtingMethodeCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.375--20220321094419 | VerrichtingTypeGeboortezorgCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.333--20210615102522 | VerrichtingType_ChirurgischeIngrepen_3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.288--20200123134654 | VerrichtingType_Kindspecifiek |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.303--20200213102349 | VerrichtingType_Maternaal |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.329--20210525162006 | VerrichtingType_ProblematiekKind |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.307--20200226094046 | VerrichtingType_Zwangerschap |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.173--20130320000000 | Vliezen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.173--20201210140520 | Vliezen |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.249--20181119171103 | Vloeien |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.331--20210607115708 | VoedingSoort_GZ |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.319--20201112122448 | VoorgenomenPlaatsBaring (3.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.228--20170201140644 | Voorgenomen voeding |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.191--20140121165337 | Vruchtwater |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.178--20131230000000 | WerkelijkePlaatsBaring22 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.321--20201117110614 | Werkelijke plaats baring 3.2 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.308--20210126165826 | WijzeBeginBaring_32 |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.248--20181119170402 | Wond |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.5--20171231000000 | WondRandCodelijst |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.11.374--20220316115154 | ZorgVoorKindOnzekerheid |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.292--20200623140138 | ZorgVoorKindVaardigheid |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | 2.16.840.1.113883.2.4.3.11.60.90.77.11.308--20201006103803 | ZorgverlenerType (3.2) |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | bc-BirthObservation-code | bc-BirthObservation-code |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | bc-ChildObservation-code | bc-ChildObservation-code |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | bc-DeliveryObservation-code | bc-DeliveryObservation-code |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | bc-FetusObservation-code | bc-FetusObservation-code |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | bc-MaternalObservation-code | bc-MaternalObservation-code |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | bc-PregnancyObservation-code | bc-PregnancyObservation-code |
| nictiz.fhir.nl.stu3.geboortezorg#1.3.3 | bc-ProcedureObservation-code | bc-ProcedureObservation-code |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-activity-reason-for-R4 | Cross-version VS for R2.Activity Reason for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-allergyintolerance-substance-code-for-R4 | Cross-version VS for R2.AllergyIntolerance Substance and Negation Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-approach-site-codes-for-R4 | Cross-version VS for R2.SNOMED CT Anatomical Structure for Administration Site Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-body-site-for-R4 | Cross-version VS for R2.SNOMED CT Body Structures for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-bodysite-laterality-for-R4 | Cross-version VS for R2.Laterality for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-bodysite-relative-location-for-R4 | Cross-version VS for R2.Bodysite Location Modifier for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-c80-facilitycodes-for-R4 | Cross-version VS for R2.Facility Type Code Value Set for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-c80-practice-codes-for-R4 | Cross-version VS for R2.Practice Setting Code Value Set for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-care-plan-activity-for-R4 | Cross-version VS for R2.Care Plan Activity for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-care-plan-category-for-R4 | Cross-version VS for R2.Care Plan Category for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-clinical-findings-for-R4 | Cross-version VS for R2.SNOMED CT Clinical Findings for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-condition-cause-for-R4 | Cross-version VS for R2.Condition Cause Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-condition-code-for-R4 | Cross-version VS for R2.Condition/Problem/Diagnosis Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-condition-outcome-for-R4 | Cross-version VS for R2.Condition Outcome Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-condition-predecessor-for-R4 | Cross-version VS for R2.Condition Predecessor Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-condition-severity-for-R4 | Cross-version VS for R2.Condition/Diagnosis Severity for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-condition-stage-for-R4 | Cross-version VS for R2.Condition Stage for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-consistency-type-for-R4 | Cross-version VS for R2.Fluid Consistency Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-daf-bodysite-for-R4 | Cross-version VS for R2.Vaccine Administered Body Site for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-daf-encounter-reason-for-R4 | Cross-version VS for R2.DAF Encounter Diagnoses for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-daf-manifestation-ccda-codes-for-R4 | Cross-version VS for R2.Manifestation C-CDA codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-daf-observation-ccdasmokingstatus-for-R4 | Cross-version VS for R2.Smoking Status for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-daf-problem-for-R4 | Cross-version VS for R2.Problem Value Set for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-daf-procedure-type-for-R4 | Cross-version VS for R2.DAFProcedureType for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-daf-substance-for-R4 | Cross-version VS for R2.DAF Substance-Reactant for Intolerance and Negation Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-dataelement-sdccode-for-R4 | Cross-version VS for R2.DataElement SDC Concept for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-dataelement-sdcobjectclass-for-R4 | Cross-version VS for R2.DataElement SDC Object Class for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-dataelement-sdcobjectclassproperty-for-R4 | Cross-version VS for R2.DataElement SDC Object Class for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-designation-use-for-R4 | Cross-version VS for R2.Designation Use for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-diagnostic-order-event-for-R4 | Cross-version VS for R2.Diagnostic Order Event Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-diet-type-for-R4 | Cross-version VS for R2.Diet Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-digital-media-subtype-for-R4 | Cross-version VS for R2.Media SubType for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-encounter-reason-for-R4 | Cross-version VS for R2.Encounter Reason Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-entformula-type-for-R4 | Cross-version VS for R2.Enteral Formula Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-flag-code-for-R4 | Cross-version VS for R2.Flag Code for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-focal-subject-for-R4 | Cross-version VS for R2.Focal Subject Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-food-type-for-R4 | Cross-version VS for R2.Food Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-goal-start-event-for-R4 | Cross-version VS for R2.GoalStartEvent for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-immunization-reason-for-R4 | Cross-version VS for R2.Immunization Reason Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-investigation-sets-for-R4 | Cross-version VS for R2.Condition/Diagnosis Certainty for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-manifestation-codes-for-R4 | Cross-version VS for R2.SNOMED CT Clinical Findings for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-manifestation-or-symptom-for-R4 | Cross-version VS for R2.Manifestation and Symptom Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-media-view-for-R4 | Cross-version VS for R2.Media Collection View/Projection for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-medication-codes-for-R4 | Cross-version VS for R2.SNOMED CT Medication Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-medication-form-codes-for-R4 | Cross-version VS for R2.SNOMED CT Form Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-medication-package-form-codes-for-R4 | Cross-version VS for R2.SNOMED CT Form Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-modified-foodtype-for-R4 | Cross-version VS for R2.Texture Modified Food Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-no-immunization-reason-for-R4 | Cross-version VS for R2.Immunization Reasons for Not Immunizing Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-nutrient-code-for-R4 | Cross-version VS for R2.Nutrient Modifier Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-observation-methods-for-R4 | Cross-version VS for R2.Observation Methods for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-participant-role-for-R4 | Cross-version VS for R2.Participant Roles for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-performer-role-for-R4 | Cross-version VS for R2.Procedure Performer Role Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-procedure-category-for-R4 | Cross-version VS for R2.Procedure Category Codes (SNOMED CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-procedure-code-for-R4 | Cross-version VS for R2.Procedure Codes (SNOMED CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-procedure-followup-for-R4 | Cross-version VS for R2.Procedure Follow up Codes (SNOMED CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-procedure-not-performed-reason-for-R4 | Cross-version VS for R2.Procedure Not Performed Reason (SNOMED-CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-procedure-outcome-for-R4 | Cross-version VS for R2.Procedure Outcome Codes (SNOMED CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-procedure-reason-for-R4 | Cross-version VS for R2.Procedure Reason Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-profile-code-for-R4 | Cross-version VS for R2.Structure Definition Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-allergyintolerance-reason-refuted-for-R4 | Cross-version VS for R2.Reasons for refuting allergy or intolerance codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-communication-reason-not-performed-for-R4 | Cross-version VS for R2.Communication reason not performed codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-condition-certainty-for-R4 | Cross-version VS for R2.Condition/Diagnosis Certainty for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-deviceuserequest-reason-rejected-for-R4 | Cross-version VS for R2.Reasons for rejecting device use request codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-diagnosticorder-reason-rejected-for-R4 | Cross-version VS for R2.Reasons for rejecting a diagnostic order for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-encounter-canceled-reason-for-R4 | Cross-version VS for R2.Reasons for canceled or refused encounter codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-encounter-condition-role-for-R4 | Cross-version VS for R2.SNOMED CT Qualifier For Type of Diagnosis Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-goal-reason-rejected-for-R4 | Cross-version VS for R2.Reasons for rejecting goal codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-medication-dose-type-for-R4 | Cross-version VS for R2.SNOMED CT Dosages Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-observation-body-position-for-R4 | Cross-version VS for R2.Body Position for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-patient-disability-for-R4 | Cross-version VS for R2.Disability Value Set for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-priority-for-R4 | Cross-version VS for R2.SNOMED CT Priorities Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-qicore-referralrequest-reason-rejected-for-R4 | Cross-version VS for R2.Reasons for rejecting a referral request for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-questionnaire-answers-for-R4 | Cross-version VS for R2.Questionnaire Answer Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-questionnaire-category-for-R4 | Cross-version VS for R2.Questionnaire Category Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-referencerange-meaning-for-R4 | Cross-version VS for R2.Observation Reference Range Meaning Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-route-codes-for-R4 | Cross-version VS for R2.SNOMED CT Route Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-sdcde-dataelement-sdccode-for-R4 | Cross-version VS for R2.DataElement SDC Concept for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-specimen-collection-method-for-R4 | Cross-version VS for R2.SpecimenCollectionMethod for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-specimen-container-type-for-R4 | Cross-version VS for R2.SpecimenContainer for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-substance-code-for-R4 | Cross-version VS for R2.Substance Code for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-substance-sct-for-R4 | Cross-version VS for R2.DAF SNOMED CT Substances Other Than Clinical Drugs for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-supplement-type-for-R4 | Cross-version VS for R2.Supplement Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-supplyrequest-when-for-R4 | Cross-version VS for R2.Supply Request When for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-texture-code-for-R4 | Cross-version VS for R2.Texture Modifier Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-uslab-clinical-findings-for-R4 | Cross-version VS for R2.SNOMED CT Clinical Findings for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-uslab-obs-codedresults-for-R4 | Cross-version VS for R2.SNOMED CT Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-uslab-spec-bodysite-for-R4 | Cross-version VS for R2.USLab Specimen Body Site for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-uslab-spec-type-for-R4 | Cross-version VS for R2.USLab Specimen Type for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4.r4b#0.0.1-snapshot-2 | R2-vaccination-protocol-dose-target-for-R4 | Cross-version VS for R2.Vaccination Protocol Dose Target Codes for use in FHIR R4 |
| ca.on.oh-dhdr#4.0.2-alpha1.0.6 | dhdr-medication-repeat-pattern | Medication Repeat Pattern |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-boston-bowel-preparation-scale | Colonoscopy Report Boston Bowel Preparation Scale |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-complication | Colonoscopy Report Complications |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-complication-consequence | Colonoscopy Report Complication Consequences |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-current-medication | Colonoscopy Report Current Medication |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-followup | Colonoscopy Report Follow Up |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-medication | Colonoscopy Report Medication |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-medication-krg | KRG Medication |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-method-tissue-removal-biopsy | Colonoscopy Report Tissue Removal Method |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-normal-abnormal | Colonoscopy Report Normal/Abnormal |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-paris-polyp-classification | Colonoscopy Report Colonoscopy Paris Polyp Classification |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-relevant-conditions | Colonoscopy Report Relevant Conditions |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-sedation-level | Colonoscopy Report Sedation Level |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-segment-lesion | Colonoscopy Report Segment Lesion |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-segment-reached | Colonoscopy Report Segment Lesion |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-type | Colonoscopy Type |
| colonoscopyreport.no#0.7.23 | no-coloscopy-segment-reached | Colonoscopy Report Segment Reached |
| colonoscopyreport.no#0.7.23 | no-procedure-performer-function | Conoloscopy Report Performer Function |
| colonoscopyreport.no#0.7.23 | no-colonoscopy-procedure-reason-gastronet | Colonoscopy Report Indication |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-activity-reason-for-R4B | Cross-version VS for R3.Activity Reason for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-additional-instruction-codes-for-R4B | Cross-version VS for R3.SNOMED CT Additional Dosage Instructions for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-administration-method-codes-for-R4B | Cross-version VS for R3.SNOMED CT Administration Method Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-adverse-event-type-for-R4B | Cross-version VS for R3.SNOMED CT Clinical Findings for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-allergyintolerance-code-for-R4B | Cross-version VS for R3.AllergyIntolerance Substance/Product, Condition and Negation Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-animal-breeds-for-R4B | Cross-version VS for R3.AnimalBreeds for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-animal-species-for-R4B | Cross-version VS for R3.AnimalSpecies for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-approach-site-codes-for-R4B | Cross-version VS for R3.SNOMED CT Anatomical Structure for Administration Site Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-body-site-for-R4B | Cross-version VS for R3.SNOMED CT Body Structures for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-bodysite-laterality-for-R4B | Cross-version VS for R3.Laterality for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-bodysite-relative-location-for-R4B | Cross-version VS for R3.Bodysite Location Qualifier for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-c80-facilitycodes-for-R4B | Cross-version VS for R3.Facility Type Code Value Set for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-c80-practice-codes-for-R4B | Cross-version VS for R3.Practice Setting Code Value Set for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-care-plan-activity-for-R4B | Cross-version VS for R3.Care Plan Activity for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-care-plan-activity-outcome-for-R4B | Cross-version VS for R3.Care Plan Activity Outcome for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-care-plan-category-for-R4B | Cross-version VS for R3.Care Plan Category for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-clinical-findings-for-R4B | Cross-version VS for R3.SNOMED CT Clinical Findings for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-clinicalimpression-prognosis-for-R4B | Cross-version VS for R3.Clinical Impression Prognosis for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-condition-cause-for-R4B | Cross-version VS for R3.Condition Cause Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-condition-code-for-R4B | Cross-version VS for R3.Condition/Problem/Diagnosis Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-condition-outcome-for-R4B | Cross-version VS for R3.Condition Outcome Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-condition-predecessor-for-R4B | Cross-version VS for R3.Condition Predecessor Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-condition-severity-for-R4B | Cross-version VS for R3.Condition/Diagnosis Severity for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-condition-stage-for-R4B | Cross-version VS for R3.Condition Stage for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-consistency-type-for-R4B | Cross-version VS for R3.Fluid Consistency Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-dataelement-sdcobjectclass-for-R4B | Cross-version VS for R3.DataElement SDC Object Class for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-dataelement-sdcobjectclassproperty-for-R4B | Cross-version VS for R3.DataElement SDC Object Class for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-designation-use-for-R4B | Cross-version VS for R3.Designation Use for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-device-action-for-R4B | Cross-version VS for R3.Procedure Device Action Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-device-kind-for-R4B | Cross-version VS for R3.FHIR Device Types for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-diet-type-for-R4B | Cross-version VS for R3.Diet Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-digital-media-subtype-for-R4B | Cross-version VS for R3.Media SubType for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-encounter-reason-for-R4B | Cross-version VS for R3.Encounter Reason Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-entformula-type-for-R4B | Cross-version VS for R3.Enteral Formula Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-flag-code-for-R4B | Cross-version VS for R3.Flag Code for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-focal-subject-for-R4B | Cross-version VS for R3.Focal Subject Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-food-type-for-R4B | Cross-version VS for R3.Food Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-goal-start-event-for-R4B | Cross-version VS for R3.GoalStartEvent for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-immunization-reason-for-R4B | Cross-version VS for R3.Immunization Reason Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-immunization-recommendation-target-disease-for-R4B | Cross-version VS for R3.Immunization Recommendation Target Disease Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-investigation-sets-for-R4B | Cross-version VS for R3.Investigation Type for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-manifestation-or-symptom-for-R4B | Cross-version VS for R3.Manifestation and Symptom Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-media-view-for-R4B | Cross-version VS for R3.Media Collection View/Projection for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-medication-as-needed-reason-for-R4B | Cross-version VS for R3.SNOMED CT Medication As Needed Reason Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-medication-codes-for-R4B | Cross-version VS for R3.SNOMED CT Medication Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-medication-form-codes-for-R4B | Cross-version VS for R3.SNOMED CT Form Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-modified-foodtype-for-R4B | Cross-version VS for R3.Texture Modified Food Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-no-immunization-reason-for-R4B | Cross-version VS for R3.Immunization Reasons for Not Immunizing Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-nutrient-code-for-R4B | Cross-version VS for R3.Nutrient Modifier Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-observation-methods-for-R4B | Cross-version VS for R3.Observation Methods for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-participant-role-for-R4B | Cross-version VS for R3.Participant Roles for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-performer-role-for-R4B | Cross-version VS for R3.Procedure Performer Role Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-procedure-category-for-R4B | Cross-version VS for R3.Procedure Category Codes (SNOMED CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-procedure-code-for-R4B | Cross-version VS for R3.Procedure Codes (SNOMED CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-procedure-followup-for-R4B | Cross-version VS for R3.Procedure Follow up Codes (SNOMED CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-procedure-not-performed-reason-for-R4B | Cross-version VS for R3.Procedure Not Performed Reason (SNOMED-CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-procedure-outcome-for-R4B | Cross-version VS for R3.Procedure Outcome Codes (SNOMED CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-procedure-reason-for-R4B | Cross-version VS for R3.Procedure Reason Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-profile-code-for-R4B | Cross-version VS for R3.Structure Definition Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-questionnaire-answers-for-R4B | Cross-version VS for R3.Questionnaire Answer Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-questionnaire-category-for-R4B | Cross-version VS for R3.Questionnaire Category Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-reason-medication-not-given-codes-for-R4B | Cross-version VS for R3.SNOMED CT Reason Medication Not Given Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-reason-medication-not-taken-codes-for-R4B | Cross-version VS for R3.SNOMED CT Drugs not taken/completed Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-referencerange-appliesto-for-R4B | Cross-version VS for R3.Observation Reference Range Applies To Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-referral-type-for-R4B | Cross-version VS for R3.SNOMED CT Patient Referral for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-route-codes-for-R4B | Cross-version VS for R3.SNOMED CT Route Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-sequence-species-for-R4B | Cross-version VS for R3.SNOMED CT Codes for species for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-specimen-collection-method-for-R4B | Cross-version VS for R3.FHIR Specimen Collection Method for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-specimen-container-type-for-R4B | Cross-version VS for R3.SpecimenContainer for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-substance-code-for-R4B | Cross-version VS for R3.Substance Code for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-supplement-type-for-R4B | Cross-version VS for R3.Supplement Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-supply-item-for-R4B | Cross-version VS for R3.SNOMED CT Supply Item for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-texture-code-for-R4B | Cross-version VS for R3.Texture Modifier Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-use-context-for-R4B | Cross-version VS for R3.Context of Use ValueSet for use in FHIR R4B |
| hl7.fhir.uv.xver-r3.r4b.r4#0.0.1-snapshot-2 | R3-vaccination-protocol-dose-target-for-R4B | Cross-version VS for R3.Vaccination Protocol Dose Target Codes for use in FHIR R4B |
| acme.canada#0.0.4 | EaseOfRespirationVS | Ease of Respiration Value Set |
| ihe.pharm.mpd.r4#1.0.0-comment-2 | substance-codes | SNOMED CT Substance Codes |
| ee.fhir.terminology#1.0.0 | clinical-specialty | Clinical Specialty |
| ee.fhir.terminology#1.0.0 | eestkoste-liik | Eestkoste liik |
| tiplu.maia.schnittstellendefinition#1.2.0 | MaiaServiceRequestIntent | Maia Service Request Intent Value Set |
| ca.on.oh.setp#1.0.42 | EncounterTypeCode | CHI-EncounterTypeCode |
| ca.on.oh.setp#1.0.42 | indigenousidentitycode | Indigenous Identity Code |
| ca.on.oh.setp#1.0.42 | ethnicity-race | IAR Ethnicity Race |
| ca.on.oh.setp#1.0.42 | irrs-frequency | irrs-frequency |
| ca.on.oh.setp#1.0.42 | irrs-route-of-administration | irrs-route-of-administration |
| ca.on.oh.setp#1.0.42 | irrs-service-delivery-location-role-type | irrs-service-delivery-location-role-type |
| myhie.v4-test#0.0.1-alpha | adverse-event-event-my-core | ValueSetAdverseEventEvent (MY Core) |
| myhie.v4-test#0.0.1-alpha | allergy-manifestation-my-core | value-set-allergy-manifestation-my-core |
| myhie.v4-test#0.0.1-alpha | allergy-negation-my-core | ValueSetAllergyNegation (MY Core) |
| myhie.v4-test#0.0.1-alpha | child-identification-type-my-core | ValueSetChildIdentificationType (MY Core) |
| myhie.v4-test#0.0.1-alpha | developmental-milestone-my-core | ValueSetDevelopmentalMilestone (MY Core) |
| myhie.v4-test#0.0.1-alpha | glucose-level-my-core | ValueSetGlucoseLevel(MY Core) |
| myhie.v4-test#0.0.1-alpha | observation-glucose-my-core | ValueSetObservationGlucose (MY Core) |
| myhie.v4-test#0.0.1-alpha | observation-social-history-my-core | ValueSetObservationSocialHistory (MY Core) |
| myhie.v4-test#0.0.1-alpha | procedure-category-my-core | ValueSetProcedureCategory (MY Core) |
| myhie.v4-test#0.0.1-alpha | procedure-code-my-core | ValueSetProcedureCode (MY Core) |
| myhie.v4-test#0.0.1-alpha | side-my-core | ValueSetSide (MY Core) |
| myhie.v4-test#0.0.1-alpha | site-my-core | ValueSetSite (MY Core) |
| de.medizininformatikinitiative.kerndatensatz.seltene#2026.0.1 | mii-vs-seltene-blutgruppe | MII VS SE Blutgruppe |
| de.medizininformatikinitiative.kerndatensatz.seltene#2026.0.1 | mii-vs-seltene-clinical-diagnosis-category | MII VS SE Clinical Diagnosis Category |
| de.medizininformatikinitiative.kerndatensatz.seltene#2026.0.1 | mii-vs-seltene-genetic-basis | MII VS SE Genetic Basis |
| de.medizininformatikinitiative.kerndatensatz.seltene#2026.0.1 | mii-vs-seltene-symptom-change-status-combined | MII VS Seltene Erkrankungen Symptom Change Status (Combined) |
| de.medizininformatikinitiative.kerndatensatz.seltene#2026.0.1 | mii-vs-seltene-syndrome-category | Syndrome Category Value Set |
| de.medizininformatikinitiative.kerndatensatz.seltene#2026.0.1 | von-seltene-betroffen-vs | Von SE betroffen Value Set |
| de.gematik.schuleingangsuntersuchung#1.0.0 | ja-nein-warteliste | JaNeinWartelisteVS |
| rapportendoscopiequebec.test#0.0.69 | IntervenantEndoscopiste | IntervenantEndoscopiste |
| rapportendoscopiequebec.test#0.0.69 | IntervenantResident | IntervenantResident |
| rapportendoscopiequebec.test#0.0.69 | practitioner-role | Practitioner role |
| hl7.fhir.uv.xver-r4.r5#0.1.0 | R4-animal-breeds-for-R5 | Cross-version ValueSet R4.AnimalBreeds for use in FHIR R5 |
| hl7.fhir.uv.xver-r4.r5#0.1.0 | R4-animal-species-for-R5 | Cross-version ValueSet R4.AnimalSpecies for use in FHIR R5 |
| hl7.fhir.uv.xver-r4.r5#0.1.0 | R4-focal-subject-for-R5 | Cross-version ValueSet R4.FocalSubjectCodes for use in FHIR R5 |
| hl7.fhir.uv.xver-r4.r5#0.1.0 | R4-questionnaire-category-for-R5 | Cross-version ValueSet R4.QuestionnaireCategoryCodes for use in FHIR R5 |
| ans.fr.nos#1.5.0 | JDV-J148-ReferenceRangeAppliesTo-CISIS | JDV_J148-ReferenceRangeAppliesTo-CISIS |
| ans.fr.nos#1.5.0 | JDV-J149-BodySiteBP-ENS | JDV_J149-BodySiteBP-ENS |
| ans.fr.nos#1.5.0 | JDV-J161-Lateralite-CISIS | JDV_J161-Lateralite-CISIS |
| ans.fr.nos#1.5.0 | JDV-J276-SNOMED-UPNOS | JDV_J276-SNOMED-UPNOS |
| iteyes.myhw.core#1.1.9 | Condition-KCD-8 | myhw-fhir-condition-kcd-8 |
| ca.on.oh-seris#0.11.0-alpha1.0.5 | Race | Race |
| ca.on.oh-seris#0.11.0-alpha1.0.5 | anaesthesia-type | Anaesthesia Type |
| ca.on.oh-seris#0.11.0-alpha1.0.5 | GenderIdentity | Gender Identity |
| ca.on.oh-seris#0.11.0-alpha1.0.5 | hospital-service | Hospital Service |
| ca.on.oh-seris#0.11.0-alpha1.0.5 | IndigenousIdentity | Indigenous Identity |
| ca.on.oh-seris#0.11.0-alpha1.0.5 | observation-types | Observation Types |
| ca.on.oh-seris#0.11.0-alpha1.0.5 | procedure-complication | Procedure Complication |
| de.medizininformatikinitiative.kerndatensatz.diagnose#2025.0.1 | mii-vs-diagnose-bodystructure-snomed | MII VS Diagnose BodyStructure SNOMED |
| de.medizininformatikinitiative.kerndatensatz.diagnose#2025.0.1 | diagnoses-sct | MII VS Diagnose Diagnose-Codes SNOMED |
| hl7.fhir.uv.termchangeset.r4b#1.0.0-ballot | description-acceptability-vs | Description Acceptability Value Set |
| hl7.fhir.cl.corecl#1.7.0 | VSDiagnosticosSCT | Diagnósticos SNOMED y Ausente o Desconocido |
| de.gematik.dipag#1.0.8 | DiPagVerkehrsmittel | Digitale PatientenrechnungVerkehrsmittel |
| hl7.fhir.us.core.r4b#8.0.0 | us-core-condition-code-current | US Core Condition Codes Current |
| nictiz.fhir.nl.r4.nl-core#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.9--20220610000000 | ContainerTypeCodelijst |
| nictiz.fhir.nl.r4.nl-core#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.131.11.2--20220301153357 | VaccinatieAanleidingWaardelijst |
| nictiz.fhir.nl.r4.nl-core#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.131.11.4--20220301181306 | VaccinatieIndicatieWaardelijst |
| nictiz.fhir.nl.r4.nl-core#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.131.11.3--20220301175614 | ZiekteWaarTegenGevaccineerdWordtWaardelijst |
| de.fhir.terminologie-basis#1.0.0-alpha1 | EkgAbleitungenVS | SNOMED CT codes der EKG Ableitungen |
| de.fhir.terminologie-basis#1.0.0-alpha1 | VitalSignDE-Atemfrequenz-SNOMED-CT | VitalSignDE_Atemfrequenz_SNOMED_CT |
| de.fhir.terminologie-basis#1.0.0-alpha1 | VitalSignDE-Herzfrequenz-SNOMED-CT | VitalSignDE_Herzfrequenz_SNOMED_CT |
| de.fhir.terminologie-basis#1.0.0-alpha1 | VitalSignDE-Koerpergewicht-SNOMED-CT | VitalSignDE_Koerpergewicht_SNOMED_CT |
| de.fhir.terminologie-basis#1.0.0-alpha1 | VitalSignDE-Koerpergroesse-SNOMED-CT | VitalSignDE_Koerpergroesse_SNOMED_CT |
| de.fhir.terminologie-basis#1.0.0-alpha1 | VitalSignDE-Koerpertemperatur-SNOMED-CT | VitalSignDE_Koerperkerntemperatur_SNOMED_CT |
| de.fhir.terminologie-basis#1.0.0-alpha1 | VitalSignDE-Kopfumfang-SNOMED-CT | VitalSignDE_Kopfumfang_SNOMED_CT |
| de.fhir.terminologie-basis#1.0.0-alpha1 | VitalSignDE-Sauerstoffsaettigung-SNOMED-CT | VitalSignDE_Sauerstoffsaettigung_SNOMED_CT |
| de.fhir.terminologie-basis#1.0.0-alpha1 | lebensphase-de | LebensphaseDe ValueSet |
| rki.demis.r4.core#1.23.2 | answerSetABVP | AnswerSet für Arboviren (sonstige) |
| rki.demis.r4.core#1.23.2 | answerSetACBP | AnswerSet für Acinetobacter spp. bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| rki.demis.r4.core#1.23.2 | answerSetADEP | AnswerSet für Adenoviren; Meldepflicht bei akuter Infektion für Nachweise aus allen Körpermaterialien |
| rki.demis.r4.core#1.23.2 | answerSetADVP | AnswerSet für Adenoviren; Meldepflicht nur für den direkten Nachweis im Konjunktivalabstrich |
| rki.demis.r4.core#1.23.2 | answerSetASTP | AnswerSet für Astroviren |
| rki.demis.r4.core#1.23.2 | answerSetBANP | AnswerSet für Bacillus anthracis |
| rki.demis.r4.core#1.23.2 | answerSetBOBP | AnswerSet für (Lyme-) Borreliose, Borrelia burgdorferi |
| rki.demis.r4.core#1.23.2 | answerSetBORP | AnswerSet für Borrelia recurrentis |
| rki.demis.r4.core#1.23.2 | answerSetBOVP | AnswerSet für humanpathogene Bornaviren; Meldepflicht nur für den direkten Nachweis |
| rki.demis.r4.core#1.23.2 | answerSetBPSP | AnswerSet für Bordetella pertussis, Bordetella parapertussis |
| rki.demis.r4.core#1.23.2 | answerSetBRUP | AnswerSet für Brucella sp. |
| rki.demis.r4.core#1.23.2 | answerSetCAMP | AnswerSet für Campylobacter spp. (darmpathogen) |
| rki.demis.r4.core#1.23.2 | answerSetCAUP | AnswerSet für Candida auris; Meldepflicht nur für den direkten Nachweis |
| rki.demis.r4.core#1.23.2 | answerSetCHLP | AnswerSet für Chlamydia psittaci |
| rki.demis.r4.core#1.23.2 | answerSetCKVP | AnswerSet für Chikungunya-Virus |
| rki.demis.r4.core#1.23.2 | answerSetCLOP | AnswerSet für Clostridium botulinum oder Toxinnachweis |
| rki.demis.r4.core#1.23.2 | answerSetCLTP | AnswerSet für Tetanus, Clostridium tetani |
| rki.demis.r4.core#1.23.2 | answerSetCORP | AnswerSet für Corynebacterium spp. (Toxin bildend) |
| rki.demis.r4.core#1.23.2 | answerSetCOXP | AnswerSet für Coxiella burnetii |
| rki.demis.r4.core#1.23.2 | answerSetCRYP | AnswerSet für humanpathogene Cryptosporidium sp. |
| rki.demis.r4.core#1.23.2 | answerSetCVDP | AnswerSet für Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) |
| rki.demis.r4.core#1.23.2 | answerSetCVSP | AnswerSet für Severe-Acute-Respiratory-Syndrome-Coronavirus (SARS-CoV) |
| rki.demis.r4.core#1.23.2 | answerSetCYMP | AnswerSet für Cytomegalie, Cytomegalievirus |
| rki.demis.r4.core#1.23.2 | answerSetDENP | AnswerSet für Denguevirus |
| rki.demis.r4.core#1.23.2 | answerSetEAHP | AnswerSet für Amoebiasis, Entamoeba histolytica |
| rki.demis.r4.core#1.23.2 | answerSetEBCP | AnswerSet für Enterobacterales bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| rki.demis.r4.core#1.23.2 | answerSetEBVP | AnswerSet für Ebolavirus |
| rki.demis.r4.core#1.23.2 | answerSetECOP | AnswerSet für Escherichia coli (sonstige darmpathogene Stämme) |
| rki.demis.r4.core#1.23.2 | answerSetEHCP | AnswerSet für E. coli (enterohämorrhagische Stämme) (EHEC) |
| rki.demis.r4.core#1.23.2 | answerSetETVP | AnswerSet für Enteroviren |
| rki.demis.r4.core#1.23.2 | answerSetFRTP | AnswerSet für Francisella tularensis |
| rki.demis.r4.core#1.23.2 | answerSetFSVP | AnswerSet für FSME-Virus |
| rki.demis.r4.core#1.23.2 | answerSetGBSP | AnswerSet für Gruppe-B-Streptokokken (GBS); Meldepflicht nur für den direkten Nachweis bei Schwangeren und Neugeborenen |
| rki.demis.r4.core#1.23.2 | answerSetGFVP | AnswerSet für Gelbfiebervirus |
| rki.demis.r4.core#1.23.2 | answerSetGILP | AnswerSet für Giardia lamblia |
| rki.demis.r4.core#1.23.2 | answerSetHAVP | AnswerSet für Hepatitis-A-Virus |
| rki.demis.r4.core#1.23.2 | answerSetHBVP | AnswerSet für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
| rki.demis.r4.core#1.23.2 | answerSetHCVP | AnswerSet für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
| rki.demis.r4.core#1.23.2 | answerSetHDVP | AnswerSet für Hepatitis-D-Virus; Meldepflicht für alle Nachweise |
| rki.demis.r4.core#1.23.2 | answerSetHEVP | AnswerSet für Hepatitis-E-Virus |
| rki.demis.r4.core#1.23.2 | answerSetHFAP | AnswerSet für Andere Erreger hämorrhagischer Fieber |
| rki.demis.r4.core#1.23.2 | answerSetHFMP | AnswerSet für Hand-Fuß-Mund-Krankheit |
| rki.demis.r4.core#1.23.2 | answerSetHINP | AnswerSet für Haemophilus influenzae; Meldepflicht nur für den direkten Nachweis aus Liquor oder Blut |
| rki.demis.r4.core#1.23.2 | answerSetHTVP | AnswerSet für Hantavirus |
| rki.demis.r4.core#1.23.2 | answerSetINVP | AnswerSet für Influenzavirus; Meldepflicht nur für den direkten Nachweis |
| rki.demis.r4.core#1.23.2 | answerSetLEGP | AnswerSet für Legionella sp. |
| rki.demis.r4.core#1.23.2 | answerSetLEPP | AnswerSet für humanpathogene Leptospira sp. |
| rki.demis.r4.core#1.23.2 | answerSetLISP | AnswerSet für Listeria monocytogenes; Meldepflicht nur für den direkten Nachweis aus Blut, Liquor oder anderen normalerweise sterilen Substraten sowie aus Abstrichen von Neugeborenen |
| rki.demis.r4.core#1.23.2 | answerSetLSVP | AnswerSet für Lassavirus |
| rki.demis.r4.core#1.23.2 | answerSetMBVP | AnswerSet für Marburgvirus |
| rki.demis.r4.core#1.23.2 | answerSetMPMP | AnswerSet für Mycoplasmen |
| rki.demis.r4.core#1.23.2 | answerSetMPVP | AnswerSet für Mumpsvirus |
| rki.demis.r4.core#1.23.2 | answerSetMPXP | AnswerSet für Orthopockenviren (Mpoxvirus) |
| rki.demis.r4.core#1.23.2 | answerSetMRAP | AnswerSet für Staphylococcus aureus (Methicillin-resistente Stämme); Meldepflicht nur für den Nachweis aus Blut oder Liquor |
| rki.demis.r4.core#1.23.2 | answerSetMRSP | AnswerSet für Middle-East-Respiratory-Syndrome-Coronavirus (MERS-CoV) |
| rki.demis.r4.core#1.23.2 | answerSetMSVP | AnswerSet für Masernvirus |
| rki.demis.r4.core#1.23.2 | answerSetMYLP | AnswerSet für Mycobacterium leprae |
| rki.demis.r4.core#1.23.2 | answerSetMYTP | AnswerSet für Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis; Meldepflicht für den direkten Erregernachweis sowie nachfolgend für das Ergebnis der Resistenzbestimmung; vorab auch für den Nachweis säurefester Stäbchen im Sputum |
| rki.demis.r4.core#1.23.2 | answerSetNEIP | AnswerSet für Neisseria meningitidis; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, hämorrhagischen Hautinfiltraten oder anderen normalerweise sterilen Substraten |
| rki.demis.r4.core#1.23.2 | answerSetNOVP | AnswerSet für Norovirus |
| rki.demis.r4.core#1.23.2 | answerSetOPXP | AnswerSet für Orthopockenviren (sonstige Orthopockenviren) |
| rki.demis.r4.core#1.23.2 | answerSetPINP | AnswerSet für Parainfluenzavirus |
| rki.demis.r4.core#1.23.2 | answerSetPKVP | AnswerSet für Orthopockenviren (Variolavirus) |
| rki.demis.r4.core#1.23.2 | answerSetPLAP | AnswerSet für Plasmodium spp. (Malaria) |
| rki.demis.r4.core#1.23.2 | answerSetPOVP | AnswerSet für Poliovirus |
| rki.demis.r4.core#1.23.2 | answerSetPVBP | AnswerSet für Ringelröteln, Parvovirus B 19 |
| rki.demis.r4.core#1.23.2 | answerSetRBVP | AnswerSet für Rabiesvirus |
| rki.demis.r4.core#1.23.2 | answerSetRICP | AnswerSet für Rickettsia prowazekii |
| rki.demis.r4.core#1.23.2 | answerSetRSVP | AnswerSet für Respiratorisches-Synzytial-Virus |
| rki.demis.r4.core#1.23.2 | answerSetRTVP | AnswerSet für Rotavirus |
| rki.demis.r4.core#1.23.2 | answerSetRUVP | AnswerSet für Rubellavirus |
| rki.demis.r4.core#1.23.2 | answerSetSALP | AnswerSet für Salmonella (sonstige) |
| rki.demis.r4.core#1.23.2 | answerSetSHIP | AnswerSet für Shigella sp. |
| rki.demis.r4.core#1.23.2 | answerSetSPAP | AnswerSet für Salmonella Paratyphi; Meldepflicht für alle direkten Nachweise |
| rki.demis.r4.core#1.23.2 | answerSetSPNP | AnswerSet für Streptococcus pneumoniae; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, Gelenkpunktat oder anderen normalerweise sterilen Substraten |
| rki.demis.r4.core#1.23.2 | answerSetSPYP | AnswerSet für Scharlach, Beta-hämolysierenden Streptokokken der Gruppe A |
| rki.demis.r4.core#1.23.2 | answerSetSTYP | AnswerSet für Salmonella Typhi; Meldepflicht für alle direkten Nachweise |
| rki.demis.r4.core#1.23.2 | answerSetTRIP | AnswerSet für Trichinella spiralis |
| rki.demis.r4.core#1.23.2 | answerSetVCHP | AnswerSet für Vibrio spp. (humanpathogen); soweit ausschließlich eine Ohrinfektion vorliegt nur bei Vibrio cholerae |
| rki.demis.r4.core#1.23.2 | answerSetVZVP | AnswerSet für Varizella-Zoster-Virus |
| rki.demis.r4.core#1.23.2 | answerSetWNVP | AnswerSet für West-Nil-Virus |
| rki.demis.r4.core#1.23.2 | answerSetYENP | AnswerSet für Yersinia spp. (darmpathogen) |
| rki.demis.r4.core#1.23.2 | answerSetYPSP | AnswerSet für Yersinia pestis |
| rki.demis.r4.core#1.23.2 | answerSetZKVP | AnswerSet für Zika-Virus |
| rki.demis.r4.core#1.23.2 | materialABVP | Material für Arboviren (sonstige) |
| rki.demis.r4.core#1.23.2 | materialACBP | Material für Acinetobacter spp. bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| rki.demis.r4.core#1.23.2 | materialADEP | Material für Adenoviren; Meldepflicht bei akuter Infektion für Nachweise aus allen Körpermaterialien |
| rki.demis.r4.core#1.23.2 | materialADVP | Material für Adenoviren; Meldepflicht nur für den direkten Nachweis im Konjunktivalabstrich |
| rki.demis.r4.core#1.23.2 | materialASTP | Material für Astroviren |
| rki.demis.r4.core#1.23.2 | materialBANP | Material für Bacillus anthracis |
| rki.demis.r4.core#1.23.2 | materialBOBP | Material für (Lyme-) Borreliose, Borrelia burgdorferi |
| rki.demis.r4.core#1.23.2 | materialBORP | Material für Borrelia recurrentis |
| rki.demis.r4.core#1.23.2 | materialBOVP | Material für humanpathogene Bornaviren; Meldepflicht nur für den direkten Nachweis |
| rki.demis.r4.core#1.23.2 | materialBPSP | Material für Bordetella pertussis, Bordetella parapertussis |
| rki.demis.r4.core#1.23.2 | materialBRUP | Material für Brucella sp. |
| rki.demis.r4.core#1.23.2 | materialCAMP | Material für Campylobacter spp. (darmpathogen) |
| rki.demis.r4.core#1.23.2 | materialCAUP | Material für Candida auris; Meldepflicht nur für den direkten Nachweis |
| rki.demis.r4.core#1.23.2 | materialCHLP | Material für Chlamydia psittaci |
| rki.demis.r4.core#1.23.2 | materialCKVP | Material für Chikungunya-Virus |
| rki.demis.r4.core#1.23.2 | materialCLOP | Material für Clostridium botulinum oder Toxinnachweis |
| rki.demis.r4.core#1.23.2 | materialCLTP | Material für Tetanus, Clostridium tetani |
| rki.demis.r4.core#1.23.2 | materialCORP | Material für Corynebacterium spp. (Toxin bildend) |
| rki.demis.r4.core#1.23.2 | materialCOXP | Material für Coxiella burnetii |
| rki.demis.r4.core#1.23.2 | materialCRYP | Material für humanpathogene Cryptosporidium sp. |
| rki.demis.r4.core#1.23.2 | materialCVDP | Material für Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) |
| rki.demis.r4.core#1.23.2 | materialCVSP | Material für Severe-Acute-Respiratory-Syndrome-Coronavirus (SARS-CoV) |
| rki.demis.r4.core#1.23.2 | materialCYMP | Material für Cytomegalie, Cytomegalievirus |
| rki.demis.r4.core#1.23.2 | materialDENP | Material für Denguevirus |
| rki.demis.r4.core#1.23.2 | materialEAHP | Material für Amoebiasis, Entamoeba histolytica |
| rki.demis.r4.core#1.23.2 | materialEBCP | Material für Enterobacterales bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation |
| rki.demis.r4.core#1.23.2 | materialEBVP | Material für Ebolavirus |
| rki.demis.r4.core#1.23.2 | materialECOP | Material für Escherichia coli (sonstige darmpathogene Stämme) |
| rki.demis.r4.core#1.23.2 | materialEHCP | Material für E. coli (enterohämorrhagische Stämme) (EHEC) |
| rki.demis.r4.core#1.23.2 | materialETVP | Material für Enteroviren |
| rki.demis.r4.core#1.23.2 | materialFRTP | Material für Francisella tularensis |
| rki.demis.r4.core#1.23.2 | materialFSVP | Material für FSME-Virus |
| rki.demis.r4.core#1.23.2 | materialGBSP | Material für Gruppe-B-Streptokokken (GBS); Meldepflicht nur für den direkten Nachweis bei Schwangeren und Neugeborenen |
| rki.demis.r4.core#1.23.2 | materialGFVP | Material für Gelbfiebervirus |
| rki.demis.r4.core#1.23.2 | materialGILP | Material für Giardia lamblia |
| rki.demis.r4.core#1.23.2 | materialHAVP | Material für Hepatitis-A-Virus |
| rki.demis.r4.core#1.23.2 | materialHBVP | Material für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
| rki.demis.r4.core#1.23.2 | materialHCVP | Material für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
| rki.demis.r4.core#1.23.2 | materialHDVP | Material für Hepatitis-D-Virus; Meldepflicht für alle Nachweise |
| rki.demis.r4.core#1.23.2 | materialHEVP | Material für Hepatitis-E-Virus |
| rki.demis.r4.core#1.23.2 | materialHFAP | Material für Andere Erreger hämorrhagischer Fieber |
| rki.demis.r4.core#1.23.2 | materialHFMP | Material für Hand-Fuß-Mund-Krankheit |
| rki.demis.r4.core#1.23.2 | materialHINP | Material für Haemophilus influenzae; Meldepflicht nur für den direkten Nachweis aus Liquor oder Blut |
| rki.demis.r4.core#1.23.2 | materialHTVP | Material für Hantavirus |
| rki.demis.r4.core#1.23.2 | materialINVP | Material für Influenzavirus; Meldepflicht nur für den direkten Nachweis |
| rki.demis.r4.core#1.23.2 | materialLEGP | Material für Legionella sp. |
| rki.demis.r4.core#1.23.2 | materialLEPP | Material für humanpathogene Leptospira sp. |
| rki.demis.r4.core#1.23.2 | materialLISP | Material für Listeria monocytogenes; Meldepflicht nur für den direkten Nachweis aus Blut, Liquor oder anderen normalerweise sterilen Substraten sowie aus Abstrichen von Neugeborenen |
| rki.demis.r4.core#1.23.2 | materialLSVP | Material für Lassavirus |
| rki.demis.r4.core#1.23.2 | materialMBVP | Material für Marburgvirus |
| rki.demis.r4.core#1.23.2 | materialMPMP | Material für Mycoplasmen |
| rki.demis.r4.core#1.23.2 | materialMPVP | Material für Mumpsvirus |
| rki.demis.r4.core#1.23.2 | materialMPXP | Material für Orthopockenviren (Mpoxvirus) |
| rki.demis.r4.core#1.23.2 | materialMRAP | Material für Staphylococcus aureus (Methicillin-resistente Stämme); Meldepflicht nur für den Nachweis aus Blut oder Liquor |
| rki.demis.r4.core#1.23.2 | materialMRSP | Material für Middle-East-Respiratory-Syndrome-Coronavirus (MERS-CoV) |
| rki.demis.r4.core#1.23.2 | materialMSVP | Material für Masernvirus |
| rki.demis.r4.core#1.23.2 | materialMYLP | Material für Mycobacterium leprae |
| rki.demis.r4.core#1.23.2 | materialMYTP | Material für Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis; Meldepflicht für den direkten Erregernachweis sowie nachfolgend für das Ergebnis der Resistenzbestimmung; vorab auch für den Nachweis säurefester Stäbchen im Sputum |
| rki.demis.r4.core#1.23.2 | materialNEIP | Material für Neisseria meningitidis; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, hämorrhagischen Hautinfiltraten oder anderen normalerweise sterilen Substraten |
| rki.demis.r4.core#1.23.2 | materialNOVP | Material für Norovirus |
| rki.demis.r4.core#1.23.2 | materialOPXP | Material für Orthopockenviren (sonstige Orthopockenviren) |
| rki.demis.r4.core#1.23.2 | materialPINP | Material für Parainfluenzavirus |
| rki.demis.r4.core#1.23.2 | materialPKVP | Material für Orthopockenviren (Variolavirus) |
| rki.demis.r4.core#1.23.2 | materialPLAP | Material für Plasmodium spp. (Malaria) |
| rki.demis.r4.core#1.23.2 | materialPOVP | Material für Poliovirus |
| rki.demis.r4.core#1.23.2 | materialPVBP | Material für Ringelröteln, Parvovirus B 19 |
| rki.demis.r4.core#1.23.2 | materialRBVP | Material für Rabiesvirus |
| rki.demis.r4.core#1.23.2 | materialRICP | Material für Rickettsia prowazekii |
| rki.demis.r4.core#1.23.2 | materialRSVP | Material für Respiratorisches-Synzytial-Virus |
| rki.demis.r4.core#1.23.2 | materialRTVP | Material für Rotavirus |
| rki.demis.r4.core#1.23.2 | materialRUVP | Material für Rubellavirus |
| rki.demis.r4.core#1.23.2 | materialSALP | Material für Salmonella (sonstige) |
| rki.demis.r4.core#1.23.2 | materialSHIP | Material für Shigella sp. |
| rki.demis.r4.core#1.23.2 | materialSPAP | Material für Salmonella Paratyphi; Meldepflicht für alle direkten Nachweise |
| rki.demis.r4.core#1.23.2 | materialSPNP | Material für Streptococcus pneumoniae; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, Gelenkpunktat oder anderen normalerweise sterilen Substraten |
| rki.demis.r4.core#1.23.2 | materialSPYP | Material für Scharlach, Beta-hämolysierenden Streptokokken der Gruppe A |
| rki.demis.r4.core#1.23.2 | materialSTYP | Material für Salmonella Typhi; Meldepflicht für alle direkten Nachweise |
| rki.demis.r4.core#1.23.2 | materialTRIP | Material für Trichinella spiralis |
| rki.demis.r4.core#1.23.2 | materialVCHP | Material für Vibrio spp. (humanpathogen); soweit ausschließlich eine Ohrinfektion vorliegt nur bei Vibrio cholerae |
| rki.demis.r4.core#1.23.2 | materialVZVP | Material für Varizella-Zoster-Virus |
| rki.demis.r4.core#1.23.2 | materialWBKP | Material für Krankheitserreger unter Berücksichtigung der Art der Krankheitserreger und der Häufigkeit ihres Nachweises wenn Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit bestehen |
| rki.demis.r4.core#1.23.2 | materialWNVP | Material für West-Nil-Virus |
| rki.demis.r4.core#1.23.2 | materialYENP | Material für Yersinia spp. (darmpathogen) |
| rki.demis.r4.core#1.23.2 | materialYPSP | Material für Yersinia pestis |
| rki.demis.r4.core#1.23.2 | materialZKVP | Material für Zika-Virus |
| rki.demis.r4.core#1.23.2 | method | Nachweismethode |
| rki.demis.r4.core#1.23.2 | substanceBANP | Analyt-Set für Bacillus anthracis |
| rki.demis.r4.core#1.23.2 | substanceCLOP | Analyt-Set für Clostridium botulinum oder Toxinnachweis |
| rki.demis.r4.core#1.23.2 | substanceCLTP | Analyt-Set für Tetanus, Clostridium tetani |
| rki.demis.r4.core#1.23.2 | substanceCORP | Analyt-Set für Corynebacterium spp. (Toxin bildend) |
| rki.demis.r4.core#1.23.2 | substanceDENP | Analyt-Set für Denguevirus |
| rki.demis.r4.core#1.23.2 | substanceEHCP | Analyt-Set für Escherichia coli (enterohämorrhagisch) |
| rki.demis.r4.core#1.23.2 | substanceHBVP | Analyt-Set für Hepatitis-B-Virus; Meldepflicht für alle Nachweise |
| rki.demis.r4.core#1.23.2 | substanceHCVP | Analyt-Set für Hepatitis-C-Virus; Meldepflicht für alle Nachweise |
| rki.demis.r4.core#1.23.2 | substancePLAP | Analyt-Set für Plasmodium spp. (Malaria) |
| rki.demis.r4.core#1.23.2 | substanceVCHP | Analyt-Set für Vibrio spp. (humanpathogen); soweit ausschließlich eine Ohrinfektion vorliegt nur bei Vibrio cholerae |
| de.gematik.isik-vitalparameter#3.1.1 | EkgAbleitungenVS | SNOMED CT codes der EKG Ableitungen |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ACVPU | UK Core ACVPU |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-AlcoholConsumption | UK Core Alcohol Consumption |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-AllergyCode | UK Core Allergy Code |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-AllergyManifestation | UK Core Allergy Manifestation |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-AllergySubstance | UK Core Allergy Substance |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BMI | UK Core BMI |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BloodGlucose | UK Core Blood Glucose |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BloodPressure-AverageDiastolic | UK Core Blood Pressure Average Diastolic |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BloodPressure-AverageSystolic | UK Core Blood Pressure Average Systolic |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BloodPressure-CuffSize | UK Core Blood Pressure Cuff Size |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BloodPressure-DeviceType | UK Core Blood Pressure Device Type |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BloodPressure-Diastolic | UK Core Blood Pressure Diastolic |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BloodPressure-MeasurementMethod | UK Core Blood Pressure Measurement Method |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BloodPressure-Systolic | UK Core Blood Pressure Systolic |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BloodPressure | UK Core Blood Pressure |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BodyHeightMeasurements | UK Core Body Height Measurements |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BodyPosition | UK Core Body Position |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BodySite | UK Core Body Site |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BodyTemperature | UK Core Body Temperature |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-BodyWeightMeasurements | UK Core Body Weight Measurements |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-CareSettingType | UK Core Care Setting Type |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-CompositionCategory | UK Core Composition Category |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ConditionCode | UK Core Condition Code |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-DocumentType | UK Core Document Type |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-EarlyWarningSubScore | UK Core Early Warning Sub Score |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-EarlyWarningTotalScore | UK Core Early Warning Total Score |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-EmergencyCareDischargeStatus | UK Core Emergency Care Discharge Status |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-EncounterType | UK Core Encounter Type |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-HeadCircumferenceMeasurements | UK Core Head Circumference Measurements |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-HeartRate | UK Core Heart Rate |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ImmunizationAdministrationBodySite | UK Core Immunization Administration Body Site |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ImmunizationExplanationReason | UK Core Immunization Explanation Reason |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-InspiredOxygen | UK Core Inspired Oxygen |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ListCode | UK Core List Code |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-MedicationCode | UK Core Medication Code |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-MedicationDosageMethod | UK Core Medication Dosage Method |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-MedicationForm | UK Core Medication Form |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-MedicationPrecondition | UK Core Medication Precondition |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-MedicationTradeFamily | UK Core Medication Trade Family |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ObservationType | UK Core Observation Type |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ObservationVitalSignsType | UK Core Observation Vital Signs Type |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-OxygenSaturation | UK Core Oxygen Saturation |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-PathologyAndLaboratoryMedicineObservables | UK Core Pathology And Laboratory Medicine Observables |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ProcedureCode | UK Core Procedure Code |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ReasonImmunizationNotAdministered | UK Core Reason Immunization Not Administered |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ReportCode | UK Core Report Code |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-RespirationRate | UK Core Respiration Rate |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-ServiceRequestReasonCode | UK Core Service Request Reason Code |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-SourceOfServiceRequest | UK Core Source Of Service Request |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-SpecimenBodySite | UK Core Specimen Body Site |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-SpecimenType | UK Core Specimen Type |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-SubstanceOrProductAdministrationRoute | UK Core Substance Or Product Administration Route |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-TobaccoConsumption | UK Core Tobacco Consumption |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-VaccinationProcedure | UK Core Vaccination Procedure |
| fhir.r4.ukcore.stu3.currentbuild#0.28.0-pre-release | UKCore-VaccinationProcedureSupplementary | UK Core Vaccination Procedure Supplementary |
| healthhub.fhir#2.0.9 | laterality | Health Hub Laterality |
| fhir.outburn.co.il#0.5.5 | amniotic-fluid-index | Codes for Amniotic Fluid Index |
| fhir.outburn.co.il#0.5.5 | diagnostic-procedures | diagnostic procedures during pregnencies codes |
| fhir.outburn.co.il#0.5.5 | observation-clinical-findings-detect | Detected and Not-detected modifiers |
| fhir.outburn.co.il#0.5.5 | observation-clinical-findings-pos-neg | Positive and Negative modifiers |
| fhir.outburn.co.il#0.5.5 | observation-clinical-findings-yes-sus | Yes and Suspected modifiers |
| fhir.outburn.co.il#0.5.5 | jcpm-delivery-complication-treatment-medications | Delivery Complication Treatment Medications codes |
| fhir.outburn.co.il#0.5.5 | jcpm-delivery-complication-treatment-procedures | Delivery Complication Treatment Procedures codes |
| fhir.outburn.co.il#0.5.5 | jcpm-delivery-diagnoses | Delivery Diagnoses codes |
| fhir.outburn.co.il#0.5.5 | jcpm-method-of-delivery-category | Delivery Method Category codes |
| fhir.outburn.co.il#0.5.5 | jcpm-delivery-observation-codes | Delivery Observation Codes codes |
| fhir.outburn.co.il#0.5.5 | jcpm-delivery-medications | Delivery Procedures Medication codes |
| fhir.outburn.co.il#0.5.5 | jcpm-delivery-procedures | Delivery Procedures codes |
| fhir.outburn.co.il#0.5.5 | jcpm-method-of-delivery | Method of Delivery |
| fhir.outburn.co.il#0.5.5 | jcpm-method-of-induced-abortion | Method of Induced Abortion |
| fhir.outburn.co.il#0.5.5 | jcpm-pregnancy-diagnoses | Pregnancy Diagnoses codes |
| fhir.outburn.co.il#0.5.5 | jcpm-pregnancy-findings | Pregnancy Findings codes |
| fhir.outburn.co.il#0.5.5 | condition-umbilical-cord-complications | Umbilical Cord Complications |
| fhir.outburn.co.il#0.5.5 | jcpm-umbilical-obs-code | Umbilical Cord Observation Codes |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-AllergyCertainty-1 | Care Connect Allergy Certainty |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-AllergyCode-1 | Care Connect Allergy Code |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-AllergyExposureRoute-1 | Care Connect Allergy Exposure Route |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-AllergySeverity-1 | Care Connect Allergy Severity |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-CareSettingType-1 | Care Connect Care Setting Type |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ListCode-1 | Care Connect List Code |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ManufacturedMaterialSnCT-1 | Care Connect Manufactured Material SnCT |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-MedicationCode-1 | Care Connect Medication Code |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-MedicationDosageMethod-1 | Care Connect Medication Dosage Method |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-MedicationDosageRoute-1 | Care Connect Medication Dosage Route |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-MedicationForm-1 | Care Connect Medication Form |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-MedicationSupplyType-1 | Care Connect Medication Supply Type |
| nhsdigital.fhir.stu3#1.3.0 | CareConnect-ReligiousAffiliation-1 | Care Connect Religious Affiliation |
| nhsdigital.fhir.stu3#1.3.0 | CarePlanType-1 | Care Plan Type |
| nhsdigital.fhir.stu3#1.3.0 | CareSettingType-1 | Care Setting Type |
| nhsdigital.fhir.stu3#1.3.0 | DCH-AABRHearingTest-Outcome-1 | DCH AABR Hearing Test Outcome |
| nhsdigital.fhir.stu3#1.3.0 | DCH-AOAEHearingTest-Outcome-1 | DCH AOAE Hearing Test Outcome |
| nhsdigital.fhir.stu3#1.3.0 | DCH-APGARScoreObservation-1 | DCH APGAR Score Observation |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ASQ3AssessmentToolType-1 | DCH ASQ 3 Assessment Tool Type |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ASQSEAssessmentToolType-1 | DCH ASQ SE Assessment Tool Type |
| nhsdigital.fhir.stu3#1.3.0 | DCH-AdmissionReason-1 | DCH-AdmissionReason-1 |
| nhsdigital.fhir.stu3#1.3.0 | DCH-AlcoholUse-1 | DCH Alcohol Use |
| nhsdigital.fhir.stu3#1.3.0 | DCH-AssessmentScale-1 | DCH Assessment Scale |
| nhsdigital.fhir.stu3#1.3.0 | DCH-AttemptedDeliveryType-1 | DCH Attempted Delivery Type |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcome-1 | DCH Blood Spot Outcome |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcomeCFSnCT-1 | DCH Blood Spot Outcome CF SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcomeCHTSnCT-1 | DCH Blood Spot Outcome CHT SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcomeGA1SnCT-1 | DCH Blood Spot Outcome GA1 SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcomeHCUSnCT-1 | DCH Blood Spot Outcome HCU SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcomeIVASnCT-1 | DCH Blood Spot Outcome IVA SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcomeMCADDSnCT-1 | DCH Blood Spot Outcome MCADD SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcomeMSUDSnCT-1 | DCH Blood Spot Outcome MSUD SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcomePKUSnCT-1 | DCH Blood Spot Outcome PKU SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-BloodSpotOutcomeSCDSnCT-1 | DCH Blood Spot Outcome SCD SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ClinicalRiskFactorSnCT-1 | DCH Clinical Risk Factor SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-DevelopmentalSkill-1 | DCH Developmental Skill |
| nhsdigital.fhir.stu3#1.3.0 | DCH-DevelopmentalSkillObservation-1 | DCH Developmental Skill Observation |
| nhsdigital.fhir.stu3#1.3.0 | DCH-Diagnosis-Condition-1 | DCH Diagnosis Condition |
| nhsdigital.fhir.stu3#1.3.0 | DCH-DischargeDestinationEmergencyCare-1 | DCH Discharge Destination Emergency Care |
| nhsdigital.fhir.stu3#1.3.0 | DCH-DrugOrSubstanceUse-1 | DCH Drug Or Substance Use |
| nhsdigital.fhir.stu3#1.3.0 | DCH-EducationalAssessmentOutcome-1 | DCH Educational Assessment Outcome |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ExaminationFindingOutcome-1 | DCH Examination Finding Outcome |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ExaminationFindingProcedure-1 | DCH Examination Finding Procedure |
| nhsdigital.fhir.stu3#1.3.0 | DCH-FamilyHistory-1 | DCH Family History |
| nhsdigital.fhir.stu3#1.3.0 | DCH-FeedingMethod-1 | DCH Feeding Method |
| nhsdigital.fhir.stu3#1.3.0 | DCH-FinalDeliveryType-1 | DCH Final Delivery Type |
| nhsdigital.fhir.stu3#1.3.0 | DCH-HeadCircumferenceSnCT-1 | DCH Head Circumference SnCT |
| nhsdigital.fhir.stu3#1.3.0 | DCH-HearingScreeningOutcome-1 | DCH Hearing Screening Outcome |
| nhsdigital.fhir.stu3#1.3.0 | DCH-HouseholdAlcoholStatus-1 | DCH Household Alcohol Status |
| nhsdigital.fhir.stu3#1.3.0 | DCH-HouseholdSmokingStatus-1 | DCH Household Smoking Status |
| nhsdigital.fhir.stu3#1.3.0 | DCH-HouseholdSubstanceStatus-1 | DCH Household Substance Status |
| nhsdigital.fhir.stu3#1.3.0 | DCH-IdenticalTwinIndicator-1 | DCH Identical Twin Indicator |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ImmunisationRoute-1 | DCH Immunisation Route |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ImmunisationSite-1 | DCH Immunisation Site |
| nhsdigital.fhir.stu3#1.3.0 | DCH-IndividualRequirement-Cognitive-1 | DCH Individual Requirement - Cognitive |
| nhsdigital.fhir.stu3#1.3.0 | DCH-IndividualRequirement-CommunicationMethod-1 | DCH Individual Requirement - Communication Method |
| nhsdigital.fhir.stu3#1.3.0 | DCH-IndividualRequirement-CommunicationProfessional-1 | DCH Individual Requirement - Communication Professional |
| nhsdigital.fhir.stu3#1.3.0 | DCH-IndividualRequirement-CommunicationSupport-1 | DCH Individual Requirement - Communication Support |
| nhsdigital.fhir.stu3#1.3.0 | DCH-IndividualRequirement-ContactMethod-1 | DCH Individual Requirement - Contact Method |
| nhsdigital.fhir.stu3#1.3.0 | DCH-IndividualRequirement-GPOptOutIndicator-1 | DCH Individual Requirement - GP Opt Out Indicator |
| nhsdigital.fhir.stu3#1.3.0 | DCH-IndividualRequirement-InformationFormat-1 | DCH Individual Requirement - Information Format |
| nhsdigital.fhir.stu3#1.3.0 | DCH-IndividualRequirement-MobilityNeed-1 | DCH Individual Requirement - Mobility Need |
| nhsdigital.fhir.stu3#1.3.0 | DCH-InformationOrAdviceGiven-1 | DCH Information Or Advice Given |
| nhsdigital.fhir.stu3#1.3.0 | DCH-MaternalProblemsInPregnancy-FamilyHistory-1 | DCH Maternal Problems In Pregnancy Family History |
| nhsdigital.fhir.stu3#1.3.0 | DCH-NCMPWithdrawalReason-1 | DCH NCMP Withdrawal Reason |
| nhsdigital.fhir.stu3#1.3.0 | DCH-Occupation-1 | DCH Employment Status |
| nhsdigital.fhir.stu3#1.3.0 | DCH-OutcomeStatusEyes-1 | DCH Outcome Status Eyes |
| nhsdigital.fhir.stu3#1.3.0 | DCH-OutcomeStatusHeart-1 | DCH Outcome Status Heart |
| nhsdigital.fhir.stu3#1.3.0 | DCH-OutcomeStatusHips-1 | DCH Outcome Status Hips |
| nhsdigital.fhir.stu3#1.3.0 | DCH-OutcomeStatusTestes-1 | DCH Outcome Status Testes |
| nhsdigital.fhir.stu3#1.3.0 | DCH-PersonSmokingStatus-1 | DCH Person Smoking Status |
| nhsdigital.fhir.stu3#1.3.0 | DCH-PhysicalProblemAtBirth-1 | DCH Physical Problem At Birth |
| nhsdigital.fhir.stu3#1.3.0 | DCH-PresentingComplaintEmergencyCare-1 | DCH Presenting Complaint Emergency Care |
| nhsdigital.fhir.stu3#1.3.0 | DCH-Problem-Condition-1 | DCH Problem Condition |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ProblemDuringDelivery-1 | DCH Problem During Delivery |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ProcedureEmergencyCare-1 | DCH Procedure Emergency Care |
| nhsdigital.fhir.stu3#1.3.0 | DCH-PutToBreastIndicator-1 | DCH Put To Breast Indicator |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ReasonForReferral-1 | DCH Reason For Referral |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ReasonNotAdminsitered-1 | DCH Reason Not Adminsitered |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ReferralSourceEmergencyCare-1 | DCH Referral Source Emergency Care |
| nhsdigital.fhir.stu3#1.3.0 | DCH-SafeguardingObservationCode-1 | DCH Safeguarding Observation Code |
| nhsdigital.fhir.stu3#1.3.0 | DCH-ServiceReferredTo-1 | DCH Service Referred To |
| nhsdigital.fhir.stu3#1.3.0 | DCH-SourceOfReferral-1 | DCH Source of Referral |
| nhsdigital.fhir.stu3#1.3.0 | DCH-SpecialEducationalNeed-1 | DCH Special Educational Need |
| nhsdigital.fhir.stu3#1.3.0 | DCH-Weight-1 | DCH Weight |
| nhsdigital.fhir.stu3#1.3.0 | DD4C-AssessmentScaleSimpleReferenceSetSnCT-1 | DD4C Assessment Scale Simple Reference Set |
| nhsdigital.fhir.stu3#1.3.0 | DD4C-LastingPowerAttorney-Code-1 | DD4C Lasting Power Attorney Code |
| nhsdigital.fhir.stu3#1.3.0 | DeviceType-1 | Device Type |
| nhsdigital.fhir.stu3#1.3.0 | DocumentType-1 | Document Type |
| nhsdigital.fhir.stu3#1.3.0 | EOL-AdvanceDecisionToRefuseTreatment-1 | EOL Advance Decision to Refuse Treatment |
| nhsdigital.fhir.stu3#1.3.0 | EOL-AwareOfDecisionSnCT-1 | EOL Prognosis Awareness SnCT |
| nhsdigital.fhir.stu3#1.3.0 | EOL-CPRStatus-Code-1 | EOL CPR Status Code |
| nhsdigital.fhir.stu3#1.3.0 | EOL-ConsentDecisionSnCT-1 | EOL Consent Decision SnCT |
| nhsdigital.fhir.stu3#1.3.0 | EOL-FunctionalStatusType-Code-1 | EOL Functional Status Type Code |
| nhsdigital.fhir.stu3#1.3.0 | EOL-IssueOfAnticipatoryMedicines-1 | EOL Issue of Anticipatory Medicines |
| nhsdigital.fhir.stu3#1.3.0 | EOL-PreferredPlaceDeath-Code-1 | EOL Preferred Place Death Code |
| nhsdigital.fhir.stu3#1.3.0 | EOL-Prognosis-Code-1 | EOL Prognosis Code |
| nhsdigital.fhir.stu3#1.3.0 | EOL-Register-Code-1 | End of Life Register Flag Code |
| nhsdigital.fhir.stu3#1.3.0 | ITK-ADRT-1 | ITK Advance Decision to Refuse Treatment |
| nhsdigital.fhir.stu3#1.3.0 | ITK-AccessibleInformation-1 | ITK Accessible Information |
| nhsdigital.fhir.stu3#1.3.0 | ITK-AllergyFlagCode-1 | Allergy Flag Code |
| nhsdigital.fhir.stu3#1.3.0 | ITK-Cognition-1 | ITK Cognition |
| nhsdigital.fhir.stu3#1.3.0 | ITK-FamilyHistoryIllness-1 | ITK Family History Illness |
| nhsdigital.fhir.stu3#1.3.0 | ITK-LPoA-1 | ITK Lasting Power of Attorney |
| nhsdigital.fhir.stu3#1.3.0 | ITK-Mobility-1 | ITK Mobility |
| nhsdigital.fhir.stu3#1.3.0 | ITK-OccupationalHistory-1 | ITK Occupational History |
| nhsdigital.fhir.stu3#1.3.0 | NIPE-Outcome-1 | NIPE Outcome |
| nhsdigital.fhir.stu3#1.3.0 | NRL-PracticeSetting-1 | NRL Practice Setting |
| nhsdigital.fhir.stu3#1.3.0 | NRL-RecordClass-1 | NRL Record Class |
| nhsdigital.fhir.stu3#1.3.0 | NRL-RecordType-1 | NRL Record Type |
| nhsdigital.fhir.stu3#1.3.0 | NRLS-RecordType-1 | NRLS Record Type |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-AccessibleInformationCommunicationProfessional-1 | AccessibleInformation - Communication Professional |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-AccessibleInformationCommunicationSupport-1 | Accessible Information - Communication Support |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-AccessibleInformationSpecificContactMethod-1 | Accessible Information - Specific Contact Method |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-AccessibleInformationSpecificInformationFormat-1 | Accessible Information - Specific Information Format |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-AdditionalCommunicationSupport-1 | Additional Communication Support |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-AdditionalNeed-1 | Additional Need |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-AdditionalSupport-1 | Additional Support |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-BespokeReasonableAdjustment-1 | Bespoke Reasonable Adjustment |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-CommunityLanguageSupport-1 | Community Language Support |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-EnvironmentAdjustment-1 | Environment Adjustment |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-FlagCode-1 | Reasonable Adjustments Record Flag Code |
| nhsdigital.fhir.stu3#1.3.0 | RARecord-IndividualCareRequirement-1 | Individual Care Requirement |
| nhsdigital.fhir.stu3#1.3.0 | ReasonForReferralSnCT-1 | Reason For Referral SnCT |
| nhsdigital.fhir.stu3#1.3.0 | UEC-ConditionCode-1 | UEC Condition Code |
| nhsdigital.fhir.stu3#1.3.0 | UEC-ObservationCode-1 | UEC Observation Code |
| medmij.fhir.nl.r4.imageavailability#1.0.0-rc.2 | 2.16.840.1.113883.2.4.3.11.60.106.11.19--20240205123345 | AnatomicalRegion(MCWG) |
| medmij.fhir.nl.r4.imageavailability#1.0.0-rc.2 | 2.16.840.1.113883.2.4.3.11.60.106.11.22--20240205133006 | practiceSettingCode(MCWG) |
| medmij.fhir.nl.r4.imageavailability#1.0.0-rc.2 | 2.16.840.1.113883.2.4.3.11.60.133.11.1--20230808113539 | VerrichtingTypeDHDCodelijst met nullFlavor |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-additional-instruction-codes-for-R4 | Cross-version VS for R5.SNOMEDCTAdditionalDosageInstructions for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-administration-method-codes-for-R4 | Cross-version VS for R5.SNOMEDCTAdministrationMethodCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-adverse-event-contributing-factor-for-R4 | Cross-version VS for R5.AdverseEventContributingFactor for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-adverse-event-mitigating-action-for-R4 | Cross-version VS for R5.AdverseEventMitigatingAction for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-adverse-event-outcome-for-R4 | Cross-version VS for R5.AdverseEventOutcome for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-adverse-event-preventive-action-for-R4 | Cross-version VS for R5.AdverseEventPreventiveAction for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-adverse-event-supporting-info-for-R4 | Cross-version VS for R5.AdverseEventSupportingInforation for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-adverse-event-type-for-R4 | Cross-version VS for R5.AdverseEventType for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-allergen-class-for-R4 | Cross-version VS for R5.CodesForAllergenClasses for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-allergyintolerance-code-for-R4 | Cross-version VS for R5.SubstanceProductAndConditionAndNegationCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-approach-site-codes-for-R4 | Cross-version VS for R5.SNOMEDCTAnatomicalStructureAdministrationSites for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-body-site-for-R4 | Cross-version VS for R5.SNOMEDCTBodyStructures for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-bodystructure-bodylandmarkorientation-clockface-position-for-R4 | Cross-version VS for R5.BodystructureBodyLandmarkClockFacePosition for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-bodystructure-code-for-R4 | Cross-version VS for R5.SNOMEDCTMorphologicAbnormalities for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-bodystructure-relative-location-for-R4 | Cross-version VS for R5.BodystructureLocationQualifier for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-c80-facilitycodes-for-R4 | Cross-version VS for R5.FacilityTypeCodeValueSet for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-c80-practice-codes-for-R4 | Cross-version VS for R5.PracticeSettingCodeValueSet for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-care-plan-activity-performed-for-R4 | Cross-version VS for R5.CarePlanActivityPerformed for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-care-plan-category-for-R4 | Cross-version VS for R5.CarePlanCategory for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-clinical-findings-for-R4 | Cross-version VS for R5.SNOMEDCTClinicalFindings for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-clinicalimpression-change-pattern-for-R4 | Cross-version VS for R5.ClinicalImpressionChangePatter for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-clinicalimpression-prognosis-for-R4 | Cross-version VS for R5.ClinicalImpressionPrognosis for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-clinicalimpression-status-reason-for-R4 | Cross-version VS for R5.ClinicalImpressionStatusReason for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-communication-request-status-reason-for-R4 | Cross-version VS for R5.CommunicationRequestStatusReason for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-condition-code-for-R4 | Cross-version VS for R5.ConditionProblemDiagnosisCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-condition-outcome-for-R4 | Cross-version VS for R5.ConditionOutcomeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-condition-severity-for-R4 | Cross-version VS for R5.ConditionDiagnosisSeverity for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-condition-stage-for-R4 | Cross-version VS for R5.ConditionStage for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-condition-stage-type-for-R4 | Cross-version VS for R5.ConditionStageType for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-consistency-type-for-R4 | Cross-version VS for R5.FluidConsistencyTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-container-material-for-R4 | Cross-version VS for R5.ContainerMaterials for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-designation-use-for-R4 | Cross-version VS for R5.DesignationUse for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-device-action-for-R4 | Cross-version VS for R5.ProcedureDeviceActionCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-device-kind-for-R4 | Cross-version VS for R5.FHIRDeviceTypes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-device-property-type-for-R4 | Cross-version VS for R5.DeviceType for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-device-type-for-R4 | Cross-version VS for R5.DeviceType for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-dicom-cid-244-Laterality-for-R4 | Cross-version VS for R5.Laterality for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-diet-type-for-R4 | Cross-version VS for R5.DietCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-disease-status-for-R4 | Cross-version VS for R5.DiseaseStatus for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-disease-symptom-procedure-for-R4 | Cross-version VS for R5.DiseaseSymptomProcedure for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-edible-substance-type-for-R4 | Cross-version VS for R5.TypesOfEdibleSubstances for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-encounter-reason-for-R4 | Cross-version VS for R5.EncounterReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-entformula-type-for-R4 | Cross-version VS for R5.EnteralFormulaTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-flag-code-for-R4 | Cross-version VS for R5.FlagCode for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-food-type-for-R4 | Cross-version VS for R5.FoodTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-goal-start-event-for-R4 | Cross-version VS for R5.GoalStartEvent for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-immunization-reason-for-R4 | Cross-version VS for R5.ImmunizationReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-immunization-recommendation-reason-for-R4 | Cross-version VS for R5.ImmunizationRecommendationReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-immunization-target-disease-for-R4 | Cross-version VS for R5.ImmunizationTargetDiseaseCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-interactant-for-R4 | Cross-version VS for R5.Interactant for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-interaction-effect-for-R4 | Cross-version VS for R5.InteractionEffect for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-interaction-management-for-R4 | Cross-version VS for R5.InteractionManagement for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-manifestation-or-symptom-for-R4 | Cross-version VS for R5.ManifestationAndSymptomCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-measurement-property-for-R4 | Cross-version VS for R5.CodesForProductCharacteristics for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-medication-as-needed-reason-for-R4 | Cross-version VS for R5.SNOMEDCTMedicationAsNeededReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-medication-codes-for-R4 | Cross-version VS for R5.SNOMEDCTMedicationCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-medication-form-codes-for-R4 | Cross-version VS for R5.SNOMEDCTFormCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-modified-foodtype-for-R4 | Cross-version VS for R5.TextureModifiedFoodTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-not-consumed-reason-for-R4 | Cross-version VS for R5.ReasonsFoodItemNotConsumed for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-nutrient-code-for-R4 | Cross-version VS for R5.NutrientModifierCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-nutrition-product-category-for-R4 | Cross-version VS for R5.CategoriesOfNutritionProducts for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-nutrition-product-nutrient-for-R4 | Cross-version VS for R5.CodesForNutritionProductNutrients for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-observation-methods-for-R4 | Cross-version VS for R5.ObservationMethods for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-participant-role-for-R4 | Cross-version VS for R5.ParticipantRoles for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-performer-role-for-R4 | Cross-version VS for R5.ProcedurePerformerRoleCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-practitioner-role-for-R4 | Cross-version VS for R5.PractitionerRole for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-prepare-patient-prior-specimen-collection-for-R4 | Cross-version VS for R5.PreparePatient for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-procedure-category-for-R4 | Cross-version VS for R5.ProcedureCategoryCodesSNOMEDCT for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-procedure-code-for-R4 | Cross-version VS for R5.ProcedureCodesSNOMEDCT for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-procedure-followup-for-R4 | Cross-version VS for R5.ProcedureFollowUpCodesSNOMEDCT for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-procedure-not-performed-reason-for-R4 | Cross-version VS for R5.ProcedureNotPerformedReasonSNOMEDCT for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-procedure-outcome-for-R4 | Cross-version VS for R5.ProcedureOutcomeCodesSNOMEDCT for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-procedure-reason-for-R4 | Cross-version VS for R5.ProcedureReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-product-characteristic-codes-for-R4 | Cross-version VS for R5.ProductCharacteristic for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-questionnaire-answers-for-R4 | Cross-version VS for R5.QuestionnaireAnswerCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-reason-medication-not-given-codes-for-R4 | Cross-version VS for R5.SNOMEDCTReasonMedicationNotGivenCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-reason-medication-status-codes-for-R4 | Cross-version VS for R5.SNOMEDCTDrugTherapyStatusCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-referencerange-appliesto-for-R4 | Cross-version VS for R5.ObservationReferenceRangeAppliesToCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-route-codes-for-R4 | Cross-version VS for R5.SNOMEDCTRouteCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-servicerequest-category-for-R4 | Cross-version VS for R5.ServiceRequestCategoryCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-snomed-intl-gps-for-R4 | Cross-version VS for R5.SnomedIntlGps for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-specimen-collection-for-R4 | Cross-version VS for R5.SpecimenCollection for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-specimen-collection-method-for-R4 | Cross-version VS for R5.FHIRSpecimenCollectionMethod for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-specimen-container-type-for-R4 | Cross-version VS for R5.SpecimenContainerType for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-specimen-processing-method-for-R4 | Cross-version VS for R5.SpecimenProcessingMethod for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-substance-code-for-R4 | Cross-version VS for R5.SubstanceCode for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-substance-codes-for-R4 | Cross-version VS for R5.SNOMEDCTSubstanceCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-supplement-type-for-R4 | Cross-version VS for R5.SupplementTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-supply-item-for-R4 | Cross-version VS for R5.SNOMEDCTSupplyItem for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-texture-code-for-R4 | Cross-version VS for R5.TextureModifierCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-therapy-for-R4 | Cross-version VS for R5.Therapy for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-undesirable-effect-classification-for-R4 | Cross-version VS for R5.UndesirableEffectClassification for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-undesirable-effect-symptom-for-R4 | Cross-version VS for R5.UndesirableEffectSymptom for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-use-context-for-R4 | Cross-version VS for R5.ContextOfUseValueSet for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-v3-AllergyStatus-for-R4 | Cross-version VS for R5.AllergyStatus for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-v3-KnowledgeSubjectObservationValue-for-R4 | Cross-version VS for R5.KnowledgeSubjectObservationValue for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-v3-KnowledgeSubtopicObservationValue-for-R4 | Cross-version VS for R5.KnowledgeSubtopicObservationValue for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-v3-ObservationMeasureCountableItems-for-R4 | Cross-version VS for R5.ObservationMeasureCountableItems for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4.r4#0.0.1-snapshot-2 | R5-v3-immunizationForecastStatusObservationValue-for-R4 | Cross-version VS for R5.ImmunizationForecastStatusObservationValue for use in FHIR R4 |
| hl7se.fhir.base#1.1.0 | SEBaseAddressPersonVS | SE ValueSet for official address types |
| hl7se.fhir.base#1.1.0 | SEBaseSKRYrkeSpecialtyVS | SKR ValueSet for clinical specialties |
| hl7se.fhir.base#1.1.0 | SEBaseSKRYrkeVS | SKR ValueSet for occupations |
| rki.emiga.case#0.3.0-alpha.6 | ClinicalInformationPresentVS | Klinische Informationen vorhanden |
| hl7.eu.fhir.pcsp#0.1.0 | laterality-qualifier-lrub-vs | Laterality Qualifier Value Set |
| hl7.eu.fhir.pcsp#0.1.0 | mcode-body-location-qualifier-vs | Body Location Qualifier Value Set |
| hl7.eu.fhir.pcsp#0.1.0 | mcode-cancer-staging-system-vs | Cancer Staging System Value Set |
| hl7.eu.fhir.pcsp#0.1.0 | otherInfos-condition-vs | Other Infors Condition |
| hl7.eu.fhir.pcsp#0.1.0 | relapse-type-vs | Relapse type (Local/Distant/Combined) |
| hl7.eu.fhir.pcsp#0.1.0 | vs-Gvhd-type-eu-pcsp | Gvhd condition |
| hl7.eu.fhir.pcsp#0.1.0 | vs-ProstheticProcedureType-eu-pcsp | Prosthetic Surgical Procedure Type |
| hl7.eu.fhir.pcsp#0.1.0 | vs-action-eu-pcsp | Surgical Actions |
| hl7.eu.fhir.pcsp#0.1.0 | vs-affectedOrgan-eu-pcsp | Affected Organs (surgery) |
| hl7.eu.fhir.pcsp#0.1.0 | vs-amputationProcedureType-eu-pcsp | Amputation Surgical Procedure Type |
| hl7.eu.fhir.pcsp#0.1.0 | vs-calcest-eu-pcsp | Calculated|Estimated |
| hl7.eu.fhir.pcsp#0.1.0 | vs-colostomyProcedureType-eu-pcsp | Colostomy Surgical Procedure Type |
| hl7.eu.fhir.pcsp#0.1.0 | vs-fromToPosteriorAnterior-eu-pcsp | Body Location Qualifier Value Set |
| hl7.eu.fhir.pcsp#0.1.0 | vs-gastrostomyProcedureType-eu-pcsp | Gastrostomy Surgical Procedure Type |
| hl7.eu.fhir.pcsp#0.1.0 | vs-hereditary-eu-pcsp | Hereditary Predispositions or Disease |
| hl7.eu.fhir.pcsp#0.1.0 | vs-isotopes-eu-pcsp | Radiotherapy Isotopes |
| hl7.eu.fhir.pcsp#0.1.0 | vs-radiotherapyDoseType-eu-pcsp | Radiotherapy Dose Type |
| hl7.eu.fhir.pcsp#0.1.0 | vs-radiotherapyType-eu-pcsp | Radiotherapy Type |
| hl7.eu.fhir.pcsp#0.1.0 | vs-sacrifiedOrgan-eu-pcsp | Sacrified Organs (surgery) |
| hl7.eu.fhir.pcsp#0.1.0 | vs-sct-prophylaxis-cathegory-eu-pcsp | SCT Prophylaxis Cathegory |
| hl7.eu.fhir.pcsp#0.1.0 | vs-sct-prophylaxis-type-eu-pcsp | SCT Prophylaxis Type |
| hl7.eu.fhir.pcsp#0.1.0 | vs-sct-type-eu-pcsp | Stem Cell Transplantation type |
| fhir.dicom#2025.3.20250714 | sect_CID_10.html | InterventionalDrug |
| fhir.dicom#2025.3.20250714 | sect_CID_100.html | QuantitativeDiagnosticImagingProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_1000.html | CTTransversePlaneReferenceBasis |
| fhir.dicom#2025.3.20250714 | sect_CID_10002.html | IrradiationEventType |
| fhir.dicom#2025.3.20250714 | sect_CID_10005.html | XRayRadiationDoseProcedureTypeReported |
| fhir.dicom#2025.3.20250714 | sect_CID_10006.html | XRayFilterMaterial |
| fhir.dicom#2025.3.20250714 | sect_CID_10009.html | Measured/Calculated |
| fhir.dicom#2025.3.20250714 | sect_CID_1001.html | AnatomicalReferenceBasis |
| fhir.dicom#2025.3.20250714 | sect_CID_10010.html | DoseMeasurementDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_10013.html | CTAcquisitionType |
| fhir.dicom#2025.3.20250714 | sect_CID_10014.html | CTIVContrastImagingTechnique |
| fhir.dicom#2025.3.20250714 | sect_CID_10016.html | AnodeTargetMaterial |
| fhir.dicom#2025.3.20250714 | sect_CID_1002.html | AnatomicalReferenceBasisHead |
| fhir.dicom#2025.3.20250714 | sect_CID_10020.html | SourceofProjectionXRayDoseInformation |
| fhir.dicom#2025.3.20250714 | sect_CID_1003.html | AnatomicalReferenceBasisSpine |
| fhir.dicom#2025.3.20250714 | sect_CID_1004.html | AnatomicalReferenceBasisChest |
| fhir.dicom#2025.3.20250714 | sect_CID_10043.html | IntravenousExtravasationSymptom |
| fhir.dicom#2025.3.20250714 | sect_CID_10044.html | RadiosensitiveOrgan |
| fhir.dicom#2025.3.20250714 | sect_CID_10045.html | RadiopharmaceuticalPatientState |
| fhir.dicom#2025.3.20250714 | sect_CID_1005.html | AnatomicalReferenceBasisAbdomen/Pelvis |
| fhir.dicom#2025.3.20250714 | sect_CID_1006.html | AnatomicalReferenceBasisExtremity |
| fhir.dicom#2025.3.20250714 | sect_CID_10060.html | OrganforRadiationDoseEstimate |
| fhir.dicom#2025.3.20250714 | sect_CID_10066.html | AttenuatorCategory |
| fhir.dicom#2025.3.20250714 | sect_CID_10067.html | RadiationAttenuatorMaterial |
| fhir.dicom#2025.3.20250714 | sect_CID_10072.html | ReportedValueType |
| fhir.dicom#2025.3.20250714 | sect_CID_101.html | ImagingProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_108.html | DiagnosticImagingProcedurewithoutIVContrast |
| fhir.dicom#2025.3.20250714 | sect_CID_109.html | DiagnosticImagingProcedurewithIVContrast |
| fhir.dicom#2025.3.20250714 | sect_CID_11.html | AdministrationRoute |
| fhir.dicom#2025.3.20250714 | sect_CID_11002.html | AcousticCouplingMedium |
| fhir.dicom#2025.3.20250714 | sect_CID_11006.html | PhotoacousticImagedProperty |
| fhir.dicom#2025.3.20250714 | sect_CID_12.html | ImagingContrastAgent |
| fhir.dicom#2025.3.20250714 | sect_CID_1200.html | ContraindicationsForCTImaging |
| fhir.dicom#2025.3.20250714 | sect_CID_12001.html | UltrasoundProtocolType |
| fhir.dicom#2025.3.20250714 | sect_CID_12002.html | UltrasoundProtocolStageType |
| fhir.dicom#2025.3.20250714 | sect_CID_12008.html | OBGYNAmnioticSacMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_1201.html | ContraindicationsForXAImaging |
| fhir.dicom#2025.3.20250714 | sect_CID_12020.html | FetalBiometryAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12021.html | FetalLongBoneAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12022.html | FetalCraniumAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12023.html | PelvisandUterusAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12024.html | VascularUltrasoundReportDocumentTitle |
| fhir.dicom#2025.3.20250714 | sect_CID_12025.html | OBGYNUltrasoundBeamPath |
| fhir.dicom#2025.3.20250714 | sect_CID_12100.html | VascularUltrasoundReportDocumentTitle |
| fhir.dicom#2025.3.20250714 | sect_CID_12102.html | TemporalPeriodRelatingtoProcedureorTherapy |
| fhir.dicom#2025.3.20250714 | sect_CID_12103.html | VascularUltrasoundAnatomicLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_12104.html | ExtracranialArtery |
| fhir.dicom#2025.3.20250714 | sect_CID_12105.html | IntracranialCerebralVessel |
| fhir.dicom#2025.3.20250714 | sect_CID_12106.html | IntracranialCerebralVessel(Unilateral) |
| fhir.dicom#2025.3.20250714 | sect_CID_12107.html | UpperExtremityArtery |
| fhir.dicom#2025.3.20250714 | sect_CID_12108.html | UpperExtremityVein |
| fhir.dicom#2025.3.20250714 | sect_CID_12109.html | LowerExtremityArtery |
| fhir.dicom#2025.3.20250714 | sect_CID_12110.html | LowerExtremityVein |
| fhir.dicom#2025.3.20250714 | sect_CID_12111.html | AbdominopelvicArtery(Paired) |
| fhir.dicom#2025.3.20250714 | sect_CID_12112.html | AbdominopelvicArtery(Unpaired) |
| fhir.dicom#2025.3.20250714 | sect_CID_12113.html | AbdominopelvicVein(Paired) |
| fhir.dicom#2025.3.20250714 | sect_CID_12114.html | AbdominopelvicVein(Unpaired) |
| fhir.dicom#2025.3.20250714 | sect_CID_12115.html | RenalVessel |
| fhir.dicom#2025.3.20250714 | sect_CID_12116.html | VesselSegmentModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_12117.html | VesselBranchModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_12118.html | MeasurementOrientation |
| fhir.dicom#2025.3.20250714 | sect_CID_12119.html | VascularUltrasoundProperty |
| fhir.dicom#2025.3.20250714 | sect_CID_12121.html | VascularIndex/Ratio |
| fhir.dicom#2025.3.20250714 | sect_CID_12122.html | OtherVascularProperty |
| fhir.dicom#2025.3.20250714 | sect_CID_12125.html | AbdominopelvicVessel |
| fhir.dicom#2025.3.20250714 | sect_CID_12130.html | OrganPart(NonLateralized) |
| fhir.dicom#2025.3.20250714 | sect_CID_12131.html | OrganPart(Lateralized) |
| fhir.dicom#2025.3.20250714 | sect_CID_12140.html | PelvicVasculatureAnatomicalLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_12141.html | FetalVasculatureAnatomicalLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_12200.html | EchocardiographyLeftVentricleMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12201.html | LeftVentricleLinearMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12203.html | LeftVentricleOtherMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12204.html | EchocardiographyRightVentricleMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12205.html | EchocardiographyLeftAtriumMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12207.html | EchocardiographyMitralValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12208.html | EchocardiographyTricuspidValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12209.html | EchocardiographyPulmonicValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12210.html | EchocardiographyPulmonaryArteryMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12211.html | EchocardiographyAorticValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12214.html | EchocardiographyPulmonaryVeinMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12218.html | EchocardiographyCongenitalAnomalyMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12219.html | PulmonaryVeinModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_12221.html | FlowDirection |
| fhir.dicom#2025.3.20250714 | sect_CID_12222.html | OrificeFlowProperty |
| fhir.dicom#2025.3.20250714 | sect_CID_12223.html | EchocardiographyStrokeVolumeOrigin |
| fhir.dicom#2025.3.20250714 | sect_CID_12224.html | UltrasoundImageMode |
| fhir.dicom#2025.3.20250714 | sect_CID_12226.html | EchocardiographyImageView |
| fhir.dicom#2025.3.20250714 | sect_CID_12233.html | CardiacPhase |
| fhir.dicom#2025.3.20250714 | sect_CID_12234.html | RespirationState |
| fhir.dicom#2025.3.20250714 | sect_CID_12235.html | MitralValveAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12236.html | EchocardiographyAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12237.html | EchocardiographyAnatomicSiteModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_12239.html | CardiacOutputProperty |
| fhir.dicom#2025.3.20250714 | sect_CID_12240.html | LeftVentricleAreaMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12241.html | TricuspidValveFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12242.html | AorticValveFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12243.html | LeftVentricleFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12244.html | CongenitalFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12246.html | CardiacUltrasoundIndicationforStudy |
| fhir.dicom#2025.3.20250714 | sect_CID_12247.html | Pediatric,FetalandCongenitalCardiacSurgicalIntervention |
| fhir.dicom#2025.3.20250714 | sect_CID_12248.html | CardiacUltrasoundSummaryCode |
| fhir.dicom#2025.3.20250714 | sect_CID_12249.html | CardiacUltrasoundFetalSummaryCode |
| fhir.dicom#2025.3.20250714 | sect_CID_12250.html | CardiacUltrasoundCommonLinearMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12251.html | CardiacUltrasoundLinearValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12252.html | CardiacUltrasoundCardiacFunction |
| fhir.dicom#2025.3.20250714 | sect_CID_12253.html | CardiacUltrasoundAreaMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12254.html | CardiacUltrasoundHemodynamicMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12257.html | CardiacUltrasoundLeftVentricleMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12258.html | CardiacUltrasoundRightVentricleMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12259.html | CardiacUltrasoundVentriclesMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12260.html | CardiacUltrasoundPulmonaryArteryMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12261.html | CardiacUltrasoundPulmonaryVein |
| fhir.dicom#2025.3.20250714 | sect_CID_12262.html | CardiacUltrasoundPulmonaryValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12263.html | CardiacUltrasoundVenousReturnPulmonaryMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12264.html | CardiacUltrasoundVenousReturnSystemicMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12265.html | CardiacUltrasoundAtriaandAtrialSeptumMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12266.html | CardiacUltrasoundMitralValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12267.html | CardiacUltrasoundTricuspidValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12268.html | CardiacUltrasoundAtrioventricularValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12269.html | CardiacUltrasoundInterventricularSeptumMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12270.html | CardiacUltrasoundAorticValveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12271.html | CardiacUltrasoundOutflowTractMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12272.html | CardiacUltrasoundSemilunarValve,AnnulateandSinusMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12273.html | CardiacUltrasoundAorticSinotubularJunctionMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12274.html | CardiacUltrasoundAortaMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12275.html | CardiacUltrasoundCoronaryArteryMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12276.html | CardiacUltrasoundAortoPulmonaryConnectionMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12277.html | CardiacUltrasoundPericardiumandPleuraMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12279.html | CardiacUltrasoundFetalGeneralMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12280.html | CardiacUltrasoundTargetSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12281.html | CardiacUltrasoundTargetSiteModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_12282.html | CardiacUltrasoundVenousReturnSystemicFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12283.html | CardiacUltrasoundVenousReturnPulmonaryFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12284.html | CardiacUltrasoundAtriaandAtrialSeptumFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12285.html | CardiacUltrasoundAtrioventricularValveFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12286.html | CardiacUltrasoundInterventricularSeptumFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12287.html | CardiacUltrasoundVentricleFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12288.html | CardiacUltrasoundOutflowTractFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12289.html | CardiacUltrasoundSemilunarValve,AnnulusandSinusFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12290.html | CardiacUltrasoundPulmonaryArteryFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12291.html | CardiacUltrasoundAortaFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12292.html | CardiacUltrasoundCoronaryArteryFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12293.html | CardiacUltrasoundAortopulmonaryConnectionFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12294.html | CardiacUltrasoundPericardiumandPleuraFindingSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12301.html | MeasurementSelectionReason |
| fhir.dicom#2025.3.20250714 | sect_CID_12302.html | EchoFindingObservationType |
| fhir.dicom#2025.3.20250714 | sect_CID_12303.html | EchoMeasurementType |
| fhir.dicom#2025.3.20250714 | sect_CID_12304.html | CardiovascularMeasuredProperty |
| fhir.dicom#2025.3.20250714 | sect_CID_12305.html | BasicEchoAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12306.html | EchoFlowDirection |
| fhir.dicom#2025.3.20250714 | sect_CID_12307.html | CardiacPhaseandTimePoint |
| fhir.dicom#2025.3.20250714 | sect_CID_12308.html | UltrasoundShearWaveMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_12312.html | FetalEchocardiographyImageView |
| fhir.dicom#2025.3.20250714 | sect_CID_12321.html | ElastographySite |
| fhir.dicom#2025.3.20250714 | sect_CID_12322.html | ElastographyMeasurementSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12323.html | UltrasoundRelevantPatientCondition |
| fhir.dicom#2025.3.20250714 | sect_CID_12325.html | LiverUltrasoundStudyIndication |
| fhir.dicom#2025.3.20250714 | sect_CID_12331.html | StructuralHeartProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_12332.html | StructuralHeartDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_12339.html | StructuralHeartProcedureAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_12341.html | IndicationforStructuralHeartProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_12342.html | BradycardiacAgent |
| fhir.dicom#2025.3.20250714 | sect_CID_13.html | ImagingContrastAgentIngredient |
| fhir.dicom#2025.3.20250714 | sect_CID_18.html | RadiopharmaceuticalIsotope |
| fhir.dicom#2025.3.20250714 | sect_CID_19.html | PatientOrientation |
| fhir.dicom#2025.3.20250714 | sect_CID_2.html | AnatomicModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_20.html | PatientOrientationModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_21.html | PatientEquipmentRelationship |
| fhir.dicom#2025.3.20250714 | sect_CID_210.html | QualitativeEvaluationModifierType |
| fhir.dicom#2025.3.20250714 | sect_CID_211.html | QualitativeEvaluationModifierValue |
| fhir.dicom#2025.3.20250714 | sect_CID_212.html | GenericAnatomicLocationModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_218.html | QuantitativeImageFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_219.html | GeometryGraphicalRepresentation |
| fhir.dicom#2025.3.20250714 | sect_CID_220.html | SignificanceLevel |
| fhir.dicom#2025.3.20250714 | sect_CID_221.html | MeasurementRangeConcept |
| fhir.dicom#2025.3.20250714 | sect_CID_222.html | Normality |
| fhir.dicom#2025.3.20250714 | sect_CID_223.html | NormalRangeValue |
| fhir.dicom#2025.3.20250714 | sect_CID_225.html | MeasurementUncertaintyConcept |
| fhir.dicom#2025.3.20250714 | sect_CID_226.html | PopulationStatisticalDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_23.html | CranioCaudadAngulation |
| fhir.dicom#2025.3.20250714 | sect_CID_230.html | YesNo |
| fhir.dicom#2025.3.20250714 | sect_CID_231.html | YesNoOnly |
| fhir.dicom#2025.3.20250714 | sect_CID_240.html | PresentAbsent |
| fhir.dicom#2025.3.20250714 | sect_CID_241.html | PresentAbsentOnly |
| fhir.dicom#2025.3.20250714 | sect_CID_242.html | NormalAbnormal |
| fhir.dicom#2025.3.20250714 | sect_CID_244.html | Laterality |
| fhir.dicom#2025.3.20250714 | sect_CID_245.html | LateralitywithMedian |
| fhir.dicom#2025.3.20250714 | sect_CID_246.html | RelativeLaterality |
| fhir.dicom#2025.3.20250714 | sect_CID_247.html | LateralityLeftRightOnly |
| fhir.dicom#2025.3.20250714 | sect_CID_25.html | Radiopharmaceutical |
| fhir.dicom#2025.3.20250714 | sect_CID_250.html | PositiveNegative |
| fhir.dicom#2025.3.20250714 | sect_CID_251.html | ComplicationSeverity |
| fhir.dicom#2025.3.20250714 | sect_CID_252.html | SMLSizeDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_26.html | NuclearMedicineProjection |
| fhir.dicom#2025.3.20250714 | sect_CID_27.html | BasicCardiacView |
| fhir.dicom#2025.3.20250714 | sect_CID_272.html | SpecificObservationSubjectClass |
| fhir.dicom#2025.3.20250714 | sect_CID_300.html | MultienergyRelevantMaterial |
| fhir.dicom#2025.3.20250714 | sect_CID_3003.html | HemodynamicWaveformSource |
| fhir.dicom#2025.3.20250714 | sect_CID_3010.html | CardiovascularAnatomicStructure |
| fhir.dicom#2025.3.20250714 | sect_CID_3011.html | ElectrophysiologyAnatomicLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3014.html | CoronaryArterySegment |
| fhir.dicom#2025.3.20250714 | sect_CID_3015.html | CoronaryArtery |
| fhir.dicom#2025.3.20250714 | sect_CID_3016.html | MajorCoronaryArtery |
| fhir.dicom#2025.3.20250714 | sect_CID_3019.html | CardiovascularAnatomicStructureModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_3035.html | EEGAnnotation–NeurophysiologicEnumeration |
| fhir.dicom#2025.3.20250714 | sect_CID_3038.html | PatternEvent |
| fhir.dicom#2025.3.20250714 | sect_CID_3049.html | EEGProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_3050.html | PatientConsciousness |
| fhir.dicom#2025.3.20250714 | sect_CID_31.html | AbstractPrior |
| fhir.dicom#2025.3.20250714 | sect_CID_3101.html | CardiacProceduralStateValue |
| fhir.dicom#2025.3.20250714 | sect_CID_3102.html | Rest/StressState |
| fhir.dicom#2025.3.20250714 | sect_CID_3107.html | PETCardiologyRadiopharmaceutical |
| fhir.dicom#2025.3.20250714 | sect_CID_3108.html | NM/PETProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_3110.html | NuclearCardiologyProtocol |
| fhir.dicom#2025.3.20250714 | sect_CID_3111.html | NuclearCardiologyRadiopharmaceutical |
| fhir.dicom#2025.3.20250714 | sect_CID_3113.html | PerfusionDefectType |
| fhir.dicom#2025.3.20250714 | sect_CID_3115.html | StressImagingQualityIssue |
| fhir.dicom#2025.3.20250714 | sect_CID_3116.html | NMExtracardiacFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3118.html | LevelofRisk |
| fhir.dicom#2025.3.20250714 | sect_CID_3119.html | LVFunction |
| fhir.dicom#2025.3.20250714 | sect_CID_3120.html | PerfusionFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3121.html | PerfusionMorphology |
| fhir.dicom#2025.3.20250714 | sect_CID_3122.html | VentricularEnlargement |
| fhir.dicom#2025.3.20250714 | sect_CID_3200.html | StressTestProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_3201.html | IndicationsforStressTest |
| fhir.dicom#2025.3.20250714 | sect_CID_3202.html | ChestPain |
| fhir.dicom#2025.3.20250714 | sect_CID_3203.html | ExerciserDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_3204.html | StressAgent |
| fhir.dicom#2025.3.20250714 | sect_CID_3205.html | IndicationsforPharmacologicalStressTest |
| fhir.dicom#2025.3.20250714 | sect_CID_3206.html | NoninvasiveCardiacImagingProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_3207.html | StressTestProcedurePhase |
| fhir.dicom#2025.3.20250714 | sect_CID_3208.html | ExerciseECGSummaryCode |
| fhir.dicom#2025.3.20250714 | sect_CID_3209.html | StressImagingSummaryCode |
| fhir.dicom#2025.3.20250714 | sect_CID_3210.html | SpeedofResponse |
| fhir.dicom#2025.3.20250714 | sect_CID_3211.html | BPResponse |
| fhir.dicom#2025.3.20250714 | sect_CID_3213.html | StressHemodynamicFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3215.html | PerfusionFindingMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_3220.html | StressSymptom |
| fhir.dicom#2025.3.20250714 | sect_CID_3221.html | StressTestTerminationReason |
| fhir.dicom#2025.3.20250714 | sect_CID_3230.html | ECGFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3231.html | STSegmentFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3232.html | STSegmentLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3233.html | STSegmentMorphology |
| fhir.dicom#2025.3.20250714 | sect_CID_3234.html | EctopicBeatMorphology |
| fhir.dicom#2025.3.20250714 | sect_CID_3235.html | PerfusionComparisonFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3236.html | ToleranceComparisonFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3237.html | WallMotionComparisonFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3238.html | StressScoringScale |
| fhir.dicom#2025.3.20250714 | sect_CID_3241.html | HemodynamicMeasurementTechnique |
| fhir.dicom#2025.3.20250714 | sect_CID_3250.html | CatheterizationProcedurePhase |
| fhir.dicom#2025.3.20250714 | sect_CID_3254.html | ElectrophysiologyProcedurePhase |
| fhir.dicom#2025.3.20250714 | sect_CID_3261.html | StressProtocol |
| fhir.dicom#2025.3.20250714 | sect_CID_3262.html | ECGPatientStateValue |
| fhir.dicom#2025.3.20250714 | sect_CID_3271.html | HemodynamicPhysiologicalChallenge |
| fhir.dicom#2025.3.20250714 | sect_CID_3337.html | HemodynamicAnnotation |
| fhir.dicom#2025.3.20250714 | sect_CID_3403.html | PercutaneousEntry |
| fhir.dicom#2025.3.20250714 | sect_CID_3405.html | ProcedureActionValue |
| fhir.dicom#2025.3.20250714 | sect_CID_3411.html | IntracoronaryDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_3413.html | AdverseOutcome |
| fhir.dicom#2025.3.20250714 | sect_CID_3414.html | ProcedureUrgency |
| fhir.dicom#2025.3.20250714 | sect_CID_3416.html | RespirationRhythm |
| fhir.dicom#2025.3.20250714 | sect_CID_3422.html | DeviceUseAction |
| fhir.dicom#2025.3.20250714 | sect_CID_3423.html | NumericDeviceCharacteristic |
| fhir.dicom#2025.3.20250714 | sect_CID_3425.html | InterventionParameter |
| fhir.dicom#2025.3.20250714 | sect_CID_3428.html | CardiovascularImagingProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_3429.html | CatheterizationDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_3440.html | PeripheralPulseLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3441.html | PatientAssessment |
| fhir.dicom#2025.3.20250714 | sect_CID_3442.html | PeripheralPulseMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_3451.html | CalibrationObject |
| fhir.dicom#2025.3.20250714 | sect_CID_3462.html | ChamberIdentification |
| fhir.dicom#2025.3.20250714 | sect_CID_3463.html | VentricleIdentification |
| fhir.dicom#2025.3.20250714 | sect_CID_3466.html | PlaneIdentification |
| fhir.dicom#2025.3.20250714 | sect_CID_3472.html | CardiacContractionPhase |
| fhir.dicom#2025.3.20250714 | sect_CID_3480.html | IVUSProcedurePhase |
| fhir.dicom#2025.3.20250714 | sect_CID_3481.html | IVUSDistanceMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_3482.html | IVUSAreaMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_3483.html | IVUSLongitudinalMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_3485.html | IVUSVolumeMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_3487.html | IntravascularVolumetricRegion |
| fhir.dicom#2025.3.20250714 | sect_CID_3488.html | Min/Max/Mean |
| fhir.dicom#2025.3.20250714 | sect_CID_3489.html | CalciumDistribution |
| fhir.dicom#2025.3.20250714 | sect_CID_3491.html | IVUSLesionMorphology |
| fhir.dicom#2025.3.20250714 | sect_CID_3492.html | VascularDissectionClassification |
| fhir.dicom#2025.3.20250714 | sect_CID_3494.html | IVUSNonMorphologicalFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3495.html | IVUSPlaqueComposition |
| fhir.dicom#2025.3.20250714 | sect_CID_3496.html | IVUSFiducialPoint |
| fhir.dicom#2025.3.20250714 | sect_CID_3497.html | IVUSArterialMorphology |
| fhir.dicom#2025.3.20250714 | sect_CID_3515.html | SpecimenCollection |
| fhir.dicom#2025.3.20250714 | sect_CID_3520.html | BloodSourceType |
| fhir.dicom#2025.3.20250714 | sect_CID_3531.html | OxygenAdministration |
| fhir.dicom#2025.3.20250714 | sect_CID_3553.html | CirculatorySupport |
| fhir.dicom#2025.3.20250714 | sect_CID_3554.html | Ventilation |
| fhir.dicom#2025.3.20250714 | sect_CID_3555.html | Pacing |
| fhir.dicom#2025.3.20250714 | sect_CID_3560.html | BloodPressureMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_3600.html | RelativeTime |
| fhir.dicom#2025.3.20250714 | sect_CID_3602.html | HemodynamicPatientState |
| fhir.dicom#2025.3.20250714 | sect_CID_3604.html | ArterialLesionLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3606.html | ArterialSourceLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3607.html | VenousSourceLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3608.html | AtrialSourceLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3609.html | VentricularSourceLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3610.html | GradientSourceLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3611.html | PressureMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_3614.html | NonmitralValveArea |
| fhir.dicom#2025.3.20250714 | sect_CID_3615.html | ValveArea |
| fhir.dicom#2025.3.20250714 | sect_CID_3616.html | HemodynamicPeriodMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_3617.html | ValveFlow |
| fhir.dicom#2025.3.20250714 | sect_CID_3619.html | HemodynamicResistanceMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_3620.html | HemodynamicRatio |
| fhir.dicom#2025.3.20250714 | sect_CID_3621.html | FractionalFlowReserve |
| fhir.dicom#2025.3.20250714 | sect_CID_3627.html | MeasurementType |
| fhir.dicom#2025.3.20250714 | sect_CID_3628.html | CardiacOutputMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_3629.html | ProcedureIntent |
| fhir.dicom#2025.3.20250714 | sect_CID_3630.html | CardiovascularAnatomicLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_3640.html | Hypertension |
| fhir.dicom#2025.3.20250714 | sect_CID_3641.html | HemodynamicAssessment |
| fhir.dicom#2025.3.20250714 | sect_CID_3642.html | DegreeFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3651.html | HemodynamicMeasurementPhase |
| fhir.dicom#2025.3.20250714 | sect_CID_3670.html | ECGProcedureType |
| fhir.dicom#2025.3.20250714 | sect_CID_3671.html | ReasonforECGStudy |
| fhir.dicom#2025.3.20250714 | sect_CID_3676.html | LeadMeasurementTechnique |
| fhir.dicom#2025.3.20250714 | sect_CID_3677.html | SummaryCodesECG |
| fhir.dicom#2025.3.20250714 | sect_CID_3700.html | CathDiagnosis |
| fhir.dicom#2025.3.20250714 | sect_CID_3701.html | CardiacValve/Tract |
| fhir.dicom#2025.3.20250714 | sect_CID_3703.html | WallMotion |
| fhir.dicom#2025.3.20250714 | sect_CID_3704.html | MyocardiumWallMorphologyFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3705.html | ChamberSize |
| fhir.dicom#2025.3.20250714 | sect_CID_3706.html | OverallContractility |
| fhir.dicom#2025.3.20250714 | sect_CID_3707.html | VSDDescription |
| fhir.dicom#2025.3.20250714 | sect_CID_3710.html | CoronaryDominance |
| fhir.dicom#2025.3.20250714 | sect_CID_3711.html | ValvularAbnormality |
| fhir.dicom#2025.3.20250714 | sect_CID_3712.html | VesselDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_3713.html | TIMIFlowCharacteristic |
| fhir.dicom#2025.3.20250714 | sect_CID_3714.html | Thrombus |
| fhir.dicom#2025.3.20250714 | sect_CID_3715.html | LesionMargin |
| fhir.dicom#2025.3.20250714 | sect_CID_3716.html | Severity |
| fhir.dicom#2025.3.20250714 | sect_CID_3717.html | LeftVentricleMyocardialWall17SegmentModel |
| fhir.dicom#2025.3.20250714 | sect_CID_3718.html | MyocardialWallSegmentsinProjection |
| fhir.dicom#2025.3.20250714 | sect_CID_3719.html | CanadianClinicalClassification |
| fhir.dicom#2025.3.20250714 | sect_CID_3721.html | CardiovascularSurgery |
| fhir.dicom#2025.3.20250714 | sect_CID_3722.html | DiabeticTherapy |
| fhir.dicom#2025.3.20250714 | sect_CID_3723.html | MIType |
| fhir.dicom#2025.3.20250714 | sect_CID_3724.html | SmokingHistory |
| fhir.dicom#2025.3.20250714 | sect_CID_3726.html | CoronaryInterventionIndication |
| fhir.dicom#2025.3.20250714 | sect_CID_3727.html | CatheterizationIndication |
| fhir.dicom#2025.3.20250714 | sect_CID_3728.html | CathFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3729.html | AdmissionStatus |
| fhir.dicom#2025.3.20250714 | sect_CID_3736.html | NYHAClassification |
| fhir.dicom#2025.3.20250714 | sect_CID_3739.html | CathProcedureType |
| fhir.dicom#2025.3.20250714 | sect_CID_3740.html | ThrombolyticAdministration |
| fhir.dicom#2025.3.20250714 | sect_CID_3741.html | LabVisitMedicationAdministration |
| fhir.dicom#2025.3.20250714 | sect_CID_3742.html | PCIMedicationAdministration |
| fhir.dicom#2025.3.20250714 | sect_CID_3743.html | Clopidogrel/TiclopidineAdministration |
| fhir.dicom#2025.3.20250714 | sect_CID_3744.html | EFTestingMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_3745.html | CalculationMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_3746.html | PercutaneousEntrySite |
| fhir.dicom#2025.3.20250714 | sect_CID_3754.html | VascularComplication |
| fhir.dicom#2025.3.20250714 | sect_CID_3755.html | CathComplication |
| fhir.dicom#2025.3.20250714 | sect_CID_3756.html | CardiacPatientRiskFactor |
| fhir.dicom#2025.3.20250714 | sect_CID_3757.html | CardiacDiagnosticProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_3758.html | CardiovascularFamilyHistory |
| fhir.dicom#2025.3.20250714 | sect_CID_3760.html | HypertensionTherapy |
| fhir.dicom#2025.3.20250714 | sect_CID_3761.html | AntilipemicAgent |
| fhir.dicom#2025.3.20250714 | sect_CID_3762.html | AntiarrhythmicAgent |
| fhir.dicom#2025.3.20250714 | sect_CID_3764.html | MyocardialInfarctionTherapy |
| fhir.dicom#2025.3.20250714 | sect_CID_3769.html | ConcernType |
| fhir.dicom#2025.3.20250714 | sect_CID_3770.html | ProblemStatus |
| fhir.dicom#2025.3.20250714 | sect_CID_3772.html | HealthStatus |
| fhir.dicom#2025.3.20250714 | sect_CID_3773.html | UseStatus |
| fhir.dicom#2025.3.20250714 | sect_CID_3774.html | SocialHistory |
| fhir.dicom#2025.3.20250714 | sect_CID_3777.html | CardiovascularImplant |
| fhir.dicom#2025.3.20250714 | sect_CID_3778.html | Stage |
| fhir.dicom#2025.3.20250714 | sect_CID_3779.html | ImplantedDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_3781.html | LeftVentricleMyocardialWall18SegmentModel |
| fhir.dicom#2025.3.20250714 | sect_CID_3782.html | LeftVentricleBasalWall6Segments |
| fhir.dicom#2025.3.20250714 | sect_CID_3783.html | LeftVentricleMidlevelWall6Segments |
| fhir.dicom#2025.3.20250714 | sect_CID_3784.html | LeftVentricleApicalWall4Segments |
| fhir.dicom#2025.3.20250714 | sect_CID_3785.html | LeftVentricleApicalWall6Segments |
| fhir.dicom#2025.3.20250714 | sect_CID_3802.html | PlaqueStructure |
| fhir.dicom#2025.3.20250714 | sect_CID_3805.html | StenosisType |
| fhir.dicom#2025.3.20250714 | sect_CID_3806.html | StenosisShape |
| fhir.dicom#2025.3.20250714 | sect_CID_3808.html | AneurysmType |
| fhir.dicom#2025.3.20250714 | sect_CID_3809.html | AssociatedCondition |
| fhir.dicom#2025.3.20250714 | sect_CID_3810.html | VascularMorphology |
| fhir.dicom#2025.3.20250714 | sect_CID_3813.html | StentFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3814.html | StentComposition |
| fhir.dicom#2025.3.20250714 | sect_CID_3815.html | SourceofVascularFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_3817.html | VascularSclerosisType |
| fhir.dicom#2025.3.20250714 | sect_CID_3820.html | NoninvasiveVascularProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_3823.html | RespiratoryStatus |
| fhir.dicom#2025.3.20250714 | sect_CID_3826.html | HeartRhythm |
| fhir.dicom#2025.3.20250714 | sect_CID_3827.html | VesselSegment |
| fhir.dicom#2025.3.20250714 | sect_CID_3829.html | PulmonaryArtery |
| fhir.dicom#2025.3.20250714 | sect_CID_3831.html | StenosisLength |
| fhir.dicom#2025.3.20250714 | sect_CID_3832.html | StenosisGrade |
| fhir.dicom#2025.3.20250714 | sect_CID_3835.html | CardiacVolumeMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_3837.html | FiducialFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_3838.html | DiameterDerivation |
| fhir.dicom#2025.3.20250714 | sect_CID_3839.html | CoronaryVein |
| fhir.dicom#2025.3.20250714 | sect_CID_3840.html | PulmonaryVein |
| fhir.dicom#2025.3.20250714 | sect_CID_3843.html | MyocardialSubsegment |
| fhir.dicom#2025.3.20250714 | sect_CID_3850.html | ContrastBolusSubstance |
| fhir.dicom#2025.3.20250714 | sect_CID_4.html | AnatomicRegion |
| fhir.dicom#2025.3.20250714 | sect_CID_4005.html | PartialViewSectionforMammography |
| fhir.dicom#2025.3.20250714 | sect_CID_4009.html | DXAnatomyImaged |
| fhir.dicom#2025.3.20250714 | sect_CID_4010.html | DXView |
| fhir.dicom#2025.3.20250714 | sect_CID_4011.html | DXViewModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_4012.html | ProjectionEponymousName |
| fhir.dicom#2025.3.20250714 | sect_CID_4013.html | AnatomicRegionforMammography |
| fhir.dicom#2025.3.20250714 | sect_CID_4014.html | ViewforMammography |
| fhir.dicom#2025.3.20250714 | sect_CID_4015.html | ViewModifierforMammography |
| fhir.dicom#2025.3.20250714 | sect_CID_4016.html | AnatomicRegionforIntraoralRadiography |
| fhir.dicom#2025.3.20250714 | sect_CID_4017.html | AnatomicRegionModifierforIntraoralRadiography |
| fhir.dicom#2025.3.20250714 | sect_CID_4018.html | PrimaryAnatomicStructureforIntraoralRadiography(PermanentDentitionDesignationofTeeth) |
| fhir.dicom#2025.3.20250714 | sect_CID_4019.html | PrimaryAnatomicStructureforIntraoralRadiography(DeciduousDentitionDesignationofTeeth) |
| fhir.dicom#2025.3.20250714 | sect_CID_4020.html | PETRadionuclide |
| fhir.dicom#2025.3.20250714 | sect_CID_4021.html | PETRadiopharmaceutical |
| fhir.dicom#2025.3.20250714 | sect_CID_4025.html | PrimaryAnatomicStructureforIntraoralRadiography(SupernumeraryDentitionDesignationofTeeth) |
| fhir.dicom#2025.3.20250714 | sect_CID_4026.html | PrimaryAnatomicStructureforIntraoralandCraniofacialRadiographyTeeth |
| fhir.dicom#2025.3.20250714 | sect_CID_4028.html | CraniofacialAnatomicRegion |
| fhir.dicom#2025.3.20250714 | sect_CID_4029.html | DermatologyAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_4030.html | CT,MRandPETAnatomyImaged |
| fhir.dicom#2025.3.20250714 | sect_CID_4031.html | CommonAnatomicRegion |
| fhir.dicom#2025.3.20250714 | sect_CID_4032.html | MRSpectroscopyMetabolite |
| fhir.dicom#2025.3.20250714 | sect_CID_4033.html | MRProtonSpectroscopyMetabolite |
| fhir.dicom#2025.3.20250714 | sect_CID_4040.html | EndoscopyAnatomicRegion |
| fhir.dicom#2025.3.20250714 | sect_CID_4042.html | XA/XRFAnatomyImaged |
| fhir.dicom#2025.3.20250714 | sect_CID_4050.html | DrugorContrastAgentCharacteristic |
| fhir.dicom#2025.3.20250714 | sect_CID_4051.html | GeneralDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_4052.html | PhantomDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_4061.html | HeadandNeckPrimaryAnatomicStructure |
| fhir.dicom#2025.3.20250714 | sect_CID_4062.html | VLView |
| fhir.dicom#2025.3.20250714 | sect_CID_4063.html | VLDentalView |
| fhir.dicom#2025.3.20250714 | sect_CID_4064.html | VLViewModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_4065.html | VLDentalViewModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_4066.html | OrthognathicFunctionalCondition |
| fhir.dicom#2025.3.20250714 | sect_CID_4067.html | OrthodonticFindingbyInspection |
| fhir.dicom#2025.3.20250714 | sect_CID_4068.html | OrthodonticObservableEntity |
| fhir.dicom#2025.3.20250714 | sect_CID_4069.html | DentalOcclusion |
| fhir.dicom#2025.3.20250714 | sect_CID_4070.html | OrthodonticTreatmentProgress |
| fhir.dicom#2025.3.20250714 | sect_CID_4071.html | GeneralPhotographyDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_4072.html | DevicesforthePurposeofDentalPhotography |
| fhir.dicom#2025.3.20250714 | sect_CID_4200.html | OphthalmicImagingAgent |
| fhir.dicom#2025.3.20250714 | sect_CID_4201.html | PatientEyeMovementCommand |
| fhir.dicom#2025.3.20250714 | sect_CID_4202.html | OphthalmicPhotographyAcquisitionDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_4203.html | OphthalmicPhotographyIllumination |
| fhir.dicom#2025.3.20250714 | sect_CID_4204.html | OphthalmicFilter |
| fhir.dicom#2025.3.20250714 | sect_CID_4205.html | OphthalmicLens |
| fhir.dicom#2025.3.20250714 | sect_CID_4206.html | OphthalmicChannelDescription |
| fhir.dicom#2025.3.20250714 | sect_CID_4207.html | OphthalmicImagePosition |
| fhir.dicom#2025.3.20250714 | sect_CID_4208.html | MydriaticAgent |
| fhir.dicom#2025.3.20250714 | sect_CID_4209.html | OphthalmicAnatomicStructureImaged |
| fhir.dicom#2025.3.20250714 | sect_CID_4210.html | OphthalmicTomographyAcquisitionDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_4211.html | OphthalmicOCTAnatomicStructureImaged |
| fhir.dicom#2025.3.20250714 | sect_CID_4214.html | OphthalmicHorizontalDirection |
| fhir.dicom#2025.3.20250714 | sect_CID_4215.html | OphthalmicVerticalDirection |
| fhir.dicom#2025.3.20250714 | sect_CID_4216.html | OphthalmicVisualAcuityType |
| fhir.dicom#2025.3.20250714 | sect_CID_4220.html | VisualFixationQualityDuringAcquisition |
| fhir.dicom#2025.3.20250714 | sect_CID_4221.html | VisualFixationQualityProblem |
| fhir.dicom#2025.3.20250714 | sect_CID_4222.html | OphthalmicMacularGridProblem |
| fhir.dicom#2025.3.20250714 | sect_CID_4231.html | LensStatus |
| fhir.dicom#2025.3.20250714 | sect_CID_4232.html | VitreousStatus |
| fhir.dicom#2025.3.20250714 | sect_CID_4233.html | OphthalmicAxialLengthMeasurementsSegmentName |
| fhir.dicom#2025.3.20250714 | sect_CID_4234.html | RefractiveSurgeryType |
| fhir.dicom#2025.3.20250714 | sect_CID_4237.html | LensConstantType |
| fhir.dicom#2025.3.20250714 | sect_CID_4238.html | RefractiveErrorType |
| fhir.dicom#2025.3.20250714 | sect_CID_4253.html | VisualFieldStaticPerimetryFixationStrategy |
| fhir.dicom#2025.3.20250714 | sect_CID_4254.html | VisualFieldStaticPerimetryTestAnalysisResult |
| fhir.dicom#2025.3.20250714 | sect_CID_4255.html | VisualFieldIlluminationColor |
| fhir.dicom#2025.3.20250714 | sect_CID_4256.html | VisualFieldProcedureModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_4266.html | OphthalmicAnatomicStructureReferencePoint |
| fhir.dicom#2025.3.20250714 | sect_CID_4273.html | RetinalSegmentationSurface |
| fhir.dicom#2025.3.20250714 | sect_CID_4275.html | AnteriorEyeSegmentationSurface |
| fhir.dicom#2025.3.20250714 | sect_CID_4286.html | GanglionCellMeasurementExtent |
| fhir.dicom#2025.3.20250714 | sect_CID_4402.html | HistoryofMalignantMelanoma |
| fhir.dicom#2025.3.20250714 | sect_CID_4403.html | HistoryofMelanomainSitu |
| fhir.dicom#2025.3.20250714 | sect_CID_4404.html | HistoryofNonMelanomaSkinCancer |
| fhir.dicom#2025.3.20250714 | sect_CID_4405.html | SkinDisorder |
| fhir.dicom#2025.3.20250714 | sect_CID_4406.html | PatientReportedLesionCharacteristic |
| fhir.dicom#2025.3.20250714 | sect_CID_4408.html | LesionVisualFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_4409.html | SkinProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_4410.html | TopicalTreatment |
| fhir.dicom#2025.3.20250714 | sect_CID_4411.html | LesionColor |
| fhir.dicom#2025.3.20250714 | sect_CID_4412.html | SpecimenStainforConfocalMicroscopy |
| fhir.dicom#2025.3.20250714 | sect_CID_5.html | TransducerApproach |
| fhir.dicom#2025.3.20250714 | sect_CID_501.html | VolumetricViewDescription |
| fhir.dicom#2025.3.20250714 | sect_CID_502.html | VolumetricViewModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_6.html | TransducerOrientation |
| fhir.dicom#2025.3.20250714 | sect_CID_60.html | ImagingAgentAdministrationAdverseEvent |
| fhir.dicom#2025.3.20250714 | sect_CID_6000.html | OverallBreastComposition |
| fhir.dicom#2025.3.20250714 | sect_CID_6001.html | OverallBreastCompositionfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6002.html | ChangeSinceLastMammogramorPriorSurgery |
| fhir.dicom#2025.3.20250714 | sect_CID_6003.html | ChangeSinceLastMammogramorPriorSurgeryfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6004.html | MammographyShapeCharacteristic |
| fhir.dicom#2025.3.20250714 | sect_CID_6005.html | ShapeCharacteristicfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6006.html | MammographyMarginCharacteristic |
| fhir.dicom#2025.3.20250714 | sect_CID_6007.html | MarginCharacteristicfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6008.html | DensityModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_6009.html | DensityModifierfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_601.html | BiosafetyLevel |
| fhir.dicom#2025.3.20250714 | sect_CID_6010.html | MammographyCalcificationType |
| fhir.dicom#2025.3.20250714 | sect_CID_6011.html | CalcificationTypefromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6012.html | CalcificationDistributionModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_6013.html | CalcificationDistributionModifierfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6014.html | MammographySingleImageFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_6015.html | SingleImageFindingfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6016.html | MammographyCompositeFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6017.html | CompositeFeaturefromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6018.html | ClockfaceLocationorRegion |
| fhir.dicom#2025.3.20250714 | sect_CID_6019.html | ClockfaceLocationorRegionfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_602.html | BiosafetyControlReason |
| fhir.dicom#2025.3.20250714 | sect_CID_6020.html | QuadrantLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_6021.html | QuadrantLocationfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6022.html | Side |
| fhir.dicom#2025.3.20250714 | sect_CID_6023.html | SidefromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6024.html | Depth |
| fhir.dicom#2025.3.20250714 | sect_CID_6025.html | DepthfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6026.html | MammographyAssessment |
| fhir.dicom#2025.3.20250714 | sect_CID_6027.html | AssessmentfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6028.html | MammographyRecommendedFollowup |
| fhir.dicom#2025.3.20250714 | sect_CID_6029.html | RecommendedFollowupfromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_603.html | AnimalRoomType |
| fhir.dicom#2025.3.20250714 | sect_CID_6030.html | MammographyPathologyCode |
| fhir.dicom#2025.3.20250714 | sect_CID_6031.html | BenignPathologyCodefromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6032.html | HighRiskLesionPathologyCodefromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6033.html | MalignantPathologyCodefromBIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6037.html | MammographyQuantitativeTemporalDifferenceType |
| fhir.dicom#2025.3.20250714 | sect_CID_6038.html | MammographyQualitativeTemporalDifferenceType |
| fhir.dicom#2025.3.20250714 | sect_CID_6039.html | NippleCharacteristic |
| fhir.dicom#2025.3.20250714 | sect_CID_6040.html | NonlesionObjectType |
| fhir.dicom#2025.3.20250714 | sect_CID_6043.html | MammographyCADAnalysisType |
| fhir.dicom#2025.3.20250714 | sect_CID_6050.html | BreastProcedureReported |
| fhir.dicom#2025.3.20250714 | sect_CID_6051.html | BreastProcedureReason |
| fhir.dicom#2025.3.20250714 | sect_CID_6052.html | BreastImagingReportSectionTitle |
| fhir.dicom#2025.3.20250714 | sect_CID_6053.html | BreastImagingReportElement |
| fhir.dicom#2025.3.20250714 | sect_CID_6054.html | BreastImagingFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_6055.html | BreastClinicalFindingorIndicatedProblem |
| fhir.dicom#2025.3.20250714 | sect_CID_6056.html | AssociatedFindingforBreast |
| fhir.dicom#2025.3.20250714 | sect_CID_6057.html | DuctographyFindingforBreast |
| fhir.dicom#2025.3.20250714 | sect_CID_6058.html | ProcedureModifiersforBreast |
| fhir.dicom#2025.3.20250714 | sect_CID_6059.html | BreastImplantType |
| fhir.dicom#2025.3.20250714 | sect_CID_606.html | AnimalShelterType |
| fhir.dicom#2025.3.20250714 | sect_CID_6060.html | BreastBiopsyTechnique |
| fhir.dicom#2025.3.20250714 | sect_CID_6061.html | BreastImagingProcedureModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_6062.html | InterventionalProcedureComplication |
| fhir.dicom#2025.3.20250714 | sect_CID_6063.html | InterventionalProcedureResult |
| fhir.dicom#2025.3.20250714 | sect_CID_6064.html | UltrasoundFindingforBreast |
| fhir.dicom#2025.3.20250714 | sect_CID_6065.html | InstrumentApproach |
| fhir.dicom#2025.3.20250714 | sect_CID_6067.html | FluidColor |
| fhir.dicom#2025.3.20250714 | sect_CID_6069.html | NottinghamCombinedHistologicGrade |
| fhir.dicom#2025.3.20250714 | sect_CID_6070.html | BloomRichardsonHistologicGrade |
| fhir.dicom#2025.3.20250714 | sect_CID_6071.html | HistologicGradingMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_6072.html | BreastImplantFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_6080.html | GynecologicalHormone |
| fhir.dicom#2025.3.20250714 | sect_CID_6081.html | BreastCancerRiskFactor |
| fhir.dicom#2025.3.20250714 | sect_CID_6082.html | GynecologicalProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_6083.html | ProceduresforBreast |
| fhir.dicom#2025.3.20250714 | sect_CID_6084.html | MammoplastyProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_6085.html | TherapiesforBreast |
| fhir.dicom#2025.3.20250714 | sect_CID_6086.html | MenopausalPhase |
| fhir.dicom#2025.3.20250714 | sect_CID_6087.html | GeneralRiskFactor |
| fhir.dicom#2025.3.20250714 | sect_CID_6088.html | OBGYNMaternalRiskFactor |
| fhir.dicom#2025.3.20250714 | sect_CID_6089.html | Substance |
| fhir.dicom#2025.3.20250714 | sect_CID_609.html | AnimalFeedingMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_6091.html | RelativeFrequencyofEventValue |
| fhir.dicom#2025.3.20250714 | sect_CID_6092.html | Usage/ExposureQualitativeConcept |
| fhir.dicom#2025.3.20250714 | sect_CID_6096.html | PregnancyStatus |
| fhir.dicom#2025.3.20250714 | sect_CID_6097.html | SideofFamily |
| fhir.dicom#2025.3.20250714 | sect_CID_6099.html | RacialGroup |
| fhir.dicom#2025.3.20250714 | sect_CID_610.html | WaterType |
| fhir.dicom#2025.3.20250714 | sect_CID_6100.html | ChestComponentCategory |
| fhir.dicom#2025.3.20250714 | sect_CID_6102.html | ChestFindingorFeatureModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_6103.html | AbnormalLinesFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6104.html | AbnormalOpacityFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6105.html | AbnormalLucencyFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6107.html | WidthDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_6108.html | ChestAnatomicStructureAbnormalDistribution |
| fhir.dicom#2025.3.20250714 | sect_CID_6109.html | RadiographicAnatomyFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_611.html | AnesthesiaCategoryCodeTypeforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_6110.html | LungAnatomyFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6111.html | BronchovascularAnatomyFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6112.html | PleuraAnatomyFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6113.html | MediastinumAnatomyFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6114.html | OsseousAnatomyFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6115.html | OsseousAnatomyModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_6116.html | MuscularAnatomy |
| fhir.dicom#2025.3.20250714 | sect_CID_6117.html | VascularAnatomy |
| fhir.dicom#2025.3.20250714 | sect_CID_6118.html | SizeDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_6119.html | ChestBorderShape |
| fhir.dicom#2025.3.20250714 | sect_CID_612.html | AnesthesiaCategoryCodeTypefromAnesthesiaQualityInitiative |
| fhir.dicom#2025.3.20250714 | sect_CID_6120.html | ChestBorderDefinition |
| fhir.dicom#2025.3.20250714 | sect_CID_6121.html | ChestOrientationDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_6122.html | ChestContentDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_6124.html | LocationinChest |
| fhir.dicom#2025.3.20250714 | sect_CID_6125.html | GeneralChestLocation |
| fhir.dicom#2025.3.20250714 | sect_CID_6126.html | LocationinLung |
| fhir.dicom#2025.3.20250714 | sect_CID_6127.html | SegmentLocationinLung |
| fhir.dicom#2025.3.20250714 | sect_CID_6128.html | ChestDistributionDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_6129.html | ChestSiteInvolvement |
| fhir.dicom#2025.3.20250714 | sect_CID_613.html | AnesthesiaInductionCodeTypeforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_6130.html | SeverityDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_6132.html | ChestCalcificationDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_6133.html | ChestQuantitativeTemporalDifferenceType |
| fhir.dicom#2025.3.20250714 | sect_CID_6134.html | ChestQualitativeTemporalDifferenceType |
| fhir.dicom#2025.3.20250714 | sect_CID_6137.html | CADAnalysisType |
| fhir.dicom#2025.3.20250714 | sect_CID_6138.html | ChestNonlesionObjectType |
| fhir.dicom#2025.3.20250714 | sect_CID_6139.html | NonlesionModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_614.html | AnesthesiaInductionCodeTypefromAnesthesiaQualityInitiative |
| fhir.dicom#2025.3.20250714 | sect_CID_6140.html | CalculationMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_6142.html | CalculatedValue |
| fhir.dicom#2025.3.20250714 | sect_CID_6146.html | TimePointType |
| fhir.dicom#2025.3.20250714 | sect_CID_6148.html | MediastinumFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6149.html | MediastinumAnatomy |
| fhir.dicom#2025.3.20250714 | sect_CID_615.html | AnesthesiaMaintenanceCodeTypeforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_6159.html | MalignancyType |
| fhir.dicom#2025.3.20250714 | sect_CID_616.html | AnesthesiaMaintenanceCodeTypefromAnesthesiaQualityInitiative |
| fhir.dicom#2025.3.20250714 | sect_CID_6160.html | BreastPrimaryTumorAssessmentFromAJCC |
| fhir.dicom#2025.3.20250714 | sect_CID_6161.html | PathologicalRegionalLymphNodeAssessmentforBreast |
| fhir.dicom#2025.3.20250714 | sect_CID_6162.html | AssessmentofMetastasisforBreast |
| fhir.dicom#2025.3.20250714 | sect_CID_6163.html | MenstrualCyclePhase |
| fhir.dicom#2025.3.20250714 | sect_CID_6165.html | BreastLinearMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_6166.html | CADGeometrySecondaryGraphicalRepresentation |
| fhir.dicom#2025.3.20250714 | sect_CID_617.html | AirwayManagementMethodCodeTypeforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_6170.html | LobeofLung |
| fhir.dicom#2025.3.20250714 | sect_CID_6171.html | ZoneofLung |
| fhir.dicom#2025.3.20250714 | sect_CID_618.html | AirwayManagementMethodCodeTypefromAnesthesiaQualityInitiative |
| fhir.dicom#2025.3.20250714 | sect_CID_619.html | AirwayManagementSubMethodCodeTypeforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_620.html | AirwayManagementSubMethodCodeTypefromAnesthesiaQualityInitiative |
| fhir.dicom#2025.3.20250714 | sect_CID_6201.html | ColonFindingorFeature |
| fhir.dicom#2025.3.20250714 | sect_CID_6202.html | ColonFindingorFeatureModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_6203.html | ColonNonlesionObjectType |
| fhir.dicom#2025.3.20250714 | sect_CID_6204.html | AnatomicNoncolonFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_6205.html | ClockfaceLocationforColon |
| fhir.dicom#2025.3.20250714 | sect_CID_6206.html | RecumbentPatientOrientationforColon |
| fhir.dicom#2025.3.20250714 | sect_CID_6207.html | ColonQuantitativeTemporalDifferenceType |
| fhir.dicom#2025.3.20250714 | sect_CID_6209.html | ColonMorphologyDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_621.html | MedicationTypeforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_6210.html | LocationinIntestinalTract |
| fhir.dicom#2025.3.20250714 | sect_CID_6211.html | ColonCADMaterialDescription |
| fhir.dicom#2025.3.20250714 | sect_CID_6212.html | CalculatedValueforColonFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_622.html | MedicationTypeCodeTypefromAnesthesiaQualityInitiative |
| fhir.dicom#2025.3.20250714 | sect_CID_623.html | MedicationforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_624.html | InhalationalAnesthesiaAgentforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_625.html | InjectableAnesthesiaAgentforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_626.html | PremedicationAgentforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_627.html | NeuromuscularBlockingAgentforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_629.html | CarrierGasesforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_630.html | LocalAnestheticsforSmallAnimalAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_6300.html | ProstateAnatomy |
| fhir.dicom#2025.3.20250714 | sect_CID_6301.html | ProstateSectorAnatomyfromPIRADSv2 |
| fhir.dicom#2025.3.20250714 | sect_CID_6302.html | ProstateSectorAnatomyfromEuropeanConcensus16Sector(Minimal)Model |
| fhir.dicom#2025.3.20250714 | sect_CID_6303.html | ProstateSectorAnatomyfromEuropeanConcensus27Sector(Optimal)Model |
| fhir.dicom#2025.3.20250714 | sect_CID_6304.html | ProstateSectorAnatomyfromPIRADSv2.1 |
| fhir.dicom#2025.3.20250714 | sect_CID_631.html | ProcedurePhaseRequiringAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_6312.html | CrosssectionalScanPlaneOrientation |
| fhir.dicom#2025.3.20250714 | sect_CID_6313.html | HistoryofProstateDisease |
| fhir.dicom#2025.3.20250714 | sect_CID_6319.html | AbdominalInterventionType |
| fhir.dicom#2025.3.20250714 | sect_CID_632.html | SurgicalProcedurePhaseRequiringAnesthesia |
| fhir.dicom#2025.3.20250714 | sect_CID_6320.html | AbdominopelvicIntervention |
| fhir.dicom#2025.3.20250714 | sect_CID_6321.html | ProstateCancerDiagnosticProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_6322.html | ProstateCancerFamilyHistory |
| fhir.dicom#2025.3.20250714 | sect_CID_6323.html | ProstateCancerTherapy |
| fhir.dicom#2025.3.20250714 | sect_CID_6327.html | ProstateImagingIndication |
| fhir.dicom#2025.3.20250714 | sect_CID_6333.html | mpMRIAssessmentType |
| fhir.dicom#2025.3.20250714 | sect_CID_6334.html | mpMRIAssessmentTypefromPIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6335.html | mpMRIAssessmentValue |
| fhir.dicom#2025.3.20250714 | sect_CID_6336.html | MRIAbnormality |
| fhir.dicom#2025.3.20250714 | sect_CID_6337.html | mpMRIProstateAbnormalityfromPIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6338.html | mpMRIBenignProstateAbnormalityfromPIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6339.html | MRIShapeCharacteristic |
| fhir.dicom#2025.3.20250714 | sect_CID_634.html | AnimalHandlingPhase |
| fhir.dicom#2025.3.20250714 | sect_CID_6340.html | ProstateMRIShapeCharacteristicfromPIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6341.html | MRIMarginCharacteristic |
| fhir.dicom#2025.3.20250714 | sect_CID_6342.html | ProstateMRIMarginCharacteristicfromPIRADS® |
| fhir.dicom#2025.3.20250714 | sect_CID_6347.html | ProstateMRIExtraprostaticFinding |
| fhir.dicom#2025.3.20250714 | sect_CID_6348.html | ProstateMRIAssessmentofExtraprostaticAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_635.html | HeatingMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_6350.html | EndorectalCoilFillSubstance |
| fhir.dicom#2025.3.20250714 | sect_CID_636.html | TemperatureSensorDeviceComponentTypeforSmallAnimalProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_637.html | ExogenousSubstanceType |
| fhir.dicom#2025.3.20250714 | sect_CID_638.html | ExogenousSubstance |
| fhir.dicom#2025.3.20250714 | sect_CID_639.html | TumorGraftHistologicType |
| fhir.dicom#2025.3.20250714 | sect_CID_64.html | ImagingAgentAdministrationPatientState |
| fhir.dicom#2025.3.20250714 | sect_CID_6401.html | NonlesionObjectTypePhysicalObject |
| fhir.dicom#2025.3.20250714 | sect_CID_6402.html | NonlesionObjectTypeSubstance |
| fhir.dicom#2025.3.20250714 | sect_CID_6403.html | NonlesionObjectTypeTissue |
| fhir.dicom#2025.3.20250714 | sect_CID_6404.html | ChestNonlesionObjectTypePhysicalObject |
| fhir.dicom#2025.3.20250714 | sect_CID_6405.html | ChestNonlesionObjectTypeTissue |
| fhir.dicom#2025.3.20250714 | sect_CID_641.html | Virus |
| fhir.dicom#2025.3.20250714 | sect_CID_642.html | Cytokine |
| fhir.dicom#2025.3.20250714 | sect_CID_643.html | Toxin |
| fhir.dicom#2025.3.20250714 | sect_CID_644.html | ExogenousSubstanceAdministrationSite |
| fhir.dicom#2025.3.20250714 | sect_CID_645.html | ExogenousSubstanceOriginTissue |
| fhir.dicom#2025.3.20250714 | sect_CID_646.html | PreclinicalSmallAnimalImagingProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_65.html | ImagingAgentAdministrationPremedication |
| fhir.dicom#2025.3.20250714 | sect_CID_66.html | ImagingAgentAdministrationMedication |
| fhir.dicom#2025.3.20250714 | sect_CID_67.html | ImagingAgentAdministrationCompletionStatus |
| fhir.dicom#2025.3.20250714 | sect_CID_68.html | ImagingAgentAdministrationPharmaceuticalPresentationUnit |
| fhir.dicom#2025.3.20250714 | sect_CID_69.html | ImagingAgentAdministrationConsumable |
| fhir.dicom#2025.3.20250714 | sect_CID_7.html | UltrasoundBeamPath |
| fhir.dicom#2025.3.20250714 | sect_CID_70.html | Flush |
| fhir.dicom#2025.3.20250714 | sect_CID_7000.html | DiagnosticImagingReportDocumentTitle |
| fhir.dicom#2025.3.20250714 | sect_CID_7002.html | DiagnosticImagingReportElement |
| fhir.dicom#2025.3.20250714 | sect_CID_7026.html | RadiotherapeuticDoseMeasurementDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_7027.html | SegmentedRadiotherapeuticDoseMeasurementDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_7030.html | InstitutionalDepartment/Unit/Service |
| fhir.dicom#2025.3.20250714 | sect_CID_7039.html | PediatricSizeCategory |
| fhir.dicom#2025.3.20250714 | sect_CID_7040.html | BroselowLutenPediatricSizeCategory |
| fhir.dicom#2025.3.20250714 | sect_CID_7064.html | ModelUsage |
| fhir.dicom#2025.3.20250714 | sect_CID_7101.html | BrainAtlasFiducial |
| fhir.dicom#2025.3.20250714 | sect_CID_7110.html | FiducialCategory |
| fhir.dicom#2025.3.20250714 | sect_CID_7111.html | Fiducial |
| fhir.dicom#2025.3.20250714 | sect_CID_7112.html | RadiotherapyFiducial |
| fhir.dicom#2025.3.20250714 | sect_CID_7140.html | BrainStructureforVolumetricMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_7150.html | SegmentationPropertyCategory |
| fhir.dicom#2025.3.20250714 | sect_CID_7151.html | SegmentationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_7152.html | CardiacStructureSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7153.html | CNSSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7154.html | AbdominalSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7155.html | ThoracicSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7156.html | VascularSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7157.html | DeviceSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7158.html | ArtifactSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7159.html | LesionSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7160.html | PelvicOrganSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7161.html | PhysiologySegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7163.html | BreastSegmentationTypes |
| fhir.dicom#2025.3.20250714 | sect_CID_7165.html | AbstractSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7166.html | CommonTissueSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7167.html | PeripheralNervousSystemSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7168.html | BrainLesionSegmentationTypeWithNecrosis |
| fhir.dicom#2025.3.20250714 | sect_CID_7169.html | BrainLesionSegmentationTypeWithoutNecrosis |
| fhir.dicom#2025.3.20250714 | sect_CID_7170.html | CouinaudLiverSegment |
| fhir.dicom#2025.3.20250714 | sect_CID_7171.html | LiverSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7180.html | AbstractMultidimensionalImageModelComponentSemantic |
| fhir.dicom#2025.3.20250714 | sect_CID_7186.html | AbstractMultidimensionalImageModelQualitativeDimensionSampleSemantic |
| fhir.dicom#2025.3.20250714 | sect_CID_7191.html | TissueSegmentationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_7192.html | AnatomicalStructureSegmentationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_7193.html | PhysicalObjectSegmentationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_7194.html | MorphologicallyAbnormalStructureSegmentationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_7195.html | FunctionSegmentationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_7196.html | SpatialandRelationalConceptSegmentationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_7197.html | BodySubstanceSegmentationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_7198.html | SubstanceSegmentationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_7199.html | AnatomicallyLocalizedLesionSegmentationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7230.html | AutomationofMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_7300.html | ImplantMaterial |
| fhir.dicom#2025.3.20250714 | sect_CID_7301.html | InterventionType |
| fhir.dicom#2025.3.20250714 | sect_CID_7302.html | ImplantTemplateViewOrientation |
| fhir.dicom#2025.3.20250714 | sect_CID_7304.html | ImplantTargetAnatomy |
| fhir.dicom#2025.3.20250714 | sect_CID_7307.html | ImplantComponentType |
| fhir.dicom#2025.3.20250714 | sect_CID_7308.html | HumanHipImplantComponentType |
| fhir.dicom#2025.3.20250714 | sect_CID_7309.html | HumanTraumaImplantComponentType |
| fhir.dicom#2025.3.20250714 | sect_CID_7310.html | ImplantFixationMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_74.html | ImagingAgentAdministrationConsumableCatheterType |
| fhir.dicom#2025.3.20250714 | sect_CID_7450.html | PersonRole |
| fhir.dicom#2025.3.20250714 | sect_CID_7451.html | FamilyMember |
| fhir.dicom#2025.3.20250714 | sect_CID_7452.html | OrganizationalRole |
| fhir.dicom#2025.3.20250714 | sect_CID_7453.html | PerformingRole |
| fhir.dicom#2025.3.20250714 | sect_CID_7454.html | AnimalTaxonomicRankValue |
| fhir.dicom#2025.3.20250714 | sect_CID_7458.html | PersonGenderIdentity |
| fhir.dicom#2025.3.20250714 | sect_CID_7464.html | GeneralRegionofInterestMeasurementModifier |
| fhir.dicom#2025.3.20250714 | sect_CID_7465.html | MeasurementDerivedFromMultipleROIMeasurements |
| fhir.dicom#2025.3.20250714 | sect_CID_7469.html | GenericIntensityandSizeMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_7470.html | LinearMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_7471.html | AreaMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_7472.html | VolumeMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_7480.html | Breed |
| fhir.dicom#2025.3.20250714 | sect_CID_7482.html | DXAnatomyImagedforAnimal |
| fhir.dicom#2025.3.20250714 | sect_CID_7483.html | CommonAnatomicRegionsforAnimal |
| fhir.dicom#2025.3.20250714 | sect_CID_7484.html | DXViewforAnimal |
| fhir.dicom#2025.3.20250714 | sect_CID_7486.html | MixedBreed |
| fhir.dicom#2025.3.20250714 | sect_CID_75.html | LowHighorEqual |
| fhir.dicom#2025.3.20250714 | sect_CID_7550.html | AngleMeasurement |
| fhir.dicom#2025.3.20250714 | sect_CID_76.html | PremedicationType |
| fhir.dicom#2025.3.20250714 | sect_CID_7600.html | LymphNodeAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_7601.html | HeadandNeckCancerAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_7602.html | VertebralAnatomicStructure |
| fhir.dicom#2025.3.20250714 | sect_CID_7603.html | Vertebra |
| fhir.dicom#2025.3.20250714 | sect_CID_7604.html | IntervertebralDisc |
| fhir.dicom#2025.3.20250714 | sect_CID_7701.html | FiberTractInBrainstem |
| fhir.dicom#2025.3.20250714 | sect_CID_7702.html | ProjectionandThalamicFiber |
| fhir.dicom#2025.3.20250714 | sect_CID_7703.html | AssociationFiber |
| fhir.dicom#2025.3.20250714 | sect_CID_7704.html | LimbicSystemTract |
| fhir.dicom#2025.3.20250714 | sect_CID_7705.html | CommissuralFiber |
| fhir.dicom#2025.3.20250714 | sect_CID_7706.html | CranialNerve |
| fhir.dicom#2025.3.20250714 | sect_CID_7707.html | SpinalCordFiber |
| fhir.dicom#2025.3.20250714 | sect_CID_7710.html | TractographyAnatomicSite |
| fhir.dicom#2025.3.20250714 | sect_CID_8.html | AngiographicInterventionalDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_8101.html | ContainerType |
| fhir.dicom#2025.3.20250714 | sect_CID_8102.html | ContainerComponentType |
| fhir.dicom#2025.3.20250714 | sect_CID_8103.html | AnatomicPathologySpecimenType |
| fhir.dicom#2025.3.20250714 | sect_CID_8104.html | BreastTissueSpecimenType |
| fhir.dicom#2025.3.20250714 | sect_CID_8109.html | SpecimenCollectionProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_8110.html | SpecimenSamplingProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_8111.html | SpecimenPreparationProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_8112.html | SpecimenStain |
| fhir.dicom#2025.3.20250714 | sect_CID_8113.html | SpecimenPreparationStep |
| fhir.dicom#2025.3.20250714 | sect_CID_8114.html | SpecimenFixative |
| fhir.dicom#2025.3.20250714 | sect_CID_8115.html | SpecimenEmbeddingMedia |
| fhir.dicom#2025.3.20250714 | sect_CID_8121.html | MicroscopyLensType |
| fhir.dicom#2025.3.20250714 | sect_CID_8122.html | MicroscopyIlluminatorandSensorColor |
| fhir.dicom#2025.3.20250714 | sect_CID_8124.html | MicroscopyFilter |
| fhir.dicom#2025.3.20250714 | sect_CID_8125.html | MicroscopyIlluminatorType |
| fhir.dicom#2025.3.20250714 | sect_CID_8130.html | StainingProtocol |
| fhir.dicom#2025.3.20250714 | sect_CID_8131.html | PathologyImagingProtocol |
| fhir.dicom#2025.3.20250714 | sect_CID_8134.html | AnatomicStructure |
| fhir.dicom#2025.3.20250714 | sect_CID_8135.html | MicroscopyAnnotationPropertyType |
| fhir.dicom#2025.3.20250714 | sect_CID_8136.html | MicroscopyMeasurementType |
| fhir.dicom#2025.3.20250714 | sect_CID_9.html | ImageGuidedTherapeuticProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_9000.html | PhysicalQuantityDescriptor |
| fhir.dicom#2025.3.20250714 | sect_CID_91.html | FunctionalConditionPresentDuringAcquisition |
| fhir.dicom#2025.3.20250714 | sect_CID_92.html | JointPositionDuringAcquisition |
| fhir.dicom#2025.3.20250714 | sect_CID_9268.html | PatientPositionAcquisitionDevices |
| fhir.dicom#2025.3.20250714 | sect_CID_9271.html | RTImagePatientPositionAcquisitionDevices |
| fhir.dicom#2025.3.20250714 | sect_CID_9272.html | RTROIImageAcquisitionContext |
| fhir.dicom#2025.3.20250714 | sect_CID_93.html | JointPositioningMethod |
| fhir.dicom#2025.3.20250714 | sect_CID_9300.html | ProcedureDiscontinuationReason |
| fhir.dicom#2025.3.20250714 | sect_CID_9301.html | ModalityPPSDiscontinuationReason |
| fhir.dicom#2025.3.20250714 | sect_CID_94.html | PhysicalForceAppliedDuringAcquisition |
| fhir.dicom#2025.3.20250714 | sect_CID_9501.html | PrescriptionAnatomyCategory |
| fhir.dicom#2025.3.20250714 | sect_CID_9502.html | RTSegmentAnnotationCategory |
| fhir.dicom#2025.3.20250714 | sect_CID_9505.html | FixationorPositioningDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_9513.html | FixationDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_9514.html | AnatomicalStructureforRadiotherapy |
| fhir.dicom#2025.3.20250714 | sect_CID_9515.html | RTPatientSupportDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_9516.html | RadiotherapyBolusDeviceType |
| fhir.dicom#2025.3.20250714 | sect_CID_9517.html | RadiotherapyBlockDeviceType |
| fhir.dicom#2025.3.20250714 | sect_CID_9520.html | SegmentedRTAccessoryDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_9525.html | RadiationTherapyParticle |
| fhir.dicom#2025.3.20250714 | sect_CID_9526.html | IonTherapyParticle |
| fhir.dicom#2025.3.20250714 | sect_CID_9527.html | TeletherapyIsotope |
| fhir.dicom#2025.3.20250714 | sect_CID_9528.html | BrachytherapyIsotope |
| fhir.dicom#2025.3.20250714 | sect_CID_9534.html | RadiotherapyTarget |
| fhir.dicom#2025.3.20250714 | sect_CID_9536.html | RadiotherapyPrescribingandSegmentingPersonRole |
| fhir.dicom#2025.3.20250714 | sect_CID_9541.html | BeamLimitingDeviceType |
| fhir.dicom#2025.3.20250714 | sect_CID_9545.html | FixedBeamLimitingDeviceType |
| fhir.dicom#2025.3.20250714 | sect_CID_9555.html | RadiotherapyTreatmentPlanningPersonRole |
| fhir.dicom#2025.3.20250714 | sect_CID_9562.html | RadiotherapyTreatmentDeliveryPersonRole |
| fhir.dicom#2025.3.20250714 | sect_CID_9572.html | PatientShieldingDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_9573.html | PatientTreatmentPreparationDevice |
| fhir.dicom#2025.3.20250714 | sect_CID_9577.html | PatientTreatmentPreparationProcedure |
| fhir.dicom#2025.3.20250714 | sect_CID_9579.html | RTSegmentMaterial |
| fhir.dicom#2025.3.20250714 | sect_CID_9580.html | RTSegmentationPropertyCategory |
| il.core.fhir.r4.2023#0.1.0 | il-core-allergy-intolerance-code | IL Core Allergy Intolerance Code |
| il.core.fhir.r4.2023#0.1.0 | il-core-allergy-intolerance-end-reason | IL Core Condition End Reason |
| il.core.fhir.r4.2023#0.1.0 | il-core-common-units-of-measure | IL Core Units Of Measure Codes |
| il.core.fhir.r4.2023#0.1.0 | il-core-condition-category | IL Core Condition Category Codes |
| il.core.fhir.r4.2023#0.1.0 | il-core-condition-code | IL Core Condition Code |
| il.core.fhir.r4.2023#0.1.0 | il-core-doctor-to-doctor | IL Core Doctor To Doctor Codes |
| il.core.fhir.r4.2023#0.1.0 | il-core-manifestation | IL Core Condition Codes |
| il.core.fhir.r4.2023#0.1.0 | il-core-medication-code | ILCore Medication Code |
| il.core.fhir.r4.2023#0.1.0 | il-core-medication-statement-code | ILCore Medication statement Code |
| il.core.fhir.r4.2023#0.1.0 | il-core-observation-code | IL Core Observation Codes |
| il.core.fhir.r4.2023#0.1.0 | il-core-observation-value | IL Core Observation Value Codes |
| il.core.fhir.r4.2023#0.1.0 | il-core-procedure-code | IL Core procedure Codes |
| il.core.fhir.r4.2023#0.1.0 | il-core-route-code | IL Core Route Code |
| il.core.fhir.r4.2023#0.1.0 | il-core-service-category | IL Core ServiceCategory |
| il.core.fhir.r4.2023#0.1.0 | il-core-service-type | IL Core Service type |
| il.core.fhir.r4.2023#0.1.0 | il-core-substance | IL Core Substance Codes |
| il.core.fhir.r4.2023#0.1.0 | il-core-units-of-measure | IL Core Units Of Measure Codes |
| il.core.fhir.r4.2023#0.1.0 | il-core-virtual-type | IL Core Virtual encounter Type Codes |
| il.core.fhir.r4.2023#0.1.0 | immunization-body-site | Immunization Observation Body Site list |
| il.core.fhir.r4.2023#0.1.0 | immunization-side-effect | Immunization side-effect codes |
| il.core.fhir.r4.2023#0.1.0 | organization-type | Organization Type |
| il.core.fhir.r4.2023#0.1.0 | reason-not-done | statusReason codes for Immunization profile |
| il.core.fhir.r4.2023#0.1.0 | target-disease | Target Disease Codes |
| il.core.fhir.r4.2023#0.1.0 | vaccine-code | Vaccine Codes |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.10 | Seizure or Serious Neurologic Dysfunction (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.100 | Third Degree Perineal Laceration (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.101 | Fourth Degree Perineal Laceration (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.102 | Ruptured Uterus (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.103 | Unplanned Hysterectomy (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.105 | Unplanned Operation (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.106 | Attempted Forceps Procedure (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.107 | Attempted Vacuum Procedure (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.108 | Fetal Presentation at Birth- Breech (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.109 | Fetal Presentation at Birth- Cephalic (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.11 | Newborn Given Surfactant Replacement (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.110 | Fetal Presentation at Birth- Other (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.111 | Route and Method of Delivery - Spontaneous (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.112 | Route and Method of Delivery - Forceps (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.113 | Route and Method of Delivery - Vacuum (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.114 | Route and Method of Delivery - Cesarean (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.115 | Route Method of Delivery - Trial of Labor (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.116 | Route and Method of Delivery - Scheduled C (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.119 | Problem Status Active (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.125 | Cervical Cerclage (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.127 | External Cephalic Version (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.128 | Tocolysis (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.129 | Premature Rupture (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.130 | Precipitous Labor (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.131 | Prolonged Labor (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.136 | Prepregnancy Diabetes (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.137 | Gestational Diabetes (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.138 | Prepregnancy Hypertension (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.139 | Gestational Hypertension (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.14 | Delivery (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.140 | Eclampsia (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.141 | Preterm Birth (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.142 | Poor Pregnancy Outcome History (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.143 | Infertility Treatment (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.145 | Artificial or Intrauterine Insemination (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.146 | Assistive Reproductive Technology (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.147 | Listeria (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.149 | Neonatal Death (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.15 | Physician (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.150 | Hysterotomy Hysterectomy (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.153 | Fetal Autopsy (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.154 | Karyotype Determination (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.16 | Doctor of Osteopathic Medicine (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.166 | Group B Streptococcus (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.167 | Cytomegalovirus (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.168 | Parvovirus (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.169 | Toxoplasmosis (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.176 | Transferred for Maternal Medical or Fetal Indicat |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.178 | Antibiotic Administration Procedure (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.188 | ICU Care (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.189 | Cleft Palate Alone (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.190 | Transfer to Facility (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.192 | Birth Place Hospital (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.193 | Birth Place Home Intended (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.194 | Birth Place Home Unintended (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.196 | Birth Place Freestanding Birthing Center (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.197 | Birth Place Clinic Office (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.198 | NICU Care (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.22 | Augmentation of Labor - Procedure (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.24 | Chorioamnionitis During Labor (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.25 | Fever Greater Than 100.4 (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.27 | Epidural Anesthesia - Procedure (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.29 | Spinal Anesthesia - Procedure (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.30 | Fetal Intolerance of Labor (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.31 | In-utero Resuscitation (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.32 | Further Fetal Assessment (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.33 | Operative Delivery (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.34 | Induction of Labor (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.35 | Spontaneous Onset of Labor (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.36 | Meconium Staining (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.37 | Non-vertex presentation in active phase of (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.39 | Immature Fetus (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.40 | Inflammation Indication (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.41 | Breastfed Infant (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.53 | Anencephaly of the Newborn (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.54 | Cyanotic Congenital Heart Disease (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.55 | Congenital Diaphragmatic Hernia (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.56 | Karyotype Confirmed (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.57 | Suspected Chromosomal Disorder (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.58 | Cleft Lip with or without Cleft Palate (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.6 | Neonatal Sepsis (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.60 | Cleft Lip without Cleft Palate (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.61 | Down Syndrome (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.62 | Gastroschisis of the Newborn (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.63 | Hypospadias (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.65 | Meningomyelocele/Spina Bifida - Newborn (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.66 | Omphalocele of the Newborn (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.9 | Significant Birth Injury (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.93 | Chlamydia (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.95 | Pregnant (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.96 | Hepatitis B (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.97 | Hepatitis C (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.98 | Syphilis (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.13.8.99 | Transfusion Whole Blood or Packed Red Bld (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.11 | JCIH-EHDI Hearing Loss Risk Factors |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.12 | JCIH-EHDI Hearing Loss Risk Factors - Procedures |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.14 | JCIH-EHDI Newborn Hearing Loss Diagnosis |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.15 | JCIH-EHDI Reason for no Hearing Loss Diagnosis |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.16 | JCIH-EHDI Newborn Hearing Loss Referrals |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.17 | JCIH-EHDI Newborn Hearing Procedure |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.20 | JCIH-EHDI Procedure Declined |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.15.2.7 | JCIH-EHDI Reason for no Follow-up - Patient Reason |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.1 | Autopsy Performed (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.13 | Family History (HW) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.14 | Mother Breastfeeding (HW) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.19 | Associated Conditions (HW) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.2 | Autopsy Not Performed (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.6 | Death Certification (NCHS) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.7 | Interventions (HW) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.8 | Dietary Behavior (HW) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.9 | Physical Activity Behavior (HW) |
| us.cdc.phinvads#0.12.0 | 1.3.6.1.4.1.33895.1.3.0.75 | Joint Commission Medical Reason |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.11222.4.11.5025 | Original Specimen Type Modifier PHLIP |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113762.1.4.1018.98 | Route of Administration |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.1.11.20.2 | Advance Directive Type Value Set |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.1 | Amniotic Fluid Conditions (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.10 | Type of Twin (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.11 | Twin Placenta (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.12 | Umbilical Cord Complication (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.13 | Infant Fetal Complications (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.14 | Placental Measurement (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.2 | Cord Insertion Type (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.3 | Hospital Care-Setting (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.4 | Maternal Exposures (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.5 | Intended Newborn Feeding Type (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.6 | Placenta Type (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.10.14.1.1.13.7 | Placental Conditions (HL7) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.11.20.9.34 | Patient Education |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.11.20.9.38 | Current Smoking Status (NAACCR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.11.20.9.41 | Tobacco Use |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.11.20.9.49 | Residence and Accommodation Type |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.11.20.9.60 | Priority Level (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.13.277 | Birth Defect Diagnosis |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.520.4.22 | Laterality (NAACCR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.520.4.26 | Radiation Rx and Boost Radiation SNOMEDCT (NAACCR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.520.4.29 | NAACCR SNOMEDCT Cancer Reportability List |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.88.12.3221.6.2 | Allergy/Adverse Event Type Value Set |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.88.12.3221.6.8 | Problem Severity |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.88.12.3221.7.2 | Problem Type Value Set |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.88.12.3221.7.4 | Problem Value Set |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.88.12.3221.8.19 | Medication Type Value Set |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.88.12.3221.8.9 | Body Site Value Set |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.88.12.80.21 | Medication Vehicle Value Set |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.88.12.80.60 | Social History Type Value Set |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.113883.3.88.12.80.68 | Problem Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1007 | Major Site of Disease (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1009 | Microorganism |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1010 | Microscopic Exam Culture Site (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1013 | Missing Lab Result Reason |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1014 | Modifier or Qualifier |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1018 | Non Paint Lead Source |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1019 | Non-paint lead source - hobby related |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1022 | Occupation Risk Category (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1026 | Pregnancy Trimester |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1027 | Previous Vaccine History |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1032 | Rash Distribution (VZ) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1033 | Rash Location First Noted (VZ) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1035 | Reason Therapy Stopped (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1036 | Referral Status (CRA) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1037 | Risk Category |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1051 | Substance Treatment Refusal Reason |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1052 | Transmission Setting (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1056 | Vaccination Location (CRA) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1057 | Vaccine Contraindications |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1060 | Abnormal Chest X-ray Condition Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1067 | Body Substance |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1068 | Event |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1069 | Material |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1074 | Animal |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1075 | Physical Object |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1076 | Situation with Explicit Context |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.1109 | Procedure by Site (SNOMED) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3017 | Lab Test Result (PHLIP Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3025 | Case Confirmation Method |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3026 | Case Detection Method |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3027 | Case Transmission Mode |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3028 | Contact Type (Hepatitis A) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3029 | Contact Type (Hepatitis B and C) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3033 | Number Of Sex Partners (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3034 | Outbreak Type (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3036 | Reporting Source Type |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3037 | Tattoo Obtained From (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3038 | Vaccine Dose Number (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3044 | Microbiology strain |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3045 | Microorganism (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3048 | Lab Test Interpretation |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3049 | Lab Test Result Qualitative |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3058 | Cancer Type |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3059 | Clinical Syndrome (Arbovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3060 | Immunosuppressed Condition |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3062 | Transplant Organ |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3063 | Virus Type (Arboviral Disease) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3066 | Bat Species (Animal Rabies) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3068 | Animal Species (Animal Rabies) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3069 | Yes No Unknown Not Done |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3071 | Pregnancy Outcome (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3072 | Animal Type (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3073 | Botulinum Toxin Type (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3075 | Cholera Risk Factor (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3076 | Cholera Sequelae (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3077 | Cholera Signs Symptoms (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3078 | Cyclosporiasis Signs Symptoms (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3079 | Day Care Type (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3080 | Eosin Units (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3081 | Fetal Neonatal Infection Type (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3082 | Fetal Neonatal Specimen Type |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3085 | Fresh Berries (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3086 | Fresh Herbs (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3087 | Fresh Produce (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3088 | Information Source |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3090 | Lettuce Type (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3091 | Maternal Infection (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3092 | Meat Purchase Info (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3094 | Other Related Cases |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3095 | Outbreak Type (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3096 | Pork Type (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3098 | Recreational Water (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3099 | Seafood Purchase Info (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3101 | Skin Exposure (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3107 | Travel Mode |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3108 | Travel Purpose |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3110 | Trichinellosis Signs Symptoms (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3111 | Typhoid Signs Symptoms (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3112 | Underlying Conditions |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3113 | Water Salinity (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3116 | Notifiable Condition (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3118 | Medication Treatment (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3119 | Acute Convalescent IgG Difference (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3120 | Antibiotic Received (Pertussis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3121 | Birth Attendees (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3122 | Birth Location (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3123 | Birth Outcome (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3124 | Body Region (Tetanus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3126 | Genotype (Measles) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3127 | Genotype (Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3128 | Immunization Information Source (CRS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3129 | Injury Occurred Environment (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3130 | Injury Type (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3131 | Lab Result (Pertussis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3132 | Lab Result (Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3134 | No Case Reason (CRS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3135 | Non-Live Birth Outcome (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3140 | Specimen Source (CRS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3141 | Specimen Source (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3142 | Test Method EIA IgM |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3143 | Tetanus Type (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3144 | Treatment Outcome Tetanus (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3145 | Vaccine Doses Received (Pertussis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3146 | Vaccine Doses Received (Tetanus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3148 | PCR Specimen Source (VZ) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3149 | Lab Test Method (VZ) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3160 | Microscopic Exam Type (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3161 | Primary Reason For Evaluation (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3162 | Risk Factors (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3163 | Immigration Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3164 | Sputum Culture Conversion Not Documented Reason |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3167 | Therapy Extended Reason (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3203 | Treatment status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3204 | Non-Laboratory Intervention and Procedure |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3209 | Exposure Location |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3210 | Contact Type (Hepatitis B) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3211 | Material exposure type |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3212 | Signs and Symptoms (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3213 | Signs and Symptoms (Acute Hepatitis B) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3214 | Signs and Symptoms (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3215 | Signs and Symptoms (Tularemia) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3220 | Disease Type (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3221 | Disease Type (Acute Hepatitis B) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3222 | Disease Type (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3223 | Disease Type (Tularemia) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3225 | Blood or body fluid exposure frequency |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3226 | Blood or body fluid exposure related procedure |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3228 | Sociobehavioral risk factor |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3230 | Disease Type (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3231 | Disease Type (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3232 | HIV Status (PHCR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3240 | Flu Signs and Symptoms |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3242 | Risk Factor (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3243 | Lab Test Finding (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3246 | Specimen (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3251 | Lab Test Procedure (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3252 | Lab Test Interpretation (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3253 | Obesity Severity (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3254 | Employment Status (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3255 | Case Contact Signs and Symptoms (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3256 | Time Frame (Daily Weekly) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3257 | Surveillance Method (Novel Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3258 | Change Pattern |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3259 | Age Group (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3261 | Death Location (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3262 | Lab Test Procedure (Pediatric Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3263 | Lab Test Interpretation (Pediatric Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3264 | Sterile Specimen (Pediatric Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3265 | Positive Negative Unknown |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3266 | Microorganism (Pediatric Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3267 | Non-Sterile Specimen (Pediatric Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3268 | Acute Illness Complications (Pediatric Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3269 | Underlying Conditions (Pediatric Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3271 | Therapy Prior Illness Onset (Pediatric Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3272 | Therapy After Illness Onset (Pediatric Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3275 | Relationship (Flu) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3282 | Specimen Collection Method |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3285 | Anatomical Entity (Body Site) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3288 | Vaccination Contraindication (IIS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3289 | Vaccination Reaction and Adverse Event (IIS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3293 | Evidence Of Immunity (IIS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3301 | Lab Test Interpretation (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3302 | Lab Test Procedure (Measles) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3303 | Specimen Source (Measles) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3304 | Parotitis Laterality (Mumps) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3305 | Type of Deafness (Mumps) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3306 | Lab Test Procedure (Mumps) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3307 | Specimen Source (Mumps) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3308 | Complications (Malaria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3310 | Medication Missed (Malaria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3312 | Medication Treatment (Malaria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3313 | Species (Malaria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3314 | Specimen Type (Malaria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3317 | Antimicrobial Susceptibility Test Method (IPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3318 | Bacterial Infection Syndrome (IPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3319 | Oxacillin Interpretation (IPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3320 | Serotype Method (IPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3321 | Sterile Specimen (IPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3322 | Underlying Conditions (IPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3336 | Susceptibility Result (IPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3359 | Evaluation Finding |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3407 | Case Class Status (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3409 | Transmission Setting (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3410 | Vaccine Not Given Reasons (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3411 | Body Region Tetanus (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3412 | Injury Occurred Environment (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3413 | Injury Type (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3414 | Birth Attendees (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3417 | Contact Type Hepatitis A (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3418 | Sexual Preference (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3419 | Lab Test Result Lyme (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3420 | Microorganism (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3421 | Bacterial Infection Syndrome (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3422 | Associated Conditions (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3425 | Geographic Region (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3432 | Serogroup (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3435 | Serotype (NETSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3501 | Bacterial Infectious Disease |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3502 | Infectious Disease |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3503 | Pneumonia Disease |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3587 | Flu Activity Code |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.3594 | Campylobacter Organism |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4000 | Lab Result (Amebiasis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4001 | Lab Result (Anaplasma) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4002 | Lab Result (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4003 | Lab Result (Arbovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4004 | Lab Result (Arenavirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4005 | Lab Result (Babesiosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4006 | Lab Result (Bartonellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4007 | Lab Result (Blastomycosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4008 | Lab Result (Botulism) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4009 | Lab Result (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4010 | Lab Result (California serogroup virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4011 | Lab Result (Campylobacteriosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4012 | Lab Result (Chagas) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4013 | Lab Result (Chancroid) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4014 | Lab Result (Chlamydia trachomatis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4015 | Lab Result (Cholera) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4016 | Lab Result (Clostridium perfringens) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4017 | Lab Result (Clostridium perfringens Epsilon Toxin) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4018 | Lab Result (Coccidioidomycosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4019 | Lab Result (Colorado Tick Fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4020 | Lab Result (Creutzfeldt-Jakob disease) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4021 | Lab Result (Cryptococcosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4022 | Lab Result (Cryptosporidiosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4023 | Lab Result (Cyclosporiasis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4024 | Lab Result (Cysticercosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4025 | Lab Result (Dengue) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4026 | Lab Result (Diphtheria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4027 | Lab Result (Eastern equine encephalitis virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4028 | Lab Result (Ebolavirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4029 | Lab Result (E. coli STEC) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4030 | Lab Result (Ehrlichia chaffeensis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4031 | Lab Result (Ehrlichia ewingii) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4032 | Lab Result (Ehrlichiosis Anaplasmosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4033 | Lab Result (Genital Warts) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4034 | Lab Result (Giardiasis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4035 | Lab Result (Glanders) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4036 | Lab Result (Gonorrhea) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4037 | Lab Result (Granuloma Inguinale) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4038 | Lab Result (Haemophilus influenzae) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4039 | Lab Result (Hansen's Disease) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4040 | Lab Result (Hantavirus Pulmonary Syndrome) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4041 | Lab Result (Hendra virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4042 | Lab Result (Hepatitis A) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4043 | Lab Result (Hepatitis B) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4044 | Lab Result (Hepatitis C) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4045 | Lab Result (Hepatitis D) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4046 | Lab Result (Hepatitis E) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4047 | Lab Result (Herpes Simplex) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4048 | Lab Result (Histoplasmosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4049 | Lab Result (HIV) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4050 | Lab Result (Influenza A virus, H1N1 2009 strain) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4051 | Lab Result (Jamestown Canyon virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4052 | Lab Result (Legionellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4053 | Lab Result (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4054 | Lab Result (Listeriosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4055 | Lab Result (Lyme disease) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4056 | Lab Result (Lymphogranuloma Venereum) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4057 | Lab Result (Malaria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4058 | Lab Result (Marburgvirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4059 | Lab Result (Measles) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4060 | Lab Result (Melioidosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4061 | Lab Result (Meningococcal Disease) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4062 | Lab Result (Monkeypox Orthopox) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4063 | Lab Result (MRSA) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4064 | Lab Result (Mumps) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4065 | Lab Result (Nipah Virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4066 | Lab Result (Nongonococcal Urethritis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4067 | Lab Result (Nontuberculous Mycobacteria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4068 | Lab Result (Norovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4069 | Lab Result RCMT (Pertussis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4070 | Lab Result (Plague) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4071 | Lab Result (Polio) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4072 | Lab Result (Powassan virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4073 | Lab Result (Prion Disease) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4074 | Lab Result (Psittacosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4075 | Lab Result (Q Fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4076 | Lab Result (Rabies) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4077 | Lab Result (Relapsing Fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4078 | Lab Result (Respiratory Syncytial Virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4079 | Lab Result (Rickettsial infection, other) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4080 | Lab Result (Rift Valley Fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4081 | Lab Result (Rotavirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4082 | Lab Result RCMT (Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4083 | Lab Result (Salmonellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4084 | Lab Result (SARS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4085 | Lab Result (Shigella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4086 | Lab Result (Smallpox) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4087 | Lab Result (Spotted fever rickettsiosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4088 | Lab Result (Staphylococcus aureus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4089 | Lab Result (Staphylococcus aureus enterotoxin B) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4090 | Lab Result (Staphylococcus aureus food poisoning) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4091 | Lab Result (Staphylococcal TSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4092 | Lab Result (St. Louis encephalitis virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4093 | Lab Result (Streptococcus pneumoniae) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4094 | Lab Result (Streptococcal TSS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4095 | Lab Result (Streptococcus, group A) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4096 | Lab Result (Streptococcus, group B) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4097 | Lab Result (Syphilis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4098 | Lab Result (Tetanus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4099 | Lab Result (Toxoplasmosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4100 | Lab Result (Trichinellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4101 | Lab Result (Tuberculosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4102 | Lab Result (Tularemia) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4103 | Lab Result (Typhoid Fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4104 | Lab Result (Typhus group rickettsiosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4105 | Lab Result (Vaccinia) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4106 | Lab Result (Vancomycin resistant Enterococcus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4107 | Lab Result (Varicella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4108 | Lab Result (Vesicular Stomatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4109 | Lab Result (Vibriosis, non-cholera) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4110 | Lab Result (Viral Hemorrhagic Fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4111 | Lab Result (VISA) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4112 | Lab Result (VRSA) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4113 | Lab Result (Western equine encephalitis virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4114 | Lab Result (West Nile virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4115 | Lab Result (Yellow Fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4116 | Lab Result (Yersiniosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4275 | Lab Result (Cancer Morphology) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.4276 | Lab Result (Pesticide) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.5001 | Specimen Type PHLIP |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.5004 | Specimen Reject Reason (SCT) (PHLIP) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.5013 | Suspected Agent (PHLIP Sal) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.5021 | Original Specimen Source Site PHLIP (PLT212) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.5022 | Original Specimen Source Site Modifier PHLIP |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.5023 | Original Specimen Collection Method PHLIP |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.5024 | Original Specimen Type PHLIP |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.5026 | Lab Test Result PHLIP Salmonella |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.5028 | Method Detail (PHLIP) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.6001 | Certifier Types (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.6002 | Manner of Death (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.6004 | Contributory Tobacco Use (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.6005 | Transportation Relationships (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.6027 | Smoking Status (PI) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.6054 | Lab Test Result (Reportable Conditions) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.6070 | Infections During Pregnancy - Live Birth (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.6071 | Gonorrhea (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.6072 | Trachoma (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7103 | VPD Laboratory Coded Observation |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7104 | VPD Specimen Type |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7105 | VPD Specimen Collection Method |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7106 | VPD Specimen Source Body Site |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7108 | VPD Specimen Condition |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7110 | VPD Specimen Reject Reason |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7111 | Birth Attendant Titles (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7112 | Fetal Death Time Points (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7113 | Fetal Presentations (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7115 | Karyotype Suspected Chromosomal Disorder (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7116 | Karyotype Down Syndrome (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7117 | Labor and Delivery Characteristics (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7118 | Delivery Routes (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7119 | Maternal Morbidities (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7121 | Newborn Abnormal Conditions (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7122 | Newborn Congenital Anomalies (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7123 | Onset Labor (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7124 | Birth or Delivery Occurred (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7126 | Pregnancy Risk Factors (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7135 | Infections During Pregnancy Fetal Death (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7136 | Obstetric Procedures (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7137 | Autopsy Examination (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7138 | Histological Placental Examination (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7140 | Autopsy Planned (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7142 | Non-Vertex Presentation (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7143 | Steroids For Fetal Lung Maturation (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7153 | Estimated Time of Death No Labor Ongoing (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7154 | Fetal Presentation at Birth- Unknown (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7156 | Assisted Ventilation (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7165 | Previous Cesarean (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7167 | Case Transmission Mode (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7168 | Notifiable Event Disease Condition (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7170 | Specimen Site (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7171 | Salmonella Serogroup (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7172 | Shigella Serogroup (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7173 | Campylobacter Species (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7174 | Campylobacter Nonculture Test Type (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7175 | E. coli Culture Isolate Id Serotype (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7177 | E. coli Shiga Toxin Test Type (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7178 | E. coli Shiga Toxin (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7179 | Vibrio Culture Species (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7180 | Vibrio Serotype (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7181 | Vibrio Biotype (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7182 | Vibrio Cholera Toxin Test Type (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7183 | Listeria Culture Species (BIDS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7189 | Specimen Source (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7192 | HIV Status (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7194 | Drugs Used (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7195 | Clinician Observed Lesions (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7199 | Detection Method (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7200 | Lab Results (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7203 | Quantitative Syphilis Test Result (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7206 | Lab Test Result Qualitative (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7212 | Certifier Titles (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7216 | Place of Death (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7217 | Lab Test Reactivity (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7218 | Syphilis Clinical Stage (CS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7219 | Syphilis Surveillance Stage (CS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7220 | Pregnancy Treatment Stage (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7223 | Birth Status (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7224 | Darkfield DFA Result (CS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7225 | Signs Symptoms (CS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7227 | VDRL Test Result (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7228 | CSF WBC Protein Result (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7229 | Syphilis Treatment Infant (CS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7234 | Qual Lab Result Positive (Reportable Conditions) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7235 | Qual Lab Result Negative (Reportable Conditions) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7236 | Qual Lab Result Inconc (Reportable Conditions) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7244 | History of Disease as Evidence Of Immunity (IIS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7245 | Serological Evidence Of Immunity (IIS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7247 | Symptoms (EVD Triage) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7250 | Observation Identifiers (EVD Triage) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7256 | Morphologic Abnormalities of Neoplasms |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7257 | Abdominal Pain (CDS - EHR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7258 | Weakness (CDS - EHR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7259 | Fever (CDS - EHR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7260 | Headache (CDS - EHR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7261 | Hemorrhage (CDS - EHR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7262 | Muscle Pain (CDS - EHR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7263 | Vomiting (CDS - EHR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7264 | Diarrhea (CDS - EHR) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7269 | Reason for Missing Test (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7270 | Lab Test Result Interpretation (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7273 | Death Pronouncement Finding (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7274 | Death Pronouncement Procedure (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7277 | Transport Mode to Hospital (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7282 | Complications (Mumps) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7283 | Signs and Symptoms (Mumps) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7284 | Signs and Symptoms (Pertussis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7285 | Complications (Pertussis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7329 | Type of Testing at CDC (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7332 | Setting of Further Spread |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7333 | Timing of Maternal Treatment (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7334 | Lab Test Interpretation (Pertussis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7343 | Lab Result (Chikungunya virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7344 | Lab Result (Crimean-Congo hemorrhagic fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7345 | Lab Result (Guanarito hemorrhagic fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7346 | Lab Result (Junin hemorrhagic fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7347 | Lab Result (Lassa fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7348 | Lab Result (Lujo virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7349 | Lab Result (Machupo hemorrhagic fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7350 | Lab Result (Sabia virus hemorrhagic fever) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7351 | Lab Test Performed Modifier (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7357 | Hysterectomy (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7358 | Hysterotomy (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7359 | Point of Origin (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7361 | Disposition OPD (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7362 | Follow-up Attempt Outcome (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7365 | Priority (Type) of Admission or Visit (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7369 | Present on Admission (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7379 | Methods of Disposition (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7402 | Patient Residence (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7403 | Injury or Poisoning (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7405 | Co-morbid Conditions (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7419 | Provider ED (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7422 | Fetal Death Cause or Condition (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7423 | Pregnancy Resulting From Fertility Enhancing Drugs |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7431 | Surfactant Replacement Therapy (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7432 | Asthma (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7433 | Condition Control (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7437 | Disposition ED (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7439 | Episode of Care (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7440 | Hospital Discharge Status (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7441 | Neurological Manifestation (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7449 | Qualitative Lab Result (RCMT) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7450 | Vaccine Event Information Source (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7451 | Type of Testing at CDC (VZ) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7453 | Body Region(s) of Rash |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7454 | Character of Lesions |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7458 | Transmission Mode (Zika) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7459 | Signs Symptoms (Zika) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7460 | Signs Symptoms (Arbovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7462 | Prenatal Diagnostic Procedures |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7463 | Specimen Type (Zika) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7464 | Insect Repellant |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7465 | Vector (Zika) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7466 | Complications (Zika) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7467 | Drug Disease Interaction (Dengue) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7468 | Length of Gestation in Weeks |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7469 | Microcephaly Causes |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7470 | Head Circumference Findings |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7473 | Diagnostic Lab Test Findings (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7474 | Type of Complication (VZ) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7476 | Positive Negative Equivocal Not Done |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7477 | Positive Negative 4 Fold Rise Not Done |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7478 | Serotype (Dengue) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7479 | Lab Result (Zika virus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7481 | Signs Symptoms (Dengue) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7482 | Signs Symptoms (Chikungunya) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7487 | Reason for Hospitalization (VZ) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7488 | Specimen Type (Arbovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7489 | Transmission Mode (Arbovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7490 | Clinical Syndrome - Secondary (Arbovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7491 | Pregnancy Complications (Arbovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7492 | Newborn Complications (Arbovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7494 | Pregnancy Outcome |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7495 | Serotype (Arbovirus) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7516 | Data Elements (NND Hep A Acute) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7517 | Data Elements (NND Hep B Acute) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7519 | Data Elements (NND Hep B Chronic) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7520 | Data Elements (NND Hep C Acute) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7521 | Data Elements (NND Hep C Chronic) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7523 | Data Elements (NND Pertussis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7524 | Data Elements (NND STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7526 | Method of Delivery VaginalSpon Finding (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7527 | Method of Delivery Cesarean Finding (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7528 | Method of Delivery Vaginal Forceps Finding (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7529 | Method of Delivery Vaginal Vacuum Finding (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7530 | Scheduled Cesarean Finding (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7531 | Induction of Labor Finding (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7532 | Augmentation of Labor Finding (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7538 | Type of Complication (Babesiosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7540 | Blood Product |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7541 | Clinical Manifestations (Babesiosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7543 | Lab Result (Hantavirus Infection) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7544 | Outdoor Activities |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7551 | Test Result Coded Qualitative |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7552 | Organism Identified AST (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7553 | Specimen Type AST (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7554 | Specimen Collection Site AST (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7556 | Susceptibility Test Method (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7557 | Susceptibility Test Interpretation (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.756 | Gender Identity |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7563 | Sexual Orientation |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7585 | Fetal Remains Disposition Method (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7596 | Adverse Event Severity (Malaria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7604 | Route Method of Delivery SpontaneousProcedure (NCHS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7607 | Type of Testing at CDC |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7608 | Type Of Complication (CRS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7609 | Sexual Orientation (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7610 | Gender Identity (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7614 | Case Appraisal (CRS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7615 | Pre-Pregnancy SerologicalTestInterp (CRS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7616 | Specimen From Mother Or Infant (CRS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7617 | Organism (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7621 | Signs and Symptoms (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7622 | Positive Negative Not Done |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7626 | Test Result (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7627 | Specimen Collection Source (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7633 | Day Care Setting (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7636 | Medical History (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7643 | Vibrio Species (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7644 | Vibrio Cholera Serotype (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7645 | Vibrio Cholera Biotype (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7647 | Typhoid Paratyphoid Serotype (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7648 | Yes No Not Tested (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7649 | Signs and Symptoms (Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7650 | Type Of Complication (Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7651 | Previous Case Diagnosed By (Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7653 | Specimen Type (CRS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7655 | PCR Specimen Source (CRS) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7656 | Specimen Source (Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7657 | Specimen Type (Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7659 | Type of Testing at CDC(Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7660 | Type of Complication (Measles) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7662 | Signs and Symptoms (Measles) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7663 | Data Elements (NND Malaria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7664 | Data Elements (NND Babesiosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7665 | Data Elements (NND Varicella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7666 | Signs and Symptoms (Trich) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7670 | Meat Purchase Info (Trich) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7674 | Lab Test Interpretation (Trich) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7675 | Specimen type (Trich) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7676 | Strain Type (Trich) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7677 | Form Status (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7678 | Discharge Location (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7679 | Pregnancy Status (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7680 | Fetal Outcome (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7681 | Underlying Condition (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7682 | Smoking Status (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7683 | Substance Abuse (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7684 | Mode of Delivery (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7686 | Microorganism (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7689 | Vaccination Information Source (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7690 | GAS Risk Factor (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7692 | Rehab Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7693 | Antibiotic Received (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7695 | Antibiotic Reason (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7696 | Detection Method (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7697 | Birth Location (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7698 | Gestational Age Determination (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7699 | Susceptibility Data NA (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7700 | AR Agent (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7701 | AR Test Method (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7702 | ATI Method (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7703 | MIC Operator (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7704 | Susceptibility Interpretation (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7706 | Sequelae (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7707 | Blood Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7708 | Rupture Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7709 | Delivery Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7710 | Medication Pre-Treatment (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7711 | Contact Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7714 | Legionella Diagnosis (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7716 | Definitely Possibly No (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7717 | Legionella Exposure Setting (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7718 | Healthcare Exposure Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7720 | Water Source (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7723 | Signs and Symptoms (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7724 | Personal Protective Equipment (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7725 | Respiratory Protective Equipment (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7726 | Glove Material (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7727 | Titer Test Method (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7728 | Bird Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7729 | Establishment Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7730 | Residence Location (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7731 | Insurance Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7732 | Infection Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7734 | Lab Test Interpretation (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7735 | SPN/IPD Serotype (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7736 | Serotype Method (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7738 | Isolate Not Available (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7744 | Lab Test Interpretation (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7745 | Type of Radiology Study |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7746 | Result of Radiology Study (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7747 | Diabetes Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7748 | Epidemiological Risk Factors (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7749 | Smoking Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7750 | Diagnosis Type (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7752 | Strength of Link (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7753 | Directionality of Link (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7754 | Treatment Administration Type (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7756 | Reason LTBI Not Started (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7757 | Reason LTBI Treatment Stopped (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7758 | Adverse Event Severity (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7761 | Susceptibility Test Interpretation (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7762 | Susceptibility Test Method (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7764 | Molecular Test Results (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7765 | Molecular Indel (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7767 | Reason Not Treated with RIPE (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7769 | Final Treatment Outcome (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7770 | Length of Time Drug Taken (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7772 | Side Effect of Treatment (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7773 | Serogroup Method (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7774 | Specimen Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7778 | Specimen Site (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7779 | Condition Status (FDD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7782 | Deli Meats (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7783 | Deli Salads (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7784 | Diet Type (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7786 | Food (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7787 | Food Allergy (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7788 | Food Freshness (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7789 | Fruit (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7792 | Illness (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7795 | Medical History (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7797 | Birth Location (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7798 | Pregnancy Outcome (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7801 | Signs and Symptoms (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7802 | Specimen Type (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7804 | Patient Outcome (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7805 | Yes No None (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7806 | Assisted Living Exposure Type (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7808 | N. meningitidis Serogroup (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7809 | H. influenzae Serotype (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7810 | Provider Information Source (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7813 | Specimen Source (CP-CRE) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7814 | Genotypic Test Result (CP-CRE) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7816 | Data Elements (Rubella) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7817 | Type of Dairy Product (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7818 | General Condition Status (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7820 | Born in the United States (Listeria) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7823 | Lab Test Interpretation (Legionellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7825 | Gene Name (CP-CRE) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7826 | Specimen Source Site (VPD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7832 | Clinical Manifestation (TBRD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7833 | Complications (TBRD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7836 | Organism (TBRD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7837 | Coinfection Type (TBRD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7838 | Specimen Type (TBRD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7840 | Clinical Manifestations (Lyme) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7841 | Specimen Type (Lyme) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7843 | Organism (Lyme) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7845 | Serotype Master (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7846 | Lab Test Interpretation Master (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7848 | Exposure Setting Master (RIBD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7849 | Usual Occupation and Industry (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7850 | Organism (CP-CRE) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7862 | Test Result (CP-CRE) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7864 | Specimen Source (C. auris) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7866 | Lab Test Method (MDRO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7867 | Test Result (C. auris) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7869 | Specimen Collection Setting Type (C. auris) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7870 | Type of Co-infection (C. auris) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7874 | Poison Control Center Record (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7876 | Intent of Exposure (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7877 | Extreme Weather Type (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7878 | Exposure Source (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7879 | Treatment Type (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7884 | Exposure Site Category (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7885 | Public Site of Exposure (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7886 | Treatment Location (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7887 | Underlying Conditions (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7888 | Signs and Symptoms (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7891 | Data Reporting Source (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7892 | Lab Result (Candida auris) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7895 | Lab Result Carbapenem Resistant Enterobacteriace |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7896 | Residential Site of Exposure (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7902 | GC specimen quality (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7903 | GC beta-lactamase result (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7911 | Clinical sample or isolate (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7912 | Candida auris culture result (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7913 | Candida auris PCR result (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7914 | Acinetobacter culture result (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7915 | Carbapenemase phenotypic result (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7916 | CPO phenotypic method (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7917 | CPO PCR method (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7918 | CPO AST method (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7919 | CPO PCR result (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7921 | Specimen type (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7922 | Microorganism (ARLN) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7923 | Medication Treatment (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7924 | Mother Infant Indicator (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7925 | Type of Complication (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7926 | Number of Cigarettes Smoked per Day (CO) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7927 | Dose Unit (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7928 | Lab Test Result Qualitative (Syphilis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7929 | Medication Route (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7930 | Route of Administration (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7931 | Medication Frequency Unit (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7934 | Microorganism (STD) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7936 | Contact Type (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7939 | Residence Type (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7940 | Healthcare Occupation (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7941 | Job Setting (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7942 | Exposure Setting (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7944 | Signs and Symptoms (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7945 | Clinical Finding (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7946 | Animal Type (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7947 | Risk Factor (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7949 | Treatment Type (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7951 | Reason for Test (COVID-19) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7953 | Critical Infrastructure Sector (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7955 | Location of Initial Diagnosis (Hansen) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7956 | Type of Leprosy (Hansen) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7958 | Hospital Procedure (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7959 | Underlying Condition(s) (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7960 | Disease Outcome Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7961 | Medication (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7962 | Contact Type (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7963 | Medication Administered (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7965 | Sick Animal Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7966 | Rodent Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7967 | Animal Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7968 | Clinical Manifestations (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7969 | Specimen Type (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7970 | Disease Stage (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7971 | Animal Type (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7973 | Diagnostic Test Finding (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7974 | Specimen Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7975 | Specimen Source Site (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7976 | Test Titer Type (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7977 | Brucella Exposure (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7978 | Exposure Risk (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7980 | Patient Case Status (Hansen) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7981 | Animal Ownership (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7982 | Vaccine Exposure (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7983 | Time of Day (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7984 | Hospital Procedure (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7987 | Country of Product Acquisition (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7988 | Location Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7989 | Clinical Outcome (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7990 | Specimen Type (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7991 | Procedure Type (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7992 | Public TransportationType (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7995 | Diet Type (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7996 | Post-exposure or Treatment (NND) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7997 | Treatment Type (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7998 | Severe Weather Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.7999 | Animal Type (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8000 | Test Results Anthrax |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8001 | Time of Day (CDC) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8002 | Reason Medication Not Completed (BSP) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8003 | Smoking Status (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8004 | Test Results (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8005 | Antimicrobials (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8006 | Contact Type (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8007 | Clinical Manifestations (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8008 | Clinical Manifestations (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8009 | Exposure Location (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8010 | Organism Name (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8012 | Activity Type (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8013 | Exposure Source (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8015 | Food Product Consumed (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8016 | Fresh Water or Mud Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8017 | Exposure Source (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8019 | Alcohol Use Frequency (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8020 | Anthrax Vaccine Exposure (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8021 | Total Doses of Vaccine (Anthrax) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8030 | Lab Test (Hansen) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8035 | Subject of Medication Received (Hansen) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8038 | Specimen Source Site (Brucellosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8039 | Test Results (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8040 | Pregnancy Outcome (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8041 | Lab Test Type (Leptospirosis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8042 | Test Result (Hepatitis A) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8043 | HBeAg Test Result (Hepatitis B Perinatal) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8044 | Infant Nucleic Acid Test Result (Hepatitis C) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8045 | Infant HCV Antigen Test Result (Hepatitis C) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8046 | Mother Nucleic Acid Test Result (Perinatal Hep) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8047 | Common-Source Outbreak (Hepatitis A) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8048 | Common-Source Outbreak (Hepatitis B) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8049 | Common-Source Outbreak (Hepatitis C) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8050 | Other Case Hepatitides (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8051 | Patient Epidemiological Risk Factors (Hepatitis A) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8052 | Patient Epidemiological Risk Factors (Hepatitis B) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8053 | Patient Epidemiological Risk Factors (Hepatitis C) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8055 | Source of Laboratory Test (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8056 | HBsAg Test Result (Hepatitis B Perinatal) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8057 | Infant Anti-HCVTest Result (Hepatitis C Perinatal) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8059 | Signs and Symptoms (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8060 | Test Result (Hepatitis) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8061 | HBV DNA Test Result (Hepatitis B Perinatal) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8062 | Gender Identity (USCDI) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8063 | Sexual Orientation (USCDI) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.8064 | Travel Purpose (CDC) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.834 | Allergen |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.909 | Disease |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.928 | True False (TF) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.929 | Positive Negative Unknown Not Done |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.930 | Chest XRay Result |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.931 | Vaccine Not Given Reason |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.941 | Susceptibility Result |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.946 | Specimen |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.950 | Passed Failed Unknown |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.959 | Additional Site of Disease (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.967 | Body site |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.968 | Case Classification Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.969 | Case investigation closure reason |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.970 | Case Investigation Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.972 | Case Verification (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.981 | Diagnosed Pneumonia By (VZ) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.982 | Directly Observed Therapy (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.984 | Dwelling Type |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.985 | Employment Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.988 | Countermeasure Encounter Purpose |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.991 | Environmental Investigation Reason |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.994 | General Condition Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.995 | Health Care Practice Type (TB) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.996 | History Source (CRA) |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.997 | HIV Diagnosis Based On |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.11.998 | HIV Status |
| us.cdc.phinvads#0.12.0 | 2.16.840.1.114222.4.3.20 | Specimen Source Site (Anthrax) |
| us.cdc.phinvads#0.12.0 | 6.1.4.1.19376.1.7.3.1.1.13.8.64 | Limb Reduction Defect (NCHS) |
| de.medizininformatikinitiative.kerndatensatz.dokument#2026.0.1 | mii-vs-dokument-einrichtungsart | MII VS Dokument Einrichtungart |
| de.medizininformatikinitiative.kerndatensatz.dokument#2026.0.1 | mii-vs-dokument-fachgebiet | MII VS Dokument Fachgebiet |
| de.medizininformatikinitiative.kerndatensatz.dokument#2026.0.1 | mii-vs-dokument-sct-dokument-kategorie | MII VS Dokument SCT Dokument Kategorie |
| de.medizininformatikinitiative.kerndatensatz.dokument#2026.0.1 | mii-vs-dokument-sct-dokument-typ | MII VS Dokument SCT Dokument Typ |
| de.gematik.isik-medikation#3.1.1 | SctRouteOfAdministration | SctRouteOfAdministration |
| signal.core.r4#0.2.10 | condition-severity | Condition/Diagnosis Severity |
| signal.core.r4#0.2.10 | device-action | Procedure Device Action Codes |
| signal.core.r4#0.2.10 | device-kind | FHIR Device Types |
| signal.core.r4#0.2.10 | c80-facilitycodes | Facility Type Code Value Set |
| signal.core.r4#0.2.10 | 2.16.840.1.113762.1.4.1021.32 | Gender Identity |
| signal.core.r4#0.2.10 | performer-role | Procedure Performer Role Codes |
| signal.core.r4#0.2.10 | c80-practice-codes | Practice Setting Code Value Set |
| signal.core.r4#0.2.10 | procedure-category | Procedure Category Codes (SNOMED CT) |
| signal.core.r4#0.2.10 | procedure-followup | Procedure Follow up Codes (SNOMED CT) |
| signal.core.r4#0.2.10 | procedure-not-performed-reason | Procedure Not Performed Reason (SNOMED-CT) |
| signal.core.r4#0.2.10 | procedure-outcome | Procedure Outcome Codes (SNOMED CT) |
| signal.core.r4#0.2.10 | referencerange-appliesto | Observation Reference Range Applies To Codes |
| signal.core.r4#0.2.10 | servicerequest-orderdetail | Service Request Order Details Codes |
| signal.core.r4#0.2.10 | us-core-encounter-type | US Core Encounter Type |
| ca.on.accdr.r4#1.0.1 | practitionerspecialty | PractitionerSpecialtywithFrench |
| hl7.fhir.cl.clips#0.5.0-ballot | vs-ni-ips-cl | Set de Valores del Programa Nacional de Inmunizaciones (PNI) |
| ch.fhir.ig.ch-orf#3.0.2 | ch-orf-vs-consentstatus | Consent Status |
| ch.fhir.ig.ch-orf#3.0.2 | ch-orf-vs-legalrelation | Legal Relation |
| ch.fhir.ig.ch-orf#3.0.2 | ch-orf-vs-personalrelation | Personal Relation |
| kbv.mio.emp#1.0.0-kommentierung.1 | KBV_VS_MIO_EMP_Dose_Form_SNOMED_CT | Darreichungsform SNOMED CT® |
| kbv.mio.emp#1.0.0-kommentierung.1 | KBV_VS_MIO_EMP_Drug_Therapy_Status_SNOMED_CT | Medikation Statusgrund |
| sk.registry.core.r5#4.0.0 | admission-source-vs | Admission Sources ValueSet |
| sk.registry.core.r5#4.0.0 | afib-flutter-status-vs | Atrial Fibrillation or Flutter Status ValueSet |
| sk.registry.core.r5#4.0.0 | brain-imaging-modality-vs | Brain Imaging Modality ValueSet |
| sk.registry.core.r5#4.0.0 | carotid-imaging-modality-vs | Carotid Arteries Imaging Modality ValueSet |
| sk.registry.core.r5#4.0.0 | discharge-destination-vs | Discharge Destination ValueSet |
| sk.registry.core.r5#4.0.0 | functional-score-codes-vs | Stroke Functional Score Codes ValueSet |
| sk.registry.core.r5#4.0.0 | medicationStatement-meds-codes-vs | MedicationStatement Therapy/Finding Codes |
| sk.registry.core.r5#4.0.0 | perforation-procedures-vs | Perforation Procedures ValueSet |
| sk.registry.core.r5#4.0.0 | specific-finding-codes-vs | Specific Stroke Finding Codes ValueSet |
| sk.registry.core.r5#4.0.0 | stroke-diagnosis-vs | Stroke Diagnosis ValueSet |
| sk.registry.core.r5#4.0.0 | stroke-discharge-destination-vs | Stroke Discharge Destination ValueSet |
| sk.registry.core.r5#4.0.0 | stroke-etiology-vs | Stroke Etiology ValueSet |
| sk.registry.core.r5#4.0.0 | stroke-risk-factor-snomed-vs | Stroke Risk Factor ValueSet |
| sk.registry.core.r5#4.0.0 | swallow-procedures-vs | Swallow Procedures ValueSet |
| sk.registry.core.r5#4.0.0 | swallowing-screening-timing-category-vs | Swallowing Screening Timing Category ValueSet |
| sk.registry.core.r5#4.0.0 | thrombectomy-complication-vs | Thrombectomy Complication ValueSet |
| sk.registry.core.r5#4.0.0 | vital-sign-codes-vs | Stroke Vital Sign Codes ValueSet |
| sk.registry.core.r5#4.0.0 | vs-gender-snomed | Gender (SNOMED CT) |
| de.gematik.isik-terminplanung#3.1.1 | ISiKTerminPriority | ISiKTerminPriority |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.40.2.9.12.3--20200901000000 | DagdeelCodelijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.47--20240131165054 | MedicatieToedieningRedenVanAfwijkenCodelijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.55--20230119145802 | MedicatiegebruikStopTypeCodelijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.53--20220323181942 | PrikPlakLocatieCodeLijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.42--20221114132525 | RedenWijzigen-StakenCodelijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.54--20221114181621 | RedenWijzigen-StakenWDSCodelijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.43--20221115122002 | RedenWijzigen-StoppenGebruikCodelijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.50--20221216102010 | StopTypeCodelijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.49--20221115120643 | Toedieningsafspraak-RedenWijzigen-StakenCodelijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.40.2.9.12.2--20200901000000 | WeekdagCodelijst |
| nictiz.fhir.nl.r4.medicationprocess9#2.0.0-rc.7 | 2.16.840.1.113883.2.4.3.11.60.20.77.11.48--20230112155455 | WisselendDoseerschemaStopTypeCodelijst |
| de.gematik.sterbefall#1.0.2 | StfObservationCodes | STF Observation Codes |
| medcom.fhir.dk.xdsmetadata#2.0.0-trial-use-1 | MedCom-xds-HealthcareFacilityTypeCode-VS | DK XDS HealthcareFacilityTypeCode |
| medcom.fhir.dk.xdsmetadata#2.0.0-trial-use-1 | MedCom-xds-PracticeSettingCode-VS | DK XDS PracticeSettingCode |
| medcom.fhir.dk.xdsmetadata#2.0.0-trial-use-1 | MedCom-xds-typecode-VS | DK XDS TypeCode ValueSet |
| se.electronichealth.fhir.nppr.r5#0.1.0-alpha | nppr-address-type | Typ av adress |
| se.electronichealth.fhir.nppr.r5#0.1.0-alpha | nppr-related-person-role | Relation till person |
| ca.infoway.io.ca-csd#1.1.2-dft-preBallot | delivery-method | Delivery Method |
| ca.on.ir.r4#1.0.0-draft2 | immunization-reason-code | ImmunizationReasonCode |
| rki.demis.ars#1.0.0-rc.2 | abnahmeortKoerperstelleSNOMED | Abnahmeort |
| rki.demis.ars#1.0.0-rc.2 | abnahmeortMorphologischeAnomalieSNOMED | Abnahmeort morphologische Anomalien |
| rki.demis.ars#1.0.0-rc.2 | anforderungChlamydienSentinelSNOMED | Untersuchungsanlass Chlamydien-Sentinel |
| rki.demis.ars#1.0.0-rc.2 | anforderungMasernSentinelSNOMED | Untersuchungsanlass Masern-Sentinel |
| rki.demis.ars#1.0.0-rc.2 | anforderungSNOMED | Untersuchungsanlass Diagnose oder Screening |
| rki.demis.ars#1.0.0-rc.2 | antwortNominalSNOMED | Ergebnis der Laboruntersuchung Nominal |
| rki.demis.ars#1.0.0-rc.2 | antwortPathogenBakSNOMED | Ergebnis der Laboruntersuchung BAK |
| rki.demis.ars#1.0.0-rc.2 | antwortPathogenBeschreibungMikroskopieSNOMED | Ergebnis der Laboruntersuchung Mikroskopie |
| rki.demis.ars#1.0.0-rc.2 | antwortPathogenMykSNOMED | Ergebnis der Laboruntersuchung MYK |
| rki.demis.ars#1.0.0-rc.2 | antwortPathogenParSNOMED | Ergebnis der Laboruntersuchung PAR |
| rki.demis.ars#1.0.0-rc.2 | antwortPathogenVirSNOMED | Ergebnis der Laboruntersuchung VIR |
| rki.demis.ars#1.0.0-rc.2 | antwortResistenzklassifikationSNOMED | Ergebnis der Laboruntersuchung MRE |
| rki.demis.ars#1.0.0-rc.2 | interpretationSNOMED | Angabe der Interpretation mit SNOMED CT qualifier values |
| rki.demis.ars#1.0.0-rc.2 | materialSNOMED | Probenmaterial |
| rki.demis.ars#1.0.0-rc.2 | methodeSNOMED | Testmethoden |
| egde.health.gateway#0.1.7 | care-team-role-vs | Care Team role |
| egde.health.gateway#0.1.7 | consent-vs | Consent codes from Loinc and Snomed-ct |
| egde.health.gateway#0.1.7 | organization-type-vs | Organization type |
| de.gematik.hddt#1.0.1 | hddt-device-type | Device Type of personal health devices |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-krk-stoma-status-reason | MII_VS_Onko_KRK_Stoma_Status_Reason |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-mamma-intraoperatives-imaging-praeparat | MII_VS_Onko_Mamma_Intraoperatives_Imaging_Praeparat |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-mamma-menopause-status | MII_VS_Onko_Mamma_Menopause_Status |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-mamma-operation-sct | MII_VS_Onko_Mamma_Operation_SCT |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-mamma-praeoperative-markierung-modalitaet | MII_VS_Onko_Mamma_Praeoperative_Markierung_Modalitaet |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-melanom-exzision-snomedct | MII VS Onko Melanom Exzision SNOMED CT |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-prostata-clavien-dindo | MII_VS_Onko_Prostata_Clavien_Dindo |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-prostata-gleason-patterns | MII VS Onkologie Prostata Gleason Patterns |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-prostata-gleason-primary-secondary-tertiary | MII_VS_Onko_Prostata_Gleason_PrimarySecondaryTertiary |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-prostata-gleason-score | MII_VS_Onko_Prostata_Gleason_Score |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-prostata-operation-snomedct | MII VS Onko Prostata Operation SNOMED CT |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-tnm-klassifikation-typ | MII VS Onkologie TNM Klassifikation Typ |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-tnm-m-kategorie | MII VS Onkologie TNM M Kategorie |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-tnm-n-kategorie | MII VS Onkologie TNM N Kategorie |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-tnm-t-kategorie | MII VS Onkologie TNM T Kategorie |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-weitere-klassifikationen-auspraegungen | MII Value Set Onkologie - Weitere Klassifikationen - Auspraegungen |
| de.medizininformatikinitiative.kerndatensatz.onkologie#2026.0.3 | mii-vs-onko-weitere-klassifikationen | MII Value Set Onkologie - Weitere Klassifikationen |
| silth.fhir.terminology.core#0.1.2 | vs-43file-refer-care-procedure | 43File: รหัสแสดงการให้การดูแลหรือปฐมพยาบาลผู้ป่วยขณะส่งต่อผู้ป่วย |
| silth.fhir.terminology.core#0.1.2 | vs-meta-child-development-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับพัฒนาการเด็ก |
| silth.fhir.terminology.core#0.1.2 | vs-meta-lab-observations | Metadata: รหัสการตรวจทางห้องปฏิบัติการบางส่วน |
| silth.fhir.terminology.core#0.1.2 | vs-meta-ncd-observations | Metadata: รหัสการตรวจหรือบริการคัดกรองโรค NCD |
| silth.fhir.terminology.core#0.1.2 | vs-meta-neonate-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับทารกแรกคลอด |
| silth.fhir.terminology.core#0.1.2 | vs-meta-physical-observations | Metadata: รหัสการตรวจร่างกาย |
| silth.fhir.terminology.core#0.1.2 | vs-meta-pregnancy-observations | Metadata: รหัสการตรวจหรือบริการซึ่งเกี่ยวกับการตั้งครรภ์ |
| silth.fhir.terminology.core#0.1.2 | vs-snomed-blood-abo | SNOMED CT Blood Group - ABO |
| silth.fhir.terminology.core#0.1.2 | vs-snomed-blood-rh | SNOMED CT Blood Group - Rh |
| silth.fhir.terminology.core#0.1.2 | vs-snomed-bloodgroup | SNOMED CT Blood Group |
| silth.fhir.terminology.core#0.1.2 | vs-snomed-int | SNOMED-CT International Release |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-activity-reason-for-R4 | Cross-version VS for R3.Activity Reason for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-additional-instruction-codes-for-R4 | Cross-version VS for R3.SNOMED CT Additional Dosage Instructions for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-administration-method-codes-for-R4 | Cross-version VS for R3.SNOMED CT Administration Method Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-adverse-event-type-for-R4 | Cross-version VS for R3.SNOMED CT Clinical Findings for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-allergyintolerance-code-for-R4 | Cross-version VS for R3.AllergyIntolerance Substance/Product, Condition and Negation Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-animal-breeds-for-R4 | Cross-version VS for R3.AnimalBreeds for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-animal-species-for-R4 | Cross-version VS for R3.AnimalSpecies for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-approach-site-codes-for-R4 | Cross-version VS for R3.SNOMED CT Anatomical Structure for Administration Site Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-body-site-for-R4 | Cross-version VS for R3.SNOMED CT Body Structures for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-bodysite-laterality-for-R4 | Cross-version VS for R3.Laterality for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-bodysite-relative-location-for-R4 | Cross-version VS for R3.Bodysite Location Qualifier for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-c80-facilitycodes-for-R4 | Cross-version VS for R3.Facility Type Code Value Set for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-c80-practice-codes-for-R4 | Cross-version VS for R3.Practice Setting Code Value Set for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-care-plan-activity-for-R4 | Cross-version VS for R3.Care Plan Activity for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-care-plan-activity-outcome-for-R4 | Cross-version VS for R3.Care Plan Activity Outcome for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-care-plan-category-for-R4 | Cross-version VS for R3.Care Plan Category for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-clinical-findings-for-R4 | Cross-version VS for R3.SNOMED CT Clinical Findings for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-clinicalimpression-prognosis-for-R4 | Cross-version VS for R3.Clinical Impression Prognosis for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-condition-cause-for-R4 | Cross-version VS for R3.Condition Cause Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-condition-code-for-R4 | Cross-version VS for R3.Condition/Problem/Diagnosis Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-condition-outcome-for-R4 | Cross-version VS for R3.Condition Outcome Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-condition-predecessor-for-R4 | Cross-version VS for R3.Condition Predecessor Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-condition-severity-for-R4 | Cross-version VS for R3.Condition/Diagnosis Severity for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-condition-stage-for-R4 | Cross-version VS for R3.Condition Stage for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-consistency-type-for-R4 | Cross-version VS for R3.Fluid Consistency Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-dataelement-sdcobjectclass-for-R4 | Cross-version VS for R3.DataElement SDC Object Class for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-dataelement-sdcobjectclassproperty-for-R4 | Cross-version VS for R3.DataElement SDC Object Class for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-designation-use-for-R4 | Cross-version VS for R3.Designation Use for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-device-action-for-R4 | Cross-version VS for R3.Procedure Device Action Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-device-kind-for-R4 | Cross-version VS for R3.FHIR Device Types for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-diet-type-for-R4 | Cross-version VS for R3.Diet Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-digital-media-subtype-for-R4 | Cross-version VS for R3.Media SubType for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-encounter-reason-for-R4 | Cross-version VS for R3.Encounter Reason Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-entformula-type-for-R4 | Cross-version VS for R3.Enteral Formula Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-flag-code-for-R4 | Cross-version VS for R3.Flag Code for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-focal-subject-for-R4 | Cross-version VS for R3.Focal Subject Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-food-type-for-R4 | Cross-version VS for R3.Food Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-goal-start-event-for-R4 | Cross-version VS for R3.GoalStartEvent for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-immunization-reason-for-R4 | Cross-version VS for R3.Immunization Reason Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-immunization-recommendation-target-disease-for-R4 | Cross-version VS for R3.Immunization Recommendation Target Disease Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-investigation-sets-for-R4 | Cross-version VS for R3.Investigation Type for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-manifestation-or-symptom-for-R4 | Cross-version VS for R3.Manifestation and Symptom Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-media-view-for-R4 | Cross-version VS for R3.Media Collection View/Projection for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-medication-as-needed-reason-for-R4 | Cross-version VS for R3.SNOMED CT Medication As Needed Reason Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-medication-codes-for-R4 | Cross-version VS for R3.SNOMED CT Medication Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-medication-form-codes-for-R4 | Cross-version VS for R3.SNOMED CT Form Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-modified-foodtype-for-R4 | Cross-version VS for R3.Texture Modified Food Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-no-immunization-reason-for-R4 | Cross-version VS for R3.Immunization Reasons for Not Immunizing Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-nutrient-code-for-R4 | Cross-version VS for R3.Nutrient Modifier Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-observation-methods-for-R4 | Cross-version VS for R3.Observation Methods for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-participant-role-for-R4 | Cross-version VS for R3.Participant Roles for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-performer-role-for-R4 | Cross-version VS for R3.Procedure Performer Role Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-procedure-category-for-R4 | Cross-version VS for R3.Procedure Category Codes (SNOMED CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-procedure-code-for-R4 | Cross-version VS for R3.Procedure Codes (SNOMED CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-procedure-followup-for-R4 | Cross-version VS for R3.Procedure Follow up Codes (SNOMED CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-procedure-not-performed-reason-for-R4 | Cross-version VS for R3.Procedure Not Performed Reason (SNOMED-CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-procedure-outcome-for-R4 | Cross-version VS for R3.Procedure Outcome Codes (SNOMED CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-procedure-reason-for-R4 | Cross-version VS for R3.Procedure Reason Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-profile-code-for-R4 | Cross-version VS for R3.Structure Definition Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-questionnaire-answers-for-R4 | Cross-version VS for R3.Questionnaire Answer Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-questionnaire-category-for-R4 | Cross-version VS for R3.Questionnaire Category Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-reason-medication-not-given-codes-for-R4 | Cross-version VS for R3.SNOMED CT Reason Medication Not Given Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-reason-medication-not-taken-codes-for-R4 | Cross-version VS for R3.SNOMED CT Drugs not taken/completed Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-referencerange-appliesto-for-R4 | Cross-version VS for R3.Observation Reference Range Applies To Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-referral-type-for-R4 | Cross-version VS for R3.SNOMED CT Patient Referral for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-route-codes-for-R4 | Cross-version VS for R3.SNOMED CT Route Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-sequence-species-for-R4 | Cross-version VS for R3.SNOMED CT Codes for species for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-specimen-collection-method-for-R4 | Cross-version VS for R3.FHIR Specimen Collection Method for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-specimen-container-type-for-R4 | Cross-version VS for R3.SpecimenContainer for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-substance-code-for-R4 | Cross-version VS for R3.Substance Code for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-supplement-type-for-R4 | Cross-version VS for R3.Supplement Type Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-supply-item-for-R4 | Cross-version VS for R3.SNOMED CT Supply Item for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-texture-code-for-R4 | Cross-version VS for R3.Texture Modifier Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-use-context-for-R4 | Cross-version VS for R3.Context of Use ValueSet for use in FHIR R4 |
| hl7.fhir.uv.xver-r3.r4.r4b#0.0.1-snapshot-2 | R3-vaccination-protocol-dose-target-for-R4 | Cross-version VS for R3.Vaccination Protocol Dose Target Codes for use in FHIR R4 |
| gpc.stu3.fhir-assets#1.3.0 | CareConnect-AllergyManifestation-1 | Care Connect Allergy Manifestation |
| gpc.stu3.fhir-assets#1.3.0 | CareConnect-ConditionCode-1 | Care Connect Condition Code |
| gpc.stu3.fhir-assets#1.3.0 | CareConnect-ListCode-1 | Care Connect List Code |
| gpc.stu3.fhir-assets#1.3.0 | CareConnect-VaccineCode-1 | Care Connect Vaccine Code |
| gpc.stu3.fhir-assets#1.3.0 | GPC-MedicationTradeFamily-1 | GPC Medication Trade Family |
| ca.pipeline.test.breaks#0.0.1 | anatomical-or-acquired-body-structure-code | Anatomical Or Acquired Body Structure Code (CA Pipeline Test) |
| ca.pipeline.test.breaks#0.0.1 | fake-valueset | Fake Valueset (CA Pipeline Test) |
| no.nhn.fhir.helsenorge.profiles#2.5.9-beta | serviceRequest-category-vs | ServiceRequest Category Value Set |
| no.nhn.fhir.helsenorge.profiles#2.5.9-beta | serviceRequest-performerType-vs | ServiceRequest PerformerType Value Set |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-CareSettingType | NHSDigital-CareSettingType |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-ImmunizationExplanationReason | NHS Digital Immunization Explanation Reason |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-VaccinationProcedure | Interim version of UK Core Vaccination Procedure. |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-MedicationDispense-Code | Digital Medicine MedicationDispense Code |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-MedicationRequest-Code | Digital Medicine MedicationRequest Code |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-MedicationCode | NHS Digital Medication Code |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-ReasonImmunizationNotAdministered | NHSDigital Reason Immunization Not Administered |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-VaccineCode | NHS Digital Vaccine Code |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-action-code | NHSDigital Action Code |
| uk.nhsdigital.r4.test#2.18.16-pre-release | NHSDigital-ServiceRequest-category | ServiceRequestCategory |
| uk.nhsdigital.r4.test#2.18.16-pre-release | DocumentCategory | NHSEnglandDocumentCategory |
| uk.nhsdigital.r4.test#2.18.16-pre-release | Document-Type | NHSEnglandDocumentType |
| uk.nhsdigital.r4.test#2.18.16-pre-release | covid-19-detection-of-antibody | COVID-19 SNOMED CT Detection Of Antibody |
| uk.nhsdigital.r4.test#2.18.16-pre-release | covid-19-detection-of-antigen | COVID-19 SNOMED CT Detection Of Antigen |
| uk.nhsdigital.r4.test#2.18.16-pre-release | covid-19-detection-of-virus | COVID-19 SNOMED CT Detection of Virus |
| uk.nhsdigital.r4.test#2.18.16-pre-release | covid-19-snomed-procedure-code-vs | COVID-19 SNOMED CT Procedure Code Value Set |
| uk.nhsdigital.r4.test#2.18.16-pre-release | covid-19-snomed-test-vs | COVID-19 SNOMED CT Tests Value Set |
| de.medizininformatikinitiative.kerndatensatz.prozedur#2025.0.1 | procedures-intend | MII VS Prozedur Durchführungsabsicht [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.prozedur#2025.0.1 | procedures-category-sct | MII VS Prozedur OPS Kategorien [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.prozedur#2025.0.1 | procedures-sct | MII VS Prozedur Prozeduren [SNOMED CT] |
| ca.on.oh-eforms#1.0.0-ballot6 | topic-codes | Topic Codes for Ontario Questionnaires |
| ch.fhir.ig.ch-epreg#1.0.0 | blood-group | CH EPREG VS: Blood Group |
| ch.fhir.ig.ch-epreg#1.0.0 | fetal-position | CH EPREG VS: Fetal Position |
| ch.fhir.ig.ch-epreg#1.0.0 | parent | CH EPREG VS: Parent |
| lung.ca.screen.assignment#1.0.1 | screening-tests | Lung Cancer Screening Tests |
| lung.ca.screen.assignment#1.0.1 | lung-cancer-condition | lung-cancer-condition |
| ca.on.phsd.r4-alpha#1.1.0-snapshot | condition-code | Condition Code |
| ca.on.phsd.r4-alpha#1.1.0-snapshot | health-care-provider-role-type | HealthCareProviderRoleType |
| ca.on.phsd.r4-alpha#1.1.0-snapshot | practitioner-specialty | PractitionerSpecialty |
| ca.on.phsd.r4-alpha#1.1.0-snapshot | service-category-eServices | Service Category-eServices |
| ca.on.phsd.r4-alpha#1.1.0-snapshot | service-indication | Service Indication |
| ca.on.phsd.r4-alpha#1.1.0-snapshot | wait-time-service-type | WaitTime Service Type |
| ca.on.phsd.r4-alpha#1.1.0-snapshot | service-type-eservices | Service Type eServices |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20171231000000 | AfnameprocedureCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.5.3--20171231000000 | AfwijkendAdemhalingspatroonCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20171231000000 | AlcoholGebruikStatusCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20171231000000 | AlertNaamCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20171231000000 | AllergieCategorieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.2.1.1--20171231000000 | BehandelingCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20171231000000 | BestemmingCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.2--20171231000000 | BrandwondAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.4--20171231000000 | BrandwondLateraliteitCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.3--20171231000000 | BrandwondSoortCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.9--20171231000000 | ContainerTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.9.12.3--20171231000000 | DagdeelCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.1.2--20171231000000 | DecubitusAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.1.1--20171231000000 | DecubitusCategorieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.1.3--20171231000000 | DecubitusWondLateraliteitCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.15.5--20171231000000 | DefecatieKleurCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.2--20171231000000 | DiastolischEindpuntCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.5.2--20171231000000 | DiepteCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.1--20171231000000 | DieptegraadCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.2--20171231000000 | DrinkBeperkingenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.1--20171231000000 | DrinkenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20171231000000 | DrugsGebruikStatusCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20171231000000 | DrugsOfGeneesmiddelSoortCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.2--20171231000000 | EetBeperkingenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.6--20171231000000 | ErnstCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.1--20171231000000 | EtenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.2.1.4--20171231000000 | GeverifieerdBijCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.13.1--20171231000000 | GezinssamenstellingCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.16.1--20171231000000 | GezinssamenstellingKindCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.2--20171231000000 | HartslagMeetMethodeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.1--20171231000000 | HartslagRegelmatigheidCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.15.1.2--20171231000000 | HerkomstCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.1--20171231000000 | HoorFunctieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.2--20171231000000 | HorenHulpmiddelTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.5--20171231000000 | HoudingCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.4--20171231000000 | HoudingHandhavenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.1--20171231000000 | HoudingVeranderenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.3.2--20171231000000 | HuidAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.3.3--20171231000000 | HuidLateraliteitCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.1.2--20171231000000 | HulpmiddelAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.2.1--20171231000000 | InfuuskatheterTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.7--20171231000000 | InterpretatieVlaggenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.2.4--20171231000000 | InterventieSnomedCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.12--20171231000000 | LateraliteitCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20171231000000 | LevensovertuigingCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.3--20171231000000 | LocatieGehoorapparaatCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.9--20171231000000 | LopenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.2.2--20171231000000 | LumenLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.4--20171231000000 | MateVanKritiekZijnCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.1.4--20171231000000 | MedischHulpmiddelLateraliteitCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.4--20171231000000 | MeetLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.1--20171231000000 | MeetmethodeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.3.4--20171231000000 | MeetmethodeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.3.2--20171231000000 | MetingNaamCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.10--20171231000000 | MicroorganismeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.11--20171231000000 | MonsterAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.6--20171231000000 | MonstermateriaalCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.13--20171231000000 | MorfologieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.3.3--20171231000000 | OnderzoekCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20171231000000 | OntwikkelingMotoriekCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20171231000000 | OntwikkelingSociaalCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20171231000000 | OntwikkelingTaalCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20171231000000 | OntwikkelingVerstandelijkCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.16.1.2--20171231000000 | OrderStatusCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.9.2--20171231000000 | PijnAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.9.3--20171231000000 | PijnLateraliteitCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.7.1--20171231000000 | PolsRegelmatigheidCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.5--20171231000000 | ProbleemAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.6--20171231000000 | ProbleemLateraliteitCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.2--20171231000000 | ProbleemStatusCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20171231000000 | ProbleemTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.1.1--20171231000000 | ProductTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.13.2--20171231000000 | ProtheseTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.9.6.2--20171231000000 | RedenMedicatieafspraakCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.9.11.2--20171231000000 | RedenWijzigenOfStoppenGebruikCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.1--20171231000000 | ResultaatTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.5.1--20171231000000 | RitmeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.29.4--20171231000000 | SNAQrcHulpBijEtenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.14.1--20171231000000 | SchedelomvangMeetmethodeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.3.1--20171231000000 | SondeTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.3.1--20171231000000 | SoortAandoeningCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.3.2.1--20171231000000 | SoortHulpCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.3.3--20171231000000 | SoortInterventieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20171231000000 | SoortTabakGebruikCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.16--20171231000000 | SpecifiekeStofAllergeneStoffenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.4--20171231000000 | StatusNaamSnomedCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.8--20171231000000 | StatusWaardeSnomedCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.2--20171231000000 | StomaAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.3--20171231000000 | StomaLateraliteitCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20171231000000 | StomaTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20171231000000 | SymptoomCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20171231000000 | TeKledenLichaamsdeelCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20171231000000 | TeWassenLichaamsdeelCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20171231000000 | TekstUitslagTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20171231000000 | TemperatuurTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20171231000000 | TestmethodeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.5.4--20171231000000 | ToedieningHulpmiddelCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.22.4--20171231000000 | ToiletgebruikCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.12--20171231000000 | TraplopenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.33.1--20171231000000 | UiterlijkeVerzorgingCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.7--20171231000000 | UitvoerenTransferCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.14.2--20171231000000 | UrineKatheterTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.4--20171231000000 | VerificatieStatusCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.17--20171231000000 | VeroorzakendeStofAllergeneStoffenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.34.1--20171231000000 | VerrichtenVPKHandelingCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.2--20171231000000 | VerrichtingTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.13.1--20171231000000 | VerzorgenTandenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.16.1--20171231000000 | VisueleFunctieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.31.2--20171231000000 | VoedingMethodeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.31.1--20171231000000 | VoedingSoortCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.9.12.2--20171231000000 | WeekdagCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.12--20171231000000 | WijzeVanBlootstellingCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.6--20171231000000 | WondAnatomischeLocatieCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.7--20171231000000 | WondDrainTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.8--20171231000000 | WondLateraliteitCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.4--20171231000000 | WondSoortCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.35.1--20171231000000 | ZelfstandigMedicatiegebruikCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.1--20171231000000 | ZichKledenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.1--20171231000000 | ZichWassenCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.16.2--20171231000000 | ZienHulpmiddelTypeCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.2--20171231000000 | ZindelijkheidFecesCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.1--20171231000000 | ZindelijkheidUrineCodelijst |
| nictiz.fhir.nl.stu3.zib2017#2.3.2 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.22.3--20171231000000 | ZorgBijMenstruatieCodelijst |
| hl7.fhir.uv.extensions.r3#5.3.0 | device-type | Device Type |
| hl7.fhir.uv.extensions.r3#5.3.0 | therapy | Therapy |
| fhir.hrsa.uds-plus#2.0.0 | uds-plus-sex-codes | Uds Plus Sex Codes |
| il.hdp.fhir.r4#0.5.0 | il-hdp-condition-code | ILHDP Condition Code |
| swiss.mednet.fhir#0.20.0 | mni-encounter-reason | MedNet Interface (MNI) - Encounter Reason ValueSet |
| swiss.mednet.fhir#0.20.0 | mni-obs-bloodGroup | MedNet Interface (MNI) - Blood Group Observation ValueSet |
| swiss.mednet.fhir#0.20.0 | mni-serviceRequestCode | MedNet Interface (MNI) - ServiceRequest Code ValueSet |
| de.medizininformatikinitiative.use-case.omi#0.3.26 | device-property-type-valueset | Device Property Type ValueSet |
| de.medizininformatikinitiative.use-case.omi#0.3.26 | type-code-value-set | Type Code Value Set |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-additional-instruction-codes-for-R4 | Cross-version VS for R4B.SNOMEDCTAdditionalDosageInstructions for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-administration-method-codes-for-R4 | Cross-version VS for R4B.SNOMEDCTAdministrationMethodCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-adverse-event-type-for-R4 | Cross-version VS for R4B.SNOMEDCTClinicalFindings for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-allergen-class-for-R4 | Cross-version VS for R4B.Codes for Allergen Classes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-allergyintolerance-code-for-R4 | Cross-version VS for R4B.AllergyIntoleranceSubstance/Product,ConditionAndNegationCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-animal-breeds-for-R4 | Cross-version VS for R4B.AnimalBreeds for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-approach-site-codes-for-R4 | Cross-version VS for R4B.SNOMEDCTAnatomicalStructureForAdministrationSiteCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-body-site-for-R4 | Cross-version VS for R4B.SNOMEDCTBodyStructures for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-bodysite-laterality-for-R4 | Cross-version VS for R4B.Laterality for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-bodystructure-code-for-R4 | Cross-version VS for R4B.SNOMEDCTMorphologicAbnormalities for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-bodystructure-relative-location-for-R4 | Cross-version VS for R4B.BodystructureLocationQualifier for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-c80-facilitycodes-for-R4 | Cross-version VS for R4B.FacilityTypeCodeValueSet for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-c80-practice-codes-for-R4 | Cross-version VS for R4B.PracticeSettingCodeValueSet for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-care-plan-activity-outcome-for-R4 | Cross-version VS for R4B.CarePlanActivityOutcome for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-care-plan-category-for-R4 | Cross-version VS for R4B.CarePlanCategory for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-careteam-participant-role-for-R4 | Cross-version VS for R4B.ParticipantRoles for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-clinical-findings-for-R4 | Cross-version VS for R4B.SNOMEDCTClinicalFindings for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-clinicalimpression-prognosis-for-R4 | Cross-version VS for R4B.ClinicalImpressionPrognosis for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-condition-cause-for-R4 | Cross-version VS for R4B.ConditionCauseCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-condition-code-for-R4 | Cross-version VS for R4B.Condition/Problem/DiagnosisCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-condition-outcome-for-R4 | Cross-version VS for R4B.ConditionOutcomeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-condition-predecessor-for-R4 | Cross-version VS for R4B.ConditionPredecessorCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-condition-severity-for-R4 | Cross-version VS for R4B.Condition/DiagnosisSeverity for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-condition-stage-for-R4 | Cross-version VS for R4B.ConditionStage for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-condition-stage-type-for-R4 | Cross-version VS for R4B.ConditionStageType for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-consistency-type-for-R4 | Cross-version VS for R4B.FluidConsistencyTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-container-material-for-R4 | Cross-version VS for R4B.ContainerMaterials for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-dataelement-sdcobjectclass-for-R4 | Cross-version VS for R4B.DataElementSDCObjectClass for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-dataelement-sdcobjectclassproperty-for-R4 | Cross-version VS for R4B.DataElementSDCObjectClass for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-designation-use-for-R4 | Cross-version VS for R4B.DesignationUse for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-device-action-for-R4 | Cross-version VS for R4B.ProcedureDeviceActionCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-device-kind-for-R4 | Cross-version VS for R4B.FHIRDeviceTypes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-device-type-for-R4 | Cross-version VS for R4B.DeviceType for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-diagnostic-based-on-snomed-for-R4 | Cross-version VS for R4B.DiagnosticAttachmentType for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-diet-type-for-R4 | Cross-version VS for R4B.DietCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-disease-status-for-R4 | Cross-version VS for R4B.DiseaseStatus for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-disease-symptom-procedure-for-R4 | Cross-version VS for R4B.DiseaseSymptomProcedure for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-encounter-reason-for-R4 | Cross-version VS for R4B.EncounterReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-entformula-type-for-R4 | Cross-version VS for R4B.EnteralFormulaTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-feeding-device-for-R4 | Cross-version VS for R4B.FeedingDeviceCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-flag-code-for-R4 | Cross-version VS for R4B.FlagCode for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-food-type-for-R4 | Cross-version VS for R4B.FoodTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-goal-start-event-for-R4 | Cross-version VS for R4B.GoalStartEvent for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-immunization-evaluation-target-disease-for-R4 | Cross-version VS for R4B.ImmunizationEvaluationTargetDiseaseCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-immunization-reason-for-R4 | Cross-version VS for R4B.ImmunizationReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-immunization-recommendation-reason-for-R4 | Cross-version VS for R4B.ImmunizationRecommendationReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-immunization-recommendation-target-disease-for-R4 | Cross-version VS for R4B.ImmunizationRecommendationTargetDiseaseCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-immunization-status-reason-for-R4 | Cross-version VS for R4B.ImmunizationStatusReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-immunization-target-disease-for-R4 | Cross-version VS for R4B.ImmunizationTargetDiseaseCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-interactant-for-R4 | Cross-version VS for R4B.Interactant for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-interaction-effect-for-R4 | Cross-version VS for R4B.InteractionEffect for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-interaction-management-for-R4 | Cross-version VS for R4B.InteractionManagement for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-investigation-sets-for-R4 | Cross-version VS for R4B.InvestigationType for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-manifestation-or-symptom-for-R4 | Cross-version VS for R4B.ManifestationAndSymptomCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-measurement-property-for-R4 | Cross-version VS for R4B.Codes for Product Characteristics for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-media-view-for-R4 | Cross-version VS for R4B.MediaCollectionView/Projection for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-medication-as-needed-reason-for-R4 | Cross-version VS for R4B.SNOMEDCTMedicationAsNeededReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-medication-codes-for-R4 | Cross-version VS for R4B.SNOMEDCTMedicationCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-medication-form-codes-for-R4 | Cross-version VS for R4B.SNOMEDCTFormCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-modified-foodtype-for-R4 | Cross-version VS for R4B.TextureModifiedFoodTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-nutrient-code-for-R4 | Cross-version VS for R4B.NutrientModifierCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-nutrition-product-category-for-R4 | Cross-version VS for R4B.Categories of Nutrition Products for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-nutrition-product-nutrient-for-R4 | Cross-version VS for R4B.Codes for Nutrition Product Nutrients for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-observation-methods-for-R4 | Cross-version VS for R4B.ObservationMethods for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-performer-role-for-R4 | Cross-version VS for R4B.ProcedurePerformerRoleCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-prepare-patient-prior-specimen-collection-for-R4 | Cross-version VS for R4B.PreparePatient for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-procedure-category-for-R4 | Cross-version VS for R4B.ProcedureCategoryCodes(SNOMEDCT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-procedure-code-for-R4 | Cross-version VS for R4B.ProcedureCodes(SNOMEDCT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-procedure-followup-for-R4 | Cross-version VS for R4B.ProcedureFollowUpCodes(SNOMEDCT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-procedure-not-performed-reason-for-R4 | Cross-version VS for R4B.ProcedureNotPerformedReason(SNOMED-CT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-procedure-outcome-for-R4 | Cross-version VS for R4B.ProcedureOutcomeCodes(SNOMEDCT) for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-procedure-reason-for-R4 | Cross-version VS for R4B.ProcedureReasonCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-questionnaire-answers-for-R4 | Cross-version VS for R4B.QuestionnaireAnswerCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-reason-medication-not-given-codes-for-R4 | Cross-version VS for R4B.SNOMEDCTReasonMedicationNotGivenCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-reason-medication-status-codes-for-R4 | Cross-version VS for R4B.SNOMEDCTDrugTherapyStatusCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-referencerange-appliesto-for-R4 | Cross-version VS for R4B.ObservationReferenceRangeAppliesToCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-route-codes-for-R4 | Cross-version VS for R4B.SNOMEDCTRouteCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-servicerequest-category-for-R4 | Cross-version VS for R4B.ServiceRequestCategoryCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-servicerequest-orderdetail-for-R4 | Cross-version VS for R4B.ServiceRequestOrderDetailsCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-specimen-collection-for-R4 | Cross-version VS for R4B.SpecimenCollection for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-specimen-collection-method-for-R4 | Cross-version VS for R4B.FHIRSpecimenCollectionMethod for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-specimen-container-type-for-R4 | Cross-version VS for R4B.SpecimenContainer for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-substance-code-for-R4 | Cross-version VS for R4B.SubstanceCode for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-supplement-type-for-R4 | Cross-version VS for R4B.SupplementTypeCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-supply-item-for-R4 | Cross-version VS for R4B.SNOMEDCTSupplyItem for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-texture-code-for-R4 | Cross-version VS for R4B.TextureModifierCodes for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-therapy-for-R4 | Cross-version VS for R4B.Therapy for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-undesirable-effect-classification-for-R4 | Cross-version VS for R4B.UndesirableEffectClassification for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-undesirable-effect-symptom-for-R4 | Cross-version VS for R4B.UndesirableEffectSymptom for use in FHIR R4 |
| hl7.fhir.uv.xver-r4b.r4.r4b#0.0.1-snapshot-2 | R4B-use-context-for-R4 | Cross-version VS for R4B.Context of Use ValueSet for use in FHIR R4 |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | 2.16.840.1.113883.2.4.3.11.60.26.11.7--20211028090253 | CategorieCodelijst |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | 2.16.840.1.113883.2.4.3.11.60.26.11.31--20231207101023 | DiagnoseNaamCodelijst |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | 2.16.840.1.113883.2.4.3.11.60.26.11.19--20231120131658 | ErnstCodelijst |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | 2.16.840.1.113883.2.4.3.11.60.26.11.41--20240910090504 | StartRedenCodelijst |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | 2.16.840.1.113883.2.4.3.11.60.26.11.34--20240501114150 | SymptoomErnstCodelijst |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | 2.16.840.1.113883.2.4.3.11.60.26.11.35--20240501114333 | SymptoomNaamCodelijst |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | 2.16.840.1.113883.2.4.3.11.60.26.11.16--20231120123250 | VerwachtRisicoBijBlootstellingCodelijst |
| nictiz.fhir.nl.r4.cio#1.0.0-beta.5 | 2.16.840.1.113883.2.4.3.11.60.26.11.14--20231120120019 | WijzeVanVaststellenCodelijst |
| ch.fhir.ig.ch-lab-report#2.0.0 | ch-lab-bloodgroup-antibody-vs | CH LAB-Report BloodGroup Antibody Result (SNOMED CT coded substances) |
| ch.fhir.ig.ch-lab-report#2.0.0 | ch-lab-bloodgroup-immuno-hematology-vs | CH LAB-Report BloodGroup Immunohematology Tests (SNOMED CT coded procedures) |
| hl7.fhir.uv.xver-r5.r4#0.1.0 | R5-v3-AllergyStatus-for-R4 | Cross-version ValueSet R5.AllergyStatus for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4#0.1.0 | R5-v3-KnowledgeSubtopicObservationValue-for-R4 | Cross-version ValueSet R5.KnowledgeSubtopicObservationValue for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4#0.1.0 | R5-v3-ObservationMeasureCountableItems-for-R4 | Cross-version ValueSet R5.ObservationMeasureCountableItems for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r4#0.1.0 | R5-v3-immunizationForecastStatusObservationValue-for-R4 | Cross-version ValueSet R5.ImmunizationForecastStatusObservationValue for use in FHIR R4 |
| hl7.fhir.uv.xver-r5.r3#0.1.0 | R5-v3-AllergyStatus-for-R3 | Cross-version ValueSet R5.AllergyStatus for use in FHIR STU3 |
| hl7.fhir.uv.xver-r5.r3#0.1.0 | R5-v3-KnowledgeSubtopicObservationValue-for-R3 | Cross-version ValueSet R5.KnowledgeSubtopicObservationValue for use in FHIR STU3 |
| hl7.fhir.uv.xver-r5.r3#0.1.0 | R5-v3-ObservationMeasureCountableItems-for-R3 | Cross-version ValueSet R5.ObservationMeasureCountableItems for use in FHIR STU3 |
| hl7.fhir.uv.xver-r5.r3#0.1.0 | R5-v3-immunizationForecastStatusObservationValue-for-R3 | Cross-version ValueSet R5.ImmunizationForecastStatusObservationValue for use in FHIR STU3 |
| rki.demis.igs#5.0.0 | sequencingReason | Grund der Sequenzierung |
| rki.demis.igs#5.0.0 | uploadStatus | Status des Sequenz-Uploads |
| fhir.r4.ukcore.stu2#2.0.2 | UKCore-PathologyAndLaboratoryMedicineProcedures | UK Core Pathology And Laboratory Medicine Procedures |
| kl.dk.fhir.children#2.1.0 | BodyheightSCTobservablesChildren | HøjdeObservationskoderSCT |
| ca.on.mha.pds#2.0.0-snapshot17 | addiction-substance-use | Addiction Substance Use |
| ca.on.mha.pds#2.0.0-snapshot17 | alcohol-anti-craving-medication | Alcohol Anti-Craving Medication |
| ca.on.mha.pds#2.0.0-snapshot17 | alcohol-anti-craving-medication-enrollment | Alcohol Anti-Craving Medication Enrollment |
| ca.on.mha.pds#2.0.0-snapshot17 | mha-disability-status | Disability Status |
| ca.on.mha.pds#2.0.0-snapshot17 | mha-disability-type | Disability Type |
| ca.on.mha.pds#2.0.0-snapshot17 | mha-organization-admission-discharge-reason | Discharge Reason |
| ca.on.mha.pds#2.0.0-snapshot17 | gambling-problem-identified | Gambling Problem Identified |
| ca.on.mha.pds#2.0.0-snapshot17 | gender-identity | Gender Identity |
| ca.on.mha.pds#2.0.0-snapshot17 | hcn-issuing-authority | HCN Issuing Authority |
| ca.on.mha.pds#2.0.0-snapshot17 | opioid-agonist-medication-enrollment | Opioid Agonist Medication Enrollment |
| ca.on.mha.pds#2.0.0-snapshot17 | symptoms-of-clinical-concern | Symptoms Of Clinical Concern |
| ca.on.mha.pds#2.0.0-snapshot17 | mha-race | Race |
| ca.on.mha.pds#2.0.0-snapshot17 | service-modality-type | Service Modality Type |
| ca.on.mha.pds#2.0.0-snapshot17 | transgender-identity | Transgender Identity |
| ca.on.mha.pds#2.0.0-snapshot17 | housing-status | Housing Status |
| ca.on.mha.pds#2.0.0-snapshot17 | mha-bornInCanadaResponse | Born in Canada Response |
| cgm.iop.roche.com#1.0.0 | devicePropertiesCodes | DeviceSettingsCodes |
| cgm.iop.roche.com#1.0.0 | deviceType | DeviceType |
| cgm.iop.roche.com#1.0.0 | observationCodes | ObservationCodes |
| kbv.mio.kh-entlassbrief#1.0.0-update | KBV_VS_MIO_KHE_Initiated_Services_SNOMED_CT | Veranlasste Leistungen |
| kbv.mio.kh-entlassbrief#1.0.0-update | KBV_VS_MIO_KHE_Results_Type | Befundtyp |
| ch.fhir.ig.ch-crl#0.9.0 | nkrs-serumtumourmarkers | NKRS - Serum Tumour Markers |
| ch.fhir.ig.ch-crl#0.9.0 | nkrs-treatmentgoal | NKRS - Treatment Goal |
| ch.fhir.ig.ch-crl#0.9.0 | nkrs-whocnsgradingsystem | NKRS - WHO(CNS) Grading System |
| ca.ab.fhir.psab#1.2.0 | family-member-relationship-code | FamilyMemberRelationshipCode_AB |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-additional-instruction-codes-for-R4B | Cross-version VS for R4.SNOMEDCTAdditionalDosageInstructions for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-administration-method-codes-for-R4B | Cross-version VS for R4.SNOMEDCTAdministrationMethodCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-adverse-event-type-for-R4B | Cross-version VS for R4.SNOMEDCTClinicalFindings for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-allergyintolerance-code-for-R4B | Cross-version VS for R4.AllergyIntoleranceSubstance/Product,ConditionAndNegationCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-animal-breeds-for-R4B | Cross-version VS for R4.AnimalBreeds for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-animal-species-for-R4B | Cross-version VS for R4.AnimalSpecies for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-approach-site-codes-for-R4B | Cross-version VS for R4.SNOMEDCTAnatomicalStructureForAdministrationSiteCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-body-site-for-R4B | Cross-version VS for R4.SNOMEDCTBodyStructures for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-bodysite-laterality-for-R4B | Cross-version VS for R4.Laterality for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-bodystructure-code-for-R4B | Cross-version VS for R4.SNOMEDCTMorphologicAbnormalities for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-bodystructure-relative-location-for-R4B | Cross-version VS for R4.BodystructureLocationQualifier for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-c80-facilitycodes-for-R4B | Cross-version VS for R4.FacilityTypeCodeValueSet for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-c80-practice-codes-for-R4B | Cross-version VS for R4.PracticeSettingCodeValueSet for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-care-plan-activity-outcome-for-R4B | Cross-version VS for R4.CarePlanActivityOutcome for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-care-plan-category-for-R4B | Cross-version VS for R4.CarePlanCategory for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-clinical-findings-for-R4B | Cross-version VS for R4.SNOMEDCTClinicalFindings for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-clinicalimpression-prognosis-for-R4B | Cross-version VS for R4.ClinicalImpressionPrognosis for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-condition-cause-for-R4B | Cross-version VS for R4.ConditionCauseCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-condition-code-for-R4B | Cross-version VS for R4.Condition/Problem/DiagnosisCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-condition-outcome-for-R4B | Cross-version VS for R4.ConditionOutcomeCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-condition-predecessor-for-R4B | Cross-version VS for R4.ConditionPredecessorCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-condition-severity-for-R4B | Cross-version VS for R4.Condition/DiagnosisSeverity for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-condition-stage-for-R4B | Cross-version VS for R4.ConditionStage for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-condition-stage-type-for-R4B | Cross-version VS for R4.ConditionStageType for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-consistency-type-for-R4B | Cross-version VS for R4.FluidConsistencyTypeCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-container-material-for-R4B | Cross-version VS for R4.ContainerMaterials for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-dataelement-sdcobjectclass-for-R4B | Cross-version VS for R4.DataElementSDCObjectClass for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-dataelement-sdcobjectclassproperty-for-R4B | Cross-version VS for R4.DataElementSDCObjectClass for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-designation-use-for-R4B | Cross-version VS for R4.DesignationUse for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-device-action-for-R4B | Cross-version VS for R4.ProcedureDeviceActionCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-device-kind-for-R4B | Cross-version VS for R4.FHIRDeviceTypes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-device-type-for-R4B | Cross-version VS for R4.DeviceType for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-diagnostic-based-on-snomed-for-R4B | Cross-version VS for R4.DiagnosticAttachmentType for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-diet-type-for-R4B | Cross-version VS for R4.DietCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-encounter-reason-for-R4B | Cross-version VS for R4.EncounterReasonCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-entformula-type-for-R4B | Cross-version VS for R4.EnteralFormulaTypeCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-feeding-device-for-R4B | Cross-version VS for R4.FeedingDeviceCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-flag-code-for-R4B | Cross-version VS for R4.FlagCode for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-food-type-for-R4B | Cross-version VS for R4.FoodTypeCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-goal-start-event-for-R4B | Cross-version VS for R4.GoalStartEvent for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-immunization-evaluation-target-disease-for-R4B | Cross-version VS for R4.ImmunizationEvaluationTargetDiseaseCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-immunization-reason-for-R4B | Cross-version VS for R4.ImmunizationReasonCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-immunization-recommendation-reason-for-R4B | Cross-version VS for R4.ImmunizationRecommendationReasonCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-immunization-recommendation-target-disease-for-R4B | Cross-version VS for R4.ImmunizationRecommendationTargetDiseaseCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-immunization-status-reason-for-R4B | Cross-version VS for R4.ImmunizationStatusReasonCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-immunization-target-disease-for-R4B | Cross-version VS for R4.ImmunizationTargetDiseaseCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-investigation-sets-for-R4B | Cross-version VS for R4.InvestigationType for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-manifestation-or-symptom-for-R4B | Cross-version VS for R4.ManifestationAndSymptomCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-media-view-for-R4B | Cross-version VS for R4.MediaCollectionView/Projection for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-medication-as-needed-reason-for-R4B | Cross-version VS for R4.SNOMEDCTMedicationAsNeededReasonCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-medication-codes-for-R4B | Cross-version VS for R4.SNOMEDCTMedicationCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-medication-form-codes-for-R4B | Cross-version VS for R4.SNOMEDCTFormCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-modified-foodtype-for-R4B | Cross-version VS for R4.TextureModifiedFoodTypeCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-nutrient-code-for-R4B | Cross-version VS for R4.NutrientModifierCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-observation-methods-for-R4B | Cross-version VS for R4.ObservationMethods for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-participant-role-for-R4B | Cross-version VS for R4.ParticipantRoles for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-performer-role-for-R4B | Cross-version VS for R4.ProcedurePerformerRoleCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-practitioner-role-for-R4B | Cross-version VS for R4.PractitionerRole for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-prepare-patient-prior-specimen-collection-for-R4B | Cross-version VS for R4.PreparePatient for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-procedure-category-for-R4B | Cross-version VS for R4.ProcedureCategoryCodes(SNOMEDCT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-procedure-code-for-R4B | Cross-version VS for R4.ProcedureCodes(SNOMEDCT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-procedure-followup-for-R4B | Cross-version VS for R4.ProcedureFollowUpCodes(SNOMEDCT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-procedure-not-performed-reason-for-R4B | Cross-version VS for R4.ProcedureNotPerformedReason(SNOMED-CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-procedure-outcome-for-R4B | Cross-version VS for R4.ProcedureOutcomeCodes(SNOMEDCT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-procedure-reason-for-R4B | Cross-version VS for R4.ProcedureReasonCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-questionnaire-answers-for-R4B | Cross-version VS for R4.QuestionnaireAnswerCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-questionnaire-category-for-R4B | Cross-version VS for R4.QuestionnaireCategoryCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-reason-medication-not-given-codes-for-R4B | Cross-version VS for R4.SNOMEDCTReasonMedicationNotGivenCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-reason-medication-status-codes-for-R4B | Cross-version VS for R4.SNOMEDCTDrugTherapyStatusCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-referencerange-appliesto-for-R4B | Cross-version VS for R4.ObservationReferenceRangeAppliesToCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-route-codes-for-R4B | Cross-version VS for R4.SNOMEDCTRouteCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-sequence-species-for-R4B | Cross-version VS for R4.SNOMEDCTCodesForSpecies for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-servicerequest-category-for-R4B | Cross-version VS for R4.ServiceRequestCategoryCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-servicerequest-orderdetail-for-R4B | Cross-version VS for R4.ServiceRequestOrderDetailsCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-specimen-collection-for-R4B | Cross-version VS for R4.SpecimenCollection for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-specimen-collection-method-for-R4B | Cross-version VS for R4.FHIRSpecimenCollectionMethod for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-specimen-container-type-for-R4B | Cross-version VS for R4.SpecimenContainerType for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-substance-code-for-R4B | Cross-version VS for R4.SubstanceCode for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-supplement-type-for-R4B | Cross-version VS for R4.SupplementTypeCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-supply-item-for-R4B | Cross-version VS for R4.SNOMEDCTSupplyItem for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-texture-code-for-R4B | Cross-version VS for R4.TextureModifierCodes for use in FHIR R4B |
| hl7.fhir.uv.xver-r4.r4b.r4b#0.0.1-snapshot-2 | R4-use-context-for-R4B | Cross-version VS for R4.Context of Use ValueSet for use in FHIR R4B |
| de.gematik.isik#5.1.3 | ConditionDiagnosisSeverity | ConditionDiagnosisSeverity |
| de.gematik.isik#5.1.3 | DiagnosesSCT | DiagnosesSCT |
| de.gematik.isik#5.1.3 | EncounterReasonCodes | EncounterReasonCodes |
| de.gematik.isik#5.1.3 | ISiKKernTempSctVS | ISiK Kerntemperatur SnomedCT ValueSet |
| de.gematik.isik#5.1.3 | ISiKTerminPriority | ISiKTerminPriority |
| de.gematik.isik#5.1.3 | ProzedurenCodesSCT | ProzedurenCodesSCT |
| de.gematik.isik#5.1.3 | ProzedurenKategorieSCT | ProzedurenKategorieSCT |
| de.gematik.isik#5.1.3 | SctRouteOfAdministration | SctRouteOfAdministration |
| de.gematik.isik#5.1.3 | vs-mii-icu-bodysite-observation-blutdruck | VS MII ICU BodySite Observation Blutdruck |
| de.gematik.isik#5.1.3 | vs-mii-icu-bodysite-observation-monitoring-und-vitaldaten | VS MII ICU BodySite Observation Monitoring und Vitaldaten |
| de.gematik.isik#5.1.3 | vs-mii-icu-code-monitoring-und-vitaldaten-snomed | VS MII ICU Code Monitoring und Vitaldaten [sct] |
| de.gematik.isik#5.1.3 | vs-mii-icu-method-observation-blutdruck | VS MII ICU Method Observation Blutdruck |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-labor-laborergebnis-semiquantitativ | MII VS Labor Laborergebnis Semiquantitativ |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-allgemeine-bestimmung-methode-snomed | MII VS Mikrobio Allgemeine Bestimmung Methode [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-allgemeine-kultur-ergebnis-snomed | MII VS Mikrobio Allgemeine Kultur Ergebnis [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-allgemeine-kultur-methode-snomed | MII VS Mikrobio Allgemeine Kultur Methode [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-antigen-antikoerper-methode-snomed | MII VS Mikrobio Antigen Antikoerper Methode [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-detected-not-detected-snomed | MII VS Mikrobio Detected Not Detected [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-molekulare-pathogenlast-methode-snomed | MII VS Mikrobio Molekulare Pathogenlast Methode [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-morphologie-ergebnis-snomed | MII VS Mikrobio Morphologie Ergebnis [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-morphologie-methode-snomed | MII VS Mikrobio Morphologie Methode [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-mre-klasse-snomedct | MII VS Mikrobio MRE Klasse [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-organismen-snomedct | MII VS Mikrobio Organismen [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-resistenzmechanismen-methode-snomed | MII VS Mikrobio Resistenzmechanismen Methode [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-spezifische-bestimmung-ergebnis-snomed | MII VS Mikrobio Spezifische Bestimmung Ergebnis [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-spezifische-bestimmung-methode-snomed | MII VS Mikrobio Spezifische Bestimmung Methode [SNOMED] |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-susceptibility | MII VS Mikrobio Susceptibility |
| de.medizininformatikinitiative.kerndatensatz.mikrobiologie#2027.0.0-alpha.5 | mii-vs-mikrobio-titer-methode-snomed | MII VS Mikrobio Titer Methode [SNOMED] |
| ca.on.ehr.r4#1.0.0-temporary | prescribedquantityunit | Prescribed Quantity Unit |
| ca.on.ehr.r4#1.0.0-temporary | prescriptiondosequantityunit | PrescriptionDoseQuantityUnit |
| ca.on.ehr.r4#1.0.0-temporary | medication-repeat-pattern | Medication Repeat Pattern EHR |
| ca.on.ehr.r4#1.0.0-temporary | practitioner-specialty | Practitioner Specialty EHR |
| ca.on.ehr.r4#1.0.0-temporary | procedure-body-part | Procedure Body Part EHR |
| ca.on.ehr.r4#1.0.0-temporary | procedure-contrast-used | Procedure Contrast Used EHR |
| ca.on.ehr.r4#1.0.0-temporary | procedure-laterality | Procedure Laterality EHR |
| ca.on.ehr.r4#1.0.0-temporary | procedure-service-type | Procedure Service Type EHR |
| ca.on.ehr.r4#1.0.0-temporary | provincial-imaging-procedure-code | Provincial Imaging Procedure Code EHR |
| ca.infoway.vip.mert#0.1.0-retry | mert-procedure-codes | MERT Procedure Codes |
| racsel.org#0.2.1 | lac-medication-snomed-vs | Medications SNOMED |
| tw.cohesion.fhir.clinemr#1.0.0 | procedure-cohesion-category | 中醫處置值集 |
| tw.cohesion.fhir.clinemr#1.0.0 | treatment-region-sct-tw | SNOMED CT + 臺灣診療部位值集 |
| de.medizininformatikinitiative.kerndatensatz.patho#2026.0.2 | mii-vs-patho-collection-method-snomed-ct | MII VS Patho Collection Method [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.patho#2026.0.2 | mii-vs-patho-composition-type-snomed-ct | MII VS Patho Composition Type [Snomed CT] |
| de.medizininformatikinitiative.kerndatensatz.patho#2026.0.2 | mii-vs-patho-container-type-snomed-ct | MII VS Patho Container Type [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.patho#2026.0.2 | mii-vs-patho-media-modality-snomed-ct | MII VS Patho Media Modality [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.patho#2026.0.2 | mii-vs-patho-problem-list-snomed-ct | MII VS Patho Problem List [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.patho#2026.0.2 | mii-vs-patho-processing-procedure-snomed-ct | MII VS Patho Processing Procedure [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.patho#2026.0.2 | mii-vs-patho-service-request-code | MII VS Patho Service Request Code |
| niceprofiling.v23q1#0.5.0 | NICE-AdmitSource | NICE-AdmitSource |
| niceprofiling.v23q1#0.5.0 | NICE-ConditionCodeList | NICE-ConditionCodeList |
| niceprofiling.v23q1#0.5.0 | NICE-DischargeDisposition | NICE-DischargeDisposition |
| niceprofiling.v23q1#0.5.0 | NICE-GeneralMeasurementCodeList | NICE-GeneralMeasurementCodeList |
| niceprofiling.v23q1#0.5.0 | NICE-HospitalTypeCodelist | NICE-HospitalTypeCodelist |
| niceprofiling.v23q1#0.5.0 | NICE-ProcedureCodeList | NICE-ProcedureCodeList |
| niceprofiling.v23q1#0.5.0 | NICE-TreatmentCodelist | NICE-TreatmentCodelist |
| ans.document.fr.core#0.1.0-snapshot | fr-vs-allergy-intolerance-type-document | ValueSet - FR ValueSet Allergy Intolerance Type Document |
| fhir.bfarm.de#3.0.1 | HealthAppAge | ValueSet for HealthAppAge |
| rki.demis.disease#2.2.3 | answerSetAcuteHBVD | Anwort akute Infektion aufgrund wessen bei Hepatitis B |
| rki.demis.disease#2.2.3 | answerSetAcuteHCVD | Anwort akute Infektion aufgrund wessen bei Hepatitis C |
| rki.demis.disease#2.2.3 | answerSetCauseDiagnosisMYTD | Anwort Anlass der Diagnose bei Tuberkulose |
| rki.demis.disease#2.2.3 | answerSetCoinfectionHDVD | Anwort Koinfektion mit Hepatitis B bei Hepatitis D |
| rki.demis.disease#2.2.3 | answerSetConservationCLOD | Antwort zur Art der Lebensmittelkonservierung bei Botulismus |
| rki.demis.disease#2.2.3 | answerSetConsumptionCLOD | Antwort zum Ort des Verzehrs bei Botulismus |
| rki.demis.disease#2.2.3 | answerSetDiagnosisCJKD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
| rki.demis.disease#2.2.3 | answerSetFoodCLOD | Antwort zum verzehrten Lebensmittel bei Botulismus |
| rki.demis.disease#2.2.3 | answerSetFormBAND | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Milzbrand" |
| rki.demis.disease#2.2.3 | answerSetFormCDFD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
| rki.demis.disease#2.2.3 | answerSetFormCJKD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
| rki.demis.disease#2.2.3 | answerSetFormCLOD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Botulismus" |
| rki.demis.disease#2.2.3 | answerSetFormCORD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Diphtherie" |
| rki.demis.disease#2.2.3 | answerSetFormMYBD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Tuberkulose, bei Behandlungsabbruch" |
| rki.demis.disease#2.2.3 | answerSetFormYPSD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Pest" |
| rki.demis.disease#2.2.3 | answerSetInfectionAnimalWhereHUSD | Anwort Tierkontakt wo bei Hämolytisch-urämisches Syndrom (HUS) |
| rki.demis.disease#2.2.3 | answerSetInfectionEnvironmentSettingCVDD | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
| rki.demis.disease#2.2.3 | answerSetInfectionEnvironmentSettingMYTD | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Tuberkulose" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathCJKD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Creutzfeldt-Jakob-Krankheit (CJK)" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathHAVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis A" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathHBVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis B" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathHCVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis C" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathHEVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis E" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathHUSD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathIZVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Zoonotische Influenza" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathMPXD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Mpox" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathOPXD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Orthopocken, andere" |
| rki.demis.disease#2.2.3 | answerSetInfectionPathWhoHUSD | Antwortmöglichkeiten zur Angabe der Person, bei der sich infiziert wurde, bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskAnimalHEVD | Antwort zu Tierkontakt bei Hepatitis E |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskAnimalHUSD | Antwort zu Tierkontakt bei Hämolytisch-urämisches Syndrom (HUS) |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskAnimalRBVD | Antwort zu Tierkontakt bei Tollwut |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskAnimalTTVD | Antwort zu Tierkontakt bei Tollwutexpositionsverdacht |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskCVDD | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskIZVD | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Zoonotische Influenza" |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskJobHEVD | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hepatitis E" |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskJobHTVD | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hantavirus-Erkrankung, hämorrhagischer Verlauf" |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskNEID | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Meningokokken, invasive Erkrankung" |
| rki.demis.disease#2.2.3 | answerSetInfectionRiskOtherHEVD | Antwort zu Sonstiger Kontakt bei Hepatitis E |
| rki.demis.disease#2.2.3 | answerSetLocationLymphNodeSwellingMPXD | Anwort Lokalisation der Lymphknotenschwellung bei Mpox |
| rki.demis.disease#2.2.3 | answerSetLocationMucosalLesionsMPXD | Anwort Lokalisation der Schleimhautläsionen bei Mpox |
| rki.demis.disease#2.2.3 | answerSetLocationSkinLesionsMPXD | Anwort Lokalisation der Hautläsionen bei Mpox |
| rki.demis.disease#2.2.3 | answerSetMajorSiteMYTD | Anwort hauptsächlich betroffenes Organ bei Tuberkulose |
| rki.demis.disease#2.2.3 | answerSetManufacturingCLOD | Antwort zur Art der Lebensmittelherstellung bei Botulismus |
| rki.demis.disease#2.2.3 | answerSetMethodCDFD | Antwortmöglichkeiten für die Angabe der Nachweismethode der Clostridioides-difficile-Erkrankung, schwere Verlaufsform |
| rki.demis.disease#2.2.3 | answerSetMinorSiteMYTD | Anwort weiteres betroffenes Organ bei Tuberkulose |
| rki.demis.disease#2.2.3 | answerSetPathogenHFAD | Antwortmöglichkeiten zur Angabe des Erregers bei dem Meldetatbestand "Hämorrhagisches Fieber" |
| rki.demis.disease#2.2.3 | answerSetResultOfPrevTreatmentMYTD | Anwort Ergebnis der Vorbehandlung bei Tuberkulose |
| rki.demis.disease#2.2.3 | answerSetResultOfTreatmentMYTD | Anwort Behandlungsergebnis bei Tuberkulose |
| rki.demis.disease#2.2.3 | answerSetStadiumHBVD | Anwort Stadium der Infektion bei Hepatitis B |
| rki.demis.disease#2.2.3 | answerSetStadiumHCVD | Anwort Stadium der Infektion bei Hepatitis C |
| rki.demis.disease#2.2.3 | answerSetTransmissionKindHBVD | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis B |
| rki.demis.disease#2.2.3 | answerSetTransmissionKindHCVD | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis C |
| rki.demis.disease#2.2.3 | answerSetTrimester | Antwort zum Trimester |
| rki.demis.disease#2.2.3 | diagnosisHXXD | Antwortmöglichkeiten für die Angabe einer Diagnose bei dem Meldetatbestand "Akute Virushepatitis" |
| rki.demis.disease#2.2.3 | diagnosisSXXD | Antwortmöglichkeiten für die Angabe einer Diagnose bei dem Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
| rki.demis.disease#2.2.3 | evidenceBAND | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Milzbrand" |
| rki.demis.disease#2.2.3 | evidenceBPSD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Keuchhusten" |
| rki.demis.disease#2.2.3 | evidenceCLOD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Botulismus" |
| rki.demis.disease#2.2.3 | evidenceCORD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Diphtherie" |
| rki.demis.disease#2.2.3 | evidenceCVDD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
| rki.demis.disease#2.2.3 | evidenceCVDDv1 | Coronavirus-Krankheit-2019 (COVID-19) -Symptom und -Manifestation Version 1 |
| rki.demis.disease#2.2.3 | evidenceDEND | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Denguefieber" |
| rki.demis.disease#2.2.3 | evidenceEBVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Ebolafieber" |
| rki.demis.disease#2.2.3 | evidenceGFVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Gelbfieber" |
| rki.demis.disease#2.2.3 | evidenceHAVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis A" |
| rki.demis.disease#2.2.3 | evidenceHBVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis B" |
| rki.demis.disease#2.2.3 | evidenceHCVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis C" |
| rki.demis.disease#2.2.3 | evidenceHDVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis D" |
| rki.demis.disease#2.2.3 | evidenceHEVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hepatitis E" |
| rki.demis.disease#2.2.3 | evidenceHFAD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hämorrhagisches Fieber" |
| rki.demis.disease#2.2.3 | evidenceHTVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hantavirus-Erkrankung, hämorrhagischer Verlauf" |
| rki.demis.disease#2.2.3 | evidenceHUSD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
| rki.demis.disease#2.2.3 | evidenceHXXD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Akute Virushepatitis" |
| rki.demis.disease#2.2.3 | evidenceIZVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Zoonotische Influenza" |
| rki.demis.disease#2.2.3 | evidenceLSVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Lassafieber" |
| rki.demis.disease#2.2.3 | evidenceMBVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Marburgfieber" |
| rki.demis.disease#2.2.3 | evidenceMPVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Mumps" |
| rki.demis.disease#2.2.3 | evidenceMPXD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Mpox" |
| rki.demis.disease#2.2.3 | evidenceMSVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Masern" |
| rki.demis.disease#2.2.3 | evidenceNEID | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Meningokokken, invasive Erkrankung" |
| rki.demis.disease#2.2.3 | evidenceOPXD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Orthopocken, andere" |
| rki.demis.disease#2.2.3 | evidencePKVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Pocken" |
| rki.demis.disease#2.2.3 | evidencePOVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Poliomyelitis" |
| rki.demis.disease#2.2.3 | evidenceRBVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Tollwut" |
| rki.demis.disease#2.2.3 | evidenceRUND | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Röteln, konnatal" |
| rki.demis.disease#2.2.3 | evidenceRUVD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Röteln, postnatal" |
| rki.demis.disease#2.2.3 | evidenceSPAD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Paratyphus" |
| rki.demis.disease#2.2.3 | evidenceSSPD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Subakute sklerosierende Panenzephalitis (SSPE)" |
| rki.demis.disease#2.2.3 | evidenceSTYD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Typhus" |
| rki.demis.disease#2.2.3 | evidenceSXXD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
| rki.demis.disease#2.2.3 | evidenceVCHD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Cholera" |
| rki.demis.disease#2.2.3 | evidenceVZWD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Windpocken" |
| rki.demis.disease#2.2.3 | evidenceVZZD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Herpes Zoster" |
| rki.demis.disease#2.2.3 | evidenceYPSD | Symptome und Manifestationen in Bezug auf den Meldetatbestand "Pest" |
| rki.demis.disease#2.2.3 | vaccineBAND | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Milzbrand" |
| rki.demis.disease#2.2.3 | vaccineBPSD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Keuchhusten" |
| rki.demis.disease#2.2.3 | vaccineCDFD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
| rki.demis.disease#2.2.3 | vaccineCORD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Diphtherie" |
| rki.demis.disease#2.2.3 | vaccineCVDD-SNOMED | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" als SNOMED-Code |
| rki.demis.disease#2.2.3 | vaccineDEND | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Denguefieber" |
| rki.demis.disease#2.2.3 | vaccineEBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Ebolafieber" |
| rki.demis.disease#2.2.3 | vaccineGFVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Gelbfieber" |
| rki.demis.disease#2.2.3 | vaccineHAVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis A" |
| rki.demis.disease#2.2.3 | vaccineHBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis B" |
| rki.demis.disease#2.2.3 | vaccineHDVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis D" |
| rki.demis.disease#2.2.3 | vaccineHEVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis E" |
| rki.demis.disease#2.2.3 | vaccineHXXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Akute Virushepatitis" |
| rki.demis.disease#2.2.3 | vaccineIZVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Zoonotische Influenza" |
| rki.demis.disease#2.2.3 | vaccineMPVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mumps" |
| rki.demis.disease#2.2.3 | vaccineMPXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mpox" |
| rki.demis.disease#2.2.3 | vaccineMSVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Masern" |
| rki.demis.disease#2.2.3 | vaccineMYTD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tuberkulose" |
| rki.demis.disease#2.2.3 | vaccineNEID | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Meningokokken, invasive Erkrankung" |
| rki.demis.disease#2.2.3 | vaccinePKVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Pocken" |
| rki.demis.disease#2.2.3 | vaccinePOVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Poliomyelitis" |
| rki.demis.disease#2.2.3 | vaccineRBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwut" |
| rki.demis.disease#2.2.3 | vaccineRUVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Röteln, postnatal" |
| rki.demis.disease#2.2.3 | vaccineSSPD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Subakute sklerosierende Panenzephalitis (SSPE)" |
| rki.demis.disease#2.2.3 | vaccineSTYD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Typhus" |
| rki.demis.disease#2.2.3 | vaccineSXXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
| rki.demis.disease#2.2.3 | vaccineTTVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwutexpositionsverdacht" |
| rki.demis.disease#2.2.3 | vaccineVCHD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Cholera" |
| rki.demis.disease#2.2.3 | vaccineVZWD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Windpocken" |
| rki.demis.disease#2.2.3 | vaccineVZZD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Herpes Zoster" |
| de.gematik.isik-basismodul#3.1.1 | DiagnosesSCT | DiagnosesSCT |
| de.gematik.isik-basismodul#3.1.1 | ProzedurenCodesSCT | ProzedurenCodesSCT |
| de.gematik.isik-basismodul#3.1.1 | ProzedurenKategorieSCT | ProzedurenKategorieSCT |
| hl7.fhir.uv.xver-r5.r4b#0.1.0 | R5-v3-AllergyStatus-for-R4B | Cross-version ValueSet R5.AllergyStatus for use in FHIR R4B |
| hl7.fhir.uv.xver-r5.r4b#0.1.0 | R5-v3-KnowledgeSubtopicObservationValue-for-R4B | Cross-version ValueSet R5.KnowledgeSubtopicObservationValue for use in FHIR R4B |
| hl7.fhir.uv.xver-r5.r4b#0.1.0 | R5-v3-ObservationMeasureCountableItems-for-R4B | Cross-version ValueSet R5.ObservationMeasureCountableItems for use in FHIR R4B |
| hl7.fhir.uv.xver-r5.r4b#0.1.0 | R5-v3-immunizationForecastStatusObservationValue-for-R4B | Cross-version ValueSet R5.ImmunizationForecastStatusObservationValue for use in FHIR R4B |
| nictiz.fhir.nl.stu3.bgz#2.0.3 | 2.16.840.1.113883.2.4.3.11.60.42.11.3--20241004140515 | StatusCategorieCodelijst |
| nictiz.fhir.nl.stu3.bgz#2.0.3 | 2.16.840.1.113883.2.4.3.11.60.42.11.2--20241003115148 | VerrichtingCategorieCodelijst |
| de.gematik.isik-basismodul-stufe1#1.0.10 | DiagnosesSCT | DiagnosesSCT |
| de.gematik.isik-basismodul-stufe1#1.0.10 | ProzedurenCodesSCT | ProzedurenCodesSCT |
| de.gematik.isik-basismodul-stufe1#1.0.10 | ProzedurenKategorieSCT | ProzedurenKategorieSCT |
| fhir.r4.nhsengland.stu1#1.5.0 | England-ChildProtectionPlan | England Child Protection Plan |
| ca.on.erec.r4#1.0.0-TU-snapshot1 | procedure-code | Procedure Code |
| kl.dk.fhir.term#2.4.0 | KLComplicationCodesSCT | KLKomplikationskoderSCT |
| kl.dk.fhir.term#2.4.0 | KLEvaluationTypeCodesSCT | KLVurderingTypekoderSCT |
| kl.dk.fhir.term#2.4.0 | KLObservationCodes | KLObservationskoder |
| ca.infoway.io.erec#1.3.0-dft-preBallot | CA-eReC-Referral-Type | Differentiates service requests between a referral and a consult |
| hl7.fhir.uv.xver-r3.r4b#0.1.0 | R3-questionnaire-category-for-R4B | Cross-version ValueSet STU3.Questionnaire Category Codes for use in FHIR R4B |
| tw.cathay.fhir.imri#1.0.0 | anesthesia-sct | SNOMED CT Anesthesia值集 |
| tw.cathay.fhir.imri#1.0.0 | mcode-cancer-stage-type | mCode Cancer Stage Type值集 |
| tw.cathay.fhir.imri#1.0.0 | mcode-cancer-stage | mCode Cancer Stage值集 |
| tw.cathay.fhir.imri#1.0.0 | physical-examination-sct | SNOMED CT Physical Examination值集 |
| de.medizininformatikinitiative.kerndatensatz.molgen#2026.0.4 | mii-vs-molgen-familiaere-linie | MII VS MolGen Familiäre Linie |
| de.medizininformatikinitiative.kerndatensatz.molgen#2026.0.4 | mii-vs-molgen-family-member-snomed | MII VS MolGen Family Member SNOMED |
| de.medizininformatikinitiative.kerndatensatz.molgen#2026.0.4 | mii-vs-molgen-verwandtschaftsgrad | MII VS Mol Gen Verwandtschaftsgrad |
| de.medizininformatikinitiative.kerndatensatz.molgen#2026.0.4 | mii-vs-molgen-verwandtschaftsverhaeltnis | MII VS MolGen Verwandtschaftsverhaeltnis |
| who.ddcc#1.0.1 | LabTestPathogenCovid19SnomedValueSet | Lab Test - Pathogen - COVID-19 - SNOMED CT |
| who.ddcc#1.0.1 | LabTestQualitativeResultSnomedValueSet | Lab Test - Qualitative Result - SNOMED CT |
| who.ddcc#1.0.1 | VaccineCovid19SnomedValueSet | Vaccine - COVID-19 - SNOMED CT |
| nictiz.fhir.nl.r4.immunization#2.1.0-alpha.2 | 2.16.840.1.113883.2.4.3.11.60.131.11.6--20240417113339 | ProductCodeSNOMEDCTCodeLijst |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-bodysite-observation-beatmung | MII VS ICU BodySite Observation Beatmung |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-bodysite-observation-blutdruck | MII VS ICU BodySite Observation Blutdruck |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-bodysite-observation-extrakorporale-verfahren | MII VS ICU BodySite Observation extrakorporale Verfahren |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-bodysite-observation-monitoring-und-vitaldaten | MII VS ICU BodySite Observation Monitoring und Vitaldaten |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | cam-icu-result | MII VS ICU CAM-ICU Result |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-category-procedure-beatmung-snomed | MII VS ICU Category Procedure Beatmung SNOMED |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-code-extrakorporale-verfahren | MII VS ICU Code Extrakorporale Verfahren |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-code-monitoring-und-vitaldaten-snomed | MII VS ICU Code Monitoring und Vitaldaten SNOMED |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-code-observation-beatmung-snomed | MII VS ICU Code Observation Beatmung SNOMED |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-code-observation-bilanzen-snomed | MII VS ICU Code Observation Bilanzen SNOMED |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-code-observation-extrakorporale-verfahren-snomed | MII VS ICU Code Observation extrakorporale Verfahren SNOMED |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-code-observation-pupillengroesse | MII VS ICU Code Observation Pupillengroesse |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-code-observation-pupillensymmetrie | MII VS ICU Code Observation Pupillensymmetrie |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-code-procedure-beatmung-snomed | MII VS ICU Code Procedure Beatmung SNOMED |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-devicemetric-extrakorporale-verfahren | MII VS ICU DeviceMetric extrakorporale Verfahren |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | mii-vs-icu-method-observation-blutdruck | MII VS ICU Method Observation Blutdruck |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | present-absent | MII VS ICU Present Absent |
| de.medizininformatikinitiative.kerndatensatz.icu#2026.0.2 | score-category | MII VS ICU Score Category |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-act-procedure-code | NxhVSActProcedureCode |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-arts-supervisor | NxhVSArtsSupervisor |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-colonisatie-organisme | NxhVSColonisatieOrganisme |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-snomed | NxhVSSnomed |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-toedieningsweg | NxhVSToedieningsweg |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-type-uitvoerder | NxhVSTypeUitvoerder |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-allergy-intolerance-code | NxhVSAllergyIntoleranceCode |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-allergy-intolerance-reaction-manifestations | NxhVSAllergyIntoleranceReactionManifestations |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-body-sites | NxhVSBodySites |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-nxh-vs-care-observation-code | NxhVSCareObservationCodes |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-clark-scale | NxhVSClarkScale |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-contact-relationship | NxhVSContactRelationship |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-dnr-besproken | NxhVSDNRBesproken |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-gleason-score | NxhVSGleasonScore |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-moc-therapy | NxhVSMocTherapy |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-tnm-differentiation | NxhVSTNMDifferentiation |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-tnm-stages | NxhVSTNMStages |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-verslag-type | NxhVSVerslagType |
| nexuzhealth.fhir.r4#1.0.5 | nxh-vs-yes-no | NxhVSYesNo |
| ca.on.oh.mha.pds#2.0.0-alpha-preview-0.1 | religion-and-spiritual-affiliation | ReligionAndSpiritualAffiliation |
| tw.gov.mohw.cdc.twidir#0.1.0 | snomedct-methodtype-values | 檢驗方法值集 |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetCHTP | AnswerSet für Chlamydia trachomatis, sofern es sich um einen der Serotypen L1 bis L3 handelt |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetECHP | AnswerSet für Echinococcus sp. |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetHIVP | AnswerSet für Humanes Immundefizienz-Virus (HIV) |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetLaboratoryTest-SNOMED | SNOMED-AnswerSet für Labortest |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetNCVP | AnswerSet für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetNEGP | AnswerSet für Neisseria gonorrhoeae |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetResistance-SNOMED | SNOMED-AnswerSet für Resistenz |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetTOXP | AnswerSet für Toxoplasma gondii; Meldepflicht nur bei konnatalen Infektionen |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetTRPP | AnswerSet für Treponema pallidum |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetWBKP | AnswerSet für Krankheitserreger unter Berücksichtigung der Art der Krankheitserreger und der Häufigkeit ihres Nachweises wenn Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit bestehen |
| rki.demis.laboratory.strict#5.0.0-rc.1 | interpretation-SNOMED | SNOMED-Interpretation des Testergebnisses |
| rki.demis.laboratory.strict#5.0.0-rc.1 | materialCHTP | Material für Chlamydia trachomatis, sofern es sich um einen der Serotypen L1 bis L3 handelt |
| rki.demis.laboratory.strict#5.0.0-rc.1 | materialECHP | Material für Echinococcus sp. |
| rki.demis.laboratory.strict#5.0.0-rc.1 | materialHIVP | Material für Humanes Immundefizienz-Virus (HIV) |
| rki.demis.laboratory.strict#5.0.0-rc.1 | materialNCVP | Material für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 |
| rki.demis.laboratory.strict#5.0.0-rc.1 | materialNEGP | Material für Neisseria gonorrhoeae |
| rki.demis.laboratory.strict#5.0.0-rc.1 | materialTOXP | Material für Toxoplasma gondii; Meldepflicht nur bei konnatalen Infektionen |
| rki.demis.laboratory.strict#5.0.0-rc.1 | materialTRPP | Material für Treponema pallidum |
| rki.demis.laboratory.strict#5.0.0-rc.1 | methodCombined | Nachweismethode (Kombiniert) |
| rki.demis.laboratory.strict#5.0.0-rc.1 | reasonForTesting | Untersuchungsgrund |
| rki.demis.laboratory.strict#5.0.0-rc.1 | substanceHIVP | Analyt-Set für Humanes Immundefizienz-Virus (HIV) |
| rki.demis.laboratory.strict#5.0.0-rc.1 | substanceTRPP | Analyt-Set für Treponema pallidum |
| rki.demis.laboratory.strict#5.0.0-rc.1 | answerSetPathogenCombined | AnswerSet aller spezifischen AnswerSet-ValueSets (Kombiniert) |
| rki.demis.laboratory.strict#5.0.0-rc.1 | materialCombined | Material (Kombiniert) |
| ch.fhir.ig.ch-rad-order#2.0.1 | ch-rad-order-caveat-condition | Caveat Condition |
| ch.fhir.ig.ch-rad-order#2.0.1 | ch-rad-order-caveat-device | Caveat Device |
| ch.fhir.ig.ch-rad-order#2.0.1 | ch-rad-order-caveat-qualifier-value | Qualifier Value |
| ch.fhir.ig.ch-rad-order#2.0.1 | ch-rad-order-caveat-type | Type of Caveat |
| koppeltaalv2.00#0.16.2 | koppeltaal-practitioner-role | Koppeltaal Practitioner Role ValueSet |
| koppeltaalv2.00#0.16.2 | koppeltaal-relatedperson-role | Koppeltaal RelatedPerson Role ValueSet |
| il.core.fhir.r4#0.21.0 | diagnostic-conclusion-code | Diagnostic Conclusion Codes |
| il.core.fhir.r4#0.21.0 | il-core-body-position | IL Core Body Position |
| il.core.fhir.r4#0.21.0 | il-core-device-type | IL Core Device Type codes |
| il.core.fhir.r4#0.21.0 | il-core-diagnosis-role | IL Core Diagnosis Role |
| il.core.fhir.r4#0.21.0 | il-core-drug-allergy-codes | IL Core Drug Allergy Codes |
| il.core.fhir.r4#0.21.0 | il-core-encounter-type | IL Core Encounter Type |
| il.core.fhir.r4#0.21.0 | il-core-medication-administration-code | IL Core Medication Administration Code |
| il.core.fhir.r4#0.21.0 | il-core-medication-dose-form | IL Core Medication Dose Form |
| il.core.fhir.r4#0.21.0 | il-core-non-drug-allergy-codes | IL Core Non-Drug Allergy Codes |
| il.core.fhir.r4#0.21.0 | il-core-specimen-type | IL Core Specimen type |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-reason-for-provenance | Händelseorsak |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-medical-device | Medicinteknisk produkt vid läkemedelsadministrering |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-method | Administreringsmetod |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-qualifier | Precisering av administreringsställe |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-rate-unit | Snomed CT Doseringshastighetsenhet |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-reason-for-change | Ändringsorsak |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-route | Administreringsväg |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-site | Administreringsställe |
| se.electronichealth.fhir.nll.r4#1.2.0 | nll-snomed-unit | Snomed CT Dosenhet |
| ca.infoway.io.core#1.2.0-dft-1 | visitmodalitycode | VisitModalityCode |
| ca.infoway.io.core#1.2.0-dft-1 | genderidentityvaluecode | Gender Identity Value Set |
| ca.infoway.io.core#1.2.0-dft-1 | genderusedvaluecode | Gender Used Value Set |
| ca.infoway.io.core#1.2.0-dft-1 | prescriptiondrugform | PrescribeIT Prescription Drug Form |
| ca.infoway.io.core#1.2.0-dft-1 | racializedgroupcode | Racialized Group Code |
| ca.infoway.io.core#1.2.0-dft-1 | sexassignedatbirth | Sex assigned at Birth |
| ca.infoway.io.core#1.2.0-dft-1 | sexualorientationcode | Sex Orientation Value Set |
| ca.infoway.io.core#1.2.0-dft-1 | socialhistory | Social History |
| ca.infoway.io.core#1.2.0-dft-1 | substancecode | Substance Code |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20200901000000 | AfnameprocedureCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000 | AlcoholGebruikStatusCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000 | AlertNaamCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20200901000000 | AllergieCategorieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20200901000000 | BestemmingCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.3--20200901000000 | BrandwondSoortCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.12.6--20200901000000 | CommunicatieBijzonderhedenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.8.6--20200901000000 | ConditiesTijdensMetingCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.9--20200901000000 | ContainerTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.1.1--20200901000000 | DecubitusCategorieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.15.5--20200901000000 | DefecatieKleurCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.2--20200901000000 | DiastolischEindpuntCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.4.1--20200901000000 | DieptegraadCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.2--20200901000000 | DrinkBeperkingenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.8.1--20200901000000 | DrinkenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20200901000000 | DrugsGebruikStatusCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20200901000000 | DrugsOfGeneesmiddelSoortCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.2--20200901000000 | EetBeperkingenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.6--20200901000000 | ErnstCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.7.1--20200901000000 | EtenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.15.1--20200901000000 | FecesContinentieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.2--20200901000000 | HartslagMeetMethodeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.1--20200901000000 | HartslagRegelmatigheidCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.15.1.2--20200901000000 | HerkomstCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.1--20200901000000 | HoorFunctieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.2--20200901000000 | HorenHulpmiddelTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.5--20200901000000 | HoudingCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.4--20200901000000 | HoudingHandhavenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.1--20200901000000 | HoudingVeranderenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.3.3--20200901000000 | InterpretatieFrequentieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.7--20200901000000 | InterpretatieVlaggenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.2.4--20200901000000 | InterventieSnomedCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.20.2--20200901000000 | LateraliteitCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20200901000000 | LevensovertuigingCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.20.7.1--20200901000000 | LocatieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.17.3--20200901000000 | LocatieGehoorapparaatCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.9--20200901000000 | LopenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.4--20200901000000 | MateVanKritiekZijnCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.4--20200901000000 | MeetLocatieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.4.1--20200901000000 | MeetmethodeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.10--20200901000000 | MicroorganismeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.6--20200901000000 | MonstermateriaalCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.13--20200901000000 | MorfologieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.3--20200901000000 | OntwikkelingMotoriekCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.4--20200901000000 | OntwikkelingSociaalCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.5--20200901000000 | OntwikkelingTaalCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.6--20200901000000 | OntwikkelingVerstandelijkCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.7.1--20200901000000 | PolsRegelmatigheidCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.2.1--20200901000000 | PositieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.3--20200901000000 | ProbleemNaamCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.2--20200901000000 | ProbleemStatusCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.1--20200901000000 | ProbleemTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.10.1.1--20200901000000 | ProductTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.13.2--20200901000000 | ProtheseTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.20.1--20200901000000 | RefractieMeetMethodeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.1--20200901000000 | ResultaatTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.29.4--20200901000000 | SNAQrcHulpBijEtenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.6.2--20200901000000 | SOEPRegelNaamCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.14.1--20200901000000 | SchedelomvangMeetmethodeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.3.1--20200901000000 | SoortAandoeningCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.3.2.1--20200901000000 | SoortHulpCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20200901000000 | SoortTabakGebruikCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.16--20200901000000 | SpecifiekeStofAllergeneStoffenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.4--20200901000000 | StatusNaamSnomedCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.26.8--20200901000000 | StatusWaardeSnomedCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20200901000000 | StomaTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20200901000000 | SymptoomCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20200901000000 | TabakGebruikStatusCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.2--20200901000000 | TeKledenLichaamsdeelCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.2--20200901000000 | TeWassenLichaamsdeelCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.2.1--20200901000000 | TekstUitslagTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.6.1--20200901000000 | TemperatuurTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.13.1.4--20200901000000 | TestmethodeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.22.4--20200901000000 | ToiletgebruikCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.12--20200901000000 | TraplopenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.33.1--20200901000000 | UiterlijkeVerzorgingCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.3.7--20200901000000 | UitvoerenTransferCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.5.1.4--20200901000000 | VerificatieStatusCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.17--20200901000000 | VeroorzakendeStofAllergeneStoffenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.4--20200901000000 | VerrichtingMethodeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.2--20200901000000 | VerrichtingTypeDHDCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.14.1.7--20200901000000 | VerrichtingTypeGGZCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.13.1--20200901000000 | VerzorgenTandenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.19.4--20200901000000 | VisusMeetHulpmiddelCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.12.19.2--20200901000000 | VisusMetingTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.31.2--20200901000000 | VoedingMethodeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.31.1--20200901000000 | VoedingSoortCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.8.2.12--20200901000000 | WijzeVanBlootstellingCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.7--20200901000000 | WondDrainTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.5--20200901000000 | WondRandCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.19.2.4--20200901000000 | WondSoortCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.8.2--20200901000000 | WoningAanpassingCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.7.8.3--20200901000000 | WoonOmstandigheidCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.11.1--20200901000000 | ZichKledenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.10.1--20200901000000 | ZichWassenCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.16.2--20200901000000 | ZienHulpmiddelTypeCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.2--20200901000000 | ZindelijkheidFecesCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.32.1--20200901000000 | ZindelijkheidUrineCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.4.22.3--20200901000000 | ZorgBijMenstruatieCodelijst |
| nictiz.fhir.nl.r4.zib2020#0.12.0-labtrial.1 | 2.16.840.1.113883.2.4.3.11.60.40.2.17.1.5--20200901000000 | ZorgverlenerRolCodelijst |
| hl7.fhir.us.vitalsigns#0.1.0 | bodyTempMeasMethodDeviceVS | Body Temperature Measurement Method Device value set |
| hl7.fhir.us.vitalsigns#0.1.0 | bodyWeightMeasurementAssociatedPrecondVS | Body Weight Measurement Associated Precondition value set |
| hl7.fhir.us.vitalsigns#0.1.0 | bpMeasDeviceCSVS | Blood Pressure Measurement Device and Cuff Size value set |
| hl7.fhir.us.vitalsigns#0.1.0 | clothingWornDuringMeasureVS | Clothing Worn During Measure value set |
| rki.emiga.common#1.2.0-alpha.25 | YesNoNullFlavor | Ja, Nein, Nicht ermittelbar, Nicht erhoben Antworten |
| medmij.fhir.nl.r4.core#1.1.0 | ASAScore | ASAScore ValueSet. |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-vs-biobank-body-structures-sct | MII VS Biobank BodyStructures SCT |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-vs-biobank-cellline-morphology-sct | MII VS Biobank Cellinie Morphology SCT |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-vs-biobank-cellline-proliferation | MII VS Biobank Proliferation Zellinie |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-vs-biobank-containertyp-sct | MII VS Biobank Containertyp SCT |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-vs-biobank-karyotyp-sct | MII VS Biobank Karyotyp SCT |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-vs-biobank-laboratory-procedure-sct | MII VS Biobank Laboratory Procedure SCT |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-vs-biobank-probenart-sct | MII VS Biobank Probenart SCT |
| de.medizininformatikinitiative.kerndatensatz.biobank#2026.0.1 | mii-vs-biobank-substance-additive-sct | MII VS Biobank Substance Additive |
| ch.fhir.ig.ch-ig#1.2.3 | sct | CH IG SNOMED CT |
| de.medizininformatikinitiative.kerndatensatz.mtb#2026.0.1 | mii-vs-mtb-immunohistochemistry-specific-codes | MII VS MTB Immunhistochemistry Specific Codes |
| de.medizininformatikinitiative.kerndatensatz.mtb#2026.0.1 | mii-vs-mtb-ish-method | MII VS MTB ISH Method |
| de.medizininformatikinitiative.kerndatensatz.mtb#2026.0.1 | mii-vs-mtb-tumorausbreitung | MII VS Tumorausbreitung |
| de.medizininformatikinitiative.kerndatensatz.mtb#2026.0.1 | mii-vs-mtb-who-grad-tumor-zns | MII VS WHO Grad Tumor ZNS |
| fhir.argonaut.scheduling#1.0.0 | sct-services | Argonaut Snomed CT Services |
| fhir.argonaut.scheduling#1.0.0 | specialty | Argonaut Scheduling Specialties |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Advance_Directive_Status | Information Persönliche Erklärung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Allergies | Vorliegen Allergien |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Assessment_Scales | Assessment |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Behavior_Finding | Auffälliges Verhalten |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Bladder_Continence_Status | Harnkontinenz differenzierte Einschätzung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Bowel_Continence_Status | Stuhlkontinenz differenzierte Einschätzung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Cognitive_Awareness | Bewusstseinslage |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Constraint_Control_Seclusion | Freiheitsentziehende Maßnahmen |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Diagnosis_ICNP | Pflegeproblem/Pflegediagnose ICNP |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Disability | Einschränkung Funktionen |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Disability_Degree_Presence_Status | Grad Behinderung vorhanden |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Evacuation_Bladder_Content | Art der Harnableitung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Evacuation_Intestinal_Contents | Art der Stuhlableitung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Food_Administration_Form | Kostdarreichungsform |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Food_Type | Kostform |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Health_Care_Proxy_Type | Art der Erklärung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Information_Legal_Guardian | Information gesetzliche Betreuung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Information_Medication | Information Einnahme Medikamente |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Interventions_ICNP | Pflegerische Maßnahmen ICNP |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Isolation_Necessity | Isolation Notwendig |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Isolation_Type | Isolation Art |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Living_Condition | Wohnverhältnis |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Medical_Device | Medizinprodukt |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Medical_Product_Information | Information Medizinprodukt |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Nutrition | Ernährung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Nutritional_Information | Hinweis Ernährung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Orientation_Person | Orientierung Person |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Orientation_Place | Orientierung Ort |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Orientation_Situation | Orientierung Situation |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Orientation_Time | Orientierung Zeit |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Pain_Symptom | Schmerzsymptomatik |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Payment_Exemption | Zuzahlungsbefreiung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Presence_Respiratory_Support | Vorliegen Atmungsunterstützung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Problem_Presence | Vorliegen Problem |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Relatives_Involvement | Pflege durch Angehörige |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Relatives_Notification_Status | Benachrichtigung von An- und Zugehörigen |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Respiratory_Access | Art der Luftleitung |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Result_Qualitative | Ergebnis Qualitativ |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Risk | Risiko |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Risk_Presence | Vorliegen von Risiken |
| kbv.mio.ueberleitungsbogen#1.0.0 | KBV_VS_MIO_ULB_Type_Of_Facility | Typ der Einrichtung |
| ehealth4u.package#1.0.0 | cyehr-vs-cypdisunitintakeresult | Cyprus EHR Value Set: CYPDIS Unit Intake Result |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsiadverseeventtype | Cyprus EHR Value Set: eHDSI Adverse Event Type |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsiallergennodrug | Cyprus EHR Value Set: eHDSI Allergen No Drug |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsibloodgroup | Cyprus EHR Value Set: eHDSI Blood Group |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsicodeprob | Cyprus EHR Value Set: eHDSI Code Prob |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsimedicaldevice | Cyprus EHR Value Set: eHDSI Medical Device |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsiprocedure | Cyprus EHR Value Set: eHDSI Procedure |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsireactionallergy | Cyprus EHR Value Set: eHDSI Reaction Allergy |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsiresolutionoutcome | Cyprus EHR Value Set: eHDSI Resolution Outcome |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsiseverity | Cyprus EHR Value Set: eHDSI Severity |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsisocialhistory | Cyprus EHR Value Set: eHDSI Social History |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsistatuscode | Cyprus EHR Value Set: eHDSI Status Code |
| ehealth4u.package#1.0.0 | cyehr-vs-ehdsivaccine | Cyprys EHR Value Set: eHDSI Vaccine |
| ehealth4u.package#1.0.0 | cyehr-vs-nursingcategories | Cyprus EHR Value Set: Nursing Categories |
| ehealth4u.package#1.0.0 | cyehr-vs-contactpersonlevel | Cyprus EHR Value Set: Contact Person Level |
| ehealth4u.package#1.0.0 | cyehr-vs-diet | Cyprus EHR Value Set: Diet |
| ehealth4u.package#1.0.0 | cyehr-vs-drugormedicationtype | Cyprus EHR Value Set: Drug Or Medication Type |
| ehealth4u.package#1.0.0 | cyehr-vs-drugusestatus | Cyprus EHR Value Set: Drug Use Status |
| ehealth4u.package#1.0.0 | cyehr-vs-findingrelatedtosleep | Cyprus EHR Value Set: Finding Related To Sleep |
| ehealth4u.package#1.0.0 | cyehr-vs-respiratoryrhythm | Cyprus EHR Value Set: Respiratory Rhythm |
| ehealth4u.package#1.0.0 | cyehr-vs-tobaccotype | Cyprus EHR Value Set: Tobacco Type |
| ehealth4u.package#1.0.0 | cyehr-vs-heartrhythm | Cyprus EHR Value Set: Heart Rhythm |
| ehealth4u.package#1.0.0 | cyehr-vs-alcoholstatus | Cyprus EHR Value Set: Alcohol Status |
| ehealth4u.package#1.0.0 | cyehr-vs-alcoholtypes | Cyprus EHR Value Set: Alcohol Types |
| hl7.fhir.uv.xver-r2.r5#0.1.0 | R2-bodysite-relative-location-for-R5 | Cross-version ValueSet DSTU2.Bodysite Location Modifier for use in FHIR R5 |
| hl7.fhir.uv.xver-r2.r5#0.1.0 | R2-daf-observation-ccdasmokingstatus-for-R5 | Cross-version ValueSet DSTU2.Smoking Status for use in FHIR R5 |
| hl7.fhir.uv.xver-r2.r5#0.1.0 | R2-diagnostic-order-event-for-R5 | Cross-version ValueSet DSTU2.Diagnostic Order Event Codes for use in FHIR R5 |
| hl7.fhir.uv.xver-r2.r5#0.1.0 | R2-focal-subject-for-R5 | Cross-version ValueSet DSTU2.Focal Subject Codes for use in FHIR R5 |
| hl7.fhir.uv.xver-r2.r5#0.1.0 | R2-investigation-sets-for-R5 | Cross-version ValueSet DSTU2.Condition/Diagnosis Certainty for use in FHIR R5 |
| hl7.fhir.uv.xver-r2.r5#0.1.0 | R2-questionnaire-category-for-R5 | Cross-version ValueSet DSTU2.Questionnaire Category Codes for use in FHIR R5 |
| hl7.fhir.uv.xver-r2.r5#0.1.0 | R2-vaccination-protocol-dose-target-for-R5 | Cross-version ValueSet DSTU2.Vaccination Protocol Dose Target Codes for use in FHIR R5 |
| hl7.fhir.uv.xver-r2.r4#0.1.0 | R2-bodysite-relative-location-for-R4 | Cross-version ValueSet DSTU2.Bodysite Location Modifier for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4#0.1.0 | R2-daf-observation-ccdasmokingstatus-for-R4 | Cross-version ValueSet DSTU2.Smoking Status for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4#0.1.0 | R2-diagnostic-order-event-for-R4 | Cross-version ValueSet DSTU2.Diagnostic Order Event Codes for use in FHIR R4 |
| hl7.fhir.uv.xver-r2.r4#0.1.0 | R2-vaccination-protocol-dose-target-for-R4 | Cross-version ValueSet DSTU2.Vaccination Protocol Dose Target Codes for use in FHIR R4 |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-allergene-snomedct | MII VS Kardio Allergene [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-atherosklerotisches-ereignis-snomedct | MII VS Kardio Atherosklerotisches Ereignis [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-ausschlusskriterium-acribis-scores | MII VS Kardio Ausschlusskriterium ACRIBiS Scores |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-ekg-prozedur-snomedct | MII VS Kardio EKG Prozedur [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-ethnie-snomedct | MII VS Kardio Ethnie [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-extended-condition-severity-snomedct | MII VS Kardio Extended Condition Severity [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-extended-mii-diagnosecodes-snomed | MII VS Kardio Extended MII DiagnoseCodes [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-geraetetyp-snomedct | MII VS Kardio Gerätetyp [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-gewichtsveraenderung-snomedct | MII VS Kardio Gewichtsveraenderung [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-kardiale-deviceimplantation-koerperstelle-snomedct | MII VS Kardio Kardiale Devicemimplantation Körperstelle [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-kardiale-deviceimplantation-scnomedct | MII VS Kardio Kardiale Devicemimplantation [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-klappenvitium-grad-snomedct | MII VS Kardio Klappenvitium Grad [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-klappenvitium-snomedct | MII VS Kardio Klappenvitium [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-nyha-klassen-snomedct | MII VS Kardio NYHA Klassen [SNOMED CT] |
| de.medizininformatikinitiative.kerndatensatz.kardiologie#2026.0.0-alpha.3 | mii-vs-kardio-rauchen-acribisalpha | MII VS Kardio Rauchen AcribisAlpha |
| ca.qc.sq.sgrdv#1.1.3 | sgrdv-specialty-vs | Types de professionnel SGRDV |
| fhir.r4.wales#2.4.0 | PASReferralSource | PAS Referral Source |
| rambam-fhir.health.gov.il#0.3.2 | diag-gen-attrib | Diagnosis General Attributes |
| ca.on.mi.r4#1.0.0-snapshot6 | mi-category-type | Medical Imaging Category Type |
| hl7.fhir.uv.xver-r4b.r5#0.1.0 | R4B-animal-breeds-for-R5 | Cross-version ValueSet R4B.AnimalBreeds for use in FHIR R5 |
| hl7.fhir.uv.xver-r4b.r5#0.1.0 | R4B-animal-species-for-R5 | Cross-version ValueSet R4B.AnimalSpecies for use in FHIR R5 |
| hl7.fhir.uv.xver-r4b.r5#0.1.0 | R4B-focal-subject-for-R5 | Cross-version ValueSet R4B.FocalSubjectCodes for use in FHIR R5 |
| hl7.fhir.kr.core#2.0.0 | krcore-snomed-ct-codes | KR Core SNOMED CT Codes |
| de.netzwerk-universitaetsmedizin.ebm-cpg#1.2.0 | vs-allergic-disposition-sct | Allergic Disposition SCT |
| de.netzwerk-universitaetsmedizin.ebm-cpg#1.2.0 | vs-assessment-scales | Assessment Scales |
| de.netzwerk-universitaetsmedizin.ebm-cpg#1.2.0 | vs-assessment | Assessment |
| de.netzwerk-universitaetsmedizin.ebm-cpg#1.2.0 | vs-body-positioning-snomed | Body Positioning SNOMED CT |
| de.netzwerk-universitaetsmedizin.ebm-cpg#1.2.0 | vs-drugs | Drugs |
| de.netzwerk-universitaetsmedizin.ebm-cpg#1.2.0 | vs-observations | Observations |
| de.netzwerk-universitaetsmedizin.ebm-cpg#1.2.0 | vs-procedures | Procedures |
| de.netzwerk-universitaetsmedizin.ebm-cpg#1.2.0 | vs-radiologic-finding-sct | Radiologic Finding SCT |
| de.netzwerk-universitaetsmedizin.ebm-cpg#1.2.0 | vs-substances-snomed | Substances SNOMED CT |
| ch.fhir.ig.ch-lab-order#3.0.0 | MicrobiolProcedures | Microbiological Procedure |
| ch.fhir.ig.ch-lab-order#3.0.0 | reasons-for-order | All Valid Reasons for Ordering a Lab Service |
| digidot.ny#0.2.6 | dental-conditions | Dental conditions and findings (SNOMED CT) |
| digidot.ny#0.2.6 | dental-procedures | Dental procedures (SNOMED CT) |
| digidot.ny#0.2.6 | sct-pre-dental | VS_SCT_Pre_Dental |
| digidot.ny#0.2.6 | teeth | Teeth (SNOMED CT) |
| digidot.ny#0.2.6 | tooth-surfaces | Tooth surfaces (SNOMED CT) |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-activity-reason-for-R4B | Cross-version VS for R2.Activity Reason for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-allergyintolerance-substance-code-for-R4B | Cross-version VS for R2.AllergyIntolerance Substance and Negation Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-approach-site-codes-for-R4B | Cross-version VS for R2.SNOMED CT Anatomical Structure for Administration Site Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-body-site-for-R4B | Cross-version VS for R2.SNOMED CT Body Structures for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-bodysite-laterality-for-R4B | Cross-version VS for R2.Laterality for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-bodysite-relative-location-for-R4B | Cross-version VS for R2.Bodysite Location Modifier for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-c80-facilitycodes-for-R4B | Cross-version VS for R2.Facility Type Code Value Set for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-c80-practice-codes-for-R4B | Cross-version VS for R2.Practice Setting Code Value Set for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-care-plan-activity-for-R4B | Cross-version VS for R2.Care Plan Activity for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-care-plan-category-for-R4B | Cross-version VS for R2.Care Plan Category for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-clinical-findings-for-R4B | Cross-version VS for R2.SNOMED CT Clinical Findings for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-condition-cause-for-R4B | Cross-version VS for R2.Condition Cause Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-condition-code-for-R4B | Cross-version VS for R2.Condition/Problem/Diagnosis Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-condition-outcome-for-R4B | Cross-version VS for R2.Condition Outcome Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-condition-predecessor-for-R4B | Cross-version VS for R2.Condition Predecessor Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-condition-severity-for-R4B | Cross-version VS for R2.Condition/Diagnosis Severity for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-condition-stage-for-R4B | Cross-version VS for R2.Condition Stage for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-consistency-type-for-R4B | Cross-version VS for R2.Fluid Consistency Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-daf-bodysite-for-R4B | Cross-version VS for R2.Vaccine Administered Body Site for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-daf-encounter-reason-for-R4B | Cross-version VS for R2.DAF Encounter Diagnoses for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-daf-manifestation-ccda-codes-for-R4B | Cross-version VS for R2.Manifestation C-CDA codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-daf-observation-ccdasmokingstatus-for-R4B | Cross-version VS for R2.Smoking Status for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-daf-problem-for-R4B | Cross-version VS for R2.Problem Value Set for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-daf-procedure-type-for-R4B | Cross-version VS for R2.DAFProcedureType for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-daf-substance-for-R4B | Cross-version VS for R2.DAF Substance-Reactant for Intolerance and Negation Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-dataelement-sdccode-for-R4B | Cross-version VS for R2.DataElement SDC Concept for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-dataelement-sdcobjectclass-for-R4B | Cross-version VS for R2.DataElement SDC Object Class for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-dataelement-sdcobjectclassproperty-for-R4B | Cross-version VS for R2.DataElement SDC Object Class for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-designation-use-for-R4B | Cross-version VS for R2.Designation Use for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-diagnostic-order-event-for-R4B | Cross-version VS for R2.Diagnostic Order Event Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-diet-type-for-R4B | Cross-version VS for R2.Diet Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-digital-media-subtype-for-R4B | Cross-version VS for R2.Media SubType for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-encounter-reason-for-R4B | Cross-version VS for R2.Encounter Reason Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-entformula-type-for-R4B | Cross-version VS for R2.Enteral Formula Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-flag-code-for-R4B | Cross-version VS for R2.Flag Code for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-focal-subject-for-R4B | Cross-version VS for R2.Focal Subject Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-food-type-for-R4B | Cross-version VS for R2.Food Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-goal-start-event-for-R4B | Cross-version VS for R2.GoalStartEvent for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-immunization-reason-for-R4B | Cross-version VS for R2.Immunization Reason Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-investigation-sets-for-R4B | Cross-version VS for R2.Condition/Diagnosis Certainty for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-manifestation-codes-for-R4B | Cross-version VS for R2.SNOMED CT Clinical Findings for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-manifestation-or-symptom-for-R4B | Cross-version VS for R2.Manifestation and Symptom Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-media-view-for-R4B | Cross-version VS for R2.Media Collection View/Projection for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-medication-codes-for-R4B | Cross-version VS for R2.SNOMED CT Medication Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-medication-form-codes-for-R4B | Cross-version VS for R2.SNOMED CT Form Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-medication-package-form-codes-for-R4B | Cross-version VS for R2.SNOMED CT Form Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-modified-foodtype-for-R4B | Cross-version VS for R2.Texture Modified Food Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-no-immunization-reason-for-R4B | Cross-version VS for R2.Immunization Reasons for Not Immunizing Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-nutrient-code-for-R4B | Cross-version VS for R2.Nutrient Modifier Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-observation-methods-for-R4B | Cross-version VS for R2.Observation Methods for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-participant-role-for-R4B | Cross-version VS for R2.Participant Roles for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-performer-role-for-R4B | Cross-version VS for R2.Procedure Performer Role Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-procedure-category-for-R4B | Cross-version VS for R2.Procedure Category Codes (SNOMED CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-procedure-code-for-R4B | Cross-version VS for R2.Procedure Codes (SNOMED CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-procedure-followup-for-R4B | Cross-version VS for R2.Procedure Follow up Codes (SNOMED CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-procedure-not-performed-reason-for-R4B | Cross-version VS for R2.Procedure Not Performed Reason (SNOMED-CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-procedure-outcome-for-R4B | Cross-version VS for R2.Procedure Outcome Codes (SNOMED CT) for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-procedure-reason-for-R4B | Cross-version VS for R2.Procedure Reason Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-profile-code-for-R4B | Cross-version VS for R2.Structure Definition Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-allergyintolerance-reason-refuted-for-R4B | Cross-version VS for R2.Reasons for refuting allergy or intolerance codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-communication-reason-not-performed-for-R4B | Cross-version VS for R2.Communication reason not performed codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-condition-certainty-for-R4B | Cross-version VS for R2.Condition/Diagnosis Certainty for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-deviceuserequest-reason-rejected-for-R4B | Cross-version VS for R2.Reasons for rejecting device use request codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-diagnosticorder-reason-rejected-for-R4B | Cross-version VS for R2.Reasons for rejecting a diagnostic order for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-encounter-canceled-reason-for-R4B | Cross-version VS for R2.Reasons for canceled or refused encounter codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-encounter-condition-role-for-R4B | Cross-version VS for R2.SNOMED CT Qualifier For Type of Diagnosis Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-goal-reason-rejected-for-R4B | Cross-version VS for R2.Reasons for rejecting goal codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-medication-dose-type-for-R4B | Cross-version VS for R2.SNOMED CT Dosages Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-observation-body-position-for-R4B | Cross-version VS for R2.Body Position for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-patient-disability-for-R4B | Cross-version VS for R2.Disability Value Set for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-priority-for-R4B | Cross-version VS for R2.SNOMED CT Priorities Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-qicore-referralrequest-reason-rejected-for-R4B | Cross-version VS for R2.Reasons for rejecting a referral request for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-questionnaire-answers-for-R4B | Cross-version VS for R2.Questionnaire Answer Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-questionnaire-category-for-R4B | Cross-version VS for R2.Questionnaire Category Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-referencerange-meaning-for-R4B | Cross-version VS for R2.Observation Reference Range Meaning Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-route-codes-for-R4B | Cross-version VS for R2.SNOMED CT Route Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-sdcde-dataelement-sdccode-for-R4B | Cross-version VS for R2.DataElement SDC Concept for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-specimen-collection-method-for-R4B | Cross-version VS for R2.SpecimenCollectionMethod for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-specimen-container-type-for-R4B | Cross-version VS for R2.SpecimenContainer for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-substance-code-for-R4B | Cross-version VS for R2.Substance Code for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-substance-sct-for-R4B | Cross-version VS for R2.DAF SNOMED CT Substances Other Than Clinical Drugs for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-supplement-type-for-R4B | Cross-version VS for R2.Supplement Type Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-supplyrequest-when-for-R4B | Cross-version VS for R2.Supply Request When for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-texture-code-for-R4B | Cross-version VS for R2.Texture Modifier Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-uslab-clinical-findings-for-R4B | Cross-version VS for R2.SNOMED CT Clinical Findings for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-uslab-obs-codedresults-for-R4B | Cross-version VS for R2.SNOMED CT Codes for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-uslab-spec-bodysite-for-R4B | Cross-version VS for R2.USLab Specimen Body Site for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-uslab-spec-type-for-R4B | Cross-version VS for R2.USLab Specimen Type for use in FHIR R4B |
| hl7.fhir.uv.xver-r2.r4b.r4#0.0.1-snapshot-2 | R2-vaccination-protocol-dose-target-for-R4B | Cross-version VS for R2.Vaccination Protocol Dose Target Codes for use in FHIR R4B |
| ca.on.mi.pkg#0.9.0-beta-5-testing | mi-procedure-bodypart-sct | Medical Imaging Procedure Body Part. |
| ca.on.mi.pkg#0.9.0-beta-5-testing | mi-procedure-contrast-used | Medical Imaging Procedure Contrast Used |
| ca.on.mi.pkg#0.9.0-beta-5-testing | mi-procedure-laterality-sct | Medical Imaging Procedure Laterality - SNOMED CT |
| ca.on.mi.pkg#0.9.0-beta-5-testing | mi-procedure-specialty | Medical Imaging Procedure Specialty |
| ca.on.mi.pkg#0.9.0-beta-5-testing | mi-procedure-type-sct | Medical Imaging SNOMED CT Procedure Type |
| uk.nhsengland.genomics.r4#0.6.1-pre-release | genomics-FH-SNOMED-CT-codes | Genomics FH SNOMED CT Codes |
| healthhub.fhir.dk.core#1.0.24 | Laterality2 | Health Hub Dk Core Laterality |
| medmij.fhir.nl.r4.dentalcare#1.0.0-rc.1 | CariesRisk | CariesRisk ValueSet. |
| medmij.fhir.nl.r4.dentalcare#1.0.0-rc.1 | DentalFitness | DentalFitness ValueSet. |
| medmij.fhir.nl.r4.dentalcare#1.0.0-rc.1 | OralHygiene | OralHygiene ValueSet. |
| se.electronichealth.fhir.hvo.r5#0.1.3-alpha | hvo-encounter-means | Mötesform som tjänst erbjuds i |
| se.electronichealth.fhir.hvo.r5#0.1.3-alpha | hvo-organization-type | Typ av organisation |
| se.electronichealth.fhir.hvo.r5#0.1.3-alpha | hvo-organizational-unit-type | Typ av organisatorisk enhet |
| se.electronichealth.fhir.hvo.r5#0.1.3-alpha | hvo-target-group-eligibility-characteristic | Typ av egenskap hos målgrupp |
| ca.healthpei.io.core#0.1.7-DFT | Disease | |
| ca.healthpei.io.core#0.1.7-DFT | RouteOfAdmin | Route Of Administration |
| ca.healthpei.io.core#0.1.7-DFT | Tradename | |
| ca.healthpei.io.core#0.1.7-DFT | Generic | GenericImmunizingAgent |
| ca.infoway.io.psca#2.2.0-ti-ballot | allergicconditioncode | Allergic Condition Code |
| ch.fhir.ig.swissnoso#1.0.0 | swissnoso-germ | Swissnoso Germ |
| navify.fhir.r5.rdc#1.3.0 | carbohydrate-intake-codes | CarbohydrateIntakeCodes |
| navify.fhir.r5.rdc#1.3.0 | device-kind | DeviceKind |
| navify.fhir.r5.rdc#1.3.0 | device-settings-codes | DeviceSettingsCodes |
| navify.fhir.r5.rdc#1.3.0 | diabetes-type-codes | DiabetesTypeCodes |
| navify.fhir.r5.rdc#1.3.0 | observation-codes | ObservationCodes |
| ndhm.in#6.5.0 | ndhm-alcohol-drinking-status | Alcohol Drinking Status |
| ndhm.in#6.5.0 | ndhm-benefit-type | Benefit Type |
| ndhm.in#6.5.0 | ndhm-benefitcategory | Benefit Category |
| ndhm.in#6.5.0 | ndhm-care-team-qualification | Care Team Qualification |
| ndhm.in#6.5.0 | ndhm-care-team-role | Care Team Role |
| ndhm.in#6.5.0 | ndhm-claim-type | Claim Type |
| ndhm.in#6.5.0 | ndhm-coverage-type | Coverage Type |
| ndhm.in#6.5.0 | ndhm-diagnosis-use | Diagnosis Use |
| ndhm.in#6.5.0 | ndhm-diagnostic-report-type | Diagnostic Report Type |
| ndhm.in#6.5.0 | ndhm-diagnostic-type | Diagnostic Type |
| ndhm.in#6.5.0 | ndhm-diet-type | Diet Type |
| ndhm.in#6.5.0 | ndhm-encounter-type | EncounterTypes |
| ndhm.in#6.5.0 | ndhm-general-assessment | General Assessment |
| ndhm.in#6.5.0 | ndhm-general-well-being | General Wellbeing |
| ndhm.in#6.5.0 | ndhm-lifestyle | Lifestyle |
| ndhm.in#6.5.0 | ndhm-medicine-codes | Medicine Codes |
| ndhm.in#6.5.0 | ndhm-mental-status | Mental Status |
| ndhm.in#6.5.0 | ndhm-practitioner-role | Practitioner Role |
| ndhm.in#6.5.0 | ndhm-productorservice | ProductorService |
| ndhm.in#6.5.0 | ndhm-route-of-administration | Route Of Administration |
| ndhm.in#6.5.0 | ndhm-specimen-types | Specimen Types |
| ndhm.in#6.5.0 | ndhm-tobacco-chewing-status | Tobacco Chewing Status |
| ndhm.in#6.5.0 | ndhm-tobacco-smoking-status | Tobacco Smoking Status |
| ndhm.in#6.5.0 | ndhm-vaccine-codes | Vaccine Codes |
| kl.dk.fhir.ffinst#1.0.0 | BodyTemperatureSCTObservables | TemperatureSCTObservables |
| kl.dk.fhir.ffinst#1.0.0 | BodyheightSCTobservables | BodyheightSCTobservables |
| kl.dk.fhir.ffinst#1.0.0 | BodyweightSCTobservables | BodyweightSCTobservables |
| kl.dk.fhir.ffinst#1.0.0 | ConsciousnessSCTFindings | ConsciousnessSCTFindings |
| kl.dk.fhir.ffinst#1.0.0 | DiastolicBloodPressureSCTObservables | DiastolicBloodPressureSCTObservables |
| kl.dk.fhir.ffinst#1.0.0 | EQ5DSCTfindingsActivity | EQ5DSCTfindingsActivity |
| kl.dk.fhir.ffinst#1.0.0 | EQ5DSCTfindingsAnxiety | EQ5DSCTfindingsAnxiety |
| kl.dk.fhir.ffinst#1.0.0 | EQ5DSCTfindingsHygiene | EQ5DSCTfindingsHygiene |
| kl.dk.fhir.ffinst#1.0.0 | EQ5DSCTfindingsMobility | EQ5DSCTfindingsMobility |
| kl.dk.fhir.ffinst#1.0.0 | EQ5DSCTfindingsPain | EQ5DSCTfindingsPain |
| kl.dk.fhir.ffinst#1.0.0 | HeartRateSCTobservables | HeartRateSCTobservables |
| kl.dk.fhir.ffinst#1.0.0 | OxygenSaturationSCTobservables | OxygenSaturationSCTobservables |
| kl.dk.fhir.ffinst#1.0.0 | RespirationRateSCTObservables | RespirationRateSCTObservables |
| kl.dk.fhir.ffinst#1.0.0 | SCTUrinStix | SCTUrinStix |
| kl.dk.fhir.ffinst#1.0.0 | SystolicBloodPressureSCTObservables | SystolicBloodPressureSCTObservables |
| kl.dk.fhir.ffinst#1.0.0 | TechniqesSCTCodes | TechniqesSCTCodes |
| kl.dk.fhir.ffinst#1.0.0 | VRSSCTfindingsPain | VRSSCTfindingsPain |
| kl.dk.fhir.ffinst#1.0.0 | WHO5SCTfindingsActive3 | WHO5SCTfindingsActive3 |
| kl.dk.fhir.ffinst#1.0.0 | WHO5SCTfindingsCalm2 | WHO5SCTfindingsCalm2 |
| kl.dk.fhir.ffinst#1.0.0 | WHO5SCTfindingsHappy1 | WHO5SCTfindingsHappy1 |
| kl.dk.fhir.ffinst#1.0.0 | WHO5SCTfindingsInterest5 | WHO5SCTfindingsInterest5 |
| kl.dk.fhir.ffinst#1.0.0 | WHO5SCTfindingsRested4 | WHO5SCTfindingsRested4 |
| il.fhir.r4.dgmc#0.9.4 | all-snomed-codes | All SNOMED CT Codes |
| medcom.fhir.dk.terminology#2.0.2 | medcom-conditionlist-status-valueset | MedComConditionListStatus |
| ch.fhir.ig.ch-epr-term#2.0.10 | DocumentEntry.classCode | DocumentEntry.classCode |
| ch.fhir.ig.ch-epr-term#2.0.10 | DocumentEntry.confidentialityCode | DocumentEntry.confidentialityCode |
| ch.fhir.ig.ch-epr-term#2.0.10 | DocumentEntry.healthcareFacilityTypeCode | DocumentEntry.healthcareFacilityTypeCode |
| ch.fhir.ig.ch-epr-term#2.0.10 | DocumentEntry.practiceSettingCode | DocumentEntry.practiceSettingCode |
| ch.fhir.ig.ch-epr-term#2.0.10 | DocumentEntry.typeCode | DocumentEntry.typeCode |
| ch.fhir.ig.ch-epr-term#2.0.10 | HCProfessional.hcProfession | HCProfessional.hcProfession |
| ch.fhir.ig.ch-epr-term#2.0.10 | SubmissionSet.contentTypeCode | SubmissionSet.contentTypeCode |
| hl7.fhir.uv.xver-r3.r5#0.1.0 | R3-focal-subject-for-R5 | Cross-version ValueSet STU3.Focal Subject Codes for use in FHIR R5 |
| hl7.fhir.uv.xver-r3.r5#0.1.0 | R3-questionnaire-category-for-R5 | Cross-version ValueSet STU3.Questionnaire Category Codes for use in FHIR R5 |
| fhir.tx.support.r4#0.37.0 | allergy-intolerance-substance-product-gps-uv-ips | Allergy-intolerance substance-product - GPS - IPS |
| fhir.tx.support.r4#0.37.0 | allergy-intolerance-substance-product-snomed-extended-uv-ips | Allergy intolerance substance product - SNOMED CT extended - IPS |
| fhir.tx.support.r4#0.37.0 | covid-19-cond | COVID-19 related Condition codes |
| fhir.tx.support.r4#0.37.0 | snomed-intl-ips | SNOMED CT® International Patient Set (IPS) |
| medmij.dental.care.r4#1.0.0-alpha.3 | DentalCare-ASAScore | DentalCare - ASA Score |
| medmij.dental.care.r4#1.0.0-alpha.3 | DentalCare-OralHygieneFinding | DentalCare - Oral Hygiene Finding |
| csiro.stars#0.6.1 | specimen-type-value-set | STARS Specimen Type |
| de.gematik.terminology#1.0.9-1 | epa-xds-event-code-vs | IHE XDS Event Code ValueSet für ePA |
| de.gematik.terminology#1.0.9-1 | ti-medication-type-pharmaceutical-product-vs | TI Medication Type ValueSet for a Pharmaceutical Product |
| de.gematik.terminology#1.0.9-1 | ti-medication-type-product-vs | TI Medication Type ValueSet for PZN-Medication |
| de.gematik.terminology#1.0.9-1 | ti-medication-type-vs | TI Medication Type Value Set |
| il.pcmdemo.fhir.r4#0.1.10 | pcm-snomed-service-codes | PCM Demo - Snomed Service Codes ValueSet |
| hl7.fhir.it.lab-report#0.2.0 | additivo-campione-it | Additivo Campione |
| hl7.fhir.it.lab-report#0.2.0 | campione-container-lab-it | Container Campione |
| hl7.fhir.it.lab-report#0.2.0 | results-microorganism-snomed-ct-ips-free-set | Risultato osservazione codificato - microorganismo IPS di SNOMED CT |
| hl7.fhir.it.lab-report#0.2.0 | results-observation-bloodgroup | Risultato osservazione codificato - Gruppo Sanguigno IPS di SNOMED CT |
| hl7.fhir.it.lab-report#0.2.0 | results-presence-absence-snomed-ct-ips-free-set | Risultato osservazione codificato - presenza/assenza IPS di SNOMED CT |
| hl7.fhir.it.lab-report#0.2.0 | tipo-campione-lab-it | Tipo campione |
| hl7.fhir.it.lab-report#0.2.0 | valueset-observation-value-bloodgroup | Risultato osservazione codificato gruppo sanguigno |
| hl7.fhir.it.lab-report#0.2.0 | valueset-observation-value-microorganism | Risultato osservazione codificato microorganismi |
| hl7.fhir.it.lab-report#0.2.0 | valueset-observation-value-presence-absence | Risultato osservazione codificato presenza/assenza |
| tsti.adultcheck#0.1.2 | adultcheck-code | 成人預防保健疾病史代碼集值 |
| tsti.adultcheck#0.1.2 | adultcheck-lifecode | 成人預防保健生活史代碼集值 |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ACVPU-1 | Care Connect ACVPU |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-AllergyCertainty-1 | Care Connect Allergy Certainty |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-AllergyCode-1 | Care Connect Allergy Code |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-AllergyExposureRoute-1 | Care Connect Allergy Exposure Route |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-AllergyManifestation-1 | Care Connect Allergy Manifestation |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-AllergySeverity-1 | Care Connect Allergy Severity |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-BodySite-1 | Care Connect Body Site |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-CareSettingType-1 | Care Connect Care Setting Type |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-CompositionSectionCode-1 | Care Connect Composition Section Code |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ConditionEpisodeSnCT-1 | Care Connect Condition Episode SnCT |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-DocumentType-1 | Care Connect Document Type |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-EmergencyCareDischargeStatus-1 | Care Connect Emergency Care Discharge Status |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-EncounterType-1 | Care Connect Encounter Type |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-FindingCode-1 | Care Connect Finding Code |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ImmunizationExplanationReason-2 | Care Connect Immunization Explanation Reason |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-InspiredOxygen-1 | Care Connect Inspired Oxygen |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ManufacturedMaterialSnCT-1 | Care Connect Manufactured Material SnCT |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-MedicationCode-1 | Care Connect Medication Code |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-MedicationDosageRoute-1 | Care Connect Medication Dosage Route |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-MedicationForm-1 | Care Connect Medication Form |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ProcedureCode-1 | Care Connect Procedure Code |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ReasonImmunizationNotAdministered-1 | Care Connect Reason Immunization Not Administered |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ReligiousAffiliation-1 | Care Connect Religious Affiliation |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ReportCodeSnCT-1 | Care Connect Report Code SnCT |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-SaturatedOxygenSp02Scale-1 | Care Connect Saturated Oxygen Sp02 Scale |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-SourceOfReferral-1 | Care Connect Source of Referral |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-SpecimenBodySite-1 | Care Connect Specimen Body Site |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-SpecimenType-1 | Care Connect Specimen Type |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-VaccinationProcedure-1 | Care Connect Vaccination Procedure |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ObservationMethod-1 | Care Connect Observation Method |
| careconnect.stu3.03.00.00#3.1.0 | CareConnect-ObservationType-1 | Care Connect Observation Type |
| nictiz.fhir.nl.r4.labexchange#4.0.0-beta.2 | 2.16.840.1.113883.2.4.3.11.60.25.11.414--20221221000000 | AanvraagStatusCodelijst |
| de.medizininformatikinitiative.kerndatensatz.laborbefund#2026.0.3 | mii-vs-labor-interpretation-eigenschaften-snomedct | MII VS Labor Interpretationsbeeinflussende Eigenschaften SNOMEDCT |
| de.medizininformatikinitiative.kerndatensatz.laborbefund#2026.0.3 | Laborergebnis-semiquantitativ | MII VS Labor Laborergbenis Semiquantitativ |
| de.medizininformatikinitiative.kerndatensatz.laborbefund#2026.0.3 | Laborergebnis-qualitativ | MII VS Labor Laborergebnis Qualitativ |
| de.medizininformatikinitiative.kerndatensatz.laborbefund#2026.0.3 | QuelleKlinischesBezugsdatum | MII VS Labor Quelle klinisches Bezugsdatum |
| fhir.r4.nhsengland.pathology#0.1.3-alpha | England-PathologyAndLaboratoryMedicineObservables | England Pathology And Laboratory Medicine Observables |
| fhir.r4.nhsengland.pathology#0.1.3-alpha | England-PathologyBoundedCodeListObservables | England Pathology Bounded Code List Observables |
| us.nlm.vsac#0.24.0 | 1.2.91.13925.17760.1280649 | Sneezing and Itching Grouping |
| us.nlm.vsac#0.24.0 | 1.2.91.13925.17760.15972546 | Conditions Indicating Appropriate Sinonasal Imaging |
| us.nlm.vsac#0.24.0 | 1.2.91.13925.17760.16432390 | Cerumen Impaction |
| us.nlm.vsac#0.24.0 | 1.2.91.13925.17760.16929355 | Allergic Rhinitis Grouping |
| us.nlm.vsac#0.24.0 | 1.2.91.13925.17760.18316962 | Severe Asthma |
| us.nlm.vsac#0.24.0 | 1.2.91.13925.17760.23618223 | Hearing Aids Grouping |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.33895.1.3.0.45 | Comfort Measures |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1 | Selected non pharmaceutical therapies for moderate to severe chronic pain |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1 | pain medication action plan |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1 | selected follow up visit intervals for opioid monitoring |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.234.999.4.7 | malignant neoplasms and cancer pain |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.234.999.4.9 | malignancy or cancer related pain |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150 | Cerumen on Otoscopy |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172 | Hearing Loss |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175 | Tinnitus |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178 | Ear Congestion |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179 | Ear Pruritus |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180 | Otalgia |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96 | Initial Encounter with Otolaryngologist or undefined clinician |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81 | Cerumen Impaction |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188 | Radiotherapy |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191 | Head and Neck Anatomic Locations |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194 | Ear Canal Stenosis |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197 | Exostoses |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200 | Non intact Tympanic Membrane |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246 | Hearing Aids |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250 | DO NOT USE |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252 | Irrigation |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288 | Otoscopy performed on exam |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291 | Otolaryngologist as a Clinician or Service |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275 | Dermatologic Diseases of the Ear |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20 | Keratoses Obturans |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221 | Tympanoplasty |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223 | Myringoplasty |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225 | Mastoidectomy |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227 | Ear Surgery, Other |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336 | Sleep Apnea |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237 | Allergic Rhinitis |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263 | Uncontrolled or severe asthma |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302 | Rhinosinusitis |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305 | Nasal Polyposis |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308 | Suspected Nasal Neoplasm |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215 | Sneezing as a finding |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217 | Pruritus Unspecified or Other Location |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290 | Clinicians who perform allergy testing |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279 | Radiography of face, head or neck |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318 | Eustachian Tube Dysfunction |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267 | Immunotherapy that is not Identified as Subcutaneous |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268 | Immunotherapy |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657 | Clostridium difficile infection |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724 | Ileus due to infection |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727 | Vomiting potentially due to CDI |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730 | Toxic Megacolon in adults |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732 | Abdominal Distension |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690 | Septic Shock due to C. Diff |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660 | History of CDI |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661 | Consult Infectious Disease |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691 | Abdominal Xrays for CDI |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692 | CT of abdomen with contrast for fulminant CDI |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693 | Surgical consult for CDI |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694 | Fecal microbiota transplantation |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645 | Hospitalist |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697 | Positive result indicator |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646 | Body Temperature |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648 | Diarrhea Potentially due to CDI |
| us.nlm.vsac#0.24.0 | 1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652 | Inpatient Setting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1010.1 | Substance Reactant for Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1010.2 | Clinical Substance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1018.240 | SNOMED CT CORE Problem List |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1018.98 | Route of Administration |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1021.101 | Gender Identity USCDI core |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1021.120 | Patient Sex for Quality Measurement |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1021.121 | Federal Administrative Sex |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1021.14 | Published test VS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1021.33 | Sexual Orientation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1021.40 | MDP Test Intensional |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1021.56 | Medical Reason Not Done SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.120 | Phototherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.121 | Phototherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.123 | Neonatal Jaundice |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.124 | Neonatal Jaundice |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.126 | Maternal Drug Use |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.127 | Maternal Drug Use |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.129 | Fetal Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.130 | Fetal Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.132 | Congenital Malformations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.133 | Congenital Malformations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.135 | Social Indications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.136 | Social Indications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.138 | Neonatal Severe Birth Trauma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.139 | Neonatal Severe Birth Trauma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.141 | Neonatal Severe Hypoxia or Asphyxia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.142 | Neonatal Severe Hypoxia or Asphyxia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.144 | Neonatal Severe Shock and Resuscitation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.145 | Neonatal Severe Shock and Resuscitation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.147 | Neonatal Severe Respiratory Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.148 | Neonatal Severe Respiratory Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.150 | Neonatal Severe Infection |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.151 | Neonatal Severe Infection |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.153 | Neonatal Severe Neurological Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.154 | Neonatal Severe Neurological Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.156 | Neonatal Severe Shock and Resuscitation Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.157 | Neonatal Severe Shock and Resuscitation Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.159 | Neonatal Severe Respiratory Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.160 | Neonatal Severe Respiratory Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.162 | Neonatal Severe Neurological Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.163 | Neonatal Severe Neurological Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.165 | Neonatal Severe Septicemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.166 | Neonatal Severe Septicemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.168 | Neonatal Moderate Birth Trauma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.169 | Neonatal Moderate Birth Trauma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.171 | Neonatal Moderate Respiratory Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.172 | Neonatal Moderate Respiratory Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.174 | Neonatal Moderate Respiratory Complications Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.175 | Neonatal Moderate Respiratory Complications Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.177 | Neonatal Moderate Birth Trauma with LOS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.178 | Neonatal Moderate Birth Trauma with LOS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.180 | Neonatal Moderate Respiratory Complications with LOS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.181 | Neonatal Moderate Respiratory Complications with LOS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.186 | Neonatal Moderate Respiratory complications with LOS Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.187 | Neonatal Moderate Respiratory complications with LOS Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.189 | Single Liveborn Newborn Vaginal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.190 | Single Liveborn Newborn Vaginal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.192 | Single Liveborn Newborn Cesarean |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.193 | Single Liveborn Newborn Cesarean |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.196 | Neonatal Moderate Infection with LOS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.197 | Neonatal Moderate Infection with LOS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.205 | Neonatal Intensive Care Unit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.206 | Intensive Care Unit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.209 | Blood Transfusion Administration |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.213 | Blood Transfusion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.220 | Aortic Aneurysm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.228 | Heart Failure Cardiac Arrest Related to Procedure or Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.24 | Blood Transfusion Administration |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.246 | Blood Transfusion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.248 | Conversion of Cardiac Rhythm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.250 | Hysterectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.252 | Tracheostomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.254 | Ventilation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.256 | Severe Maternal Morbidity Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.344 | Aortic Aneurysm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.357 | Conversion of Cardiac Rhythm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.358 | Hysterectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.359 | Tracheostomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.360 | Ventilation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.368 | Preadmission Observation Undelivered Mother |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.369 | ED Visit and OB Triage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.372 | COVID 19 Confirmed |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.373 | COVID 19 Confirmed |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.375 | Respiratory Conditions Related to COVID 19 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.376 | Respiratory Conditions Related to COVID 19 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.378 | Respiratory Support Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.379 | Respiratory Support Procedures Related to COVID 19 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1029.67 | Other Health Care Facility |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.102 | Suicide Attempt |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.13 | Cirrhosis SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.14 | Cirrhosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.151 | Polycystic Ovary Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.230 | Gestational Diabetes SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.233 | All Results of High Risk HPV Test |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.234 | High Risk HPV Positive Results |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.248 | Suicide Attempt SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.263 | High Risk Positive HPV Results Without HPV16 or HPV18 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.264 | CDS Pregnancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.266 | Rhabdomyolysis Intensional |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.267 | CDS Rhabdomyolysis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.268 | HPV Negative Results |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.29 | Non pharmacologic treatments for chronic pain SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.296 | SCT Findings 202209 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.302 | Test Cervical Excision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.307 | Counseling for Physical Activity CDS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.309 | SCT Findings 202309 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.311 | SCT Procedures 202209 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.312 | SCT Procedures 202309 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.36 | Non pharmacologic treatments for chronic pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.48 | Anxiety |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.51 | Sleep disordered breathing |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.52 | Anxiety |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.53 | Sleep disordered breathing |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.79 | Behavioral Counseling for Nutrition and Activity Referral |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.85 | Impaired Glucose Tolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.9 | Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.90 | Gestational Diabetes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1032.96 | Dependence on dialysis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.464 | Cluster Headache |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.555 | Patient Declines Treatment for Cluster Headache (SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.641 | Neuromodulation for migraine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.642 | No pain with headache |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.646 | Anxiety Disorders (ICD10 and SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.648 | Depression Diagnosis (ICD10 and SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.649 | Psychosis (ICD10 and SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.650 | Cluster Headache (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.660 | Acute cluster headache treatment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.662 | Long term preventive treatment for cluster headache |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.105 | Abnormal Presentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.15 | Intravenous Thrombolytic tPA Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.16 | Intraarterial Thrombolytic tPA Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.171 | Abnormal Presentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.173 | Delivery of Singleton |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.27 | Cornual Ectopic Pregnancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.59 | Delivery Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.67 | PCI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.69 | Endotracheal Intubation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1045.99 | Delivery of Singleton |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1046.225 | Opioid Medication Assisted Treatment (MAT) SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1046.243 | Opioid Use Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1046.279 | Triage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1046.283 | Emergency Department Location |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1046.284 | Emergency Department Location |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1046.285 | Mental Health Diagnosis without Substance Use Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1046.286 | Decision to Transfer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.10 | Breastfeeding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.100 | Familial Hypercholesterolemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.102 | Rhabdomyolysis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.12 | Liver Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.13 | Rhabdomyolysis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.20 | Atherosclerosis and Peripheral Arterial Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.21 | Atherosclerosis and Peripheral Arterial Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.42 | Liver Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.44 | Cerebrovascular Disease Stroke or TIA |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.46 | Ischemic Heart Disease or Related Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.47 | Stable and Unstable Angina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.502 | Overweight or Obese |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.513 | Elevated Blood Pressure Reading |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.514 | Finding of Elevated Blood Pressure or Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.525 | Referral (ophthalmology) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.527 | Retina visualization inadequate |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.528 | Refusal or Noncompliance with treatment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.530 | Vitreous hemorrhage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.553 | Uveitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.560 | Tonometry |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.576 | Vitreous hemorrhage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.580 | Intravitreal and Periocular Injections |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.581 | Intravitreal and Periocular Injections |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.587 | Lost to follow up |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.588 | Uveitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.611 | 3 Mirror Goldmann exam |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.612 | Scleral depressed exam |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.615 | Physical Disability |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.616 | Financial difficulty |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.619 | Scleral depressed exam |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.69 | Stable and Unstable Angina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.70 | Ischemic Heart Disease or Related Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.71 | Cerebrovascular Disease Stroke or TIA |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.73 | Breastfeeding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.85 | Familial Hypercholesterolemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1047.9 | Outpatient Encounters for Preventive Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1056.53 | Indicators of Human Immunodeficiency Virus (HIV) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1003 | OIA_RFs_Secondary_Prevention_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1005 | OIA_RFs_Secondary_Prevention_ICD_SM_CPT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1009 | PAE_Patient_Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1012 | PAE Conditions Short |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1044 | Anemia for Erythropoesis Simulating Agents SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1045 | Anemia for Erythropoesis Simulating Agents |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1049 | Knee pain SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.105 | conditions_heartfailure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1050 | Knee pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1051 | Knee decreased ROM SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1055 | Knee crepitus SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1069 | Urinary incontinence SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1071 | Urinary incontinence |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1073 | Hemifacial spasm SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1075 | Hemifacial spasm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1076 | Spasmodic dysphonia SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1077 | Physical therapy procedure SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1078 | Occupational therapy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1079 | Hyperhidrosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1081 | Hyperhidrosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1083 | Tic disorder SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1084 | Tic disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1085 | Esophageal achalasia SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1087 | Esophageal achalasia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1090 | Blephraospasm SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1092 | Blepharospasm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1093 | Strabismus SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1095 | Strabismus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1096 | Overactive bladder SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1098 | Overactive bladder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1099 | Movement disorders SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.110 | CKD stage4above SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1101 | Movement disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1102 | Lateral epicondylitis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1104 | Lateral epicondylitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1105 | Plantar fasciitis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1107 | Plantar fasciitits |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1108 | Cardiac CT SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.111 | CKD stage4above |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1111 | Cardiac CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1112 | Cardiac MRI SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1114 | Cardiac MRI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1115 | CT Angiography of Coronary Artery SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1117 | CT Angiography of Coronary Artery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.113 | Chronic kidney disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.117 | DigTx Cognitive Impairment SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.120 | Diabetic ketoacidosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.121 | Diabetic ketoacidosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.124 | DKD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.147 | HFrEF SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.151 | History of Hypoglycemia SCD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.17 | Atrial fibrillation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.175 | Asthma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.184 | DigTx Virtual Reality Contraindications Visual Impairment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.21 | Thoracic aorta disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.214 | Type 1 Diabetes Mellitus SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.226 | Systolic Heart Failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.244 | MRA Mineralocorticoid Receptor Antagonist Allergy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.260 | UACR SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.281 | Statins Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.282 | Statin Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.37 | relatedconditions_hypertension SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.440 | relatedconditions_T2DM SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.459 | Liver cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.47 | ACE inhibitor allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.474 | Allergy to Tdap Vaccine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.475 | Allergy to Td Vaccine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.476 | Allergy To Vaccine Component |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.478 | Allergy to HPV Vaccine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.492 | Inhaled Corticosteroids Allergy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.498 | Metformin AllergyIntolerance SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.5 | Delivery - Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.516 | Allergy to Herpes Zoster Vaccine SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.519 | Drug hypersensitivity SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.520 | Drug hypersensitivity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.524 | Chronic Hepatitis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.525 | Chronic Hepatitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.535 | Vasospastic disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.536 | Vasospastic disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.538 | Hemiplegic and basilar migraine SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.539 | Hemiplegic and basilar migraine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.541 | Peptic ulcer disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.542 | Peptic ulcer disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.545 | Bleeding disorder SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.548 | Electronic cigarettes or Vaping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.549 | Bleeding disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.561 | conditions_migraine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.562 | relatedconditions_migraine SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.563 | relatedconditions_migraine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.564 | Triptan Allergy Intolerance SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.565 | Triptan Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.566 | Ischemic bowel disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.568 | Ischemic bowel disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.570 | Allergy to house dust mites SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.572 | Allergy to house dust mites |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.574 | conditions_hyperlipidemia SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.575 | conditions_hyperlipidemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.594 | Intolerance to ARB SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.612 | Wolff Parkinson White SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.614 | Wolff Parkinson White |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.618 | relatedconditions_Asthma SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.622 | relatedconditions_Asthma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.623 | LAMA Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.624 | LABA Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.625 | BetaBlock NonCS Secondary Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.626 | Eplerenone Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.627 | Spironolactone Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.628 | SGLT2 Inhibitors Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.630 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.631 | Pneumococcal Vaccine Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.632 | Meglitinides Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.633 | DPP4i Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.635 | Alpha_glucosidase inhibitors allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.636 | Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.637 | Insulins Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.638 | TZD Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.639 | T2DM_Medications Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.643 | T2DM_Medications Allergy SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.646 | T2DM_Medication Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.647 | Statins Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.649 | ACE Inhibitors Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.650 | ARB Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.652 | Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.653 | Long Acting Beta Agonists (LABA) Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.654 | BetaBlocker NonCS Secondary Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.656 | MRA Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.657 | Eplerenone Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.658 | Spironolactone Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.659 | SGLT2i Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.660 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.661 | Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.665 | Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.666 | Human Papillomavirus (HPV) vaccine Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.670 | Pneumococcal Vaccine Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.671 | Inhaled Corticosteroids(ICS) Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.675 | GLP1RA Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.713 | PIM_IHD_CHD_CAD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.723 | Macrolide Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.724 | Macrolide Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.725 | Prednisone Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.727 | Tetracycline Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.728 | Tetracycline Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.729 | Fluoroquinolones Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.730 | Fluoroquinolone Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.732 | Penicillin Allergy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.733 | Penicillin Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.737 | Pneumonia SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.738 | Pneumonia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.742 | Pulmonary Embolism SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.743 | Pulmonary Embolism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.745 | Influenza SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.747 | Influenza |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.749 | COVID19 SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.750 | COVID19 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.753 | RSV SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.754 | RSV |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.755 | Respiratory Rate SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.757 | Respiratory Rate |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.759 | Acute Respiratory Failure SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.760 | Acute Respiratory Failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.761 | Dyspnea SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.763 | Dyspnea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.765 | Confusion SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.766 | Confusion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.767 | Drowsiness SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.769 | Drowsiness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.771 | Cyanosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.772 | Cyanosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.776 | Arterial oxygen saturation SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.790 | Simple Knee Pain SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.791 | Simple Knee Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.792 | Simple Left Knee Pain SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.793 | Simple Right Knee Pain SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.796 | Simple Right Knee Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.797 | Simple Left Knee pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.799 | Knee joint surgery SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.800 | Knee joint surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.802 | Knee Osteoarthritis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.803 | Knee Osteoarthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.804 | Osteoarthritis of right knee SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.805 | Osteoarthritis of left knee SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.808 | Osteoarthritis of right knee |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.809 | Osteoarthritis of left knee |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.810 | Hip Osteoarthritis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.812 | Hip Osteoarthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.814 | Hip joint surgery SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.815 | Hip joint surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.818 | Osteoarthritis of right hip SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.819 | Osteoarthritis of left hip SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.820 | Osteoarthritis of right hip |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.821 | Osteoarthritis of left hip |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.853 | Hyperkalemia_SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.854 | Hyperkalemia Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.862 | PIM_Ambulatory_Visits_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.876 | Alpha Glucosidase Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.878 | Inflammatory bowel disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.879 | Inflammatory bowel disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.88 | DEPRECATED Diabetes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.880 | Gastrointestinal obstruction SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.882 | Gastrointestinal obstruction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.883 | DPP4i Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.884 | Multiple endocrine neoplasia type 2 (MEN II) SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.886 | Multiple endocrine neoplasia type 2 (MEN II) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.887 | Gastroparesis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.889 | Gastroparesis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.890 | Meglitinide Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.891 | Sulfonylurea Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.893 | Peripheral edema SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.894 | Peripheral edema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.895 | TZD Allergy Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.911 | CKD stage5OrESRD SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.912 | CKD stage5OrESRD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.915 | Anxiety_SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.916 | Anxiety |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.918 | Stress_SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.92 | ASCVD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.920 | Stress |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.921 | PBH_Anxiety_SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.922 | PBH_Depression_SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.923 | PBH_Stress_SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.924 | PBH_Insomnia_SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.938 | Crohn disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.94 | Albuminuria SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.940 | Crohn disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.941 | Celiac disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.943 | Celiac disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.95 | Albuminuria |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.953 | OIA_DM_SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.954 | OIA_CAD_SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.955 | OIA_PVD_SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.956 | OIA_DM_ICD10_SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.957 | OIA_CAD_ICD10_SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.958 | OIA_PVD_ICD10_SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.964 | OIA_RFs_ACS_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.965 | OIA_RFs_ACS__ICD10_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.967 | OIA_Aortic_Calcifications_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.968 | OIA_Aortic_Calcifications_ICD10_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.97 | Sulfonylurea AllergyIntolerance SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.973 | MASLD SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.974 | MASLD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.979 | OIA_RFs_ASCVD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.980 | OIA_RFs_ASCVD_ICD10_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.982 | OIA_TIA_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.983 | OIA_TIA_ICD10_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.985 | OIA_Angina_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.987 | OIA_Angina_ICD10_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.989 | OIA_Ischemic_Hemorrhagic_Stroke_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.99 | BMI SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.990 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.992 | OIA_Myocardial_Infarction_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.993 | OIA_Myocardial_Infarction_ICD10_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.996 | OIA_PAD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.997 | OIA_PAD_ICD10_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.10 | Nutrition Diagnosis SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.101 | Hospice Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.11 | Nutrition Focused Physical Findings SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.14 | Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.17 | Pediatric Enteral Formulas SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.18 | Modified Amino Acid Formulas SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.19 | Nutrition Counseling Approach and Strategies SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.2 | Food and Nutrient Delivery SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.20 | Enteral Nutrition Management SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.24 | Malnutrition Assessment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.29 | Malnutrition Assessment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.30 | Malnutrition Risk Screening |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.33 | Nutrition Assessment Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.38 | Malnutrition Screening Finding of At Risk Result |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.40 | Malnutrition Risk Screening |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.42 | Nutrition Assessment Status Finding of Severely Malnourished |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.43 | Nutrition Assessment Status Finding of Severely Malnourished |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.44 | Nutrition Assessment Status Finding of Moderately Malnourished |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.47 | Nutrition Assessment Status Finding of Moderately Malnourished |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.48 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.49 | Nutrition Focused Physical Findings Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.5 | Adult Enteral Formulas SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.50 | Enteral Nutrition Composition SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.51 | Enteral Nutrition Composition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.52 | Parenteral Nutrition Management SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.53 | Malnutrition Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.55 | Malnutrition Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.58 | Nutrition Order Item Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.59 | Diet Item Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.60 | Edible Substances |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.61 | Feeding Device SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.65 | Nutrition Recommendation Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.7 | Modular Nutrition Formulas SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.70 | Nutrition Education SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.71 | Coordination of Care by a Nutrition Professional SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.73 | Nutrition Anthropometric Measurement SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.75 | Nutrition Anthropometric Measurements Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.76 | Manage Feeding Environment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.77 | Special Food Items and Regime/Therapy for Special Food Items SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.84 | Food and Nutrition Related History SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.85 | Nutrition Diagnosis Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.87 | Feeding Device Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.88 | Nutrition Intervention Care Planning |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.89 | Malnutrition Screening Finding of At Risk Result |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.91 | Dietitian Referral |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.93 | Nutrition Care Plan |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.96 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1095.99 | Nutrition Diagnosis SNOMED CT (2) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.1 | Findings Related to Medication Management, Referral Source |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.100 | Recommendations Related to Medication Regimen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.101 | Interventions Related to Medication Regimen, Initiate Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.102 | Interventions Related to Medication Regimen, Change Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.103 | Interventions Related to Medication Regimen, Change Medication Dose |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.104 | Interventions Related to Medication Regimen, Change Medication Dosage Form |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.105 | Interventions Related to Medication Regimen, Change Medication Course |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.106 | Interventions Related to Medication Regimen, Change Medication Dosing Interval |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.107 | Interventions Related to Medication Regimen, Discontinue Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.109 | Interventions Related to Medication Regimen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.11 | Interventions Related to Medication Management, Medication Reconciliation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.110 | Interventions Related to Education, Medications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.111 | Interventions Related to Education, Medical Equiptment and Devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.112 | Interventions Related to Medication Management, Notifications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.113 | Interventions Related to Medication Management, Refill Synchronization |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.114 | Status of Patient Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.115 | Interventions Related to Education, Diseases and Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.116 | Interventions Related to Education |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.118 | Interventions Related to Medication Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.119 | Interventions Related to Medication Management, Targeted Medication Review |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.120 | Interventions Related to Medication Management, Discussion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.121 | Reasons for Interventions Related to Medication Management, Cost |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.122 | Interventions Related to Education, Immunizations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.123 | Status of Recommendations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.124 | Interventions Related to Medication Management, Provision of Documents |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.125 | Status of Compliance Ability |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.126 | Status of Interventions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.127 | Status of Disease Control |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.128 | Status of Compliance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.129 | Occupations of Providers |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.130 | Environments of Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.131 | Findings Related to Medication Management, Body Mass Index |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.132 | Findings Related to Medication Management, Alcohol Use |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.133 | Findings Related to Medication Management, Caffeine Use |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.134 | Interventions Related to Education, Diet |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.136 | Findings Related to Medication Management, Exercise |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.137 | Interventions Related to Education, Behavior |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.138 | Findings Related to Medication Management, Diet |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.139 | Status of Care Goal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.140 | Findings Related to Medication Management, Illicit Drug Use |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.141 | Interventions Related to Administration, Immunizations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.142 | Interventions Related to Care Coordination, Communication Needs |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.144 | Findings Related to Medication Management, Life Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.145 | Interventions Related to Medication Management, Device or Equipment Fitting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.146 | Findings Related to Medication Management, Immunizations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.148 | Findings Related to Medication Management, Cultural Beliefs |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.149 | Findings Related to Medication Management, Tobacco Use |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.150 | Interventions Related to Medication Regimen, Continue Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.151 | Encounter Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.152 | Encounter Class |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.156 | Allergy/Intolerance Severity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.16 | Reasons for Interventions Related to Medication Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.160 | Allergy/Intolerance Manifestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.162 | Allergy/Intolerance Substance & Negation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.163 | Allergy/Intolerance Negation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.165 | Interventions Related to Care Coordination, Benefit Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.166 | Interventions Related to Administration |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.167 | Interventions Related to Administration, Medications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.168 | Findings Related to Medication Management, Eating Habits |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.169 | Findings Related to Medication Management, Tobacco Exposure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.170 | Interventions Related to Care Coordination |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.176 | Interventions Related to Medication Management, Information Gathering |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.177 | Interventions Related to Medication Management, Care Planning |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.178 | Interventions Related to Medication Management, Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.179 | Allergy/Intolerance Substance, Food |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.180 | Allergy/Intolerance Substance, Environmental |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.181 | PharmacyEncounterReason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.182 | Encounter Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.183 | Findings Related to Medication Management, Medication related |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.197 | PharmacyAllergies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.198 | PharmacyInterventions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.200 | PharmacyReasonsForInterventions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.201 | PharmacyInterventionStatus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.202 | PharmacyCareCoordination |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.203 | PharmacyReferralsTo |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.204 | PharmacyGoalStatusOutcome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.205 | PharmacyTypeOfProfession |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.207 | PharmacyEnvironmentsOfCare |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.208 | PharmacyEncounterType |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.209 | PharmacytEncounterClass |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.212 | PharmacyAllergyIntoleranceManifestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.213 | PharmacyReasonForMedicationChange |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.214 | PharmacyEducation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.215 | PharmacyEducationStatus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.216 | PharmacyReferralsFrom |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.218 | Reasons for Interventions Related to Medication Management, Discontinue Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.224 | Social Determinants of Health Problem Observation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.227 | Findings Related to Medication Management, Infectious Disease Symptoms |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.229 | COVID19 Related Disease, Test, or Exposure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.230 | Maternity Health Interventions Value Set |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.231 | Social Determinants of Health Interventions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.232 | Maternity Health Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.233 | Reason Medication Discontinued Lack of Indication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.234 | Reason Medication Discontinued Lack of Effectiveness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.235 | Reason Medication Discontinued Safety Issue Occurred |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.236 | Reason Medication Discontinued Compliance Issue other than cost |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.237 | Recommendation to Resolve Medication Therapy Problem |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.239 | Reason Medication Discontinued Patient Unable to Afford |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.3 | Findings Related to Medication Management, Transitions Between Health Care Settings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.35 | Interventions Related to Medication Management, Comprehensive Medication Review |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.5 | Reasons for Interventions Related to Medication Management, Unnecessary Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.53 | Reasons for Interventions Related to Medication Management, Adverse Events |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.55 | Reasons for Interventions Related to Medication Management, Adherence |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.56 | Findings Related to Medication Management, Multiple Providers |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.58 | Findings Related to Medication Management, Chronic Disease Present |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.59 | Findings Related to Medication Management, Taking Medication for Chronic Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.6 | Reasons for Interventions Related to Medication Management, New or Additional Therapy Required |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.60 | Findings Related to Medication Management, Health Literacy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.61 | Findings Related to Medication Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.7 | Reasons for Interventions Related to Medication Management, Ineffective Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.8 | Reasons for Interventions Related to Medication Management, Dose Too Low |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.83 | Assessments Related to Medication Management, General Assessments |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.84 | Assessments Related to Medication Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.85 | Assessments Related to Medication Management, Assessments Using Assessment Scales |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.86 | Interventions Related to Medication Regimen, Monitoring |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.87 | Interventions Related to Care Coordination, Consultations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.88 | Interventions Related to Care Coordination, Referrals to Other Providers |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.89 | Interventions Related to Care Coordination, Referrals for Specific Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.9 | Reasons for Interventions Related to Medication Management, Dose Too High |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.90 | Recommendations Related to Medication Regimen, Continue Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.91 | Recommendations Related to Medication Regimen, Initiate Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.92 | Recommendations Related to Medication Regimen, Change Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.93 | Recommendations Related to Medication Regimen, Change Medication Dose |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.94 | Recommendations Related to Medication Regimen, Change Medication Dosage Form |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.95 | Recommendations Related to Medication Regimen, Change Medication Course |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.97 | Recommendations Related to Medication Regimen, Change Medication Dosing Interval |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.98 | Recommendations Related to Medication Regimen, Discontinue Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1096.99 | Recommendations Related to Medication Regimen, Monitoring |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.12 | Medication Route |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.24 | Extended Pregnancy Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.27 | Care Team Member Function (SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.29 | Allergy Clinical Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.30 | Care Team Member Function |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.35 | Arthritis Feedback Types (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.45 | Bidirectional Services eReferral Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.46 | Bidirectional Services eReferral Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.50 | Transport vehicle type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.53 | Sex |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.54 | Specimen type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.58 | Acute COVID 19 Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1099.59 | Medication Adherence SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.101 | Myocardial Infarction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.124 | Follow Up Within 6 Months |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.125 | Follow Up Within 6 Months |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.175 | Office and Wellness Visits for General Screening |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.178 | Office and Wellness Visits for General Screening |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.179 | Hypertensive disorders in pregnancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.182 | Eclampsia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.183 | Gestational Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.184 | Preexisting Hypertension in Pregnancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.185 | Postpartum Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.187 | Postpartum Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.188 | Preexisting Hypertension in Pregnancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.190 | Spontaneous or Elective Abortion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.191 | Preeclampsia or Eclampsia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.193 | Spontaneous or Elective Abortion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.84 | Statin Associated Muscle Symptoms |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1108.85 | Statin Associated Muscle Symptoms |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.12 | Cornual Ectopic Pregnancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.14 | Perforation of Uterus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.16 | Uterine Rupture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.18 | Transabdominal Cerclage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.2 | Transabdominal Cerclage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.23 | Intensive Care Unit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.24 | Uterine Horn |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.25 | Metroplasty |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.36 | Placenta Accreta Spectrum Previa or Vasa Previa |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.37 | Placenta Accreta Spectrum Previa or Vasa Previa |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.38 | Outpatient Surgery Service |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.41 | Statin Allergen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.42 | Statin Allergen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.54 | Total Parenteral Nutrition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.57 | Ischemic Stroke Thrombosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.60 | Ischemic Stroke Other |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.64 | Application of Venous Foot Pumps |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.65 | Application of Intermittent Pneumatic Compression Devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.66 | Application of Graduated Compression Stockings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.67 | 20 to 42 Plus Weeks Gestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.68 | 37 to 42 Plus Weeks Gestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.69 | 37 to 38 Weeks Gestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.71 | 20 to 42 Plus Weeks Gestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.73 | 37 to 42 Plus Weeks Gestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.75 | 37 to 38 Weeks Gestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1110.76 | History of Atrial Ablation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.126 | Hospital Settings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.143 | Observation Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.161 | All Primary and Secondary Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.164 | Admit Inpatient |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.171 | Opioid Use Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.173 | Sickle Cell Disease with and without Crisis SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.175 | Sickle Cell Disease with and without Crisis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.177 | Opioid Medication Assisted Treatment (MAT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.179 | Cancer Related Pain SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1111.180 | Cancer Related Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1114.14 | Medication drug class for allergen intolerance SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1115.12 | Healthcare Agent Ordinality |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1115.19 | Obligation or Prohibition Instruction Type Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1115.30 | Cardiopulmonary Resuscitation Order Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1115.31 | Cardiopulmonary Resuscitation Procedures Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1115.32 | Additional Portable Medical Order Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1115.33 | Initial Treatment Portable Medical Order Procedures Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1115.34 | Additional portable medical order Procedures Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1115.5 | Advance Directive Content Type SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.100 | Pathological M Stage M1c |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.101 | Pathological N Stage N3 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.102 | N Stage pN1a |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.103 | N Stage pN1b |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.105 | Pathological N Stage pN1mi |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.106 | Pathological N Stage N2b |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.107 | Pathological N Stage N2a |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.108 | Pathological N Stage N2 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.109 | Pathological N Stage N1b |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.110 | Pathological N Stage N1a |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.112 | Pathological N Stage N0 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.114 | Pathological T Stage T4d |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.115 | Pathological T Stage T4c |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.116 | Pathological T Stage T4b |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.117 | Pathological T Stage T4a |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.118 | Pathological T Stage T4 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.120 | N Stage N2C |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.121 | T Stage T3c |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.122 | T Stage T3b |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.123 | T Stage T3a |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.124 | Pathological T Stage T3 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.125 | T Stage T2c |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.126 | T Stage T2b |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.127 | T Stage T2a |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.128 | Pathological T Stage T2 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.129 | Pathological T Stage T1c |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.132 | Pathological T Stage T1b |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.135 | Pathological T Stage T1a |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.136 | Pathological T Stage T1 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.137 | Pathological T Stage T1mic |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.139 | Pathological T Stage T0 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.142 | Cancer Stage III |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.143 | Cancer Stage IIIA |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.144 | Cancer Stage IIIB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.145 | Cancer Stage IIIC |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.146 | Cancer Stage IV |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.147 | Cancer Stage IVA |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.148 | Cancer Stage IVB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.149 | Cancer Stage IVC |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.160 | ECOG Performance Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.162 | ECOG Performance Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.164 | Karnofsky Performance Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.185 | Breast Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.191 | Cancer Stage II |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.192 | Cancer Stage IIA |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.193 | Cancer Stage IIB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.256 | Colorectal Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.280 | Cancer Stage IA |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.281 | Cancer Stage IB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.286 | Cancer Stage IIC |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.291 | Positive Result |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.292 | Negative Result |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.300 | Pathological N Stage N1C |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.365 | Hospice Care Referral or Admission |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.439 | T Category |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.440 | N Category |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.441 | M Category |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.442 | TNM Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.539 | Fallopian Tube Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.547 | Cancer Stage 1C |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.555 | Gender Female |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.556 | Gender Male |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.557 | Pathological N Stage N3a |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.558 | Pathological N Stage N3b |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.95 | M Stage M0 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.97 | Pathological M Stage M1 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.98 | Pathological M Stage M1a |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.99 | Pathological M Stage M1b |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1121.6 | Most/Moderately Effective Contraceptive SNOMED Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.11 | Sleep Apnea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.12 | Toxic Megacolon in adults |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.13 | Septic Shock due to C. Diff |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.15 | Body Temperature |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.16 | Diarrhea Potentially due to CDI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.17 | Abdominal Distension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.18 | Vomiting potentially due to CDI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.19 | Ileus due to infection |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.20 | Clostridium difficile infection |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1130.9 | Immunotherapy For Allergic Rhinitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.1 | C2S Alcohol Use Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.11 | C2S Amphetamine Use Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.15 | C2S Cannabis Use DIsorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.18 | C2S Cocaine Use Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.22 | C2S Hallucinogens |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.27 | C2S HIV/AIDS Information Sensitivity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.30 | C2S Inhalants |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.36 | C2S Mental Health Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.42 | C2S Opioids |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.43 | C2S Other Psychoactive Substance Use Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.46 | C2S Sedative Hypnotic, or anxiolytic related disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.51 | C2S Tobacco Use Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.58 | C2S Sensitive Categories |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.65 | Test C2S Alcohol Use Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1142.67 | Test C2S HIV/AIDS Information Sensitivity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1012 | S. Typhi Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1016 | S. Paratyphi Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1021 | Dark Urine (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1022 | Acute Onset [Qualifier Value] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1024 | Acute Viral Hepatitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1029 | Listeriosis [Listeria species] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1033 | Encephalitis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1035 | Indeterminate or Equivocal Lab Result Value |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1037 | Smoking Status [Current Nonsmoker] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1048 | Parkinson’s disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1050 | Parkinsonism [Secondary] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1065 | Consciousness [Decreased Level] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1071 | Drug Use [IV Evidence] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1072 | Miosis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1077 | Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1083 | Rash [Pustular Vesicular] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1084 | Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1090 | Syphilis [Congenital] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1091 | Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1092 | Congenital heart disease (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1093 | Hearing impairment (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1095 | Microcephaly (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1096 | Developmental delay (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.112 | Tetanus (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1124 | COVID_19 (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1143 | COVID_19 (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1145 | Resistant Lab Result Value |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.115 | Mumps (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1156 | Staphylococcus aureus (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1197 | Cervical Lymphadenitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1207 | CRE (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1210 | Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1212 | Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1213 | NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1214 | Carbapenemase resistance mechanism (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1224 | Therapeutic Response to Medication [Improved] |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1225 | Altered Mental Status (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1230 | Eschar (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1231 | Hypotension (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1233 | Localized Edema (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1237 | Tachycardia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1239 | RCKMS Conditions (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.124 | Poliomyelitis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1240 | Maternal Condition Puerperium (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1242 | Non pestis Yersiniosis Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1244 | Blastomycosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1246 | Blastomycosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1269 | Tuberculosis [Latent Infection] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1274 | Histoplasmosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1294 | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1295 | Seizure [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.130 | Influenza (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1309 | RSV (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1314 | Wheezing (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1325 | Tobacco Use and Exposure (Social History) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1335 | Hospitalized [Inpatient] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1336 | Creutzfeldt Jakob Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1337 | Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1349 | Cerebrospinal Fluid (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.135 | Chronic Hepatitis B Virus Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1350 | Endocervical (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1351 | Tissue (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1352 | Specimen from a Normally Sterile Site (Specimen Type)(SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1353 | Urethral Swab (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1355 | Wound (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.136 | Invasive Pneumococcal Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1369 | Serum (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1379 | Fish Poisoning (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1388 | Occupational Asthma (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1389 | Asthma (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1391 | Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1393 | WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1405 | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1407 | Cancer [Malignant Neoplasms] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1418 | Alpha gal syndrome (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1422 | Ptosis of Eyelid [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1424 | Constipation [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1426 | Intubation [Respiratory Tract] (Procedure) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1430 | Infant Botulism (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1446 | Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1447 | MRSA (Disorders (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1449 | Staphylococcus aureus infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.145 | Varicella (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1463 | VRE (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1464 | VRE (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1468 | Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1469 | Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1470 | Enterococcus species (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1471 | Amebiasis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1485 | Norovirus (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1487 | Clostridioides difficile infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1505 | Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1507 | Arsenic Exposure and Toxicity (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1513 | Urine (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1514 | Mercury Exposure and Toxicity (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1516 | Cryptococcosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1532 | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1533 | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1534 | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1538 | Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.154 | Hepatitis C Virus Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1546 | Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1551 | Meningitis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1552 | Bacterial Meningitis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1553 | Fungal Meningitis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1554 | Parasitic Meningitis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1559 | Photophobia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1562 | Bacteria [Causing Meningitis] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1563 | Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1564 | Viruses [Causing Meningitis] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1580 | Animal Bite [Dog] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1581 | Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1582 | Animal Bite [Excluding Mammals] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1584 | Animal Bite [Unspecified Animal] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1605 | Vaccine Adverse Event (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1606 | Vaccinia disease or adverse event (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.161 | Vibriosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1613 | Keratitis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1626 | Thrombocytopenic Purpura [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1651 | Chagas Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1661 | Cervical lymphadenopathy [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1662 | Conjunctival injection (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1663 | Drying of lips (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1667 | Edema of hands or feet (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1679 | Pseudomonas aeruginosa (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1687 | NU_Gunshot Wound (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.169 | Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.170 | Chlamydia trachomatis Infection (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1700 | Encephalitis [Viral] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1702 | Encephalitis [Parasitic] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1712 | Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1714 | Parasites [Causing Encephalitis] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1715 | Viruses [Causing Encephalitis] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1716 | Drowning and Submersion (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1718 | Motor Vehicle Injury (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1720 | Enterovirus Infection [Non polio] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1722 | Enterovirus Infection [Non polio] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1739 | Head Injury (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1745 | Rotavirus Disease (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1748 | Chemical Pneumonitis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1755 | Vomitus (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1758 | Asbestosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1772 | Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1773 | CLABSI (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1775 | Ophthalmia neonatorum (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1778 | Genital herpes (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1785 | Elevated liver enzyme (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1789 | Granuloma Inguinale (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1791 | Ulcer [Genital, Perineal, or Perianal Area] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1797 | Bronchial Wash (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1800 | Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.181 | Coccidioidomycosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1823 | Borrelia species (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1824 | Spirochetes (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1829 | Polyarthritis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1835 | Rheumatoid nodules (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1842 | Ventilator associated event (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1844 | Leishmaniasis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.185 | Brucellosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1864 | Taeniasis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1866 | Taeniasis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.187 | Dengue Virus Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1878 | Surgical Site Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1882 | Carbapenemase production (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1892 | Toxoplasmosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1895 | Toxoplasmosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1902 | Orthopox (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1923 | Coronary artery aneurysm (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1924 | Coronary artery dilatation (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1925 | Ectatic coronary artery (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1926 | Left ventricular ejection fraction [Decreased Level] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1928 | Shock (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1930 | Troponin [Elevated Level] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1931 | Oral mucosa Inflammation (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1935 | Strongyloidiasis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1941 | Strongyloidiasis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1942 | Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1943 | Jamestown Canyon Virus Diseases (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1947 | Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1948 | Keystone Virus Diseases (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1949 | La Crosse Virus Diseases (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1950 | Snowshoe hare Virus Diseases (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1951 | Trivittatus Virus Diseases (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1959 | Keystone Virus Diseases (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1960 | La Crosse Virus Diseases (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1961 | Snowshoe hare Virus Diseases (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1962 | Trivittatus Virus Diseases (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1963 | Hepatitis C Virus Infection, Perinatal (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1964 | Encephalomyelitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1966 | Drug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1968 | Hepatitis D Virus Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1973 | Hepatitis D Virus Infection (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1974 | Baylisascariasis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1975 | Baylisascariasis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1978 | Larva Migrans (Neural, Ocular, or Visceral) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1980 | California Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1982 | California Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1987 | Flank Pain (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1988 | Bone Pain (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1989 | Abscess (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1991 | Focal Brain Lesions (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1992 | Pathologic Fractures [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1994 | Granulomas (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1996 | Skin Lesions (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1998 | Angiostrongyliasis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1999 | Lymphocytic Choriomeningitis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2001 | Lymphocytic Choriomeningitis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2007 | Eosinophilic meningitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2017 | Rash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.202 | Trichinellosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2020 | Lymphadenopathy [Acute] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2023 | Tick Paralysis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2024 | Bacillary angiomatosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2025 | Animal Bite or Scratch [Cat] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2027 | Bartonellosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2029 | Bartonellosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2030 | Bartonella henselae infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2031 | Bartonella quintana infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2032 | Bartonella bacilliformis infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2036 | Bartonella henselae (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2037 | Bartonella quintana (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2038 | Bartonella bacilliformis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.204 | Giardiasis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2052 | Echinococcosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2054 | Cystic Echinococcosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2056 | Alveolar Echinococcosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2060 | Echinococcosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2061 | Genital Warts (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2062 | Pseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2064 | Diphyllobothriasis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2066 | Diphyllobothriasis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2068 | Angiostrongyliasis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2069 | Pelvic Inflammatory Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2070 | Pelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2071 | Pelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2075 | Lower Abdominal Tenderness (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2077 | Tenderness with motion of the cervix (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2078 | Adnexal Tenderness (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2079 | Uterine Tenderness (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2080 | Leukocytosis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2082 | Purulent material in the peritoneal cavity (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2083 | Pelvic Abscess (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2087 | Nongonococcal Urethritis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2089 | Urethritis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2091 | Urethral discharge (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2093 | Dysuria (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2096 | Cyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2098 | Rhinitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2101 | Pleuritis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2105 | Methemoglobinemia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2106 | Methemoglobinemia [Non Congenital] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2110 | Anencephaly (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2112 | Fetal Anencephaly (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2114 | Cleft Lip Alone (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2116 | Fetal Cleft Lip (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2117 | Cleft Palate Alone (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2119 | Cleft Lip with Cleft Palate (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2121 | Fetal Spina Bifida (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2122 | Spina Bifida (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2124 | Down Syndrome (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2126 | Fetal Down Syndrome (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2129 | Bacteremia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2131 | Gastroschisis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2133 | Fatal Familial Insomnia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2135 | Gerstmann Straussler Scheinker Syndrome (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2137 | Prion Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2140 | Phenylketonuria (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2145 | Tuberculosis [Suspected] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2146 | Congenital Rubella Syndrome [Suspected] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2147 | Limb Reduction (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2150 | Congenital Hearing Loss (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2153 | Primary Congenital Hypothyroidism (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2154 | Congenital Hypothyroidism [Unspecified] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2163 | Dengue Virus Infection [Suspected] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2164 | Mumps [Suspected] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2165 | Pertussis [Suspected] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2196 | Lung Tissue (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2197 | Granuloma [Unspecified] (Finding by Microscopic Observation in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2202 | Abnormal Lung Sounds (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2204 | Anemia [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2209 | Microangiopathic Changes (Schistocytes, Burr cells, or Helmet cells) (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2212 | Invasive Cronobacter Infection (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2214 | Necrotizing Enterocolitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2216 | Abscess [Brain] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2218 | Urinary Tract Infection (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2220 | Amniotic Fluid (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2221 | Congenital Cytomegalovirus (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2231 | Congenital Cytomegalovirus Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2233 | Cytomegalovirus Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2241 | Stillbirth (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2247 | Extrapulmonary [NTM] (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2250 | Lower Respiratory [Excluding Sputum] (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2255 | Carbapenem Resistant Bacterial Infection [Carbapenemase Producing] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2256 | CP_CRE (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2259 | Neonatal Abstinence Syndrome (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.226 | Lyme Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2261 | High Pitched Cry (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2262 | Inability to Console (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2264 | Hypertonia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2266 | Tremors (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2268 | Myoclonus (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2270 | Poor Sleep (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2272 | Alterations in Feeding (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2274 | Excoriation (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2276 | Sneezing (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2278 | Nasal Congestion (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2280 | Yawning (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2281 | Cutaneous Mottling (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2282 | Sweating (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2284 | Feeding Intolerance (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2286 | Respiratory Distress or Nasal Flaring (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2289 | In Utero Substance Exposure (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2291 | Childbirth (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2295 | Opioids, Benzodiazepines, or Barbiturates (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2296 | NonOpioid, NonBenzodiazepine, or NonBarbiturate Substances (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2297 | Exposure or suspected exposure to harmful algae or algae toxins (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2305 | Gram_negative Diplococcus (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2307 | D_Transposition of the Great Arteries (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2308 | L_Transposition of the Great Arteries (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2309 | Transposition of the Great Arteries [Unspecified] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2311 | Interrupted Aortic Arch (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2313 | Coarctation of the Aorta (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2315 | Ebstein Anomaly (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2317 | Pulmonary valve atresia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2319 | Pulmonary valve stenosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2321 | Fetal Pulmonary valve stenosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2322 | Double Outlet Right Ventricle (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2324 | Hypoplastic left heart syndrome (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2326 | Single Ventricle (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2328 | Tetralogy of Fallot (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2330 | Truncus Arteriosus (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2332 | Atrioventricular septal defect (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2334 | Total Anomalous Pulmonary Venous Connection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2336 | Tricuspid valve atresia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2338 | Tricuspid valve stenosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2340 | Fetal Tricuspid valve stenosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2341 | Exposure to Measles (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2342 | Increased Risk for Exposure to Measles (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2349 | Consistent with Tuberculosis (Finding in Chest Xray Imaging Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2356 | Skin (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2358 | Unspecified Tissue (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2368 | Perinatal Hepatitis B (Maternal Hepatitis B Virus Infection) (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2369 | Necrotizing Fasciitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2371 | Renal Impairment [Acute or Unspecified] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2373 | Coagulopathy [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2375 | Rash [Erythematous, Macular, or Desquamating of Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2377 | Soft Tissue Necrosis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2381 | Specimen from a Nonsterile Site (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2383 | Absence of Skin Lesions (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2384 | Neuralgia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2386 | Peripheral Nerve Thickening (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2387 | Nerve (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2407 | Firearm Injury (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2415 | Cranial Nerve Involvement (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2416 | Unusual Change in Behavior (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2417 | Radiculitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2418 | Subarachnoid Hemorrhage (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2420 | Discitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2423 | Respiratory Insufficiency [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2425 | Conjunctival Suffusion (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2430 | Pleural effusion (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2432 | Abdominal swelling (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2434 | Neck swelling (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2436 | Diaphoresis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2438 | Edema (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2442 | Anthrax [Anthrax toxin lethal factor] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2443 | Influenza A (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2444 | Influenza B (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2445 | Influenza [Unspecified] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2452 | Influenza (unspecified influenza virus in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2453 | Influenza (influenza B virus in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2463 | Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2464 | CP_ Carbapenem Resistant Enterobacterales (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2470 | Enterobacterales species [excluding Proteus spp., Providencia spp., and Morganella spp.] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2471 | Proteus spp., Providencia spp., and Morganella spp. (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2473 | Enterobacterales species [Carbapenem Resistant] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2474 | Enterobacterales species [Carbapenemase Producing] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2475 | Aortic valve stenosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2479 | Microtia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2480 | Anotia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2482 | Anophthalmia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2484 | Microphthalmia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2486 | Atrial septal defect (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2488 | Fetal Aortic valve stenosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2489 | Congenital Posterior Urethral Valves (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2491 | Bladder Exstrophy (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2493 | Encephalocele (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2496 | Choanal Atresia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2498 | Cloacal Exstrophy (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2500 | Renal Agenesis or Hypoplasia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2502 | Trisomy 13 (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2504 | Fetal Trisomy 13 (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2506 | Galactosemia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2516 | Hypospadias (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2518 | Trisomy 18 (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2519 | Fetal Trisomy 18 (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2527 | Chlamydia species [Unspecified] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2528 | Ventricular septal defect (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2531 | Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.264 | Viral Hemorrhagic Fever (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.272 | Present or Positive Lab Result Value |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.287 | Varicella (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.300 | Meningococcal Disease (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.304 | Pesticide Related Illness (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.329 | Apnea (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.333 | Shigellosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.340 | Influenza (influenza A or B virus in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.341 | Campylobacteriosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.353 | Diarrhea (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.356 | HIV Infection (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.359 | Botulism (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.362 | Hansen’s Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.365 | Silicosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.371 | Cryptosporidiosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.375 | Cyclosporiasis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.386 | Vibriosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.395 | Syphilis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.40 | STEC Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.408 | Hepatitis B Virus Infection (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.422 | Tuberculosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.43 | Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.460 | HIV Infection or AIDS (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.48 | Salmonellosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.494 | Ehrlichiosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.505 | Toxic Shock Syndrome (TSS) (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.516 | Brucellosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.534 | Smallpox (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.542 | Spotted Fever Rickettsiosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.580 | Arboviral Disease [Other] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.586 | Viral Hemorrhagic Fever (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.6 | Diphtheria (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.606 | Tuberculosis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.632 | Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.650 | Jaundice (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.660 | Hypertonia [Excluding Congenital Hypertonia] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.663 | Erythema Nodosum (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.664 | Congenital Zika Syndromes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.666 | Guillain Barré syndrome (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.668 | Rash (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.672 | Arthralgia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.674 | Conjunctivitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.676 | Pregnant (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.677 | Postpartum (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.679 | Hearing Loss (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.681 | Abdominal Pain (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.686 | Erythema Multiforme (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.692 | Eosinophilia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.702 | Weight Loss (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.709 | Cough [Non Productive] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.711 | Wound Infection (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.714 | Sepsis [Septicemia] [Unspecified Organism] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.715 | Meningitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.718 | Cellulitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.719 | Myositis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.721 | Otitis Media (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.723 | Otitis Externa (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.727 | Acute Upper Respiratory Illness (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.733 | Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.750 | Chest Pain (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.758 | Muscle Spasms (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.763 | Parotitis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.765 | Aseptic Meningitis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.766 | Encephalitis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.777 | Mastitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.779 | Pancreatitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.789 | Purpura (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.79 | Campylobacteriosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.793 | Novel Influenza A Virus Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.794 | Sore Throat (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.795 | Influenza (influenza A virus in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.796 | Influenza (Novel influenza A virus in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.809 | Headache (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.810 | Backache (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.823 | Pneumoconiosis (Unspecified) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.836 | Lead in Blood (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.839 | Acid Fast Bacilli (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.86 | Hemolytic Uremic Syndrome (HUS) (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.864 | Nausea (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.865 | Confusion (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.867 | Dyspnea (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.869 | Loss of Consciousness (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.87 | Thrombotic Thrombocytopenic Purpura (TTP) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.875 | SARS (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.881 | Difficulty Breathing (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.895 | Rhinorrhea (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.907 | Arthritis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.91 | Cough (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.910 | Epididymitis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.914 | Osteomyelitis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.918 | Spondylitis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.928 | Bleeding [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.930 | ECG Abnormalities [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.931 | Hematemesis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.934 | Hematuria [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.935 | Hemoptysis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.937 | Gastrointestinal Hemorrhage [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.942 | Petechiae [Non Traumatic] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.952 | Thrombocytopenia [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.956 | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.957 | Regional Lymphadenitis [Including Bubo] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.96 | Salmonellosis [Salmonella Species and Subspecies] (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.963 | Arboviral Disease [Other] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.969 | Proteinuria [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.970 | Bulbar Weakness (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.976 | Dysphagia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.978 | Impaired Respiration [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.979 | Botulism (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.98 | Shigellosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.999 | Chlamydia species (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.110 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.112 | Pressure Injury Deep Tissue |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.113 | Pressure Injury Stage 2, 3, 4 or Unstageable |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.122 | Inpatient Falls |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.125 | Bleeding at Non Critical Site |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.143 | Bleeding at Critical Site |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.144 | Bleeding at Critical Site |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.146 | Bleeding at Non Critical Site |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.160 | Abdominal or Pelvic CT Scan with Contrast |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.163 | Ultrasound of Lower Extremities |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.165 | Ultrasound of Lower Extremities |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.171 | Inpatient Falls |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.188 | Extracorporeal Membrane Oxygenation (ECMO) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.191 | Intra Aortic Balloon Pump |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.11 | Bladder Cancer Staging Ta for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.12 | Bladder Cancer staging T1 for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.13 | Bladder Cancer staging Tis for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.15 | Carcinoma of urinary bladder, superficial |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.17 | High grade bladder cancer Ta for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.18 | Immunocompromised state for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.19 | Systemic chemotherapy for urology care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.20 | Corticosteroids for patients receiving Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.21 | Calcineurin inhibitors for patients receiving Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.23 | Immunomodulators for patients undergoing Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.24 | Monoclonal antibody for patient undergoing Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.28 | Radiotherapy for patients undergoing Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.29 | Plasmacytoid cell, morphologic abnormality for urology care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.30 | Sarcomatoid, morphologic abnormality for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.31 | Micropapillary, morphologic abnormality, for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.39 | Mixed histology urothelial cell carcinoma for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.40 | Cystectomy for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.44 | Unavailability of Bacillus Calmette Guerin for urology care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.55 | Cystectomy for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.56 | Active Tuberculosis for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.58 | Bladder Cancer Staging Tis for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.8 | Tuberculosis Diagnosis Prior to Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1151.9 | Leukemia Diagnosis Prior to Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.13 | Preventative Clinical Encounters |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.16 | Intensive Lifestyle Interventions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.17 | Intensive lifestyle interventions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.23 | Outpatient Clinical Encounters |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.24 | Outpatient Clinical Encounters |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.25 | Reason for No Intensive Lifestyle Intervention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.28 | Type 2 Diabetes Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.29 | Type 2 Diabetes Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.41 | Sickle Cell Disease with Vaso Occlusive Episode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.42 | Sickle Cell Disease with Vaso Occlusive Episode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.49 | Medication Therapy Management Services for Essential Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.79 | Medication Therapy Management Services for Essential Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.85 | Renal Colic |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.86 | Renal Colic |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1160.9 | Preventative Clinical Encounters |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1164.50 | Urinary retention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1164.52 | Urinary retention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1164.66 | Morbid Obesity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1164.67 | Morbid Obesity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.1 | Pregnancy Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.109 | Sterilization SNOMED Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.113 | Prenatal Care Specific Visits SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.114 | Prenatal Care Specific Visits |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.122 | Prenatal Care Visits SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.124 | Pregnancy Related Diagnoses SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.126 | Non Live Birth Diagnoses SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.133 | Pregnancy Related Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.134 | Female Sterilization SNOMED Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.135 | General Prenatal Care Visits |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.137 | Non Live Birth Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.138 | IUD Surveillance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.139 | IUD Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.140 | IUD Devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.141 | Contraceptive Patch SNOMED Devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.142 | Female Sterilization Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.144 | Contraceptive Patch SNOMED Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.145 | Contraceptive Patch SNOMED Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.151 | Infecund Not for Contraceptive Reasons Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.152 | Live Birth Delivery Procedures SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.153 | Contraceptive Ring SNOMED Surveillance Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.154 | Contraceptive Ring SNOMED Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.155 | Contraceptive Ring SNOMED Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.161 | Contraceptive Implant SNOMED Devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.163 | Contraceptive Implant SNOMED Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.164 | Contraceptive Implant SNOMED Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.165 | Infecund Not for Contraceptive Reasons SNOMED Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.17 | Contraceptive Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.174 | Contraceptive Patch Devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.177 | Live Birth Delivery Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.178 | Contraceptive Ring Surveillance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.18 | Contraception Not Used Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.181 | Injectable Contraceptive SNOMED Surveillance Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.182 | Injectable Contraceptive SNOMED Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.183 | Injectable Contraceptive SNOMED Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.189 | Oral Contraceptive Pill SNOMED Surveillance Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.190 | Oral Contraceptive Pill SNOMED Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.191 | Oral Contraceptive Pill SNOMED Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.192 | Contraceptive Implant SNOMED Surveillance Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.197 | Injectable Contraceptive Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.198 | Injectable Contraceptive Surveillance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.199 | Oral Contraceptive Pill Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.200 | Oral Contraceptive Pill Surveillance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.201 | Contraceptive Implant Devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.202 | Contraceptive Implant Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.203 | Contraceptive Implant Surveillance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.209 | Yes and No Answers |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.21 | Contraceptive Provision Method |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.210 | Pap Smear Results |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.22 | Pregnancy Intention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.24 | Clinical Provider Role |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.3 | Organism Detection |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.31 | English Proficiency |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.86 | Intrauterine Devices SNOMED Devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.87 | Intrauterine Devices SNOMED Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.88 | Intrauterine Device SNOMED Provision Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.89 | Intrauterine Devices SNOMED Surveillance Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1166.96 | Infecund Not for Contraceptive Reasons SNOMED Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.10 | ASN Screening Declined |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.15 | Intervention for Positive Transportation Insecurity Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.16 | Intervention for Positive Food Insecurity Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.19 | Intervention for Positive Food Insecurity Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.2 | Intracranial or Intraspinal surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.20 | Intervention for Positive Homelessness Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.21 | Intervention for Positive Housing Instability Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.27 | Mental Health Diagnosis without Substance Use Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.29 | Bed Assigned |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.3 | Malignant Intracranial Neoplasm Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.31 | Healthcare Agent & Power of Attorney Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.34 | Advance Directive Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.37 | Portable Medical Order(s) Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.38 | Advance Care Planning Discussion Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.42 | Healthcare Agent & Power of Attorney Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.43 | Advance Directive Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.45 | Advance Care Planning Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.47 | Portable Medical Order(s) Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.48 | Portable Medical Order(s) Documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.5 | Allergy to thrombolytics |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.50 | Intervention for Positive Utility Insecurity Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.52 | Intervention for Positive Transportation Insecurity Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.54 | Intervention for Positive Housing Instability Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.56 | Intervention for Positive Homelessness Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.57 | Non Invasive Oxygen Therapy Device Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.6 | Thrombolytics Adverse Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1170.8 | Intervention for Positive Utility Insecurity Screen |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1176.58 | Food Insecurity Screening Positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.100 | Allergy or Intolerance to ACE Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.101 | Allergy or Intolerance to ARB Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.102 | Chronic Kidney Disease Stage 1 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.103 | Chronic Kidney Disease Stage 2 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.104 | Chronic Kidney Disease Stage 3 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.105 | Chronic Kidney Disease Stage 4 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.106 | Chronic Kidney Disease Stage 5 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.111 | AHA GWTG Chronic Kidney Disease Stage 2 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.115 | AHA GWTG Chronic Kidney Disease Stage 1 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.116 | AHA GWTG Chronic Kidney Disease Stage 3 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.117 | AHA GWTG Chronic Kidney Disease Stage 4 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.118 | SNOMED CT Atrial Fibrillation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.121 | AHA GWTG Atrial Fibrillation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.123 | SNOMED CT Hyperlipidemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.125 | AHA GWTG Hyperlipidemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.126 | SNOMED CT Hypertriglyceridemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.129 | AHA GWTG Hypertriglyceridemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.130 | SNOMED CT Gestational Diabetes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.132 | AHA GWTG Gestational Diabetes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.133 | SNOMED CT Hyperglycemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.135 | AHA GWTG Hyperglycemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.136 | SNOMED CT Nonobstructive CAD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.138 | AHA GWTG Nonobstructive coronary artery disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.15 | Non Tobacco Smoking Product User |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.21 | Referral to cardiac rehab |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.22 | Cardiac Rehabilitation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.32 | Heart Transplant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.33 | Heart Transplant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.34 | Allergy to MRA Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.40 | Cardiac Rehabilitation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.5 | Hypothyroidism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.52 | Cardiac Pacer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.53 | Cardiac Pacer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.55 | Heart Transplant Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.56 | Heart Transplant Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.57 | Left Ventricular Assist Device Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.58 | Left Ventricular Assist Device Complications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.6 | Hypothyroidism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.60 | Left Ventricular Assist Device Placement |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.61 | Left Ventricular Assist Device Placement |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.67 | Diastolic Heart Failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.68 | Diastolic Heart Failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.69 | Allergy to SGLT2 Inhibitors |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.70 | Intolerance to SGLT2 Inhibitors |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.71 | Intolerance to MRA Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.74 | Mitral Stenosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.75 | Mitral Stenosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.77 | Mechanical Prosthetic Heart Valve |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.78 | Mechanical Prosthetic Heart Valve |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.8 | Anorexia Nervosa |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.83 | Systolic Heart Failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.84 | Systolic Heart Failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.9 | Anorexia Nervosa |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.96 | AHA GWTG Long COVID19 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1178.97 | AHA GWTG Long COVID19 SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.1 | Wound internal item and/or body structure visible value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.11 | Wound exudate appearance value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.12 | Wound exudate color value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.13 | Exudate odor value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.14 | Wound anatomic location value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.16 | Skin temperature value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.17 | Skin color enumerated value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.18 | Skin turgor value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.19 | Skin and mucous membrane integrity value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.2 | Periwound condition value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.20 | Skin moisture value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.3 | Wound Type Etiology value set |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.4 | Wound episode value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.6 | Wound bed appearance value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.60 | Wound type reference set |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.7 | Wound bed color value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.74 | Nonverbal pain indicators reference set |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.76 | Pain associated signs and symptoms reference set |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.77 | Pain body location reference set |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.8 | Wound edge description value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.80 | Pain quality reference set |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.81 | Pain speed of onset reference set |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1181.9 | Presence absence value set (foundation metadata concept) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1186.2 | Common drug classes for allergy and intolerance documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1186.3 | Common dietary substances for allergy and intolerance documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1186.4 | Common environmental substances for allergy and intolerance documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1186.5 | Common refutations for substance causes for allergy and intolerance documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1186.7 | Common substances for allergy and intolerance documentation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1186.8 | Common substances for allergy and intolerance documentation including refutations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.11 | NHSNCriterionOfDiagnosisCode(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.13 | NHSNInfectionConditionCode(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.15 | NHSNInfectionTypeCode(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.17 | NHSNInfectionFirstReportedSource(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.19 | NHSNLOS/MENDischargeDisposition(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.23 | NHSNSameDayOutcomeMeasure(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.25 | NHSNSignificantPathogenCode(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.27 | NHSNSpinalFusionApproachCode(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.29 | NHSNVascularAccessTypeCode(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.31 | NHSNVascularSpecimenCollectionSite(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.6 | NHSNPathogenCodeARO |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.74 | Enteral Medication Route |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.75 | Intravenous Medication Route |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.8 | NHSNRoleOfPerformerCode(SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.88 | Digestive, Intramuscular, Intravenous Route of Administration |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1190.91 | Long Term Care Discharge Disposition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1139 | S4G Hyperlipidemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1291 | S4G Cardiomyopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1292 | S4G Tricuspid valve disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1293 | S4G Pompe disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1294 | S4G Malignant hyperthermia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1295 | S4G Malignancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1297 | S4G Intestinal polyp |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1298 | S4G Hamartoma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1299 | S4G Diabetes mellitus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1300 | S4G Muscular dystrophy and weakness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1325 | S4G Hamartoma and S4G Intestinal Polyp |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1326 | S4G Malignancy and S4G Intestinal Polyp |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.1358 | Beta lactam medicinal product SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.4466 | Pharyngeal specimens |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.4467 | Urogenital & Anorectal Specimens |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.788 | Social Determinants of Health Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.789 | Social Determinants of Health Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1196.790 | Social Determinants of Health Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1206.51 | VTE Symptoms |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1206.53 | Provider Types |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1206.60 | Screening Mammogram (SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1206.64 | Diagnostic Mammography (SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1206.67 | BI_RADS Categories 0, 4, and 5 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1206.68 | BI_RADS Categories 1, 2, and 3 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1213.115 | Kratom containing compounds |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1213.121 | Gastrointestinal bleeding episode and Risk of GI Bleeding 1 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1213.123 | Gastrointestinal bleeding episode and Risk of GI Bleeding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.1 | Bronchiectasis Disorder SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.101 | Occupational Therapy Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.103 | Speech Language Therapy Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.105 | Intermittent Skilled Nursing Home Health Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.107 | Breathing Test Procedure During Sleep |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.11 | Interstitial Lung Disease SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.115 | Spine or Neck Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.117 | Spine or Neck Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.119 | Hypoventilation Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.12 | Interstitial Lung Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.121 | Hypoventilation Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.122 | Respiratory Assist Device Qualifying Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.134 | Sleep Related Symptom for Positive Airway Pressure Device Use Evaluation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.135 | Past Medical History Condition Related to Need for Positive Airway Pressure Device |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.136 | Home or Facility Care Location |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.137 | Fracture of Bone Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.139 | Fracture of Bone Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.14 | Cystic Fibrosis Lung Disease SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.140 | Severe Obesity Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.142 | Severe Obesity Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.143 | Transfer from Bed Impairment SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.145 | Transfer from Bed Impairment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.146 | Ability to Safely Sit in Chair or Wheelchair Impairment SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.148 | Ability to Safely Sit in Chair or Wheelchair Impairment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.149 | Fall or Fall Risk from Wheelchair or Stretcher SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.15 | Cystic Fibrosis Lung Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.152 | Muscle, Tendon or Joint Contracture Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.154 | Muscle, Tendon or Joint Contracture Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.155 | Muscle Weakness or Myasthenia Gravis Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.158 | Myocardial Infarction Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.16 | Neoplasm of Lung or Trachea Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.160 | Myocardial Infarction Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.161 | Amputation Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.164 | Lower Extremity Deep Vein Thrombosis Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.167 | Spinal Cord Injury or Paralysis Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.169 | Spinal Cord Injury or Paralysis Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.170 | Demyelinating Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.172 | Demyelinating Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.173 | Grade 2, 3 or 4 Decubitus Ulcer on Buttock Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.176 | Wound Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.178 | Wound Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.179 | Danger to Self or Others Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.18 | Neoplasm of Lung or Trachea Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.181 | Danger to Self or Others Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.182 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.184 | Behavioral Disorder Related to Need for Non Emergency Ambulance Transfer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.185 | Pain on Movement or Joint Pain Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.187 | Pain on Movement or Joint Pain Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.188 | Non Emergency Ambulance Transport Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.189 | Osteoarthritis Disorder SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.19 | Secondary Erythrocytosis Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.191 | Osteoarthritis Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.194 | Non Emergency Ambulance Transport Qualifying Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.198 | Hepatic Medical History |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.21 | Secondary Erythrocytosis Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.23 | Acute or Chronic Heart Failure Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.24 | Acute or Chronic Heart Failure Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.25 | Home Oxygen Therapy Qualifying Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.26 | Device Use Patient Activity Level |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.29 | Sleep Apnea or Breathing Related Sleep Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.3 | Bronchiectasis Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.31 | Sleep Apnea or Breathing Related Sleep Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.34 | Diabetes Mellitus Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.35 | Diabetes Mellitus Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.36 | Restrictive Lung Disease SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.38 | Restrictive Lung Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.39 | Chest Wall Deformity Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.41 | Chest Wall Deformity Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.42 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.44 | Motor Neuron Disease or Spinal Muscular Atrophy Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.45 | Chronic Respiratory Failure Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.47 | Chronic Respiratory Failure Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.48 | Ventilator Therapy Qualifying Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.5 | Chronic Obstructive Lung Disease SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.6 | Chronic Obstructive Lung Disease (COPD) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.64 | Urinary Incontinence Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.66 | Urinary Incontinence Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.67 | Chronic Urinary Retention Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.69 | Chronic Urinary Retention Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.70 | Urinary Incontinence or Chronic Urinary Retention Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.8 | Hypoxemia Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.81 | Organ Transplant History Significant to Immunosuppressive Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.86 | Hyperglycemia or Hypoglycemia Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.88 | Hyperglycemia or Hypoglycemia Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.9 | Hypoxemia Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.90 | Organ Transplant Procedure Significant to Immunosuppressive Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.91 | Pulmonary Hypertension Disorder SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.93 | Pulmonary Hypertension Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.95 | Physical Therapy Procedure SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.96 | Occupational Therapy Procedure SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.97 | Speech Language Therapy Procedure SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1219.99 | Physical Therapy Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.135 | Last Menstrual Period (LMP) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.149 | Abortion, All (SNOMED CT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.150 | Abortion, All |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.156 | Abortion, Elective |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.165 | Abortion, Elective |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.167 | Abortion, Surgical Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.168 | Abortion, Surgical Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.170 | Abortion, Spontaneous / Miscarriage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.171 | Abortion, Spontaneous / Miscarriage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.173 | Contraception, Counseling |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.174 | Contraception, Counseling |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.180 | Contraception, Surveillance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.182 | Contraception, Surveillance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.187 | Infertility, Female |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.188 | Infertility, Female |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.190 | Infertility, Male |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.191 | Infertility, Male |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.192 | Infertility, All |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.194 | Gender Identity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.195 | Intersex Surgery, History |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.196 | Intersex Surgery, Non specific |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.197 | Intersex Surgery, Female to Male |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.199 | Intersex Surgery, Female to Male |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.200 | Intersex Surgery, Male to Female Sex |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.202 | Intersex Surgery, Male to Female Sex |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.203 | Intersex Surgery, All |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.205 | Stillbirth |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1221.208 | Sexual Orientation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.100 | Sleep Apnea Disorders SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.102 | Sleep Apnea Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.103 | PostTraumatic Stress Disorder PTSD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.105 | PostTraumatic Stress Disorder PTSD SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1203 | Medication Literacy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1213 | Elder and Child Abuse SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1229 | Education Level SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1281 | Elder and Child Abuse |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1375 | Tinnitus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1377 | Brain Fog |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1378 | Depression Symptoms |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1379 | Mood Swings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1380 | Anxiety |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1381 | Lightheadedness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1382 | Stress |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1383 | Grief and Suffering |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1384 | Insomnia and Other Sleep Difficulties |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1385 | Impaired Sense of Taste |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1386 | Pink Eye Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1388 | Pink Eye Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1392 | Lymphadenopathy Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1394 | Lymphadenopathy Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1395 | Visual Changes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1396 | Impaired Sense of Smell |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1398 | Fatigue |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1399 | Chills |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1400 | Fever |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1401 | Functional and Mobility Impairment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1403 | Orthostatic Intolerance |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1405 | Cough |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1406 | Dyspnea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1409 | Wheezing |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1413 | Sinonasal Congestion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1414 | Respiratory Distress |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1415 | Edema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1419 | Weight Changes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1422 | Immunologic Changes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1424 | Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1425 | Arthralgia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1426 | Chest Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1427 | Headache |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1428 | Myalgia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1429 | Back Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1430 | Pain in Extremities |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1431 | Pain in Throat |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1432 | Palpitations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1433 | Tachycardia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1434 | Bleeding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1435 | Abdominal Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1436 | Diarrhea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1437 | Gastroesophageal Reflux |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1438 | Nausea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1439 | Vomiting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1440 | Constipation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1441 | Difficulty Swallowing |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1443 | Loss of Appetite |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1444 | Paresthesia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1445 | Rash |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1446 | Covid Toes (Toes and/or Fingers) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1447 | Itching |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1448 | Menstrual Cycle Irregularities |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1449 | Lower Urinary Tract Symptoms |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1450 | Urinary Incontinence |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1451 | Dizziness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1453 | Hair Loss |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1455 | Disability Severity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1456 | Hypercoagulability |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1457 | Post Exertional Malaise |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1458 | Chronic Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1459 | Neurogenic Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1460 | Impaired Hearing |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1461 | Parkinsonia Like Symptoms |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1462 | Bronchiectasis Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1463 | Bronchiectasis Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1464 | Chronic obstructive pulmonary disease (COPD) Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1466 | Chronic obstructive pulmonary disease (COPD) Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1467 | Interstitial lung disease Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1469 | Interstitial lung disease Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1470 | Asthma Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1472 | Asthma Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1473 | Fibromyalgia Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1475 | Fibromyalgia Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1477 | Herpes zoster Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1478 | Herpes zoster |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1479 | Pulmonary embolism Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1481 | Pulmonary embolism Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1482 | Hypertension, Pulmonary Hypertension SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1484 | Hypertension, Pulmonary Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1485 | Language and Speech Problems |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1486 | Postural tachycardia syndrome (POTS) Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1488 | Postural tachycardia syndrome (POTS) Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1489 | Functional disorder of gastrointestinal tract Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1491 | Functional disorder of gastrointestinal tract Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1492 | Autonomic dysfunction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1496 | Mast Cell Activation Syndrome (MCAS) Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1498 | Mast Cell Activation Syndrome (MCAS) Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1500 | Debility or Frailty SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1502 | Debility or Frailty |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1503 | Ehlers Danlos syndrome (EDS) Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1505 | Ehlers Danlos syndrome (EDS) Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1506 | Malnutrition Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1508 | Narcolepsy Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1510 | Narcolepsy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1514 | Small Fiber Neuropathy Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1516 | Small Fiber Neuropathy Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1517 | Malnutrition Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1518 | Neuropathy Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1519 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1521 | Multisystem Inflammatory Syndrome in Adults (MIS A) Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1522 | Congestive heart failure Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1524 | Congestive heart failure Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1526 | Cognitive disorder SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1527 | Post Acute Sequelae of Sars Cov 2 infection (PASC) SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1530 | Post Acute Sequelae of Sars Cov 2 infection (PASC) Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1531 | Hypertension, Persistent SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1532 | Acute Renal Failure Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1534 | Acute Renal Failure Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1535 | Complication due to Diabetes Mellitus Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1537 | Complication due to Diabetes Mellitus Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1538 | Coronary Revascularization History SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1540 | Coronary Revascularization History |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1541 | Heart Failure Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1543 | Heart Failure Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1547 | Hypertension, Primary and Secondary Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1548 | Cerebrovascular Disease Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1549 | Cerebrovascular Disease Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1550 | Migraine Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1552 | Migraine Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1553 | Chronic Tension type Headache Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1555 | Chronic Tension type Headache Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1556 | Low Back Pain SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1558 | Low Back Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1559 | Metabolic Syndrome Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1561 | Metabolic Syndrome Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1563 | Hypertension, Persistent |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1564 | Pregnancy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1566 | Pregnancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.157 | Chronic Kidney Disease All Stages (1 through 5) SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.159 | Chronic Kidney Disease All Stages (1 through 5) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1595 | Acute COVID 19 Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1599 | Cardiomyopathy Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1601 | Atherosclerotic Cardiovascular Disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1603 | Neuropathy Diagnosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.1606 | Left Ventricular Hypertrophy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.22 | Alcohol Use Disorder SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.25 | Peripheral Vascular Disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.27 | Peripheral Vascular Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.28 | Hepatitis C Condition SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.30 | Hepatitis C Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.31 | Diabetic Neuropathy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.33 | Diabetic Neuropathy Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.36 | Obesity Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.37 | Obesity SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.4 | Chronic Kidney Disease Type or Cause SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.41 | Tuberculosis (Disorders) SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.417 | Prediabetes (Borderline Diabetes) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.419 | Prediabetes (Borderline Diabetes) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.420 | Maturity Onset Diabetes of the Young (MODY) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.43 | Tuberculosis Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.45 | Hypoalbuminemia Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.47 | Hypoalbuminemia Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.48 | Hyperkalemia Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.481 | Diabetic Coma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.482 | Diabetic Coma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.491 | Diabetic Peripheral Angiopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.492 | Diabetic Peripheral Angiopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.496 | Cataract of the Eye |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.498 | Cataract of the Eye |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.499 | Rubeosis Iridis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.50 | Hyperkalemia Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.501 | Rubeosis Iridis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.507 | Emotional Distress caused by Chronic Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.508 | Emotional Distress caused by Chronic Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.51 | Anemia Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.512 | Hypoglycemic Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.513 | Hypoglycemic Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.514 | Hypoglycemia Unawareness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.516 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.517 | Hyperglycemic Hyperosmolar Nonketotic Syndrome HHNS |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.519 | Ketoacidosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.520 | Ketoacidosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.522 | Diabetic Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.523 | Diabetic Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.525 | Diabetic Foot Ulcer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.526 | Diabetic Foot Ulcer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.529 | Charcot Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.53 | Anemia Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.531 | Charcot Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.533 | Cellulitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.535 | Diabetic Hand or Diabetic Cheiroarthropathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.539 | Necrobiosis Lipoidica (Skin Lesions) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.540 | Necrobiosis Lipoidica (Skin Lesions) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.542 | Gangrene |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.543 | Gangrene |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.545 | Dupuytren's Contracture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.546 | Dupuytren's Contracture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.548 | Scleroderma or Thick Skin Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.549 | Scleroderma or Thick Skin Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.555 | Acanthosis Nigricans |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.556 | Acanthosis Nigricans |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.557 | Eruptive Xanthomatosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.559 | Periodontitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.560 | Periodontitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.562 | Amputated Limb (Not Traumatic) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.563 | Amputated Limb (Not Traumatic) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.565 | Hypertension, Essential or Primary SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.568 | Hypertension, Secondary SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.571 | Hypertension Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.579 | Cardiomyopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.58 | Hypercalcemia Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.580 | NYHA Heart Failure Functional Classifications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.581 | American Heart Association Heart Failure Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.584 | Atherosclerotic Cardiovascular Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.586 | Gout |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.587 | Psoriatic Arthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.588 | Reactive Arthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.591 | Cannabis Use |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.592 | Hearing Impairment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.6 | Chronic Kidney Disease Type or Cause |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.60 | Hypercalcemia Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.607 | Angina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.608 | Angina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.61 | Hypocalcemia Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.610 | Unstable Angina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.611 | Unstable Angina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.613 | Ischemic Heart Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.614 | Ischemic Heart Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.615 | Left Ventricular Hypertrophy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.618 | Stroke |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.620 | Transient Ischemic Attack |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.621 | Transient Ischemic Attack |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.626 | Aneurysm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.627 | Aneurysm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.63 | Hypocalcemia Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.635 | Aortic Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.636 | Aortic Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.638 | Carotid Stenosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.639 | Carotid Stenosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.64 | Hyperphosphatemia Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.641 | Intracranial Stenosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.642 | Intracranial Stenosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.644 | Pulmonary Edema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.645 | Pulmonary Edema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.647 | Osteoarthritis (Oa) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.648 | Osteoarthritis (Oa) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.650 | Rheumatoid Arthritis (Ra) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.651 | Rheumatoid Arthritis (Ra) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.653 | Infectious Arthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.654 | Infectious Arthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.656 | Temporomandibular Disorder Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.659 | Irritable Bowel Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.66 | Hyperphosphatemia Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.660 | Irritable Bowel Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.662 | Neuropathic Pain (Neuralgia) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.663 | Neuropathic Pain (Neuralgia) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.665 | Neuromas |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.666 | Neuromas |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.668 | Phantom Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.669 | Phantom Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.67 | Hematuria Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.671 | Entrapment Neuropathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.672 | Entrapment Neuropathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.674 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.675 | Myalgic Encephalomyelitis or Chronic Fatigue Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.677 | Psychotic Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.678 | Psychotic Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.680 | Post Partum Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.681 | Post Partum Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.683 | Seasonal Affective Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.684 | Seasonal Affective Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.686 | Psychological Trauma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.687 | Psychological Trauma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.689 | Grief or Loss |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.69 | Hematuria Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.690 | Grief or Loss |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.692 | Suicide Risk |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.693 | Suicide Risk |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.695 | Vaping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.696 | Vaping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.699 | Tobacco Use or Exposure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.70 | Metabolic Acidosis Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.701 | Binge Drinking |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.702 | Binge Drinking |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.705 | Drug Misuse |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.707 | Drug Misuse |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.709 | Sensory Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.714 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.715 | Lower Urinary Tract Symptoms (LUTS) From Benign Prostatic Hyperplasia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.717 | Urinary Incontinence |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.718 | Urinary Incontinence |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.72 | Metabolic Acidosis Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.720 | Urinary Urgency |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.721 | Urinary Urgency |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.723 | Urinary Frequency |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.724 | Urinary Frequency |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.726 | Nocturia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.727 | Nocturia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.729 | Pelvic Organ Prolapse |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.73 | Hyperlipidemia Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.730 | Pelvic Organ Prolapse |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.732 | Erectile Dysfunction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.733 | Erectile Dysfunction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.735 | Interstitial Cystitis or Bladder Pain Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.736 | Interstitial Cystitis or Bladder Pain Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.738 | Recurrent Urinary Tract Infections |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.739 | Recurrent Urinary Tract Infections |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.741 | Hypertriglyceridemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.742 | Hypertriglyceridemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.744 | Hypothyroidism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.745 | Hypothyroidism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.747 | Menopause |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.748 | Menopause |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.75 | Hyperlipidemia Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.750 | Testicular Hypofunction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.751 | Testicular Hypofunction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.753 | Primary Aldosteronism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.754 | Primary Aldosteronism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.756 | Restless Leg Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.757 | Restless Leg Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.76 | Chronic Pain Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.760 | Claudication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.761 | Claudication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.762 | Angioedema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.764 | Angioedema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.769 | Nonalcoholic Fatty Liver Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.770 | Nonalcoholic Fatty Liver Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.772 | Thalassemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.773 | Thalassemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.78 | Chronic Pain SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.79 | Arthritis Disorders SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.800 | Temporomandibular Disorder Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.81 | Arthritis Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.82 | Preeclampsia Disorders SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.84 | Preeclampsia Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.840 | Spinal Cord Compression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.841 | Spinal Cord Compression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.843 | Alcohol Use (Revised 2021) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.845 | Alcohol Use |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.85 | Hyperuricemia Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.87 | Hyperuricemia Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.88 | Vitamin D Deficiency Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.90 | Vitamin D Deficiency Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.91 | Alkaline Phosphatase Deficiency Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.93 | Alkaline Phosphatase Deficiency Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.95 | Uremic Pruritus Conditions SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.96 | Uremic Pruritus Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.97 | Insomnia Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1222.99 | Insomnia Disorders SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1225.5 | Glaucoma SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1226.1 | Scleritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1226.3 | Scleritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1228.6 | Outpatient Encounter Locations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.60 | Guillain Barre Syndrome, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.61 | Febrile seizure, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.62 | Encephalomyelitis and encephalitis, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.63 | Disseminated Intravascular Coagulation, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.64 | Deep Vein Thrombosis, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.65 | Bells Palsy, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.66 | Appendicitis, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.67 | Anaphylaxis, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.68 | Acute Myocardial Infarction, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.69 | Multisystem Inflammatory Syndrome, SNOMED codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.7 | Anaphylaxis, SNOMED codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.70 | Multisystem Inflammatory Syndrome, diagnosis codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1234.8 | Appendicitis, SNOMED codes for AE reporting |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.100 | Cardiomyopathy Hypertrophic Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.167 | End Stage Renal Disease (ESRD)_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.172 | End Stage Renal Disease (ESRD)_HD_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.173 | Systolic Blood Pressure_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.176 | Systolic Blood Pressure_HD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.177 | Diastolic Blood Pressure_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.18 | Annual Physical SNOMED CN5 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.180 | Diastolic Blood Pressure_HD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.181 | Remote Blood Pressure_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.182 | Remote Blood Pressure_HD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.184 | Acute Inpatient_CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.186 | Acute Inpatient_HD_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.188 | ED Visit_CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.190 | Pregnancy_HD_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.191 | Pregnancy_CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.193 | ED Visit_HD_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.194 | Lipid Panel_Event_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.198 | Lipid Panel_Event_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.20 | Annual Physical CN5 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.203 | Unknown Glucose_Event_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.204 | Unknown Glucose_Lab_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.205 | Bone Marrow Transplant CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.207 | Bone Marrow Transplant_HD_CN_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.211 | Immunocompromising Conditions_HD_CN_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.212 | Immunocompromising Conditions CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.213 | Cerebrospinal Fluid Leak CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.215 | Cerebrospinal Fluid Leak_HD_CN_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.216 | Anatomic or Functional Asplenia CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.219 | Anatomic or Functional Asplenia_HD_CN_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.220 | Sickle cell Anemia and HB S Disease CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.222 | Sickle cell Anemia and HB S Disease_HD_CN_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.223 | Pneumococcal Vaccine CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.227 | Pneumococcal Vaccine_HD_CN_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.228 | Influenza Vaccine CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.232 | Influenza Vaccine_HD_CN_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.233 | Cochlear Implant CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.237 | Cochlear Implant_HD_CN_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.238 | Chemotherapy CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.241 | Chemotherapy_HD_CN_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.254 | Pregnancy Loss_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.257 | Pregnancy Loss_HD_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.260 | Heart Failure (CHF)_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.265 | Heart Failure (CHF)_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.276 | LDL_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.280 | LDL_Lab_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.298 | FIT DNA_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.299 | FIT DNA Test_Lab_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.303 | Sigmoidoscopy_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.304 | Sigmoidoscopy_Event_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.308 | Colonoscopy_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.309 | Colonoscopy_Event_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.313 | FOBT Lab_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.314 | FOBT Lab Test_Lab_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.317 | Colorectal Cancer_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.318 | Colorectal Cancer_HD_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.321 | Absence of Cervix Diagnosis_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.322 | Absence of Cervix Diagnosis_HD_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.326 | Hysterectomy With No Residual Cervix_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.327 | Hysterectomy With No Residual Cervix_HD_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.331 | High Risk HPV Test_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.332 | High Risk HPV Test_HD_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.336 | Cervical Cytology_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.337 | Cervical Cytology_HD_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.340 | AFib (Atrial Fibrillation)_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.344 | AFib (Atrial Fibrillation)_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.357 | Coronary Artery Disease (CAD)_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.359 | Coronary Artery Disease (CAD)_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.360 | Allergy List_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.362 | Allergy List_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.364 | Other Revascularization_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.366 | Other Revascularization_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.367 | Ischemic Vascular Disease (IVD)_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.369 | Ischemic Vascular Disease (IVD)_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.370 | Muscular Pain and Disease_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.372 | Muscular Pain and Disease_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.373 | Cirrhosis_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.375 | Cirrhosis_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.376 | IVF_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.378 | IVF_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.382 | Pre_Hypertension (Pre_HTN)_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.384 | Family History Hypertension (HTN)_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.385 | Family History Hypertension (HTN)_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.402 | First Trimester_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.406 | First Trimester_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.409 | Birth Event_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.413 | Birth Event_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.414 | Obesity_Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.417 | Obesity_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.420 | Pre_Hypertension (Pre_HTN)_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.429 | Vitals Body Height SnoMed |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.430 | Vitals Body Height |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.434 | Anxiety_Clinical Grouping Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.436 | Anxiety_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.449 | bwell_Vital_Blood Oxygen_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.450 | bwell_Vital_Systolic Blood Pressure_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.451 | bwell_Vital_Diastolic Blood Pressure_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.452 | bwell_Vital_Heart Rate_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.455 | bwell_Vital_Body Temperature_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.458 | bwell_Vital_Respiratory Rate_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.459 | bwell_Vital_Waist Circumference_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.464 | Second Trimester_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.465 | Second Trimester_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.466 | Third Trimester_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.468 | Third Trimester_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.499 | Active Pregnancy_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.500 | Active Pregnancy_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.501 | Abnormal PSA Testing _SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.503 | Prediabetes_Clinical Grouping Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.504 | Prediabetes_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.508 | bwell_Vital_Waist Circumference_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.509 | bwell_Vital_Blood Oxygen_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.510 | bwell_Vital_Body Temperature_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.511 | bwell_Vital_Diastolic Blood Pressure_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.512 | bwell_Vital_Systolic Blood Pressure_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.515 | bwell_Vital_Heart Rate_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.516 | bwell_Vital_Respiratory Rate_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.519 | Lupus_Clinical_Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.520 | Lupus_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.523 | UTI_Clinical_Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.524 | UTI_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.530 | Postpartum_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.531 | Postpartum_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.533 | bwell_Vital_Head Circumference_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.534 | bwell_Vital_Head Circumference_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.536 | bwell_Vital_Body Surface Area_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.537 | bwell_Vital_Body Surface Area_Clinical Grouping Event |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.548 | Depression_Clinical Grouping Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.549 | Depression_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.551 | MI (Myocardial Infarction)_Clinical Grouping Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.553 | MI (Myocardial Infarction)_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.557 | CABG_Clinical Grouping Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.558 | CABG_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.563 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.564 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.566 | Essential HTN_HD_Clinical Grouping Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.567 | Essential HTN_HD_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.570 | Total and Partial Neph_HD_Clinical Grouping Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.571 | Total and Partial Neph_HD_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.577 | Kid Trans and Hx_HD_Clinical Grouping Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.578 | Kid Trans and Hx_HD_Clinical Grouping Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.587 | COPD_Clinical_Grouping_Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.588 | COPD_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.591 | Polypharmacy_Clinical_Grouping_Condition_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.593 | Polypharmacy_Clinical Condition Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.595 | Thyroid Cancer_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.597 | Thyroid Cancer_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.598 | Allergy Iodine_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.599 | Allergy to contrast_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.601 | Allergy to contrast_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.602 | Contrast induced nephropathy_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.604 | Contrast induced nephropathy_Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.605 | Systolic Blood Pressure_Compliant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.606 | Diastolic Blood Pressure_Compliant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.610 | bwell Systolic Blood Pressure Vitals_UI_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.612 | bwell Diastolic Blood Pressure Vitals_UI_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.614 | bwell Combo Blood Pressure Vitals_UI_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.615 | bwell Systolic Blood Pressure_UI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.616 | bwell Diastolic Blood Pressure_UI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.617 | bwell Combo Blood Pressure_UI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.618 | b.well Herpes Zoster Vaccine CN_HD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.619 | b.well Herpes Zoster Vaccine CN_HD_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.622 | b.well Herpes Zoster Vaccine CN_HD_2dose |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.625 | b.well Herpes Zoster Vaccine CN_HD_2dose_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.626 | b.well Herpes Zoster Vaccine CN_HD_Exclusions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.627 | b.well Herpes Zoster Vaccine CN_HD_Exclusions_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.631 | b.well Adult RSV Vaccine CN_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.637 | LP(a) Test |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.638 | b.well Adult Tetanus Vaccine CN |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.639 | BWellAdultTetanusVaccineCN_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.642 | b.well Adult Tetanus Vaccine CN_Exclusions_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.643 | b.well Adult Tetanus Vaccine CN_Exclusions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.645 | Pneumococcal Vaccine HD_CN_ Allergy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.646 | bwell COVID Vaccine CN_Allergy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.647 | bwell Covid Vaccine CN_Allergy_SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.93 | Cardiomyopathy Dilated SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.94 | Cardiomyopathy Dilated Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1235.98 | Cardiomyopathy Hypertrophic SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1237.12 | SNOMEDFindingValuesQualifierValue |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1237.13 | SNOMED Organism from LOINC Answer List |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1237.2 | SNOMED Organisms |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1240.1 | Mental Status Observation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1240.11 | Sexual Orientation Including nulls and Data Absent Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1240.12 | Pregnancy Status Observation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1240.3 | Sex |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1240.8 | Medication Adherence |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1242.2 | Sickle Cell Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1242.4 | Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.1 | Food Insecurity Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.100 | Intimate Partner Violence Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.101 | Less Than High School Education Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.103 | Less Than High School Education Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.106 | Transportation Insecurity Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.107 | Financial Insecurity Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.108 | Financial Insecurity Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.109 | Financial Insecurity Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.11 | Food Insecurity Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.110 | Medical Cost Burden Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.111 | Health Insurance Coverage Status Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.112 | Health Literacy Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.114 | Health Literacy Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.115 | Health Literacy Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.116 | Health Literacy Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.117 | Health Literacy Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.118 | Health Literacy Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.119 | Health Literacy Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.120 | Medical Cost Burden Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.121 | Health Insurance Coverage Status Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.122 | Medical Cost Burden Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.123 | Medical Cost Burden Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.124 | Health Insurance Coverage Status Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.125 | Health Insurance Coverage Status Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.137 | Cognitive disorder Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.14 | Homelessness Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.145 | Less Than High School Education Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.148 | Health Insurance Coverage Status Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.149 | Health Insurance Coverage Status Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.150 | Material Hardship Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.152 | Medical Cost Burden Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.153 | Medical Cost Burden Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.154 | Medical Cost Burden Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.158 | Homelessness Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.159 | Homelessness Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.16 | Food Insecurity Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.160 | Housing Instability Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.161 | Housing Instability Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.162 | Transportation Insecurity Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.163 | Transportation Insecurity Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.164 | Veteran Status Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.17 | Food Insecurity Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.18 | Homelessness Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.19 | Homelessness Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.20 | Homelessness Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.21 | Homelessness Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.213 | Health Insurance Coverage Status Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.214 | Veteran Status Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.215 | Veteran Status Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.217 | Digital Literacy Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.219 | Digital Literacy Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.22 | Housing Instability Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.220 | Digital Literacy Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.224 | Digital Literacy Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.225 | Digital Literacy Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.226 | Digital Literacy Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.227 | Digital Literacy Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.229 | Digital Access Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.231 | Digital Access Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.232 | Digital Access Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.233 | Digital Access Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.234 | Digital Access Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.235 | Digital Access Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.236 | Digital Access Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.24 | Housing Instability Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.241 | Utility Insecurity Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.243 | Utility Insecurity Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.244 | Utility Insecurity Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.245 | Utility Insecurity Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.246 | Utility Insecurity Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.247 | Utility Insecurity Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.25 | Transportation Insecurity Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.252 | Utility Insecurity Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.255 | Incarceration Status Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.256 | Incarceration Status Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.257 | Incarceration Status Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.258 | Incarceration Status Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.259 | Incarceration Status Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.26 | Transportation Insecurity Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.260 | Incarceration Status Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.261 | Incarceration Status Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.262 | Language Access Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.264 | Language Access Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.265 | Language Access Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.266 | Language Access Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.267 | Language Access Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.268 | Language Access Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.269 | Language Access Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.27 | Transportation Insecurity Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.28 | Transportation Insecurity Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.29 | Financial Insecurity Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.30 | Financial Insecurity Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.31 | Financial Insecurity Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.32 | Financial Insecurity Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.34 | Material Hardship Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.35 | Material Hardship Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.36 | Material Hardship Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.37 | Material Hardship Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.38 | Material Hardship Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.39 | Material Hardship Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.4 | Food Insecurity Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.41 | Unemployment Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.42 | Unemployment Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.43 | Housing Instability Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.44 | Housing Instability Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.45 | Housing Instability Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.46 | Inadequate Housing Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.48 | Inadequate Housing Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.49 | Inadequate Housing Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.5 | Social Determinants of Health General Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.50 | Inadequate Housing Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.51 | Inadequate Housing Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.52 | Inadequate Housing Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.53 | Inadequate Housing Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.54 | Less Than High School Education Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.55 | Less Than High School Education Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.56 | Less Than High School Education Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.57 | Less Than High School Education Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.58 | Unemployment Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.59 | Unemployment Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.6 | Food Insecurity Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.60 | Unemployment Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.62 | Elder Abuse Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.63 | Elder Abuse Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.64 | Elder Abuse Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.65 | Elder Abuse Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.66 | Elder Abuse Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.67 | Elder Abuse Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.68 | Elder Abuse Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.69 | Unemployment Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.7 | Food Insecurity Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.70 | Unemployment Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.71 | Social Determinants of Health Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.72 | Stress Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.73 | Stress Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.75 | Stress Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.76 | Veteran Status Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.78 | Veteran Status Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.79 | Social Connection Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.81 | Social Connection Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.82 | Intimate Partner Violence Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.84 | Intimate Partner Violence Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.85 | Stress Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.86 | Stress Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.87 | Stress Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.88 | Social Connection Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.89 | Social Connection Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.90 | Veteran Status Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.91 | Veteran Status Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.92 | Stress Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.93 | Social Connection Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.94 | Social Connection Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.95 | Social Connection Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.96 | Intimate Partner Violence Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.97 | Intimate Partner Violence Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.98 | Intimate Partner Violence Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.99 | Intimate Partner Violence Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.106 | Mechanical Ventilation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.107 | Mechanical Ventilation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.138 | COVID19 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.140 | COVID 19 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.178 | Intubation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.179 | Intubation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.180 | Tracheostomy Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.181 | Tracheostomy Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.182 | Head and Neck Surgeries with High Risk Airway Compromise |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.187 | Routes of Administration for Opioid Antagonists |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.19 | High Risk Procedures for AKI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.197 | Hospital Based Dialysis Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.199 | Hospital Based Dialysis Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.200 | Nephrectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.207 | General and Neuraxial Anesthesia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.208 | General and Neuraxial Anesthesia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.209 | Non Invasive Oxygen Therapy by Nasal Cannula or Mask |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.211 | Continuous and Bilevel Positive Airway Pressure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.213 | Non Invasive Oxygen Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.214 | Non Invasive Oxygen Therapy Devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.217 | ASA physical status class |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.220 | Smoking status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.238 | Neuromuscular Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.239 | Neuromuscular Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.240 | Degenerative Neurological Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.241 | Degenerative Neurological Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.243 | Heart and Lung Transplants |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.246 | Lung Resections and Excisions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.248 | Chest Wall Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.250 | Maxillary Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.251 | Head, Neck, and Thoracic Surgeries with High Risk Airway Compromise |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.253 | Anesthesia Requiring Monitored Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.255 | Anesthesia Requiring Monitored Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.271 | Undetectable Lab Result Value |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.272 | Undetectable Lab Result Value |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.275 | Bariatric Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.33 | Obstetrics and VTE Obstetrics |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.350 | Tuberculosis for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.351 | Tuberculosis for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.357 | Cystectomy for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.358 | Cystectomy for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.362 | Immunocompromised Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.363 | Immunocompromised Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.365 | Mixed Histology Urothelial Cell Carcinoma for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.367 | Morbid Obesity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.368 | Morbid Obesity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.369 | Unavailability of Bacillus Calmette Guerin for Urology Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.371 | Urinary Retention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.372 | Urinary Retention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.374 | Face to Face Interaction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.375 | Face to Face Interaction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.81 | Extracorporeal Membrane Oxygenation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.85 | Elective Inpatient Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.10 | Tricuspid Valve Regurgitation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.12 | Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.2 | Valvular Heart Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.22 | Acute Kidney Injury |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.23 | Anemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.24 | Cardiac Arrhythmias |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.25 | Attention Deficit and Hyperactivity Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.26 | Cerebrovascular Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.27 | Seizure Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.28 | Proteinuria |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.29 | Thyroid Hormone Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.30 | Thromboembolic Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.31 | Parkinson's Disease and Parkinsonism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.32 | Upper GI Diseases |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.33 | Failure to Thrive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.34 | Osteoporosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.35 | Mood Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.36 | Dyslipidemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.37 | Heart Failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.38 | Coronary Artery Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.39 | Chronic Kidney Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.40 | Chronic Obstructive Pulmonary Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.41 | Diabetes Mellitus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.100 | MMR Proficient |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.102 | Face To Face Interaction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.112 | Urothelial Cancer Histologies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.113 | Malignant Tumor Behavior |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.114 | Localized Bladder Cancer Stage SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.116 | Localized Bladder Cancer Staging |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.117 | Advanced Bladder Cancer Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.118 | Localized Bladder Cancer T Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.119 | Localized Bladder Cancer T Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.120 | Localized Bladder Cancer N Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.121 | Localized Bladder Cancer M Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.122 | Advanced Bladder Cancer M Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.126 | Locoregional Urothelial Cancer SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.127 | Locoregional Urothelial Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.129 | FGFR3 Gene Interpretation Positive SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.13 | HER2 Negative |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.133 | FGFR3 Gene Interpretation Positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.134 | FGFR3 Gene Interpretation Negative SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.137 | FGFR3 Gene Interpretation Negative |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.139 | Tumor Behavior |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.140 | Physcological Support for Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.141 | Referral For Pain From Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.142 | Cancer Pain Education |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.143 | Telehealth Encounters |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.144 | Pain Assessment Score |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.146 | Telehealth Encounters SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.149 | Telehealth Encounters All |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.150 | Chemo Admin SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.153 | Chemotherapy Administration All |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.156 | Radiation Treatment SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.157 | Radiation Treatment All |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.159 | Telephone Visits SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.161 | Telephone Visits All |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.165 | Referral for Depression Adult |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.166 | Referrals for Adolescent Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.167 | Follow Ups for Adolescent Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.168 | FollowUps for Adult Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.169 | Depression Screen Declined for Medical Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.17 | Metastatic Breast Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.170 | Physical Therapy Evaluations SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.172 | Physical Therapies Evaluations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.18 | Stage IA |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.183 | Locally Advanced NSCLC Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.185 | Localized NSCLC Stage Group SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.187 | Plan of Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.188 | Documentation of Plan of Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.189 | Pain Present |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.19 | Stage IB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.192 | Localized NSCLC Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.193 | Advanced NSCLC Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.194 | NSCLC M Stage (metastatic) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.195 | NSCLC T Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.196 | NSCLC N Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.197 | SCLC and rarer lung cancer histology |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.199 | EGFR Gene Interpretation Positive SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.20 | Stage IIA |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.201 | EGFR Gene Interpretation Positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.204 | EGFR Generic Molecular Variant SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.206 | EGFR Molecular Variants Osimertinib PM |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.209 | Radiation Treatment Management SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.21 | Stage IIB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.210 | Radiation Treatment Management Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.215 | Radiation Treatment Delivery SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.216 | Radiation Treatment Delivery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.22 | Stage IIIA |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.220 | MET Positive gene interpretation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.23 | Stage IIIB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.236 | ROS1 Negative (geneinterpretation) SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.238 | ROS1 Negative (geneinterpretation) SNOMEDCT,NCI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.239 | ROS1 Positive (geneinterpretation) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.24 | Stage IIIC |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.241 | ROS1 Gene Rearrangement |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.242 | RET Test (HGNC) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.243 | RET Positive (Genei interpretation ) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.244 | RET Gene Rearrangement |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.245 | RET Negative (geneinterpretaion) SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.247 | RET Negative (geneinterpretaion) SNOMEDCT,NCI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.255 | NSCLC_Tumor_resection SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.257 | NSCLC_Tumor_resection SNOMEDCT CPT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.259 | ALK Positive (geneinterpretation) SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.261 | ALK Positive (geneinterpretation) SNOMEDCT NCI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.262 | ALK Negative (geneinterpretation) SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.264 | ALK Negative (geneinterpretation) SNOMEDCT NCI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.265 | Locoregional Sites |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.266 | NSCLC N2 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.267 | NSCLC N1 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.268 | NSCLC N0 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.269 | NSCLC T3_T4 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.27 | Genetic Test Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.270 | NSCLC T2 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.271 | NSCLC T1 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.272 | Locally_Advanced_Metastatic_NSCLC Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.273 | Localized_Inclusion_NSCLC Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.274 | Localized_Exclusion_NSCLC Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.276 | Extensive SCLC Stage Group SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.278 | Extensive SCLC Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.279 | Localized SCLC Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.280 | SCLC M Stage (metastatic) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.281 | SCLC T Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.282 | SCLC N Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.283 | SCLC histology (to include those patients) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.288 | BRAF Positive (geneinterpretation) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.294 | Metastatic_Solid_Cancer_Stage Group SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.295 | Locally_Advanced_Solid_Cancer_Stage Group SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.296 | Localized_Solid_Cancer_Stage Group SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.297 | Solid cancer M Stage (metastatic) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.298 | Solid Cancer T Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.299 | Solid Cancer N Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.302 | HER2_IHC_Positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.303 | HER2 Negative (geneinterpretation/Labtestvalue) SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.307 | HER2 Negative (geneinterpretation/Labtestvalue) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.31 | HER2 Positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.313 | Localized_Solid_Cancer_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.315 | Locally_Advanced_Solid_Cancer_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.317 | Metastatic_Solid_Cancer_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.32 | HER2 Positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.320 | Solid Cancer T Stage codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.322 | RET test_Solid_cancer (HGNC) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.323 | RET Positive_Solid_Cancer (geneinterpretation) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.324 | RET Negative_Solid_Cancer (geneinterpretation) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.33 | Metastatic Breast Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.331 | Metastatic_Breast_Cancer_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.332 | Locally_Advanced_Breast_Cancer_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.333 | Localized_Breast_Cancer_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.334 | Breast cancer M Stage (metastatic) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.335 | Breast Cancer T Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.336 | Breast Cancer N Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.337 | Metastatic Sites All Breast SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.340 | Metastatic Sites All Breast (grouped, SNOMEDCT/ICD9/ICD10) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.345 | PTEN_geneinterpretation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.347 | PI3KCA_geneinterpretation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.349 | AKTI_geneinterpretation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.35 | All Metastatic Sites |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.351 | Progesterone_receptor_geneinterpretation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.353 | Estrogen_receptor_geneinterpretation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.355 | Progesterone_receptor_labinterpretation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.357 | Estrogen_receptor_labinterpretation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.358 | NSCLC M0 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.36 | All Metastatic Sites |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.362 | HER2_IHC_Negative |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.368 | HER2_Fish_test_Negative |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.369 | HER2_IHC_Equivocal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.37 | Locoregional Breast Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.370 | HER2 Positive_PM_results |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.375 | Metastatic_Thyroid_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.377 | RET Gene mutation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.378 | Locally_Advanced_Localized_Thyroid_Cancer_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.379 | Thyroid cancer M1_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.380 | Thyroid_cancer_M0_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.381 | Thyroid_cancer_T_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.382 | Thyroid_cancer_T1_T2_T3_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.383 | Thyroid_cancer_T4_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.384 | Thyroid_cancer_N1b_Stage&Above |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.385 | Thyroid_cancer_N_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.386 | Medullary_thyroid_histology |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.388 | RET Positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.389 | NSCLC N3 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.393 | Metastatic_CRC_Cancer_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.394 | Locally_Advanced_Localized_CRC_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.395 | CRC cancer M Stage (metastatic) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.396 | CRC Cancer T Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.397 | CRC Cancer N Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.399 | KRAS_negative |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.40 | Locoregional Breast Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.406 | Locally_Advanced_CRC_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.407 | Localized_CRC_Stage Group |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.408 | CRC cancer M0_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.409 | CRC_Cancer_T1_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.410 | CRC_Cancer_T2_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.411 | CRC_Cancer_T3_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.412 | CRC_Cancer_T4_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.413 | CRC Cancer N1 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.414 | CRC Cancer N2 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.415 | CRC Cancer N2b Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.418 | KRAS_positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.428 | Localized_Endometerial_Stage Group SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.431 | Endometrial_Sarcoma_Tumor_Histology_exc |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.432 | Endometrial cancer M Stage (metastatic) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.433 | Endometrial_M0_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.449 | Endometrial_ Cancer N Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.451 | Endometrial_N0_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.453 | Endometrial_N1_N2_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.455 | Endometrial_T1_T3_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.456 | Endometrial_T3_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.458 | Endometrial_T4_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.459 | Endometrial Cancer T Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.460 | Localized_Endometerial_Stage Group_SNOMED/NCIM |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.461 | Metastatic Sites All CRC |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.464 | Metastatic Sites All CRC (grouped, SNOMEDCT/ICD9/ICD10) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.466 | NTRK_Gene_rearrangment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.468 | NTRK_Positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.469 | NTRK_test_gene |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.50 | MSI High |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.502 | All Metastatic sites Endometrial SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.505 | All Metastatic sites Endometrial |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.506 | Create CRC_Cancer_T4a_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.507 | Create CRC_Cancer_T4b_Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.510 | InactiveFollowup |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.55 | MSI High |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.56 | Early and Limited Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.58 | MMR Deficient |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.60 | MMR Deficient |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.61 | Stage IIB or lower and limited |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.62 | Stage III or higher |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.63 | Stage III or higher |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.65 | Staging Unknown |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.67 | Staging Unknown |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.70 | Tumor Histology |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.78 | Advanced or Unresectable Colorectal Cancer Staging |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.79 | 0 to IIIB Colorectal Cancer Staging |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.80 | Colorectal Cancer M1 Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.83 | RAS Gene Interpretation Negative SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.85 | RAS Gene Negative |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.86 | RAS Gene Interpretation Positive SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.88 | RAS Gene Positive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.90 | Patient Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.92 | MSI Low SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.95 | MSI Low |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.97 | MMR Proficient SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1264.1 | Inpatient Pneumonia Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1264.20 | SNOMEDCT Abnormal Finding on Chest Imaging |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1264.21 | Abnormal Finding on Chest Imaging |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1264.22 | SNOMEDCT Pneumonia Definition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1264.37 | SNOMEDCT Transplant, Stem Cell and Solid |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1264.38 | Transplant, Stem Cell and Solid |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1264.42 | MRSA Organism or Substance in Lab Results |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.1 | Problem Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.11 | Information Source for Medication Adherence |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.15 | Yes or No SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.16 | Answer Set with Yes No and Unknowns |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.22 | Route of Administration of Therapeutic Agents |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.23 | Encounter Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.24 | Specimen Condition SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.26 | Healthcare Facility type (SCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.28 | Social History Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.3 | Smoking status comprehensive |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.31 | Healthcare Service Location Type Combined |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.5 | Smoking Status Pack Years SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.6 | Smoking Status Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.9 | Information Source for Medication Adherence SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.11 | Transplant Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.14 | Transplant Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.2 | Moderate Injuries (SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.3 | Diabetes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.5 | Diabetes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.6 | Immobility |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.7 | Smoking status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1282.1 | Drug Intervention Not Indicated/Contraindicated |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1282.2 | Procedure Not Indicated/Contraindicated |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1290.5 | Septic Shock |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.1.11.20.12 | HealthStatus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.1.11.20.2.6 | Wound Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.1.11.20.2.7 | Nutritional Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.1.11.20.2.9 | Nutrition Recommendations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.1.11.20.2 | Advance Directive Type Code |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.10.20.15.2.5.12 | Therapeutic Response to Medication |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.10.20.22.5.300 | Transmission Based Precaution Types |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.10.20.22.5.304 | Organism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.10.20.22.5.306 | Infectious Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.10.20.5.9.24 | NHSNVascularSpecimenCollectionSite |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.10.20.5.9.30 | NHSNLOS/MENDischargeDisposition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.10.20.5.9.40 | NHSN COVID19 Case Classification |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.10.20.5.9.50 | NHSNGenotypicTestInterpretation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.29 | DIRQuantityMeasurementTypeCodes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.34 | Patient Education |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.35 | Pressure Ulcer Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.36 | Pressure Point |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.37 | TargetSite Qualifiers |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.38 | Smoking Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.41 | Tobacco Use |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.44 | Mental and Functional Status Response |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.46 | Ability |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.49 | Residence and Accommodation Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.50 | Sensory Status Problem Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.51 | Healthcare Agent Qualifier |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.52 | Encounter SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.55 | Goal Achievement |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.56 | Referral Types |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.58 | Wound Characteristic |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.60 | Priority Level |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.61 | Care Model |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.69.1.2 | Advance Care Planning Services SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.69.1.3 | Advance Care Planning Services Grouping |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.69.17 | Obligation or Prohibition Instruction Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.69.7 | Obligation or Prohibition Instruction Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.80 | Pregnancy Status Determination Method |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.86 | Pregnancy Outcome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.87 | Postpartum Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.88 | Pregnancy Related Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.89 | D(Rh) Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.11.20.9.90 | D(Rh) Sensitized |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.13.10 | NHSNASAClassCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.13.16 | NHSNPathogenCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.13.2 | NHSNSpinalFusionApproachCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.13.20 | NHSNInfectionTypeCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.13.9 | NHSNWoundClassCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.17.4077.2.1018 | Closed Head and Facial Trauma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.136 | Perforation of Uterus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.137 | Uterine Window |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.138 | Uterine Rupture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.202 | Atrial Fibrillation or Flutter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.203 | Atrial Ablation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.204 | Carotid Intervention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.207 | Discharged to Health Care Facility for Hospice Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.209 | Discharged to Home for Hospice Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.212 | Hemorrhagic Stroke |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.214 | Intermittent pneumatic compression devices |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.222 | Intravenous route |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.223 | Subcutaneous route |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.230 | Venous foot pumps |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.235 | Hemorrhagic Stroke |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.239 | Carotid Intervention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.243 | Atrial Ablation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.246 | Atrial Fibrillation or Flutter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.247 | Ischemic Stroke |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.25 | Single Live Birth |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.252 | Ischemic Stroke Embolism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.255 | General Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.256 | Graduated compression stockings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.257 | Gynecological Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.258 | Hip Fracture Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.259 | Hip Replacement Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.26 | Single Live Born Newborn Born in Hospital |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.260 | Intracranial Neurosurgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.261 | Knee Replacement Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.263 | Obstetrical or Pregnancy Related Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.264 | Obstetrics VTE |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.27 | Dietary Intake Other than Human Milk |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.272 | Urological Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.279 | Venous Thromboembolism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.281 | Labor |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.282 | Cesarean Birth |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.286 | Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.288 | Medical Induction of Labor |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.292 | Emergency Department Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.294 | Decision to Admit to Hospital Inpatient |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.295 | Decision to Admit to Hospital Inpatient |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.298 | Psychiatric/Mental Health Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.299 | Psychiatric/Mental Health Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.30 | Human Milk |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.308 | Left Against Medical Advice |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.309 | Patient Expired |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.310 | Gynecological Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.315 | Knee Replacement Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.319 | Hip Replacement Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.323 | Hip Fracture Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.33 | Galactosemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.330 | Venous Thromboembolism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.333 | Urological Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.337 | Obstetrical or Pregnancy Related Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.340 | Obstetrics VTE |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.346 | Intracranial Neurosurgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.348 | General or Neuraxial Anesthesia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.35 | Galactosemia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.365 | General Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.369 | Cesarean Birth |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.37 | Parenteral Nutrition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.38 | Parenteral Nutrition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.384 | Medical Induction of Labor |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.395 | Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.400 | Low Risk |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.401 | Delivery Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.418 | Classical Cesarean Birth |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.421 | Classical Cesarean Birth |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.422 | Myomectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.424 | Nonelective Inpatient Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.473 | Medical Reason For Not Providing Treatment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.75 | Neonatal Intensive Care Unit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.87 | Discharge To Acute Care Facility |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.117.1.7.1.93 | Patient Refusal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1434.1047 | Skin Melanoma pT1 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.102 | Breast Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.106 | High Fiber Supplement or Diet Education |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.110 | Pancreatic Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.111 | Audio Visual Telehealth Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.112 | Telephone Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.115 | Referral to Hospice Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.116 | Referral to Palliative Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.117 | Assessment Scale for Dyspnea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.118 | Nausea or Vomiting Assessment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.119 | Enrollment in Hospice Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.120 | Palliative Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.121 | Advance Directive Including Durable Power of Attorney or Instructional |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.207 | Epithelial Ovarian Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.208 | Primary Peritoneal Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.209 | Fallopian Tube Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.215 | Colorectal Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.217 | Cancer Stage I |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.240 | Pathological N Stage N3c |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.258 | Indication for Dexamethasone |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.260 | Indication for Olanzapine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.265 | As Needed PRN |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.211 | High Fiber Supplement or Diet Education |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.214 | Pancreatic Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.215 | Audio Visual Telehealth Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.216 | Telephone Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.218 | Dyspnea Assessment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.219 | Nausea or Vomiting Assessment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.220 | Karnofsky Performance Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.221 | Referral to Hospice Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.222 | Referral to Palliative Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.223 | Palliative Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.224 | Enrollment in Hospice Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.225 | Advance Directive Including Durable Power of Attorney or Instructional |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.232 | Epithelial Ovarian Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.233 | Primary Peritoneal Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.240 | Cancer Stage 4 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.241 | Cancer Stage M1 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.247 | Indication for Dexamethasone |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.249 | Indication for Olanzapine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.2000.2 | Percutaneous Coronary Intervention SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.2000.5 | Percutaneous Coronary Intervention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4009 | Malignant Intracranial Neoplasm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4016 | STEMI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4017 | STEMI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4024 | Cerebral Vascular Lesion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4025 | Cerebral Vascular Lesion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4026 | Closed Head and Facial Trauma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4028 | Aortic Dissection or Ruptured Aortic Aneurysm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4030 | Acute Peptic Ulcer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4031 | Acute Peptic Ulcer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4033 | Dementia and Related Intracranial Pathologies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4035 | Active Bleeding or Bleeding Diathesis, Excluding Menses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4036 | Active Bleeding or Bleeding Diathesis, Excluding Menses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4043 | Dementia and Related Intracranial Pathologies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4044 | Aortic Dissection or Ruptured Aortic Aneurysm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4047 | Cardiopulmonary Emergency |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4048 | Cardiopulmonary Emergency |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4049 | Mechanical Circulatory Assist Device |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4052 | Mechanical Circulatory Assist Device |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4054 | Pregnant State |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4055 | Pregnant State |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3157.4056 | Major Surgical Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3566.2.1006 | Chronic Stable Angina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.3566.3.1002 | Chronic Stable Angina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1002 | Hospice Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1003 | Hospice Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1004 | Nutrition Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1006 | Nutrition Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1215 | Referral |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1216 | Face-to-Face Interaction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1228 | Detoxification Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1261 | Nursing Facility Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1262 | Care Services in Long Term Residential Facility |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1264 | Office Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1265 | Home Healthcare Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1266 | Outpatient Consultation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1284 | Outpatient Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1286 | Palliative Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.11.1287 | Telephone Visits |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1001 | Office Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1008 | Outpatient Consultation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1010 | Emergency Department Evaluation and Management Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1012 | Nursing Facility Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1014 | Care Services in Long Term Residential Facility |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1016 | Home Healthcare Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1046 | Referral |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1048 | Face-to-Face Interaction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1059 | Detoxification Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1080 | Telephone Visits |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1087 | Outpatient Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.101.12.1090 | Palliative Care Encounter |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1011 | Multiple Myeloma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1013 | Premature Menopause |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1014 | Multiple Myeloma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1015 | Premature Menopause |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.102.11.1031 | Acute Pharyngitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.102.11.1034 | Acute Tonsillitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.102.11.1059 | Upper Respiratory Infection |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.102.11.1066 | Comorbid Conditions for Respiratory Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.102.12.1011 | Acute Pharyngitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.102.12.1012 | Acute Tonsillitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.102.12.1017 | Competing Conditions for Respiratory Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.102.12.1022 | Upper Respiratory Infection |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.102.12.1025 | Comorbid Conditions for Respiratory Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1021 | Amenorrhea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1022 | Amenorrhea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1028 | Unilateral Oophorectomy Left |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1029 | Unilateral Oophorectomy Left |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.103.12.1001 | Diabetes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.103.12.1020 | Type 1 Diabetes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1031 | Unilateral Oophorectomy Right |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1032 | Unilateral Oophorectomy Right |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1034 | Unilateral Oophorectomy, Unspecified Laterality |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1035 | Unilateral Oophorectomy, Unspecified Laterality |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1038 | Eating Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1039 | Eating Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.104.11.1029 | Essential Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.104.12.1011 | Essential Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1042 | Major Transplant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1046 | Evidence of Bilateral Oophorectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1048 | Evidence of Bilateral Oophorectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1010 | Mental Health Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1017 | Major Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1060 | Major Depression In Remission |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1163 | Schizophrenia or Psychotic Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1178 | Pervasive Developmental Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1207 | Mental Behavioral and Neurodevelopmental Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1211 | Schizophrenia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1213 | Seizure Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1215 | REM |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1217 | Benzodiazepine Withdrawal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1219 | Alcohol Withdrawal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.11.1221 | General Anxiety |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1004 | Mental Health Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1007 | Major Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1104 | Schizophrenia or Psychotic Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1152 | Pervasive Developmental Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1203 | Mental Behavioral and Neurodevelopmental Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1205 | Schizophrenia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1206 | Seizure Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1207 | REM Sleep Behavior Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1208 | Benzodiazepine Withdrawal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1209 | Alcohol Withdrawal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.105.12.1210 | Generalized Anxiety Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.106.11.1001 | Substance Use Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.106.11.1012 | Substance Use Disorder Treatment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.106.12.1001 | Substance Use Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.106.12.1005 | Substance Use Disorder Treatment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.108.11.1001 | Malignant Neoplasm of Colon |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.108.11.1025 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.108.11.1053 | Colonoscopy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.108.12.1001 | Malignant Neoplasm of Colon |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.108.12.1009 | Malignant Neoplasm of Lymphatic and Hematopoietic Tissue |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.108.12.1020 | Colonoscopy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.109.11.1024 | Kidney Transplant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.109.11.1028 | Dialysis Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.109.12.1012 | Kidney Transplant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.109.12.1013 | Dialysis Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1066 | DTaP Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1068 | Hepatitis A |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1078 | Measles |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1086 | Measles, Mumps and Rubella (MMR) Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1087 | Mumps |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1098 | Rubella |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1105 | Varicella Zoster |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1107 | Varicella Zoster Vaccine (VZV) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1110 | Hepatitis A Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1112 | Hepatitis B Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1116 | Child Influenza Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1118 | Inactivated Polio Vaccine (IPV) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1124 | Genital Herpes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1133 | Pneumococcal Conjugate Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1148 | Rotavirus Vaccine (2 Dose Schedule) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1149 | Rotavirus Vaccine (3 Dose Schedule) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1151 | Advanced Illness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1156 | HiB Vaccine (3 dose schedule) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1157 | HiB Vaccine (4 dose schedule) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.11.1159 | Competing Conditions for Respiratory Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1022 | DTaP Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1024 | Hepatitis A |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1031 | Measles, Mumps and Rubella (MMR) Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1032 | Mumps |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1037 | Rubella |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1039 | Varicella Zoster |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1040 | Varicella Zoster Vaccine (VZV) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1041 | Hepatitis A Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1042 | Hepatitis B Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1044 | Child Influenza Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1045 | Inactivated Polio Vaccine (IPV) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1046 | Pneumococcal Conjugate Vaccine Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1047 | Rotavirus Vaccine (3 dose schedule) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1048 | Rotavirus Vaccine (2 dose schedule) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1049 | Genital Herpes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1053 | Measles |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1082 | Advanced Illness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1084 | Hib Vaccine (3 dose schedule) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.110.12.1086 | Hib Vaccine (4 dose schedule) Administered |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.111.11.1023 | Complications of Pregnancy, Childbirth and the Puerperium |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.111.11.1030 | Procedures for Sexual Activity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.111.11.1032 | Diagnosis for Sexual Activity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.111.12.1012 | Complications of Pregnancy, Childbirth and the Puerperium |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.111.12.1016 | Congenital or Acquired Absence of Cervix |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.111.12.1017 | Procedures Used to Indicate Sexual Activity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.111.12.1018 | Diagnoses Used to Indicate Sexual Activity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.112.11.1025 | Absence of Cervix |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1074 | Osteoporosis Without Current Fracture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1078 | History of hip fracture in parent |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1081 | Rheumatoid Arthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1085 | Osteogenesis Imperfecta |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1088 | Ankylosing Spondylitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1091 | Psoriatic Arthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1094 | Ehlers Danlos Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1097 | Marfan's Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1100 | Osteopenia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1201 | Osteoporosis With Current Fracture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1309 | Frailty Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.11.1311 | Frailty Symptom |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1005 | Rheumatoid Arthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1038 | Osteoporosis Without Current Fracture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1040 | History of hip fracture in parent |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1044 | Osteogenesis Imperfecta |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1045 | Ankylosing Spondylitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1046 | Psoriatic Arthritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1047 | Ehlers Danlos Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1048 | Marfan's Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1049 | Osteopenia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1050 | Osteoporosis With Current Fracture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1074 | Frailty Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.113.12.1075 | Frailty Symptom |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.114.11.1021 | Narcolepsy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.114.11.1024 | Neurologic impairment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.114.12.1011 | Narcolepsy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.114.12.1012 | Neurologic impairment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.115.11.1248 | Retinal or Dilated Eye Exam |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.115.12.1088 | Retinal or Dilated Eye Exam |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1155 | Substance Use Disorder Short Acting Medication Administration |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1157 | Substance Use Disorder Short Acting Medication Administration |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1163 | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1164 | Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1165 | Hospice Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1166 | Hospice Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1167 | Palliative Care Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1168 | Palliative Care Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.117.11.1023 | Cushings Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.117.11.1026 | Lupus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.117.11.1033 | Hyperthyroidism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.117.11.1034 | Hyperparathyroidism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.117.12.1009 | Cushings Syndrome |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.117.12.1010 | Lupus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.117.12.1015 | Hyperthyroidism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.117.12.1016 | Hyperparathyroidism |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1178 | Lower Body Fractures Excluding Ankle and Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.118.11.1042 | Counseling for Physical Activity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.118.11.1220 | Frailty Device SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.118.12.1035 | Counseling for Physical Activity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.118.12.1300 | Frailty Device |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1180 | Malignant Neoplasms of Lower and Unspecified Limbs |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1182 | Mechanical Complications Excluding Upper Body |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1184 | Partial Arthroplasty of Hip |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1189 | Removal, Revision and Supplement Procedures of the Lower Body and Spine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1194 | Malignant Neoplasms |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1196 | Atherosclerosis of the Extremities |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1198 | Atherosclerosis of the Extremities |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1199 | Lower Extremity Neurological Assessment Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.120.11.1001 | Disorders of the Immune System |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.120.11.1005 | HIV 1 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.120.11.1008 | HIV 2 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.120.11.1012 | Severe Combined Immunodeficiency |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.120.12.1001 | Disorders of the Immune System |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.120.12.1003 | HIV |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.120.12.1007 | Severe Combined Immunodeficiency |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1200 | Lower Extremity Neurological Tests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1201 | Lower Extremity Visual Inspection Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1202 | Lower Extremity Visual Inspection Test |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1203 | Monofilament Test Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1204 | Monofilament Tests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1205 | Pedal Pulse Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1206 | Peripheral Neuropathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1207 | Peripheral Neuropathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1209 | Amputation of Bilateral Feet |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.121.11.1011 | Consultant Report |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.121.12.1006 | Consultant Report |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1211 | Amputation of Bilateral Feet |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1212 | Amputation of Left Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1214 | Amputation of Left Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1215 | Amputation of Right Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1217 | Amputation of Right Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1218 | Amputation of Unspecified Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1219 | Amputation of Unspecified Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.122.11.1003 | Ambulatory |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.122.12.1003 | Ambulatory |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1220 | Foot Assessment With Abnormal Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1221 | Foot Assessment With Abnormal Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1222 | Acquired Absence of Bilateral feet |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1223 | Acquired Absence of Bilateral feet |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1224 | Acquired Absence of Left Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1226 | Acquired Absence of Left Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1227 | Acquired Absence of Right Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1229 | Acquired Absence of Right Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1230 | Lower Body Fractures Excluding Ankle and Foot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1231 | Malignant Neoplasms of Lower and Unspecified Limbs |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1232 | Mechanical Complications Excluding Upper Body |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1233 | Partial Arthroplasty of Hip |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1235 | Removal, Revision and Supplement Procedures of the Lower Body and Spine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1239 | Foot Ulcer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1241 | Foot Ulcer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1242 | Referral for Foot Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1243 | Therapeutic Footwear |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1244 | Foot Deformity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1246 | Foot Deformity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.125.11.1004 | Fluoride Varnish Application for Children |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.125.11.1007 | Dental Caries |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.125.12.1002 | Fluoride Varnish Application for Children |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.125.12.1004 | Dental Caries |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1273 | Diabetes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.195.11.1004 | Counseling for Nutrition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1005 | Bilateral Mastectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1017 | Flexible Sigmoidoscopy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1027 | Hysterectomy with No Residual Cervix |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1035 | Total Colectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1061 | Gastric Bypass Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1080 | Primary THA Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1085 | History of bilateral mastectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1086 | Status Post Left Mastectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1087 | Status Post Right Mastectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1090 | Unilateral Mastectomy, Unspecified Laterality |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1132 | Unilateral Mastectomy Left |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1133 | Unilateral Mastectomy Right |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.11.1148 | Palliative Intervention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1005 | Bilateral Mastectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1006 | Primary THA Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1010 | Flexible Sigmoidoscopy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1014 | Hysterectomy with No Residual Cervix |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1019 | Total Colectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1050 | Gastric Bypass Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1068 | History of bilateral mastectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1069 | Status Post Left Mastectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1070 | Status Post Right Mastectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1071 | Unilateral Mastectomy, Unspecified Laterality |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1075 | Major Transplant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1133 | Unilateral Mastectomy Left |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1134 | Unilateral Mastectomy Right |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.198.12.1135 | Palliative Care Intervention |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.11.1064 | Anaphylactic Reaction to DTaP Vaccine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.11.1065 | Chronic Liver Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.11.1068 | Chronic Malnutrition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.11.1100 | Malabsorption Syndromes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.11.1106 | Intussusception |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.12.1031 | Anaphylactic Reaction to DTaP Vaccine |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.12.1035 | Chronic Liver Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.12.1036 | Chronic Malnutrition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.12.1050 | Malabsorption Syndromes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.199.12.1056 | Intussusception |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1004.2446 | Lower Extremity Visual Inspection Test |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1004.2447 | Pedal Pulse Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1004.2448 | Monofilament Test Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1004.2449 | Monofilament Tests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1004.2450 | Lower Extremity Neurological Assessment Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1004.2451 | Lower Extremity Neurological Tests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1004.2452 | Lower Extremity Visual Inspection Result or Finding |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1037 | Chronic Kidney Disease, Stage 5 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1049 | Patient Provider Interaction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1068 | Dementia and Mental Degenerations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1072 | Radiation Treatment Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1079 | Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1081 | Chemotherapy Administration |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.120 | Coronary Artery Disease No MI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1244 | Renal Failure Due to ACE Inhibitor |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1256 | Allergy to ACE Inhibitor or ARB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1257 | Intolerance to ACE Inhibitor or ARB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1333 | Allergy to Beta Blocker Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1334 | Intolerance to Beta Blocker Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1353 | Limited Life Expectancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1377 | Level of Severity of Retinopathy Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1381 | Macular Edema Findings Present |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1401 | Cognitive Assessment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1509 | Acute and Subacute Iridocyclitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1521 | Burn Confined to Eye and Adnexa |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1524 | Cataract Secondary to Ocular Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1527 | Cataract Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1530 | Cataract Congenital |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1532 | Cataract Mature or Hypermature |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1535 | Cataract Posterior Polar |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1538 | Certain Types of Iridocyclitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1542 | Chronic Iridocyclitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1544 | Cloudy Cornea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1549 | Corneal Edema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1550 | Disorders of Cornea Including Corneal Opacity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1562 | Glaucoma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1564 | Hereditary Corneal Dystrophies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1571 | Hypotony of Eye |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1574 | Injury to Optic Nerve and Pathways |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1577 | Central Corneal Ulcer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1582 | Open Wound of Eyeball |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1587 | Pathologic Myopia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1590 | Posterior Lenticonus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1601 | Retrolental Fibroplasias |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1613 | Traumatic Cataract |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1615 | Uveitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1618 | Vascular Disorders of Iris and Ciliary Body |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1621 | Visual Field Defects |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1628 | Amblyopia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1634 | Choroidal Degenerations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1637 | Choroidal Detachment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1640 | Choroidal Hemorrhage and Rupture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1643 | Degeneration of Macula and Posterior Pole |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1646 | Degenerative Disorders of Globe |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1649 | Diabetic Macular Edema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1655 | Disorders of Optic Chiasm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1658 | Disorders of Visual Cortex |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1661 | Disseminated Chorioretinitis and Disseminated Retinochoroiditis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1664 | Focal Chorioretinitis and Focal Retinochoroiditis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1667 | Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1670 | Hereditary Choroidal Dystrophies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1673 | Hereditary Retinal Dystrophies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1679 | Nystagmus and Other Irregular Eye Movements |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.168 | Cardiac Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1682 | Optic Atrophy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1685 | Optic Neuritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1688 | Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1691 | Other Background Retinopathy and Retinal Vascular Changes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1697 | Other Disorders of Optic Nerve |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1703 | Other Endophthalmitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1709 | Prior Penetrating Keratoplasty |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1715 | Purulent Endophthalmitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1718 | Retinal Detachment with Retinal Defect |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1721 | Retinal Vascular Occlusion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1724 | Other Proliferative Retinopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1730 | Separation of Retinal Layers |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1731 | Visual Acuity 20/40 or Better |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1767 | Morgagnian Cataract |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1770 | Macular Scar of Posterior Polar |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1771 | Ophthalmological Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1772 | Annual Wellness Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1773 | Speech and Hearing Evaluation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1774 | Occupational Therapy Evaluation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1775 | Behavioral Neuropsych Assessment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1776 | Psych Visit Diagnostic Evaluation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1777 | Psych Visit Psychotherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1778 | Psychoanalysis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1779 | Group Psychotherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1780 | Psych Visit for Family Psychotherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1782 | Physical Therapy Evaluation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.185 | Hypotension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.186 | Arrhythmia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.187 | Atrioventricular Block |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1912 | Major Depressive Disorder Active |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.1924 | Cardiac Pacer in Situ |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.408 | Bradycardia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.425 | Tobacco Use Cessation Counseling |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.469 | Bilateral Oophorectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.483 | Chemotherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.511 | Tobacco Non User |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.532 | Pregnancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.58 | Initial Myocardial Infarction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.61 | Asthma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.74 | Primary Open Angle Glaucoma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.80 | Diabetic Retinopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.859 | Left Ventricular Systolic Dysfunction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.860 | Moderate or Severe |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.861 | Moderate or Severe LVSD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.92 | Prostate Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1002 | Chronic Kidney Disease, Stage 5 |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1005 | Dementia and Mental Degenerations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1007 | Medical Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1008 | Patient Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1010 | Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1011 | Occupational Therapy Evaluation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1012 | Patient Provider Interaction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1018 | Psych Visit for Family Psychotherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1022 | Physical Therapy Evaluation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1023 | Behavioral or Neuropsych Assessment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1026 | Radiation Treatment Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1027 | Chemotherapy Administration |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1090 | Moderate or Severe LVSD |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1091 | Left Ventricular Systolic Dysfunction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1092 | Moderate or Severe |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1140 | Patient Reason for ACE Inhibitor or ARB Decline |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1141 | Psychoanalysis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1151 | Renal Failure Due to ACE Inhibitor |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1170 | Tobacco User |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1177 | Allergy to Beta Blocker Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1178 | Intolerance to Beta Blocker Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1187 | Group Psychotherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1189 | Tobacco Non User |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1193 | Cardiac Pacer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1211 | Allergy to ACE Inhibitor or ARB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1212 | Intolerance to ACE Inhibitor or ARB |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1240 | Annual Wellness Visit |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1241 | Acute and Subacute Iridocyclitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1259 | Limited Life Expectancy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1283 | Level of Severity of Retinopathy Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1285 | Ophthalmological Services |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1320 | Macular Edema Findings Present |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1332 | Cognitive Assessment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1409 | Burn Confined to Eye and Adnexa |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1410 | Cataract Secondary to Ocular Disorders |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1411 | Cataract Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1412 | Cataract Congenital |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1413 | Cataract Mature or Hypermature |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1414 | Cataract Posterior Polar |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1415 | Certain Types of Iridocyclitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1416 | Chronic Iridocyclitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1417 | Cloudy Cornea |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1418 | Corneal Edema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1419 | Disorders of Cornea Including Corneal Opacity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1423 | Glaucoma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1424 | Hereditary Corneal Dystrophies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1426 | Hypotony of Eye |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1427 | Injury to Optic Nerve and Pathways |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1428 | Central Corneal Ulcer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1430 | Open Wound of Eyeball |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1432 | Pathologic Myopia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1433 | Posterior Lenticonus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1438 | Retrolental Fibroplasias |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1443 | Traumatic Cataract |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1444 | Uveitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1445 | Vascular Disorders of Iris and Ciliary Body |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1446 | Visual Field Defects |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1448 | Amblyopia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1450 | Choroidal Degenerations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1451 | Choroidal Detachment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1452 | Choroidal Hemorrhage and Rupture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1453 | Degeneration of Macula and Posterior Pole |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1454 | Degenerative Disorders of Globe |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1455 | Diabetic Macular Edema |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1457 | Disorders of Optic Chiasm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1458 | Disorders of Visual Cortex |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1459 | Disseminated Chorioretinitis and Disseminated Retinochoroiditis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1460 | Focal Chorioretinitis and Focal Retinochoroiditis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1461 | Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1462 | Hereditary Choroidal Dystrophies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1463 | Hereditary Retinal Dystrophies |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1465 | Nystagmus and Other Irregular Eye Movements |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1466 | Optic Atrophy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1467 | Optic Neuritis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1468 | Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1469 | Other Background Retinopathy and Retinal Vascular Changes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1471 | Other Disorders of Optic Nerve |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1473 | Other Endophthalmitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1475 | Prior Penetrating Keratoplasty |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1477 | Purulent Endophthalmitis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1478 | Retinal Detachment with Retinal Defect |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1479 | Retinal Vascular Occlusion |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1480 | Other Proliferative Retinopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1482 | Separation of Retinal Layers |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1483 | Visual Acuity 20/40 or Better |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1491 | Major Depressive Disorder Active |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1492 | Psych Visit Diagnostic Evaluation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1496 | Psych Visit Psychotherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1530 | Speech and Hearing Evaluation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1558 | Morgagnian Cataract |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1559 | Macular Scar of Posterior Polar |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1563 | Underweight |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1568 | Follow Up for Adult Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1569 | Follow Up for Adolescent Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1570 | Referral for Adolescent Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1571 | Referral for Adult Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1576 | Outpatient Encounters for Preventive Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1578 | Follow Up Within 4 Weeks |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1580 | Referral to Primary Care or Alternate Provider |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1581 | Lifestyle Recommendation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1582 | Patient Declined |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1583 | Referral or Counseling for Alcohol Consumption |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.1584 | Hospice Care Ambulatory |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.319 | Prostate Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.326 | Primary Open Angle Glaucoma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.327 | Diabetic Retinopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.353 | End Stage Renal Disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.362 | Asthma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.366 | Arrhythmia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.367 | Atrioventricular Block |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.368 | Cardiac Pacer in Situ |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.369 | Coronary Artery Disease No MI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.370 | Hypotension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.371 | Cardiac Surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.376 | Heart Failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.398 | Prostate Cancer Treatment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.399 | Salvage Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.403 | Initial Myocardial Infarction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.412 | Bradycardia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.451 | Pain Warranting Further Investigation for Prostate Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.471 | Bilateral Oophorectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.3.485 | Chemotherapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1525 | Follow Up for Above Normal BMI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1526 | Follow Up for Above Normal BMI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1527 | Referrals Where Weight Assessment May Occur |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1528 | Follow Up for Below Normal BMI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1551 | Follow Up for Below Normal BMI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1578 | Palliative Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1579 | Palliative or Hospice Care |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1610 | Referrals Where Weight Assessment May Occur |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1751 | Encounter to Evaluate BMI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1834 | Encounter to Document Medications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.1917 | Encounter to Document Medications |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1.886 | Encounter to Evaluate BMI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1475 | Referral to Primary Care or Alternate Provider |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1508 | Lifestyle Recommendation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1510 | Weight Reduction Recommended |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1511 | Dietary Recommendations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1515 | Dietary Recommendations |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1518 | Recommendation to Increase Physical Activity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1537 | Follow Up Within 4 Weeks |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1914 | Encounter to Screen for Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1916 | Encounter to Screen for Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1918 | Encounter to Screen for Blood Pressure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.1920 | Encounter to Screen for Blood Pressure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.2387 | Overweight or Obese |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.2388 | Underweight |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.2395 | Finding of Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.259 | Diagnosis of Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.263 | Diagnosis of Hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.467 | Follow Up for Adolescent Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.468 | Follow Up for Adult Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.537 | Referral for Adolescent Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.538 | Referral for Adult Depression |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.791 | Patient Declined |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.805 | Weight Reduction Recommended |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.810 | Recommendation to Increase Physical Activity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.600.823 | Referral or Counseling for Alcohol Consumption |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.1250 | Major Surgical Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.1743 | General or Neuraxial Anesthesia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.1940 | Immunocompromised Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.2262 | CABG Surgeries |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.2343 | Immunocompromised Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.3011 | Acute Myocardial Infarction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.3024 | Acute Myocardial Infarction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.307 | Encounter Inpatient |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.335 | Bone Marrow Transplant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.336 | Bone Marrow Transplant |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.694 | CABG Surgeries |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.737 | PCI |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.666.5.747 | Endotracheal Intubation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.128 | Bipolar Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.246 | Personality Disorder Emotionally Labile |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.249 | Personality Disorder Emotionally Labile |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.254 | Dysthymia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.257 | Dysthymia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.262 | Deceased |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.269 | Hepatitis B |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.272 | Hepatitis B |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.273 | Live Birth or Delivery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.275 | Live Birth or Delivery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.278 | Delivery - Diagnosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.44 | Bipolar Disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.1.82 | Delivery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.67.1.101.11.721 | Deceased |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1001 | Strabismic Amblyopia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1003 | Refractive Amblyopia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1008 | Aphakia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1010 | Infantile and Juvenile Cataract |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1012 | Congenital Corneal or Anterior Segment Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1014 | Eyelid or Orbital Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1016 | Coloboma of Optic Disc |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1018 | Hemorrhage of Optic Nerve Sheath |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1020 | Optic Nerve Hypoplasia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1022 | Disorder of Visual Cortex Due to Underlying Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1024 | Cortical Blindness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.2.1026 | Congenital Condition of Retina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1000 | Strabismic Amblyopia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1001 | Refractive Amblyopia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1005 | Aphakia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1006 | Infantile and Juvenile Cataract |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1007 | Congenital Corneal or Anterior Segment Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1008 | Eyelid or Orbital Conditions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1009 | Coloboma of Optic Disc |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1010 | Hemorrhage of Optic Nerve Sheath |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1011 | Optic Nerve Hypoplasia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1012 | Disorder of Visual Cortex Due to Underlying Condition |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1013 | Cortical Blindness |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.8420.3.1014 | Congenital Condition of Retina |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.88.12.3221.6.2 | Allergy and Intolerance Type |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.88.12.3221.6.8 | Severity |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.88.12.3221.7.2 | Problem Type (SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.88.12.3221.7.4 | Problem |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.88.12.3221.8.9 | Body Site Value Set |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.88.12.80.28 | Procedure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.88.12.80.60 | Social History Type (SCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.88.12.80.68 | Problem Status |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.24.7.14 | Clinically Important Bacteria and Fungi |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.24.7.281 | Bacterial Skin Commensals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.3180 | NHSNInsertionSiteCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.3181 | NHSNRoleOfPerformerCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.3194 | NHSNSignificantPathogenCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.3195 | NHSNCriterionOfDiagnosisCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.3196 | NHSNInfectionConditionCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.3249 | NHSNSpecimenTypeCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.3283 | NHSNOrganismASTCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.3361 | NHSNRouteOfAdministrationAURPCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.6007 | NHSNVascularAccessTypeCode |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.6074 | NHSNStaphAureusTestResults |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.7214 | NHSNSameDayOutcomeMeasure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.114222.4.11.7215 | NHSNInfectionFirstReportedSource |
| us.nlm.vsac#0.24.0 | 2.16.840.113883.3.67.1.101.3.2444 | Major Depression Including Remission |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.550 | Oxygen Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.554 | External Vagus Nerve Stimulation (SNOMEDCT) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.665 | Oxygen Therapy (Physical Object) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1034.667 | External Vagus Nerve Stimulator |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1110 | Cardiac MRA SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1122 | Coronary calcium CT SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1123 | Coronary calcium CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1124 | Pericardial disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1126 | Pericardial disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1128 | Acute pericarditis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1131 | Congenital heart disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1132 | Congenital heart disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1133 | Coronary artery anomaly SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1135 | Coronary artery anomaly |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1137 | Constrictive pericarditis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1139 | Constrictive pericarditis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1140 | Ebstein anomaly SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1142 | Ebstein anomaly |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1143 | Cardiomyopathy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1145 | Cardiomyopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1146 | Valvular heart disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1148 | Valvular heart disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1149 | Supravalvular aortic stenosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1152 | Endocarditis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1154 | Endocarditis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1155 | Supravalvular aortic stenosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1156 | Hypertrophic cardiomyopathy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1158 | Hypertrophic cardiomyopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1159 | Cardiac arrest SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1161 | Cardiac arrest |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1162 | Syncope and Presyncope SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1164 | Syncope and Presyncope |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1165 | Mitral regurgitation SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1167 | Mitral regurgitation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1168 | Tricuspid regurgitation SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1170 | Tricuspid regurgitation |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1171 | Cardiac amyloidosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1173 | Cerebrovascular disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1175 | Cerebrovascular disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1176 | Tetralogy of Fallot SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1178 | Tetralogy of Fallot |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1180 | Neoplasm of heart SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1182 | Neoplasm of heart |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1184 | Paracardiac neoplasm SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1185 | Paracardiac neoplasm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1187 | Cardiac valve repair SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1188 | Cardiac valve repair |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1189 | Heart valve replacement SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1191 | Heart valve replacement |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1192 | Bioprosthetic heart valve SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1194 | Atrial septal defect repair SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1195 | Atrial septal defect repair |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1196 | Transesophageal echocardiogram SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1198 | Transesophageal echocardiography |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1199 | Mechanical heart valve SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1201 | Prostate cancer SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1203 | Prostate cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1205 | Ovarian cancer SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1206 | Ovarian cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1208 | Fallopian tube cancer SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1209 | Fallopian tube cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1211 | Primary peritoneal cancer SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1212 | Primary peritoneal cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1215 | Exocrine pancreatic cancer SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1216 | Exocrine pancreatic cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1217 | Lung cancer SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1219 | Lung cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1223 | Lymphoma SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1225 | Lymphoma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1226 | Intracranial disorder SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1228 | Intracranial disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1229 | Head injury SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1231 | Head injury |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1233 | Hematuria SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1235 | Hematuria |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1237 | Indeterminate sex SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1238 | Intedeterminate sex |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1240 | CT Abdomen or Pelvis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1241 | CT Abdomen or Pelvis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1242 | CT Abdomen and Pelvis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1244 | CT Abdomen and Pelvis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1247 | Prostate biopsy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1248 | Prostate biopsy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1249 | Abdominal pain SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1250 | Pelvic pain SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1252 | Abdominal and Pelvic Pain |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1257 | Hysterectomy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1258 | Hysterectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1259 | Aneurysm of peripheral artery SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1261 | Aneurysm of peripheral artery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1262 | Heart failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1263 | Adult respiratory distress syndrome SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1265 | Adult respiratory distress syndrome (ARDS) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1266 | Ascending aorta disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1268 | Ascending aorta disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1269 | Atherosclerotic coronary artery disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1271 | Atherosclerotic coronary artery disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1272 | Restrictive cardiomyopathy SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1274 | Restrictive cardiomyopathy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1275 | Ischemic heart disease SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1277 | Ischemic heart disease |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1278 | Pulmonary hypertension SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1280 | Pulmonary hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1282 | Cardiac trauma SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1283 | Cardiac trauma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1284 | Cor pulmonale SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1286 | Cor pulmonale |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1287 | Septic shock |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1288 | Myocarditis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1290 | Myocarditis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1291 | Pulmonary artery stenosis SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1293 | Pulmonary artery stenosis |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1294 | Ventricular aneurysm SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1296 | Ventricular aneurysm |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1297 | Rejection of transplanted heart SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1299 | Rejection of transplanted heart |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1300 | Coronary artery fistula SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1301 | Left ventricular dysfunction SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1303 | Left ventricular dysfunction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1305 | Right ventricular dysfunction SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1306 | Right ventricular dysfunction |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1307 | Mitral valve disorder SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1310 | Tricuspid valve disorder SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1311 | Mitral valve disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1312 | Tricuspid valve disorder |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1313 | Papillary muscle rupture SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1315 | Papillary muscle rupture |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1316 | Myocardial disorder SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1318 | Coronary angiography SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1319 | Coronary angiography |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1321 | Cardiac catheterization excluding angiography SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1322 | Cardiac catheterization excluding angiography |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1324 | Thoracic aorta surgery SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1325 | Thoracic aorta surgery |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1328 | Mild persistent, moderate, or severe asthma SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1329 | Mild persistent, moderate, or severe asthma |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1345 | Thoracic aortic aneurysm or dissection SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.1346 | Thoracic aortic aneurysm or dissection |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.39 | relatedconditions_hypertension |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.506 | Abdominal aortic aneurysm or dissection SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.507 | Abdominal aortic aneurysm or dissection |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1078.591 | Azotemia SCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1115.42 | Hospice or Palliative Care enrollment indicator |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.498 | Bone Evaluation Normal |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.532 | Body Surface Area |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1116.614 | Bisphosphonate Therapy Declined |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1013 | S. Typhi Infection (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1014 | S. Paratyphi Infection (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1069 | Cyanosis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1190 | Chikungunya Virus Disease (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.120 | Meningococcal Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1316 | Bronchiolitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.139 | Invasive Haemophilus influenzae Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1611 | Blepharitis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1741 | Brain Injury [Traumatic] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1807 | Interstitial Lung Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1827 | Carditis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1831 | Chorea [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1849 | Leishmaniasis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1852 | Lymphatic Filariasis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.1870 | Cysticercosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.229 | Malaria (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2389 | Oculocephalic reflex (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2390 | Loss of appetite (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2391 | Intractable hiccups (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2392 | Delirium (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2394 | Areflexia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2396 | Ataxia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2397 | Vasomotor changes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2398 | Hypotonia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2400 | Bruising [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2402 | Coma (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2537 | Biliary Atresia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2539 | Diaphragmatic hernia [Congenital] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2541 | Clubfoot (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2542 | Fetal Clubfoot (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2544 | Fetal Cystic Fibrosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2546 | Cystic Fibrosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2551 | Sweat (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2552 | Esophageal Atresia/Tracheoesophageal Fistula (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2554 | Fetal Alcohol Syndrome (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2555 | Fetal Alcohol Spectrum Disorders (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2556 | In Utero Exposure to Alcohol (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2559 | Attention Difficulty (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.256 | Babesiosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2560 | Hyperactive Behavior (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2563 | Underweight (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2565 | Poor Coordination (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2568 | Short Stature (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2569 | Omphalocele (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2571 | Medium chain Acyl CoA Dehydrogenase Deficiency (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2578 | Homocystinuria (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2586 | Chemical Pneumonitis [Occupational] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2588 | Candidemia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2595 | Candidemia (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2596 | Severe Combined Immunodeficiency (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2598 | Fetal Severe Combined Immunodeficiency (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2600 | Rectal and Large Intestinal Atresia and Stenosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2604 | X linked Adrenoleukodystrophy (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2620 | Sickle Cell Anemia (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2627 | Spinal Muscular Atrophy (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2629 | Fetal Spinal Muscular Atrophy (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2633 | Small Intestinal Atresia and Stenosis (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2635 | Oropouche Virus Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2637 | Oropouche Virus Disease (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2641 | Arthrogryposis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2643 | Congenital Anomalies of the Eye (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2645 | Congenital Anomalies of the Brain (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2647 | Neurologic Dysfunction [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2649 | Generalized Rash (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2651 | Meningitis [Unspecified for Viral Conditions] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2653 | Encephalitis [Unspecified for Viral Conditions] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2674 | Plasma (Specimen Type) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2679 | Acute Hepatitis C Virus Infection (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2686 | Clay Colored Stool (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2687 | Hepatic Encephalopathy (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2690 | Ascites (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2693 | Non_Opioid Substance Abuse, Dependence, and Other Use [Excluding Overdose and Poisoning] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2694 | Organ Transplant (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2696 | Dialysis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2698 | Blood Transfusion (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2700 | Incarceration (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2702 | Homelessness or Housing Instability (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2704 | Sexual Orientation (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2706 | Long Term Care Facility Resident (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2712 | Diabetes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2716 | Meningitis [Unspecified for Bacterial Conditions] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2741 | Thrush (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2743 | Shingles (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2747 | Artificial Insemination (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2748 | Hemophilia or Other Coagulation Disorder (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2750 | Exposure to Sexually Transmitted Infection (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2753 | High Risk Sexual Behavior (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2755 | Candidiasis [Bronchi, Trachea, Lungs, or Esophogeal] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2757 | Herpes Simplex [Chronic Ulcers, Bronchitis, Pneumonitis, or Esophagitis] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2758 | Isosporiasis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2760 | Kaposi's Sarcoma (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2762 | Lymphoma (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2764 | Progressive Multifocal Leukoencephalopathy (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2766 | Wasting Syndrome [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2768 | Pneumocystis Pneumonia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2771 | Isosporiasis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2776 | Pneumocystis (Organism or Substance in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2777 | Vaginitis or Vulvitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2779 | Vaginal discharge (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2780 | Rectal discharge (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2781 | Rectal pain (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2782 | Rectal bleeding (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2784 | Penile discharge (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2785 | Abnormal Vaginal Bleeding (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2787 | Pain with Sexual Intercourse (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2789 | Balanitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2791 | Cervical Friability (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2792 | Cervical Ectopy (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2794 | Proctitis or Proctocolitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2795 | Pelvic or Perineal Pain (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2797 | Increased frequency or urgency of urination (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2799 | Testicular Pain (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2801 | Anal Itching (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2803 | Infective Arthritis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2805 | Ulcer [Oral or Oropharyngeal] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2806 | Ulcer [Oral or Oropharyngeal] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2808 | Rectal Fistula or Stricture [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2809 | Perirectal Abscess (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2811 | Anal Fissure (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2814 | Malaria Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2816 | Lyme disease Additional Context Diagnosis Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2817 | Malaria Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2822 | Meningococcal disease Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2825 | Middle East Respiratory Syndrome (MERS) Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2827 | Middle East Respiratory Syndrome (MERS) Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2828 | Middle East Respiratory Syndrome (MERS) Additional Context Diagnosis Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2830 | Mpox Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2835 | Mpox Additional Context Diagnosis Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2837 | Anaplasmosis Additional Context Diagnosis Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2840 | Anaplasmosis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2846 | Mumps Additional Context Symptom Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2849 | Babesiosis Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2851 | Babesiosis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2855 | Campylobacteriosis Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2857 | Campylobacteriosis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2861 | Chlamydia trachomatis infection Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2866 | COVID19 Additional Context Diagnosis Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2868 | Norovirus Infection Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2870 | COVID19 Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2872 | COVID19 Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2875 | Cryptosporidiosis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2878 | Cyclosporiasis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2886 | Eastern equine encephalitis virus disease Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2890 | Pertussis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2894 | Ehrlichiosis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2896 | Escherichia coli Infection Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2898 | Escherichia coli Infection Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2904 | Pertussis Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2905 | Giardiasis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2909 | Gonorrhea Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.291 | Toxic Effects of Lead (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2915 | Hepatitis A Virus infection Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2917 | Powassan virus disease Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2918 | Hepatitis A Virus infection Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2922 | Hepatitis B Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2924 | Hepatitis C Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2933 | Invasive Haemophilus Influenzae Disease Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2937 | Legionellosis Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2940 | Legionellosis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2942 | Listeriosis Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2944 | Listeriosis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2949 | Lyme disease Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2951 | Salmonella Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2953 | Salmonella Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2954 | Salmonella Additional Context Diagnosis Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2958 | Severe Acute Respiratory Syndrome (SARS) Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2960 | Severe Acute Respiratory Syndrome (SARS) Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2962 | Severe Acute Respiratory Syndrome (SARS) Additional Context Diagnosis Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2965 | Shigellosis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2967 | Shigellosis Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2968 | Cholestasis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2971 | Blindness (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2973 | Tinnitus (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2975 | Frontal Bossing (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2977 | Retinal Vasculitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2978 | Rhagades (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2980 | Saber Shin (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2982 | Saddle Nose (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2984 | Snuffles (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2986 | Aortitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2989 | Alopecia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2992 | Streptococcal Disease Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2993 | Dementia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2994 | Hyperbilirubinemia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2996 | Nephrotic Syndrome (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.2998 | Nonimmune Hydrops (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3000 | Numbness (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3002 | Optic Neuropathy (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3004 | Osteitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3006 | Paralysis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3008 | Uveitis (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3010 | Vertigo (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3011 | Tenosynovitis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3013 | Pustular Skin Lesions (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3016 | Streptococcal Disease Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3018 | Syphilis Additional Context Specimen Source Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3024 | Tuberculosis Additional Context Diagnosis Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3027 | Varicella Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3031 | Vibriosis Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.3036 | Zika Virus Disease Additional Context Symptom Codes (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.457 | Acute Hepatitis [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.590 | Zika Virus Disease (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.633 | Chlamydia trachomatis Infection [Conjunctivitis] (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.688 | Myalgia (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.783 | Congenital Rubella Syndrome (Disorders) (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.838 | Caseating Granuloma (Finding by Microscopic Observation in Lab Results) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.859 | Dizziness (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.901 | Acute Renal Failure [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1146.939 | Pulmonary Hemorrhage [Unspecified Cause] (SNOMED) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.149 | Inferior Vena Cava (IVC) Filter Placement |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.151 | Inferior Vena Cava (IVC) Filter Placement |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.155 | CT Angiography of Chest |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.167 | Pulmonary Ventilation/Perfusion (VQ) Scan |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1147.170 | Pulmonary Ventilation/Perfusion (VQ) Scan |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.277 | Toxic Stress Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.278 | Racism Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.279 | Racism Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.280 | Toxic Stress Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.281 | Racism Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.286 | Toxic Stress Diagnoses SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.288 | Toxic Stress Diagnoses |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.289 | Toxic Stress Goals |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.290 | Toxic Stress Interventions SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.291 | Racism Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.292 | Toxic Stress Service Requests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.308 | Racism Goals SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.309 | Protective Factors Findings SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.311 | Protective Factors Findings |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1247.312 | Social Determinants of Health Programs SNOMED CT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.266 | CT Angiography of Chest |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.408 | Bladder Cancer Site |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.409 | Bladder Cancer Site |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.410 | Prostate Anatomical Site |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.411 | Prostate Anatomical Site |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.412 | Active Depression Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1248.413 | Active Depression Management |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1251.11 | Congenital Heart Disease (structural) |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.512 | Biphosphonate Therapy Not Done Medical Reason SNOMEDCT |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1260.513 | Biphosphonate Therapy Not Done Patient Reason SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.35 | Portable Medical Orders – Detailed Categories and Interventions |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1267.36 | Device Types |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.16 | Solid Organ Transplant Procedures |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.17 | Solid Organ Transplant Procedures SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.21 | Pruritus |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.22 | Pruritus Diagnoses SNOMED |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.23 | Solid Organ Transplant Diagnosis Codes |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.24 | Neuraxial Anesthesia |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1272.26 | Intravenous Heparin Administration Route |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1280.2 | Exposure Location |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113762.1.4.1290.28 | Lead Screening Tests |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.268 | Family History of Breast Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.269 | Patient Declined Or Refused Genetic Testing |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.271 | Family History of Prostate Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.273 | Pathological Stage |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.274 | Genetic Counseling |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.3.276 | Metastatic Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.250 | Family History of Breast Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.251 | Family History of Prostate Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.253 | Secondary Cancer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.1444.5.254 | Genetic Counseling |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1285 | Unilateral Mastectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1286 | Total Nephrectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1289 | Total Nephrectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1290 | Partial Nephrectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.464.1003.1293 | Partial Nephrectomy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.213 | Prostate Cancer Treatment |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.25 | Heart Failure |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.303 | Cardiac Pacer |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.305 | Patient Reason for ACE Inhibitor or ARB Decline |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.311 | Patient Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.313 | Medical Reason |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.324 | Salvage Therapy |
| us.nlm.vsac#0.24.0 | 2.16.840.1.113883.3.526.2.325 | Pain Warranting Further Investigation for Prostate Cancer |
| kbv.mio.diga#1.1.0 | KBV_VS_MIO_DIGA_Problem_Type | Problemtyp |
| ca.on.hrm.r4#1.0.1-snapshot2 | current-smoking-status | Current Smoking Status |
| ans.fr.terminologies#1.11.1 | JDV-J151-BodySiteBodyTemperature-ENS | JDV_J151_BodySiteBodyTemperature_ENS |
| ans.fr.terminologies#1.11.1 | jdv-abord-veineux-central-cisis | JDV Abord Veineux Central CISIS |
| ans.fr.terminologies#1.11.1 | jdv-abord-veineux-peripherique-cisis | JDV Abord Veineux Peripherique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-acces-artere-cisis | JDV Acces Artere CISIS |
| ans.fr.terminologies#1.11.1 | jdv-acte-obp-cisis | JDV Acte Obp CISIS |
| ans.fr.terminologies#1.11.1 | jdv-acte-prelevement-cisis | JDV Acte Prelevement CISIS |
| ans.fr.terminologies#1.11.1 | jdv-addition-grandeur-cisis | JDV Addition Grandeur CISIS |
| ans.fr.terminologies#1.11.1 | jdv-age-cisis | JDV Age CISIS |
| ans.fr.terminologies#1.11.1 | jdv-aide-au-deplacement-cisis | JDV Aide Au Deplacement CISIS |
| ans.fr.terminologies#1.11.1 | jdv-allergie-vaccin-cisis | JDV Allergie Vaccin CISIS |
| ans.fr.terminologies#1.11.1 | jdv-antecedent-personnel-cisis | JDV Antecedent Personnel CISIS |
| ans.fr.terminologies#1.11.1 | jdv-appreciation-diagnostic-centre-cisis | JDV Appreciation Diagnostic Centre CISIS |
| ans.fr.terminologies#1.11.1 | jdv-artere-anterieure-cisis | JDV Artere Anterieure CISIS |
| ans.fr.terminologies#1.11.1 | jdv-artere-cervelet-cisis | JDV Artere Cervelet CISIS |
| ans.fr.terminologies#1.11.1 | jdv-artere-posterieure-cisis | JDV Artere Posterieure CISIS |
| ans.fr.terminologies#1.11.1 | jdv-artere-tronc-cisis | JDV Artere Tronc CISIS |
| ans.fr.terminologies#1.11.1 | jdv-aspect-liquide-amniotique-cisis | JDV Aspect Liquide Amniotique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-autre-risque-cisis | JDV Autre Risque CISIS |
| ans.fr.terminologies#1.11.1 | jdv-autre-symptome-avc-cisis | JDV Autre Symptome Avc CISIS |
| ans.fr.terminologies#1.11.1 | jdv-autre-symptome-ex-neuro-cisis | JDV Autre Symptome Ex Neuro CISIS |
| ans.fr.terminologies#1.11.1 | jdv-cas-sporadique-familial-cisis | JDV Cas Sporadique Familial CISIS |
| ans.fr.terminologies#1.11.1 | jdv-cdd-fa-cisis | JDV Cdd Fa CISIS |
| ans.fr.terminologies#1.11.1 | jdv-cervelet-localisation-cisis | JDV Cervelet Localisation CISIS |
| ans.fr.terminologies#1.11.1 | jdv-circonstance-deces-cisis | JDV Circonstance Deces CISIS |
| ans.fr.terminologies#1.11.1 | jdv-code-probleme-cisis | JDV Code Probleme CISIS |
| ans.fr.terminologies#1.11.1 | jdv-collectivite-sujets-a-risque-rougeole-cisis | Jdv Collectivite Sujets A Risque Rougeole CISIS |
| ans.fr.terminologies#1.11.1 | jdv-conduite-a-tenir-1-cisis | JDV Conduite A Tenir 1 CISIS |
| ans.fr.terminologies#1.11.1 | jdv-conduite-a-tenir-2-cisis | JDV Conduite A Tenir 2 CISIS |
| ans.fr.terminologies#1.11.1 | jdv-conduite-a-tenir-3-cisis | JDV Conduite A Tenir 3 CISIS |
| ans.fr.terminologies#1.11.1 | jdv-contexte-activite-cisis | JDV Contexte Activite CISIS |
| ans.fr.terminologies#1.11.1 | jdv-contre-indication-cisis | JDV Contrindication CISIS |
| ans.fr.terminologies#1.11.1 | jdv-date-consultation-cisis | JDV Date Consultation CISIS |
| ans.fr.terminologies#1.11.1 | jdv-deficience-physique-cisis | JDV Deficience Physique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-depistage-neonatal-cisis | Jdv Depistage Neonatal CISIS |
| ans.fr.terminologies#1.11.1 | jdv-deplacement-cisis | JDV Deplacement CISIS |
| ans.fr.terminologies#1.11.1 | jdv-destination-obp-sne-cisis | JDV Destination Obp Sne CISIS |
| ans.fr.terminologies#1.11.1 | jdv-destination-transfert-2-cisis | jdv Destination Transfert 2 CISIS |
| ans.fr.terminologies#1.11.1 | jdv-destination-transfert-cisis | JDV Destination Transfert CISIS |
| ans.fr.terminologies#1.11.1 | jdv-difficulte-cisis | JDV Difficulte CISIS |
| ans.fr.terminologies#1.11.1 | jdv-disposition-pretherapeutique-cisis | JDV Disposition Pretherapeutique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-etat-naissance-cisis | JDV Etat Naissance CISIS |
| ans.fr.terminologies#1.11.1 | jdv-etat-perinee-cisis | JDV Etat Perinee CISIS |
| ans.fr.terminologies#1.11.1 | jdv-etat-psychique-cisis | JDV Etat Psychique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-etiologie-avc-cisis | JDV Etiologie Avc CISIS |
| ans.fr.terminologies#1.11.1 | jdv-evaluation-depression-geriatrique-resultat-cisis | JDV Evaluation Depression Geriatrique Resultat CISIS |
| ans.fr.terminologies#1.11.1 | jdv-evaluation-douleur-cisis | JDV Evaluation Douleur CISIS |
| ans.fr.terminologies#1.11.1 | jdv-evolution-cisis | JDV Evolution CISIS |
| ans.fr.terminologies#1.11.1 | jdv-evolution-rougeole-cisis | JDV Evolution Rougeole CISIS |
| ans.fr.terminologies#1.11.1 | jdv-examen-realise-cisis | JDV Examen Realise CISIS |
| ans.fr.terminologies#1.11.1 | jdv-exposition-west-nile-cisis | Jdv Exposition West Nile CISIS |
| ans.fr.terminologies#1.11.1 | jdv-facteur-de-risque-professionnel-cisis | JDV Facteur De Risque Professionnel CISIS |
| ans.fr.terminologies#1.11.1 | jdv-facteur-de-risque-social-cisis | JDV Facteur De Risque Social CISIS |
| ans.fr.terminologies#1.11.1 | jdv-facteur-risque-rougeole-cisis | JDV Facteur Risque Rougeole CISIS |
| ans.fr.terminologies#1.11.1 | jdv-geste-reanimation-nouveau-ne-cisis | JDV Geste Reanimation Nouveau Ne CISIS |
| ans.fr.terminologies#1.11.1 | jdv-gestion-effet-secondaire-cisis | JDV Gestion Effet Secondaire CISIS |
| ans.fr.terminologies#1.11.1 | jdv-gravite-cisis | JDV Gravite CISIS |
| ans.fr.terminologies#1.11.1 | jdv-groupe-rhesus-cisis | JDV Groupe Rhesus CISIS |
| ans.fr.terminologies#1.11.1 | jdv-handicap-deficit-dlu-dom-cisis | JDV Handicap Deficit Dlu Dom CISIS |
| ans.fr.terminologies#1.11.1 | jdv-handicap-deficit-dlu-ehpad-cisis | JDV Handicap Deficit Dlu Ehpad CISIS |
| ans.fr.terminologies#1.11.1 | jdv-health-status-code-cisis | JDV Health Status Code CISIS |
| ans.fr.terminologies#1.11.1 | jdv-hemisphere-lobaire-cisis | JDV Hemisphere Lobaire CISIS |
| ans.fr.terminologies#1.11.1 | jdv-hemisphere-profond-cisis | JDV Hemisphere Profond CISIS |
| ans.fr.terminologies#1.11.1 | jdv-human-substance-administration-site-cisis | JDV Human Substance Administration Site CISIS |
| ans.fr.terminologies#1.11.1 | jdv-immunization-approach-site-code-cisis | JDV Immunization Approach Site Code CISIS |
| ans.fr.terminologies#1.11.1 | jdv-impact-mutation-cisis | JDV Impact Mutation CISIS |
| ans.fr.terminologies#1.11.1 | jdv-importance-clinique-cisis | JDV Importance Clinique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-imputabilite-cisis | JDV Imputabilite CISIS |
| ans.fr.terminologies#1.11.1 | jdv-interpretation-ecg-cisis | JDV Interpretation Ecg CISIS |
| ans.fr.terminologies#1.11.1 | jdv-investigation-realisee-cisis | JDV Investigation Realisee CISIS |
| ans.fr.terminologies#1.11.1 | jdv-issue-grossesse-cisis | JDV Issue Grossesse CISIS |
| ans.fr.terminologies#1.11.1 | jdv-jour-semaine-cisis | JDV Jour Semaine CISIS |
| ans.fr.terminologies#1.11.1 | jdv-lateralite-cisis | JDV Lateralite CISIS |
| ans.fr.terminologies#1.11.1 | jdv-lateralite-manuelle-cisis | JDV Lateralite Manuelle CISIS |
| ans.fr.terminologies#1.11.1 | jdv-lateralite-technique-imagerie-cisis | JDV Lateralite Technique Imagerie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-lieu-accouchement-cisis | JDV Lieu Accouchement CISIS |
| ans.fr.terminologies#1.11.1 | jdv-lieu-contact-rougeole-cisis | JDV Lieu Contact Rougeole CISIS |
| ans.fr.terminologies#1.11.1 | jdv-lieu-de-vie-cisis | JDV Lieu De Vie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-localisation-anatomique-cisis | JDV Localisation Anatomique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-localisation-anesthesie-cisis | JDV Localisation Anesthesie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-localisation-hemorragie-cerebrale-cisis | JDV Localisation Hemorragie Cerebrale CISIS |
| ans.fr.terminologies#1.11.1 | jdv-localisation-infarctus-cerebral-cisis | JDV Localisation Infarctus Cerebral CISIS |
| ans.fr.terminologies#1.11.1 | jdv-localisation-prelevement-ccu-cisis | JDV Localisation Prelevement Ccu CISIS |
| ans.fr.terminologies#1.11.1 | jdv-localisation-thrombose-veineuse-cisis | JDV Localisation Thrombose Veineuse CISIS |
| ans.fr.terminologies#1.11.1 | jdv-malformation-antenatale-cisis | JDV Malformation Antenatale CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mesure-associee-cisis | JDV Mesure Associee CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mesure-lentille-delivree-cisis | JDV Mesure Lentille Delivree CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mesure-lentille-prescrite-cisis | JDV Mesure Lentille Prescrite CISIS |
| ans.fr.terminologies#1.11.1 | jdv-methode-accouchement-cisis | JDV Methode Accouchement CISIS |
| ans.fr.terminologies#1.11.1 | jdv-methode-de-mesure-acuite-visuelle-cisis | JDV Methode De Mesure Acuite Visuelle CISIS |
| ans.fr.terminologies#1.11.1 | jdv-modalite-demande-acte-imagerie-cisis | JDV Modalite Demande Acte Imagerie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-modalite-entree-cisis | JDV Modalite Entree CISIS |
| ans.fr.terminologies#1.11.1 | jdv-modalite-sortie-cisis | JDV Modalite Sortie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-modalite-sortie-esms-cisis | JDV Modalite Sortie ESMS CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mode-accouchement-cisis | JDV Mode Accouchement CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mode-de-vie-cisis | JDV Mode De Vie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mode-debut-travail-cisis | JDV Mode Debut Travail CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mode-naissance-cisis | JDV Mode Naissance CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mode-sortie-cisis | JDV Mode Sortie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mode-sortie-obp-scm-cisis | JDV Mode Sortie Obp Scm CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mode-sortie-obp-sem-cisis | JDV Mode Sortie Obp Sem CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mode-sortie-obp-sne-cisis | JDV Mode Sortie Obp Sne CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mode-sortie-obp-snm-cisis | JDV Mode Sortie Obp Snm CISIS |
| ans.fr.terminologies#1.11.1 | jdv-modificateur-topographique-cisis | JDV Modificateur Topographique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-motif-echographie-cisis | JDV Motif Echographie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-motif-mise-a-jour-cisis | JDV Motif Mise A Jour CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mso-resultat-qualitatif-2-cisis | Jdv MSO Resultat Qualitatif 2 CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mso-resultat-qualitatif-3-cisis | Jdv MSO Resultat Qualitatif 3 CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mso-resultat-qualitatif-4-cisis | Jdv MSO Resultat Qualitatif 4 CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mso-resultat-qualitatif-5-cisis | Jdv MSO Resultat Qualitatif 5 CISIS |
| ans.fr.terminologies#1.11.1 | jdv-mso-resultat-qualitatif-cisis | Jdv MSO Resultat Qualitatif CISIS |
| ans.fr.terminologies#1.11.1 | jdv-objectif-activite-cisis | JDV Objectif Activite CISIS |
| ans.fr.terminologies#1.11.1 | jdv-obp-test-audition-cisis | JDV Obp Test Audition CISIS |
| ans.fr.terminologies#1.11.1 | jdv-observation-enfant-cisis | JDV Observation Enfant CISIS |
| ans.fr.terminologies#1.11.1 | jdv-observation-etat-patient-cisis | JDV Observation Etat Patient CISIS |
| ans.fr.terminologies#1.11.1 | jdv-oeil-examine-cisis | JDV Oeil Examine CISIS |
| ans.fr.terminologies#1.11.1 | jdv-orientation-base-du-prisme-cisis | JDV Orientation Base Du Prisme CISIS |
| ans.fr.terminologies#1.11.1 | jdv-origine-effet-indesirable-cisis | JDV Origine Effet Indesirable CISIS |
| ans.fr.terminologies#1.11.1 | jdv-origine-information-vaccin-rougeole-cisis | Jdv Origine Information Vaccin Rougeole CISIS |
| ans.fr.terminologies#1.11.1 | jdv-patho-1ere-semaine-cs8-cisis | JDV Patho 1ere Semaine Cs8 CISIS |
| ans.fr.terminologies#1.11.1 | jdv-presentation-foetale-cisis | JDV Presentation Foetale CISIS |
| ans.fr.terminologies#1.11.1 | jdv-prise-en-charge-reguliere-cisis | JDV Prise En Charge Reguliere CISIS |
| ans.fr.terminologies#1.11.1 | jdv-quantite-liquide-amniotique-cisis | JDV Quantite Liquide Amniotique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-rcp-appareil-cisis | JDV RCP Appareil CISIS |
| ans.fr.terminologies#1.11.1 | jdv-rcp-organe-cisis | JDV RCP Organe CISIS |
| ans.fr.terminologies#1.11.1 | jdv-realisation-activite-cisis | JDV Realisation Activite CISIS |
| ans.fr.terminologies#1.11.1 | jdv-recherche-aghbs-cisis | JDV Recherche Aghbs CISIS |
| ans.fr.terminologies#1.11.1 | jdv-reference-range-applies-to-cisis | JDV Reference Range Applies To CISIS |
| ans.fr.terminologies#1.11.1 | jdv-region-anatomique-cisis | JDV Region Anatomique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-reperage-trouble-neurodeveloppement-cisis | JDV Reperage Trouble Neurodeveloppement CISIS |
| ans.fr.terminologies#1.11.1 | jdv-ressource-utilisee-cisis | JDV Ressource Utilisee CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-acide-ascorbique-cisis | JDV Resultat Depistage Acide Ascorbique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-bilirubinemie-cisis | JDV Resultat Depistage Bilirubinemie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-bilirubinurie-cisis | JDV Resultat Depistage Bilirubinurie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-cetonemie-cisis | JDV Resultat Depistage Cetonemie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-cholesterol-cisis | JDV Resultat Depistage Cholesterol CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-cisis | JDV Resultat Depistage CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-corps-cetoniques-cisis | JDV Resultat Depistage Corps Cetoniques CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-crp-cisis | JDV Resultat Depistage Crp CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-glucose-cisis | JDV Resultat Depistage Glucose CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-glycemie-cisis | JDV Resultat Depistage Glycemie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-hematurie-cisis | JDV Resultat Depistage Hematurie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-leucocyturie-cisis | JDV Resultat Depistage Leucocyturie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-nitriturie-cisis | JDV Resultat Depistage Nitriturie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-proteinurie-cisis | JDV Resultat Depistage Proteinurie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-rupture-membrane-ph-cisis | JDV Resultat Depistage Rupture Membrane Ph CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-depistage-urobilinogenurie-cisis | JDV Resultat Depistage Urobilinogenurie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-qualitatif-cisis | Jdv Resultat Qualitatif CISIS |
| ans.fr.terminologies#1.11.1 | jdv-resultat-recherche-hpv-ccu-cisis | JDV Resultat Recherche Hpv Ccu CISIS |
| ans.fr.terminologies#1.11.1 | jdv-score-asa-cisis | JDV Score Asa CISIS |
| ans.fr.terminologies#1.11.1 | jdv-score-cormack-cisis | JDV Score Cormack CISIS |
| ans.fr.terminologies#1.11.1 | jdv-score-mallampati-cisis | JDV Score Mallampati CISIS |
| ans.fr.terminologies#1.11.1 | jdv-sedentarite-cisis | JDV Sedentarite CISIS |
| ans.fr.terminologies#1.11.1 | jdv-serotype-dengue-cisis | JDV Serotype Dengue CISIS |
| ans.fr.terminologies#1.11.1 | jdv-severite-observation-cisis | JDV Severite Observation CISIS |
| ans.fr.terminologies#1.11.1 | jdv-site-intervention-cisis | JDV Site Intervention CISIS |
| ans.fr.terminologies#1.11.1 | jdv-situation-matrimoniale-cisis | Jdv Situation Matrimoniale CISIS |
| ans.fr.terminologies#1.11.1 | jdv-static-sem-procedure-cisis | JDV Static Sem Procedure CISIS |
| ans.fr.terminologies#1.11.1 | jdv-statut-actuel-diagnostic-cisis | JDV Statut Actuel Diagnostic CISIS |
| ans.fr.terminologies#1.11.1 | jdv-statut-document-cisis | JDV Statut Document CISIS |
| ans.fr.terminologies#1.11.1 | jdv-statut-evt-cisis | JDV Statut Evt CISIS |
| ans.fr.terminologies#1.11.1 | jdv-statut-grossesse-cisis | JDV Statut Grossesse CISIS |
| ans.fr.terminologies#1.11.1 | jdv-statut-resultat-cisis | JDV Statut Resultat CISIS |
| ans.fr.terminologies#1.11.1 | jdv-statut-tabagique-cisis | JDV Statut Tabagique CISIS |
| ans.fr.terminologies#1.11.1 | jdv-symptome-avc-cisis | JDV Symptome Avc CISIS |
| ans.fr.terminologies#1.11.1 | jdv-taille-cisis | JDV Taille CISIS |
| ans.fr.terminologies#1.11.1 | jdv-technique-diagnostic-cisis | JDV Technique Diagnostic CISIS |
| ans.fr.terminologies#1.11.1 | jdv-topo-trouble-cisis | JDV Topo Trouble CISIS |
| ans.fr.terminologies#1.11.1 | jdv-traitement-preventif-cisis | JDV Traitement Preventif CISIS |
| ans.fr.terminologies#1.11.1 | jdv-traitement-soins-frcp-cisis | JDV Traitement Soins Frcp CISIS |
| ans.fr.terminologies#1.11.1 | jdv-transfert-mutation-cisis | JDV Transfert Mutation CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-acte-eunv-cisis | JDV Type Acte Eunv CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-acte-post-partum-cisis | JDV Type Acte Post Partum CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-analgesie-cisis | JDV Type Analgesie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-anesthesie-apres-naissance-cisis | JDV Type Anesthesie Apres Naissance CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-anesthesie-avant-naissance-cisis | JDV Type Anesthesie Avant Naissance CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-anesthesie-cisis | JDV Type Anesthesie CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-de-distance-de-visualisation-cisis | JDV Type De Distance De Visualisation CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-de-suivi-cisis | JDV Type De Suivi CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-directive-anticipee-cisis | JDV Type Directive Anticipee CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-dispositif-oculaire-cisis | JDV Type Dispositif Oculaire CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-evenement-indesirable-previsible-cisis | JDV Type Evenement Indesirable Previsible CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-event-indesirable-previsible-cisis | JDV Type Event Indesirable Previsible CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-garde-cisis | JDV Type Garde CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-intervention-cisis | JDV Type Intervention CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-intervention-voie-basse-cisis | JDV Type Intervention Voie Basse CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-intubation-cisis | JDV Type Intubation CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-presentation-cisis | JDV Type Presentation CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-produit-sanguin-labile-cisis | JDV Type Produit Sanguin Labile CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-service-cisis | JDV Type Service CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-traitement-frcp-cisis | JDV Type Traitement Frcp CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-traitement-iv-cisis | JDV Type Traitement Iv CISIS |
| ans.fr.terminologies#1.11.1 | jdv-type-traitement-pps-cisis | JDV Type Traitement Pps CISIS |
| ans.fr.terminologies#1.11.1 | jdv-ufcv-composant-prothese-valvulaire-cisis | JDV UFCV Composant Prothese Valvulaire CISIS |
| ans.fr.terminologies#1.11.1 | jdv-ufcv-lateralite-cisis | JDV UFCV Lateralite CISIS |
| ans.fr.terminologies#1.11.1 | jdv-ufcv-localisation-defibrillateur-cisis | JDV UFCV Localisation Defibrillateur CISIS |
| ans.fr.terminologies#1.11.1 | jdv-ufcv-localisation-sonde-cisis | JDV UFCV Localisation Sonde CISIS |
| ans.fr.terminologies#1.11.1 | jdv-ufcv-stade-nyha-cisis | JDV UFCV Stade Nyha CISIS |
| ans.fr.terminologies#1.11.1 | jdv-ufcv-voie-abord-cisis | JDV UFCV Voie Abord CISIS |
| kr.mohw.myhealthway#1.0.2-beta.4 | myhealthway-allergyintolerance-manifestation-codes | MyHealthWay AllergyIntolerance Manifestation Codes |
| kr.mohw.myhealthway#1.0.2-beta.4 | myhealthway-snomedct-codes | MyHealthWay SNOMED CT Codes |
| phis.ig.dev#0.1.7 | krcore-condition-codes | KR Core Condition Code |
| phis.ig.dev#0.1.7 | krcore-observation-labresult-codes | KR Core Lab Result Observation Codes |
No resources found
Note: links and images are rebased to the (stated) source
SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).
Copyright Statement:
© 2002-2016 International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO http://www.ihtsdo.org/snomed-ct/get-snomed-ct
Properties
| Code | URL | Description | Type |
| inactive | http://snomed.info/field/Concept.active | Whether the code is active or not (defaults to false). Not the same as deprecated | boolean |
| definitionStatusId | http://snomed.info/field/Concept.definitionStatusId | Either of the codes that are descendants of 900000000000444006 | code |
| parent | http://.........? | A SNOMED CT concept id that has the target of a direct is-a relationship from the concept | code |
| child | http://.........? | A SNOMED CT concept id that has a direct is-a relationship to the concept | code |
| moduleId | http://snomed.info/field/Concept.moduleId | The SNOMED CT concept id of the module that the concept belongs to. | code |
| normalForm | http://.........? | Generated Normal form expression for the provided code or expression, with terms | string |
| normalFormTerse | http://.........? | Generated Normal form expression for the provided code or expression, conceptIds only | string |
| Due to | http://snomed.info/id/42752001 | code | |
| Associated with | http://snomed.info/id/47429007 | code | |
| Associated morphology | http://snomed.info/id/116676008 | code | |
| Has specimen | http://snomed.info/id/116686009 | code | |
| Specimen source morphology | http://snomed.info/id/118168003 | code | |
| Specimen source topography | http://snomed.info/id/118169006 | code | |
| Specimen source identity | http://snomed.info/id/118170007 | code | |
| Specimen procedure | http://snomed.info/id/118171006 | code | |
| Part of | http://snomed.info/id/123005000 | code | |
| Has active ingredient | http://snomed.info/id/127489000 | code | |
| Subject of information | http://snomed.info/id/131195008 | code | |
| Causative agent | http://snomed.info/id/246075003 | code | |
| Associated finding | http://snomed.info/id/246090004 | code | |
| Component | http://snomed.info/id/246093002 | code | |
| Severity | http://snomed.info/id/246112005 | code | |
| Occurrence | http://snomed.info/id/246454002 | code | |
| Episodicity | http://snomed.info/id/246456000 | code | |
| Technique | http://snomed.info/id/246501002 | code | |
| Revision status | http://snomed.info/id/246513007 | code | |
| Units | http://snomed.info/id/246514001 | code | |
| After | http://snomed.info/id/255234002 | code | |
| Access | http://snomed.info/id/260507000 | code | |
| Method | http://snomed.info/id/260686004 | code | |
| Priority | http://snomed.info/id/260870009 | code | |
| Clinical course | http://snomed.info/id/263502005 | code | |
| Laterality | http://snomed.info/id/272741003 | code | |
| Associated procedure | http://snomed.info/id/363589002 | code | |
| Finding site | http://snomed.info/id/363698007 | code | |
| Laterality | http://snomed.info/id/363699004 | code | |
| Direct morphology | http://snomed.info/id/363700003 | code | |
| Direct substance | http://snomed.info/id/363701004 | code | |
| Has focus | http://snomed.info/id/363702006 | code | |
| Has intent | http://snomed.info/id/363703001 | code | |
| Procedure site | http://snomed.info/id/363704007 | code | |
| Has definitional manifestation | http://snomed.info/id/363705008 | code | |
| Indirect morphology | http://snomed.info/id/363709002 | code | |
| Indirect device | http://snomed.info/id/363710007 | code | |
| Has interpretation | http://snomed.info/id/363713009 | code | |
| Interprets | http://snomed.info/id/363714003 | code | |
| Measurement method | http://snomed.info/id/370129005 | code | |
| Property | http://snomed.info/id/370130000 | code | |
| Recipient category | http://snomed.info/id/370131001 | code | |
| Scale type | http://snomed.info/id/370132008 | code | |
| Specimen substance | http://snomed.info/id/370133003 | code | |
| Time aspect | http://snomed.info/id/370134009 | code | |
| Pathological process | http://snomed.info/id/370135005 | code | |
| Procedure site - Direct | http://snomed.info/id/405813007 | code | |
| Procedure site - Indirect | http://snomed.info/id/405814001 | code | |
| Procedure device | http://snomed.info/id/405815000 | code | |
| Procedure morphology | http://snomed.info/id/405816004 | code | |
| Finding context | http://snomed.info/id/408729009 | code | |
| Procedure context | http://snomed.info/id/408730004 | code | |
| Temporal context | http://snomed.info/id/408731000 | code | |
| Subject relationship context | http://snomed.info/id/408732007 | code | |
| Route of administration | http://snomed.info/id/410675002 | code | |
| Has dose form | http://snomed.info/id/411116001 | code | |
| Finding method | http://snomed.info/id/418775008 | code | |
| Finding informer | http://snomed.info/id/419066007 | code | |
| Using device | http://snomed.info/id/424226004 | code | |
| Using energy | http://snomed.info/id/424244007 | code | |
| Using substance | http://snomed.info/id/424361007 | code | |
| Surgical approach | http://snomed.info/id/424876005 | code | |
| Using access device | http://snomed.info/id/425391005 | code | |
| Role group | http://snomed.info/id/609096000 | code | |
| Property type | http://snomed.info/id/704318007 | code | |
| Inheres in | http://snomed.info/id/704319004 | code | |
| Towards | http://snomed.info/id/704320005 | code | |
| Characterizes | http://snomed.info/id/704321009 | code | |
| Process agent | http://snomed.info/id/704322002 | code | |
| Process duration | http://snomed.info/id/704323007 | code | |
| Process output | http://snomed.info/id/704324001 | code | |
| Relative to | http://snomed.info/id/704325000 | code | |
| Precondition | http://snomed.info/id/704326004 | code | |
| Direct site | http://snomed.info/id/704327008 | code | |
| Specified by | http://snomed.info/id/704346009 | code | |
| Observes | http://snomed.info/id/704347000 | code | |
| Is about | http://snomed.info/id/704647008 | code |
Filters
| Code | Description | operator | Value |
| concept | Filter that includes concepts based on their logical definition. e.g. [concept] [is-a] [x] - include all concepts with an is-a relationship to concept x, or [concept] [in] [x]- include all concepts in the reference set identified by concept x | is-a in | A SNOMED CT code |
| expression | The result of the filter is the result of executing the given SNOMED CT Expression Constraint | = | A SNOMED CT ECL expression (see http://snomed.org/ecl) |
| expressions | Whether post-coordinated expressions are included in the value set | = | true or false |
This code system http://snomed.info/sct defines many codes, but they are not represented here
FHIR
FHIRsmith{
"resourceType": "CodeSystem",
"id": "snomedct",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "http://snomed.info/sct",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.6.96"
}
],
"version": "1.0.0",
"name": "SNOMED_CT",
"title": "SNOMED CT (all versions)",
"status": "active",
"experimental": false,
"date": "2026-05-21T02:34:35+00:00",
"publisher": "Cục Công nghệ thông tin - Bộ Y tế",
"contact": [
{
"telecom": [
{
"system": "url",
"value": "https://moh.gov.vn/"
},
{
"system": "url",
"value": "https://ehealth.gov.vn/"
}
]
}
],
"description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "704"
},
{
"system": "urn:iso:std:iso:3166",
"code": "VN"
}
]
}
],
"copyright": "© 2002-2016 International Health Terminology Standards Development Organisation (IHTSDO). All rights reserved. SNOMED CT®, was originally created by The College of American Pathologists. \"SNOMED\" and \"SNOMED CT\" are registered trademarks of the IHTSDO http://www.ihtsdo.org/snomed-ct/get-snomed-ct",
"caseSensitive": false,
"hierarchyMeaning": "is-a",
"compositional": true,
"versionNeeded": false,
"content": "not-present",
"filter": [
{
"code": "concept",
"description": "Filter that includes concepts based on their logical definition. e.g. [concept] [is-a] [x] - include all concepts with an is-a relationship to concept x, or [concept] [in] [x]- include all concepts in the reference set identified by concept x",
"operator": [
"is-a",
"in"
],
"value": "A SNOMED CT code"
},
{
"code": "expression",
"description": "The result of the filter is the result of executing the given SNOMED CT Expression Constraint",
"operator": [
"="
],
"value": "A SNOMED CT ECL expression (see http://snomed.org/ecl)"
},
{
"code": "expressions",
"description": "Whether post-coordinated expressions are included in the value set",
"operator": [
"="
],
"value": "true or false"
}
],
"property": [
{
"code": "inactive",
"uri": "http://snomed.info/field/Concept.active",
"description": "Whether the code is active or not (defaults to false). Not the same as deprecated",
"type": "boolean"
},
{
"code": "definitionStatusId",
"uri": "http://snomed.info/field/Concept.definitionStatusId",
"description": "Either of the codes that are descendants of 900000000000444006",
"type": "code"
},
{
"code": "parent",
"uri": "http://.........?",
"description": "A SNOMED CT concept id that has the target of a direct is-a relationship from the concept",
"type": "code"
},
{
"code": "child",
"uri": "http://.........?",
"description": "A SNOMED CT concept id that has a direct is-a relationship to the concept",
"type": "code"
},
{
"code": "moduleId",
"uri": "http://snomed.info/field/Concept.moduleId",
"description": "The SNOMED CT concept id of the module that the concept belongs to.",
"type": "code"
},
{
"code": "normalForm",
"uri": "http://.........?",
"description": "Generated Normal form expression for the provided code or expression, with terms",
"type": "string"
},
{
"code": "normalFormTerse",
"uri": "http://.........?",
"description": "Generated Normal form expression for the provided code or expression, conceptIds only",
"type": "string"
},
{
"code": "Due to",
"uri": "http://snomed.info/id/42752001",
"type": "code"
},
{
"code": "Associated with",
"uri": "http://snomed.info/id/47429007",
"type": "code"
},
{
"code": "Associated morphology",
"uri": "http://snomed.info/id/116676008",
"type": "code"
},
{
"code": "Has specimen",
"uri": "http://snomed.info/id/116686009",
"type": "code"
},
{
"code": "Specimen source morphology",
"uri": "http://snomed.info/id/118168003",
"type": "code"
},
{
"code": "Specimen source topography",
"uri": "http://snomed.info/id/118169006",
"type": "code"
},
{
"code": "Specimen source identity",
"uri": "http://snomed.info/id/118170007",
"type": "code"
},
{
"code": "Specimen procedure",
"uri": "http://snomed.info/id/118171006",
"type": "code"
},
{
"code": "Part of",
"uri": "http://snomed.info/id/123005000",
"type": "code"
},
{
"code": "Has active ingredient",
"uri": "http://snomed.info/id/127489000",
"type": "code"
},
{
"code": "Subject of information",
"uri": "http://snomed.info/id/131195008",
"type": "code"
},
{
"code": "Causative agent",
"uri": "http://snomed.info/id/246075003",
"type": "code"
},
{
"code": "Associated finding",
"uri": "http://snomed.info/id/246090004",
"type": "code"
},
{
"code": "Component",
"uri": "http://snomed.info/id/246093002",
"type": "code"
},
{
"code": "Severity",
"uri": "http://snomed.info/id/246112005",
"type": "code"
},
{
"code": "Occurrence",
"uri": "http://snomed.info/id/246454002",
"type": "code"
},
{
"code": "Episodicity",
"uri": "http://snomed.info/id/246456000",
"type": "code"
},
{
"code": "Technique",
"uri": "http://snomed.info/id/246501002",
"type": "code"
},
{
"code": "Revision status",
"uri": "http://snomed.info/id/246513007",
"type": "code"
},
{
"code": "Units",
"uri": "http://snomed.info/id/246514001",
"type": "code"
},
{
"code": "After",
"uri": "http://snomed.info/id/255234002",
"type": "code"
},
{
"code": "Access",
"uri": "http://snomed.info/id/260507000",
"type": "code"
},
{
"code": "Method",
"uri": "http://snomed.info/id/260686004",
"type": "code"
},
{
"code": "Priority",
"uri": "http://snomed.info/id/260870009",
"type": "code"
},
{
"code": "Clinical course",
"uri": "http://snomed.info/id/263502005",
"type": "code"
},
{
"code": "Laterality",
"uri": "http://snomed.info/id/272741003",
"type": "code"
},
{
"code": "Associated procedure",
"uri": "http://snomed.info/id/363589002",
"type": "code"
},
{
"code": "Finding site",
"uri": "http://snomed.info/id/363698007",
"type": "code"
},
{
"code": "Laterality",
"uri": "http://snomed.info/id/363699004",
"type": "code"
},
{
"code": "Direct morphology",
"uri": "http://snomed.info/id/363700003",
"type": "code"
},
{
"code": "Direct substance",
"uri": "http://snomed.info/id/363701004",
"type": "code"
},
{
"code": "Has focus",
"uri": "http://snomed.info/id/363702006",
"type": "code"
},
{
"code": "Has intent",
"uri": "http://snomed.info/id/363703001",
"type": "code"
},
{
"code": "Procedure site",
"uri": "http://snomed.info/id/363704007",
"type": "code"
},
{
"code": "Has definitional manifestation",
"uri": "http://snomed.info/id/363705008",
"type": "code"
},
{
"code": "Indirect morphology",
"uri": "http://snomed.info/id/363709002",
"type": "code"
},
{
"code": "Indirect device",
"uri": "http://snomed.info/id/363710007",
"type": "code"
},
{
"code": "Has interpretation",
"uri": "http://snomed.info/id/363713009",
"type": "code"
},
{
"code": "Interprets",
"uri": "http://snomed.info/id/363714003",
"type": "code"
},
{
"code": "Measurement method",
"uri": "http://snomed.info/id/370129005",
"type": "code"
},
{
"code": "Property",
"uri": "http://snomed.info/id/370130000",
"type": "code"
},
{
"code": "Recipient category",
"uri": "http://snomed.info/id/370131001",
"type": "code"
},
{
"code": "Scale type",
"uri": "http://snomed.info/id/370132008",
"type": "code"
},
{
"code": "Specimen substance",
"uri": "http://snomed.info/id/370133003",
"type": "code"
},
{
"code": "Time aspect",
"uri": "http://snomed.info/id/370134009",
"type": "code"
},
{
"code": "Pathological process",
"uri": "http://snomed.info/id/370135005",
"type": "code"
},
{
"code": "Procedure site - Direct",
"uri": "http://snomed.info/id/405813007",
"type": "code"
},
{
"code": "Procedure site - Indirect",
"uri": "http://snomed.info/id/405814001",
"type": "code"
},
{
"code": "Procedure device",
"uri": "http://snomed.info/id/405815000",
"type": "code"
},
{
"code": "Procedure morphology",
"uri": "http://snomed.info/id/405816004",
"type": "code"
},
{
"code": "Finding context",
"uri": "http://snomed.info/id/408729009",
"type": "code"
},
{
"code": "Procedure context",
"uri": "http://snomed.info/id/408730004",
"type": "code"
},
{
"code": "Temporal context",
"uri": "http://snomed.info/id/408731000",
"type": "code"
},
{
"code": "Subject relationship context",
"uri": "http://snomed.info/id/408732007",
"type": "code"
},
{
"code": "Route of administration",
"uri": "http://snomed.info/id/410675002",
"type": "code"
},
{
"code": "Has dose form",
"uri": "http://snomed.info/id/411116001",
"type": "code"
},
{
"code": "Finding method",
"uri": "http://snomed.info/id/418775008",
"type": "code"
},
{
"code": "Finding informer",
"uri": "http://snomed.info/id/419066007",
"type": "code"
},
{
"code": "Using device",
"uri": "http://snomed.info/id/424226004",
"type": "code"
},
{
"code": "Using energy",
"uri": "http://snomed.info/id/424244007",
"type": "code"
},
{
"code": "Using substance",
"uri": "http://snomed.info/id/424361007",
"type": "code"
},
{
"code": "Surgical approach",
"uri": "http://snomed.info/id/424876005",
"type": "code"
},
{
"code": "Using access device",
"uri": "http://snomed.info/id/425391005",
"type": "code"
},
{
"code": "Role group",
"uri": "http://snomed.info/id/609096000",
"type": "code"
},
{
"code": "Property type",
"uri": "http://snomed.info/id/704318007",
"type": "code"
},
{
"code": "Inheres in",
"uri": "http://snomed.info/id/704319004",
"type": "code"
},
{
"code": "Towards",
"uri": "http://snomed.info/id/704320005",
"type": "code"
},
{
"code": "Characterizes",
"uri": "http://snomed.info/id/704321009",
"type": "code"
},
{
"code": "Process agent",
"uri": "http://snomed.info/id/704322002",
"type": "code"
},
{
"code": "Process duration",
"uri": "http://snomed.info/id/704323007",
"type": "code"
},
{
"code": "Process output",
"uri": "http://snomed.info/id/704324001",
"type": "code"
},
{
"code": "Relative to",
"uri": "http://snomed.info/id/704325000",
"type": "code"
},
{
"code": "Precondition",
"uri": "http://snomed.info/id/704326004",
"type": "code"
},
{
"code": "Direct site",
"uri": "http://snomed.info/id/704327008",
"type": "code"
},
{
"code": "Specified by",
"uri": "http://snomed.info/id/704346009",
"type": "code"
},
{
"code": "Observes",
"uri": "http://snomed.info/id/704347000",
"type": "code"
},
{
"code": "Is about",
"uri": "http://snomed.info/id/704647008",
"type": "code"
}
]
}